Pseudohypoaldosteronism O +
in O +
eight O +
families O +
: O +
different O +
forms O +
of O +
inheritance O +
are O +
evidence O +
for O +
various O +
genetic O +
defects O +
. O +

Pseudohypoaldosteronism O +
is O +
a O +
rare O +
hereditary O +
disorder O +
presenting O +
in O +
early O +
infancy O +
with O +
renal O +
salt O +
loss O +
leading O +
to O +
hyponatremia O +
and O +
hyperkalemia O +
despite O +
high O +
levels O +
of O +
plasma O +
aldosterone O +
. O +

The O +
patients O +
are O +
insensitive O +
to O +
mineralocorticoids O +
; O +
however O +
, O +
sodium O +
supplementation O +
is O +
able O +
to O +
correct O +
electrolyte O +
abnormalities O +
. O +

Absent O +
or O +
greatly O +
diminished O +
type O +
I B-Gene +
aldosterone I-Gene +
receptors I-Gene +
in O +
peripheral O +
mononuclear O +
leucocytes O +
have O +
been O +
recently O +
demonstrated O +
and O +
explain O +
the O +
lack O +
of O +
response O +
to O +
mineralocorticoids O +
. O +

We O +
have O +
studied O +
the O +
mode O +
of O +
inheritance O +
in O +
eight O +
families O +
with O +
a O +
total O +
of O +
nine O +
patients O +
. O +

There O +
was O +
evidence O +
for O +
an O +
autosomal O +
recessive O +
form O +
of O +
inheritance O +
in O +
four O +
families O +
, O +
while O +
the O +
other O +
four O +
families O +
appeared O +
to O +
have O +
an O +
autosomal O +
dominant O +
mode O +
of O +
transmission O +
. O +

In O +
three O +
families O +
the O +
autosomal O +
recessive O +
form O +
was O +
characterized O +
by O +
normal B-Gene +
receptor I-Gene +
as O +
well O +
as O +
hormone O +
data O +
in O +
both O +
parents O +
, O +
while O +
in O +
one O +
family O +
receptor O +
levels O +
in O +
both O +
parents O +
were O +
greatly O +
reduced O +
, O +
but O +
hormone O +
levels O +
were O +
normal O +
. O +

In O +
the O +
four O +
families O +
with O +
an O +
autosomal O +
dominant O +
mode O +
of O +
transmission O +
there O +
was O +
always O +
one O +
parent O +
with O +
reduced O +
receptor O +
binding O +
in O +
peripheral O +
mononuclear O +
leucocytes O +
and O +
elevated O +
serum O +
hormone O +
levels O +
. O +

These O +
parents O +
were O +
entirely O +
asymptomatic O +
. O +

In O +
an O +
extended O +
family O +
we O +
were O +
able O +
to O +
study O +
an O +
aunt O +
and O +
her O +
newborn O +
daughter O +
, O +
who O +
were O +
both O +
also O +
biochemically O +
affected O +
but O +
clinically O +
asymptomatic O +
. O +

It O +
, O +
therefore O +
, O +
appears O +
that O +
this O +
dual O +
pattern O +
of O +
genetic O +
transmission O +
may O +
indicate O +
differing O +
genetic O +
defects O +
which O +
cause O +
the O +
same O +
clinical O +
picture O +
of O +
pseudohypoaldosteronism O +
. O +

Risk O +
factors O +
for O +
breast O +
recurrence O +
in O +
premenopausal O +
and O +
postmenopausal O +
patients O +
with O +
ductal O +
cancers O +
treated O +
by O +
conservation O +
therapy O +
. O +

Risk O +
factors O +
for O +
local O +
failure O +
were O +
evaluated O +
for O +
496 O +
clinical O +
Stage O +
I O -
- O -
II O +
patients O +
with O +
infiltrating O +
ductal O +
carcinomas O +
( O +
median O +
follow O -
- O -
up O +
, O +
71 O +
months O +
) O +
treated O +
by O +
conservative O +
surgery O +
and O +
radiotherapy O +
. O +

Monofactorial O +
analysis O +
identified O +
the O +
following O +
factors O +
to O +
be O +
correlated O +
with O +
increased O +
risk O +
: O +
moderate O -
/ O -
marked O +
mononuclear O +
cell O +
reaction O +
( O +
MCR O +
) O +
, O +
high O +
histologic O +
grade O +
( O +
G O +
) O +
, O +
extensive O +
intraductal O +
component O +
( O +
EIC O +
) O +
, O +
tumor O +
necrosis O +
, O +
macroscopic O +
multiplicity O +
, O +
estrogen B-Gene +
receptor I-Gene +
negativity O +
, O +
anatomic O +
tumor O +
size O +
, O +
age O +
younger O +
than O +
40 O +
years O +
, O +
and O +
vascular O +
invasion O +
. O +

Only O +
MCR O +
, O +
G O +
, O +
and O +
EIC O +
proved O +
significant O +
in O +
Cox O +
multivariate O +
analysis O +
. O +

These O +
risk O +
factors O +
were O +
highly O +
age O +
dependent O +
, O +
with O +
EIC O +
markedly O +
more O +
prevalent O +
in O +
women O +
younger O +
than O +
50 O +
, O +
MCR O +
and O +
G O +
in O +
women O +
younger O +
than O +
40 O +
. O +

Separate O +
Cox O +
analysis O +
for O +
premenopausal O +
patients O +
showed O +
that O +
MCR O -
/ O -
EIC O +
determined O +
risk O +
independent O +
of O +
resection O +
margins O +
: O +
tumors O +
with O +
MCR O +
had O +
a O +
28 O +
% O +
, O +
and O +
with O +
EIC O +
a O +
22 O +
% O +
probability O +
of O +
recurring O +
locally O +
by O +
5 O +
years O +
. O +

Premenopausal O +
patients O +
with O +
neither O +
risk O +
factor O +
had O +
a O +
very O +
low O +
failure O +
rate O +
( O +
2.6 O +
% O +
at O +
5 O +
years O +
) O +
, O +
regardless O +
of O +
age O +
. O +

For O +
postmenopausal O +
patients O +
risk O +
of O +
breast O +
recurrence O +
was O +
determined O +
both O +
by O +
adequacy O +
of O +
resection O +
margins O +
and O +
grade O +
, O +
with O +
a O +
high O +
local O +
failure O +
rate O +
for O +
patients O +
having O +
G3 O +
tumors O +
with O +
positive O +
or O +
indeterminate O +
margins O +
( O +
31 O +
% O +
at O +
5 O +
years O +
) O +
. O +

The O +
authors O +
conclude O +
that O +
the O +
microscopic O +
examination O +
is O +
the O +
only O +
useful O +
tool O +
for O +
assessing O +
the O +
risk O +
of O +
local O +
failure O +
, O +
which O +
is O +
quite O +
low O +
for O +
the O +
majority O +
of O +
patients O +
treated O +
with O +
breast O +
conservation O +
. O +

High O -
- O -
risk O +
patients O +
can O +
be O +
recognized O +
morphologically O +
. O +

The O +
age O +
dependence O +
of O +
morphologic O +
risk O +
factors O +
appears O +
to O +
explain O +
the O +
high O +
local O +
failure O +
rate O +
seen O +
in O +
patients O +
younger O +
than O +
40 O +
. O +

Human O +
immunodeficiency O +
virus O +
vpr O +
product O +
is O +
a O +
virion B-Gene -
- I-Gene -
associated I-Gene +
regulatory I-Gene +
protein I-Gene +
. O +

The O +
vpr B-Gene +
product I-Gene +
of O +
the O +
human O +
immunodeficiency O +
virus O +
type O +
1 O +
( O +
HIV-1 O +
) O +
acts O +
in O +
trans O +
to O +
accelerate O +
virus O +
replication O +
and O +
cytopathic O +
effect O +
in O +
T O +
cells O +
. O +

Here O +
it O +
is O +
shown O +
that O +
the O +
HIV-1 O +
viral O +
particle O +
contains O +
multiple O +
copies O +
of O +
the O +
vpr B-Gene +
protein I-Gene +
. O +

The O +
vpr B-Gene +
product I-Gene +
is O +
the O +
first O +
regulatory O +
protein O +
of O +
HIV-1 O +
to O +
be O +
found O +
in O +
the O +
virus O +
particle O +
. O +

This O +
observation O +
raises O +
the O +
possibility O +
that O +
vpr O +
acts O +
to O +
facilitate O +
the O +
early O +
steps O +
of O +
infection O +
before O +
de O +
novo O +
viral O +
protein O +
synthesis O +
occurs O +
. O +

Steroid O +
dose O +
sparing O +
: O +
pharmacodynamic O +
responses O +
to O +
single O +
versus O +
divided O +
doses O +
of O +
methylprednisolone O +
in O +
man O +
. O +

Inhibitory O +
drug O +
interactions O +
affecting O +
the O +
metabolism O +
of O +
methylprednisolone O +
( O +
MP O +
) O +
may O +
produce O +
either O +
steroid O +
sparing O +
or O +
adverse O +
effects O +
partly O +
by O +
increasing O +
the O +
exposure O +
time O +
to O +
the O +
steroid O +
. O +

This O +
phenomenon O +
can O +
be O +
mimicked O +
by O +
administering O +
MP O +
in O +
divided O +
doses O +
. O +

Two O +
types O +
of O +
responses O +
were O +
compared O +
after O +
a O +
single O +
MP O +
dose O +
( O +
40 O +
mg O +
bolus O +
) O +
and O +
a O +
divided O +
regimen O +
( O +
20 O +
mg O +
bolus O +
and O +
a O +
5 O +
mg O +
bolus O +
8 O +
hours O +
later O +
) O +
in O +
six O +
healthy O +
male O +
volunteers O +
. O +

The O +
suppression O +
of O +
basophils O +
measured O +
as O +
whole O +
blood O +
histamine O +
and O +
plasma O +
cortisol O +
concentrations O +
was O +
assessed O +
during O +
32 O +
hours O +
. O +

The O +
37.5 O +
% O +
reduction O +
in O +
dose O +
produced O +
a O +
23 O +
% O +
overall O +
decreased O +
blood O +
histamine O +
response O +
. O +

A O +
pharmacodynamic O +
model O +
for O +
basophil O +
cell O +
distribution O +
to O +
and O +
from O +
an O +
extravascular O +
compartment O +
describes O +
the O +
effects O +
of O +
MP O +
after O +
both O +
regimens O +
. O +

A O +
slower O +
initial O +
decline O +
in O +
blood O +
histamine O +
after O +
the O +
divided O +
regimen O +
may O +
be O +
related O +
to O +
incomplete O +
suppression O +
of O +
basophil O +
cell O +
return O +
to O +
blood O +
. O +

The O +
50 O +
% O +
inhibitory O +
concentrations O +
of O +
MP O +
of O +
about O +
5 O +
ng O -
/ O -
ml O +
were O +
similar O +
for O +
both O +
regimens O +
. O +

The O +
decline O +
and O +
return O +
of O +
cortisol O +
concentrations O +
were O +
similar O +
between O +
MP O +
treatments O +
with O +
suppression O +
continuing O +
for O +
24 O +
hours O +
. O +

The O +
50 O +
% O +
inhibitory O +
concentrations O +
of O +
MP O +
values O +
for O +
adrenal O +
suppression O +
were O +
about O +
1 O +
ng O -
/ O -
ml O +
. O +

Pharmacodynamic O +
modeling O +
is O +
useful O +
in O +
quantitating O +
corticosteroid O +
responses O +
and O +
generally O +
predicted O +
the O +
` O -
` O +
dose O -
- O -
sparing O +
'' O +
effects O +
that O +
were O +
achieved O +
by O +
prolonging O +
MP O +
plasma O +
concentrations O +
. O +

This O +
study O +
supports O +
previous O +
clinical O +
observations O +
that O +
patients O +
may O +
require O +
morning O +
through O +
evening O +
exposure O +
to O +
MP O +
to O +
optimize O +
efficacy O +
while O +
adrenal O +
suppression O +
is O +
being O +
minimized O +
. O +

The O +
internal O +
methionine O +
codons O +
of O +
human O +
T O -
- O -
cell O +
leukemia O +
virus O +
type O +
II O +
rex O +
gene O +
are O +
not O +
required O +
for O +
p24rex B-Gene +
production O +
or O +
virus O +
replication O +
and O +
transformation O +
. O +

Human O +
T O -
- O -
cell O +
leukemia O +
virus O +
types O +
I O +
( O +
HTLV O -
- O -
I O +
) O +
and O +
II O +
( O +
HTLV O -
- O -
II O +
) O +
have O +
two O +
nonstructural O +
trans O -
- O -
acting O +
regulatory O +
genes O +
, O +
tax O +
and O +
rex O +
, O +
located O +
in O +
the O +
3 O +
' O +
region O +
of O +
the O +
viral O +
genome O +
. O +

The O +
tax B-Gene +
gene I-Gene +
product I-Gene +
( O +
HTLV B-Gene -
- I-Gene -
I I-Gene +
p40tax I-Gene +
and O +
HTLV B-Gene -
- I-Gene -
II I-Gene +
p37tax I-Gene +
) O +
is O +
the O +
transcriptional O +
activator O +
of O +
the O +
viral O +
long O +
terminal O +
repeat O +
. O +

The O +
rex O +
gene O +
encodes O +
two O +
protein O +
products O +
, O +
p27rex B-Gene -
/ I-Gene -
p21rex I-Gene +
and O +
p26rex B-Gene -
/ I-Gene -
p24rex I-Gene +
in O +
HTLV O -
- O -
I O +
and O +
HTLV O -
- O -
II O +
, O +
respectively O +
. O +

Rex B-Gene +
acts O +
posttranscriptionally O +
to O +
facilitate O +
accumulation O +
of O +
full O -
- O -
length O +
gag B-Gene -
/ I-Gene -
pol I-Gene +
and O +
singly O +
spliced O +
env O +
mRNA O +
in O +
the O +
cytoplasm O +
of O +
HTLV O -
- O -
infected O +
cells O +
. O +

Previous O +
studies O +
showed O +
that O +
the O +
first O +
ATG O +
of O +
the O +
rex O +
gene O +
is O +
critical O +
for O +
Rex B-Gene +
production O +
and O +
function O +
. O +

The O +
importance O +
of O +
the O +
internal O +
ATGs O +
to O +
Rex B-Gene +
function O +
is O +
not O +
known O +
. O +

However O +
, O +
in O +
vitro O +
mutagenesis O +
of O +
the O +
HTLV O -
- O -
I O +
rex O +
gene O +
has O +
provided O +
indirect O +
evidence O +
which O +
suggests O +
that O +
p21rex B-Gene +
, O +
and O +
by O +
analogy O +
HTLV O -
- O -
II O +
p24rex B-Gene +
, O +
results O +
from O +
initiation O +
at O +
an O +
internal O +
AUG O +
of O +
the O +
tax O -
/ O -
rex O +
mRNA O +
. O +

By O +
using O +
an O +
infectious O +
molecular O +
clone O +
of O +
HTLV O -
- O -
II O +
, O +
we O +
investigated O +
the O +
importance O +
of O +
the O +
internal O +
ATGs O +
of O +
the O +
rex O +
gene O +
on O +
Rex B-Gene +
protein O +
production O +
and O +
function O +
. O +

Our O +
results O +
indicate O +
that O +
p24rex B-Gene +
of O +
HTLV O -
- O -
II O +
is O +
not O +
initiated O +
at O +
an O +
internal O +
AUG O +
and O +
that O +
the O +
internal O +
methionine O +
codons O +
are O +
not O +
crucial O +
to O +
the O +
function O +
of O +
the O +
rex O +
gene O +
and O +
, O +
ultimately O +
, O +
the O +
transforming O +
properties O +
of O +
the O +
virus O +
. O +

[ O +
Glucocorticoid B-Gene +
receptors I-Gene +
on O +
human O +
peripheral O +
mononuclear O +
and O +
polymorphonuclear O +
leucocytes O +
: O +
changes O +
in O +
patients O +
with O +
yang O -
- O -
deficiency O +
] O +

It O +
was O +
found O +
that O +
, O +
in O +
former O +
works O +
, O +
the O +
glucocorticoid B-Gene +
receptors I-Gene +
( O +
GCR B-Gene +
) O +
on O +
peripheral O +
mixed O +
leucocytes O +
in O +
patients O +
with O +
Yang O -
- O -
deficiency O +
were O +
decreased O +
. O +

In O +
this O +
work O +
, O +
the O +
mixed O +
leucocytes O +
were O +
further O +
separated O +
into O +
mononuclear O +
( O +
MNL O +
) O +
and O +
polymorphonuclear O +
( O +
PML O +
) O +
leucocytes O +
, O +
and O +
GCR B-Gene +
were O +
determined O +
in O +
each O +
part O +
of O +
leucocytes O +
. O +

GCR B-Gene +
on O +
MNL O +
and O +
PML O +
in O +
6 O +
Yang O +
deficient O +
patients O +
were O +
3473 O +
+ O -
/- O +
413 O +
and O +
4433 O +
+ O -
/- O +
651 O +
sites O -
/ O -
cell O +
respectively O +
, O +
statistically O +
significant O +
from O +
the O +
normal O +
control O +
group O +
( O +
4462 O +
+ O -
/- O +
962 O +
and O +
5622 O +
+ O -
/- O +
782 O +
sites O -
/ O -
cell O +
respectively O +
, O +
P O +
less O +
than O +
0.05 O +
) O +
. O +

GCR B-Gene +
on O +
MNL O +
, O +
PML O +
and O +
mixed O +
leucocytes O +
in O +
5 O +
patients O +
were O +
determined O +
simultaneously O +
, O +
and O +
all O +
lowered O +
from O +
the O +
control O +
group O +
. O +

The O +
results O +
were O +
3369 O +
+ O -
/- O +
370 O +
, O +
4986 O +
+ O -
/- O +
419 O +
and O +
4524 O +
+ O -
/- O +
852 O +
sites O -
/ O -
cell O +
respectively O +
, O +
with O +
the O +
lowest O +
GCR B-Gene +
on O +
MNL O +
and O +
highest O +
on O +
PML O +
. O +

Type B-Gene -
- I-Gene -
II I-Gene +
estrogen I-Gene +
binding I-Gene +
sites I-Gene +
in O +
a O +
lymphoblastoid O +
cell O +
line O +
and O +
growth O -
- O -
inhibitory O +
effect O +
of O +
estrogen O +
, O +
anti O -
- O -
estrogen O +
and O +
bioflavonoids O +
. O +

Type B-Gene -
- I-Gene -
II I-Gene +
estrogen I-Gene -
- I-Gene -
binding I-Gene +
sites I-Gene +
( O +
type B-Gene -
- I-Gene -
II I-Gene +
EBS I-Gene +
) O +
have O +
been O +
demonstrated O +
in O +
the O +
human O +
lymphoblastoid O +
cell O +
line O +
IM-9 O +
using O +
a O +
whole O -
- O -
cell O +
assay O +
with O +
( O +
6 O +
, O +
7 O -
- O -
3H O +
) O +
estradiol O +
( O +
3H O -
- O -
E2 O +
) O +
as O +
tracer O +
. O +

Competition O +
analysis O +
showed O +
that O +
the O +
anti O -
- O -
estrogen O +
tamoxifen O +
and O +
the O +
flavonoids O +
quercetin O +
and O +
rutin O +
competed O +
for O +
( O +
3H O +
) O +
-E2 O +
binding O +
to O +
type B-Gene -
- I-Gene -
II I-Gene +
EBS I-Gene +
. O +

Growth O +
experiments O +
demonstrated O +
that O +
diethylstilbestrol O +
( O +
DES O +
) O +
tamoxifen O +
( O +
TAM O +
) O +
, O +
quercetin O +
and O +
rutin O +
exerted O +
a O +
reversible O +
dose O -
- O -
dependent O +
inhibition O +
of O +
cell O +
proliferation O +
in O +
the O +
range O +
of O +
concentrations O +
between O +
10 O +
nM O +
and O +
10 O +
microM O +
. O +

The O +
relative O +
binding O +
affinity O +
of O +
quercetin O +
, O +
rutin O +
, O +
DES O +
and O +
TAM O +
for O +
type B-Gene -
- I-Gene -
II I-Gene +
EBS I-Gene +
correlated O +
well O +
with O +
their O +
potency O +
as O +
cell O +
growth O +
inhibitors O +
. O +

Moreover O +
, O +
hesperidin O +
, O +
a O +
flavonoid O +
which O +
does O +
not O +
bind O +
to O +
type B-Gene -
- I-Gene -
II I-Gene +
EBS I-Gene +
, O +
was O +
ineffective O +
in O +
inhibiting O +
cell O +
growth O +
. O +

Cell O -
- O -
cycle O +
analysis O +
showed O +
that O +
the O +
growth O -
- O -
inhibitory O +
effect O +
of O +
DES O +
, O +
TAM O +
or O +
quercetin O +
was O +
due O +
to O +
a O +
blocking O +
effect O +
in O +
the O +
G0-G1 O +
phases O +
. O +

Our O +
results O +
suggest O +
that O +
high O +
estrogen O +
and O +
anti O -
- O -
estrogen O +
concentrations O +
and O +
flavonoids O +
may O +
regulate O +
IM-9 O +
cell O +
growth O +
through O +
a O +
common O +
mechanism O +
involving O +
a O +
binding O +
interaction O +
with O +
type B-Gene -
- I-Gene -
II I-Gene +
EBS I-Gene +
. O +

Synthesis O +
of O +
4 O +
, O +
19-disubstituted O +
derivatives O +
of O +
DOC O +
. O +

Radioreceptor O +
assay O +
of O +
some O +
corticosteroid O +
derivatives O +
in O +
human O +
mononuclear O +
leukocytes O +
. O +

Several O +
new O +
4 O +
, O +
19-substituted O +
steroids O +
and O +
previously O +
synthesized O +
corticosteroids O +
were O +
assayed O +
for O +
affinity O +
to O +
type B-Gene +
1 I-Gene +
receptors I-Gene +
in O +
human O +
mononuclear O +
leukocytes O +
. O +

11 O +
beta O +
, O +
19-epoxy-4 O +
, O +
21-dihydroxypregn-4-ene-3 O +
, O +
20-dione O +
( O +
2 O +
) O +
was O +
hydrogenated O +
with O +
Pd O -
- O -
C O +
to O +
yield O +
a O +
mixture O +
of O +
all O +
four O +
dihydro O +
derivatives O +
5 O +
, O +
accompanied O +
by O +
4 O +
, O +
21-diacetoxy-11 O +
beta O +
, O +
19-epoxy-3-hydroxypregnan-20-one O +
( O +
6 O +
) O +
and O +
21-acetoxy-11 O +
beta O +
, O +
19-epoxy-4-hydroxypregnane-3 O +
, O +
20-dione O +
( O +
7 O +
) O +
. O +

With O +
hot O +
acetic O +
+ O +
p O -
- O -
toluenesulfonic O +
acid O +
5 O +
underwent O +
rearrangement O +
to O +
21-acetoxy-11 O +
beta O +
, O +
19-epoxypregn-5-ene-4 O +
, O +
20-dione O +
( O +
8 O +
) O +
Pd O -
- O -
C O +
hydrogenation O +
of O +
3 O +
, O +
21-diacetoxy-5 O +
beta O +
, O +
19-cyclopregna-2 O +
, O +
9 O +
( O +
11 O +
) O +
-diene-4 O +
, O +
20-dione O +
( O +
10 O +
) O +
gave O +
3 O +
, O +
21-diacetoxy-5 O +
beta O +
, O +
19-cyclopregn-5-ene-4 O +
, O +
20-dione O +
( O +
11 O +
) O +
and O +
the O +
9 O +
, O +
11-dihydro O +
derivative O +
of O +
the O +
latter O +
. O +

Treatment O +
of O +
10 O +
with O +
warm O +
HCl O +
furnished O +
19-chloro-4 O +
, O +
21-dihydroxypregna-4 O +
, O +
9 O +
( O +
11 O +
) O +
-diene-3 O +
, O +
20-dione O +
( O +
13 O +
) O +
. O +

Pd O -
- O -
C O +
hydrogenation O +
of O +
its O +
diacetate O +
14 O +
afforded O +
the O +
4 O +
, O +
5-dihydro O +
derivative O +
18 O +
, O +
19-chloro-21-acetoxypregn-9 O +
( O +
11 O +
) O +
-en-20-one O +
( O +
15 O +
) O +
, O +
its O +
4-acetoxy O +
derivative O +
16 O +
and O +
the O +
3 O +
, O +
4-diacetoxy O +
derivative O +
17 O +
. O +

When O +
tested O +
in O +
a O +
radioreceptor O +
assay O +
in O +
human O +
mononuclear O +
leukocytes O +
the O +
synthesized O +
compounds O +
showed O +
only O +
low O +
relative O +
binding O +
affinities O +
( O +
RBA O +
) O +
to O +
type B-Gene +
1 I-Gene +
receptor I-Gene +
, O +
the O +
highest O +
being O +
0.72 O +
% O +
for O +
13 O +
( O +
aldosterone O +
= O +
100 O +
% O +
) O +
. O +

For O +
comparison O +
, O +
other O +
RBA O +
in O +
this O +
system O +
were O +
: O +
19-noraldosterone O +
, O +
20 O +
% O +
; O +
18-deoxyaldosterone O +
, O +
5.8 O +
% O +
; O +
18-deoxy-19-noraldosterone O +
, O +
4.7 O +
% O +
; O +
18 O +
, O +
21-anhydroaldosterone O +
, O +
0.37 O +
% O +
; O +
17-isoaldosterone O +
, O +
7.6 O +
% O +
and O +
apoaldosterone O +
, O +
4.3 O +
% O +

Specific O +
depletion O +
of O +
the O +
B O -
- O -
cell O +
population O +
induced O +
by O +
aberrant O +
expression O +
of O +
human O +
interferon O +
regulatory O +
factor O +
1 O +
gene O +
in O +
transgenic O +
mice O +
. O +

Interferons B-Gene +
( O +
IFNs B-Gene +
) O +
are O +
well O +
known O +
both O +
as O +
antiviral B-Gene +
proteins I-Gene +
and O +
as O +
potent O +
regulators O +
of O +
cell O +
growth O +
and O +
differentiation O +
. O +

In O +
fact O +
, O +
IFNs B-Gene +
inhibit O +
growth O +
of O +
various O +
normal O +
and O +
transformed O +
cell O +
types O +
. O +

Previously O +
, O +
a O +
nuclear B-Gene +
factor I-Gene +
, O +
IRF-1 B-Gene +
( O +
interferon B-Gene +
regulatory I-Gene +
factor I-Gene +
1 I-Gene +
) O +
, O +
which O +
binds O +
to O +
type O +
I O +
IFN O +
and O +
some O +
IFN O -
- O -
inducible O +
gene O +
promoters O +
, O +
was O +
identified O +
and O +
cloned O +
. O +

Since O +
the O +
IRF-1 B-Gene +
gene O +
is O +
both O +
virus O +
and O +
IFN B-Gene +
inducible O +
, O +
an O +
intriguing O +
issue O +
is O +
raised O +
as O +
to O +
whether O +
the O +
IRF-1 O +
gene O +
is O +
functioning O +
in O +
IFN B-Gene +
-mediated O +
regulation O +
of O +
cell O +
growth O +
and O +
differentiation O +
. O +

In O +
this O +
study O +
, O +
we O +
generated O +
transgenic O +
mice O +
carrying O +
the O +
human O +
IRF-1 O +
gene O +
linked O +
to O +
the O +
human O +
immunoglobulin O +
heavy O -
- O -
chain O +
enhancer O +
. O +

In O +
the O +
transgenic O +
mice O +
, O +
all O +
the O +
lymphoid O +
tissues O +
examined O +
showed O +
a O +
dramatic O +
reduction O +
in O +
the O +
number O +
of O +
B O +
lymphocytes O +
( O +
B O +
cells O +
) O +
. O +

Preparation O +
and O +
analysis O +
of O +
bone O +
marrow O +
cells O +
from O +
the O +
chimeric O +
mice O +
indicated O +
that O +
the O +
bone O +
marrow O +
is O +
the O +
effective O +
site O +
for O +
specific O +
depletion O +
of O +
the O +
B O -
- O -
cell O +
population O +
. O +

In O +
fact O +
, O +
transgenic O +
bone O +
marrow O +
cells O +
cocultured O +
with O +
a O +
bone O +
marrow O -
- O -
derived O +
stromal O +
cell O +
line O +
revealed O +
an O +
altered O +
B O -
- O -
cell O +
maturation O +
pattern O +
. O +

Functional O +
analysis O +
of O +
cis O -
- O -
linked O +
regulatory O +
sequences O +
in O +
the O +
HLA O +
DRA O +
promoter O +
by O +
transcription O +
in O +
vitro O +
. O +

Two O +
consensus O +
sequences O +
, O +
called O +
X O +
and O +
Y O +
boxes O +
, O +
capable O +
of O +
binding O +
nuclear B-Gene +
proteins I-Gene +
and O +
regulating O +
expression O +
in O +
B O +
cells O +
have O +
been O +
defined O +
within O +
the O +
immediate O +
upstream O +
region O +
of O +
major O +
histocompatibility O +
complex O +
( O +
MHC O +
) O +
class O +
II O +
promoters O +
. O +

Unlike O +
other O +
class O +
II O +
promoters O +
, O +
the O +
HLA O -
- O -
DR O +
alpha O +
( O +
DRA O +
) O +
promoter O +
also O +
contains O +
one O +
element O +
identical O +
to O +
the O +
` O -
` O +
octamer O +
'' O +
motif O +
of O +
immunoglobulin O +
variable O +
region O +
promoters O +
that O +
is O +
responsible O +
for O +
B O +
cell O -
- O -
specific O +
transcription O +
. O +

This O +
` O -
` O +
octamer O +
` O -
` O +
in O +
the O +
context O +
of O +
DRA B-Gene +
appears O +
capable O +
of O +
binding O +
both O +
the O +
ubiquitous B-Gene +
( O +
OTF-1 B-Gene +
) O +
and O +
lymphoid B-Gene -
- I-Gene -
specific I-Gene +
( I-Gene +
OTF-2 I-Gene +
) I-Gene +
` I-Gene -
` I-Gene +
octamer I-Gene +
'' I-Gene +
binding I-Gene +
proteins I-Gene +
, O +
but O +
at O +
least O +
one O +
other O +
distinct O +
` B-Gene -
` I-Gene +
octamer I-Gene +
'' I-Gene +
complex I-Gene +
was O +
found O +
. O +

In O +
order O +
to O +
characterize O +
the O +
function O +
of O +
cis O -
- O -
acting O +
elements O +
, O +
we O +
have O +
developed O +
an O +
in O +
vitro O +
system O +
in O +
which O +
a O +
DRA O +
promoter O +
construct O +
is O +
transcribed O +
more O +
efficiently O +
in O +
extracts O +
from O +
B O +
cells O +
than O +
in O +
extracts O +
from O +
class O +
II O -
- O -
negative O +
HeLa O +
cells O +
. O +

5 O +
' O +
deletion O +
constructs O +
which O +
lacked O +
the O +
Y O +
box O +
, O +
but O +
retained O +
the O +
` O -
` O +
octamer O +
'' O +
motif O +
and O +
TATA O +
box O +
were O +
completely O +
inactive O +
, O +
and O +
internal O +
deletion O +
of O +
the O +
Y O +
box O +
reduced O +
transcription O +
by O +
95 O +
% O +
. O +

Using O +
supercoiled O +
, O +
but O +
not O +
linear O +
templates O +
, O +
we O +
observed O +
differences O +
in O +
transcription O +
efficiencies O +
from O +
templates O +
lacking O +
or O +
disrupting O +
the O +
X O +
consensus O +
element O +
that O +
reflect O +
effects O +
of O +
random O +
replacement O +
of O +
X O +
box O +
sequences O +
in O +
transient O +
expression O +
assays O +
. O +

Demonstration O +
of O +
the O +
complete O +
dependence O +
on O +
the O +
Y O +
box O +
in O +
this O +
system O +
suggests O +
that O +
, O +
despite O +
its O +
demonstrated O +
importance O +
in O +
the O +
DRA O +
promoter O +
, O +
the O +
DRA O +
` O -
` O +
octamer O +
'' O +
does O +
not O +
utilize O +
OTF-2 B-Gene +
in O +
a O +
manner O +
analogous O +
to O +
immunoglobulin O +
promoters O +
in O +
B O +
cells O +
. O +

Inhibition O +
of O +
protein B-Gene +
phosphatases I-Gene +
by O +
okadaic O +
acid O +
induces O +
AP1 B-Gene +
in O +
human O +
T O +
cells O +
. O +

To O +
examine O +
the O +
role O +
of O +
protein B-Gene +
phosphatases I-Gene +
in O +
T O +
cell O +
activation O +
, O +
Jurkat O +
cells O +
were O +
treated O +
with O +
okadaic O +
acid O +
, O +
an O +
inhibitor O +
of O +
type B-Gene +
1 I-Gene +
and I-Gene +
2A I-Gene +
phosphatases I-Gene +
, O +
and O +
nuclear O +
extracts O +
were O +
examined O +
for O +
the O +
presence O +
of O +
AP1 B-Gene +
as O +
a O +
measure O +
of O +
early O +
T O +
cell O +
activation O +
. O +

Okadaic O +
acid O +
was O +
found O +
to O +
be O +
a O +
potent O +
inducer O +
of O +
AP1 B-Gene +
. O +

In O +
contrast O +
to O +
phorbol O +
esters O +
such O +
as O +
phorbol O +
myristate O +
acetate O +
( O +
PMA O +
) O +
, O +
the O +
induction O +
of O +
AP1 B-Gene +
by O +
okadaic O +
acid O +
occurs O +
predominantly O +
by O +
transcriptional O +
activation O +
of O +
the O +
jun O +
and O +
fos O +
family O +
of O +
proto O -
- O -
oncogenes O +
. O +

Surprisingly O +
, O +
while O +
the O +
addition O +
of O +
phytohemagglutinin B-Gene +
further O +
enhanced O +
the O +
induction O +
of O +
AP1 B-Gene +
, O +
the O +
addition O +
of O +
PMA O +
inhibited O +
it O +
. O +

Okadaic O +
acid O +
treatment O +
was O +
found O +
to O +
dramatically O +
increase O +
mRNA O +
transcripts O +
of O +
the O +
jun O +
family O +
of O +
proto O -
- O -
oncogenes O +
including O +
c O -
- O -
jun O +
, O +
junD O +
, O +
and O +
junB O +
and O +
to O +
a O +
lesser O +
extent O +
the O +
fos O +
family O +
including O +
c O -
- O -
fos O +
and O +
fra-1 O +
. O +

By O +
comparison O +
, O +
PMA O +
is O +
a O +
very O +
inefficient O +
inducer O +
of O +
the O +
jun O +
gene O +
family O +
in O +
Jurkat O +
cells O +
. O +

Similar O +
to O +
its O +
effect O +
on O +
the O +
induction O +
of O +
AP1 B-Gene +
by O +
okadaic O +
acid O +
, O +
PMA O +
inhibits O +
the O +
induction O +
of O +
c O -
- O -
jun O +
mRNA O +
by O +
okadaic O +
acid O +
. O +

Transfection O +
of O +
c O -
- O -
jun O +
promoter O +
constructs O +
confirmed O +
the O +
marked O +
difference O +
between O +
PMA O +
and O +
okadaic O +
acid O +
in O +
inducing O +
c O -
- O -
jun O +
transcription O +
. O +

The O +
induction O +
of O +
AP1 B-Gene +
by O +
okadaic O +
acid O +
suggests O +
that O +
protein B-Gene +
phosphatases I-Gene +
1 I-Gene +
and I-Gene +
2A I-Gene +
( O +
PP1 B-Gene +
and O +
PP2A B-Gene +
) O +
may O +
be O +
involved O +
in O +
T O +
cell O +
activation O +
as O +
important O +
negative O +
regulators O +
of O +
the O +
transcription B-Gene +
factor I-Gene +
AP1 B-Gene +
. O +

Towards O +
a O +
molecular O +
understanding O +
of O +
T O -
- O -
cell O +
differentiation O +
. O +

Lymphoid O +
differentiation O +
is O +
one O +
of O +
the O +
best O +
studied O +
examples O +
of O +
mammalian O +
development O +
. O +

Here O +
Hans O +
Clevers O +
and O +
Michael O +
Owen O +
describe O +
how O +
the O +
cloning O +
of O +
the O +
genes O +
that O +
encode O +
T B-Gene -
- I-Gene -
cell I-Gene -
- I-Gene -
specific I-Gene +
membrane I-Gene +
proteins I-Gene +
allows O +
the O +
identification O +
of O +
transcription B-Gene +
factors I-Gene +
that O +
control O +
the O +
expression O +
of O +
these O +
T O -
- O -
cell O +
genes O +
. O +

Such O +
transcription B-Gene +
factors I-Gene +
play O +
a O +
key O +
role O +
in O +
the O +
development O +
of O +
the O +
mature O +
T O -
- O -
cell O +
phenotype O +
by O +
functioning O +
as O +
' O -
master O +
regulators O +
of O +
T O -
- O -
cell O +
differentiation O -
' O +
. O +

HTLV-1 B-Gene +
Tax I-Gene +
induces O +
expression O +
of O +
various O +
immediate O +
early O +
serum O +
responsive O +
genes O +
. O +

Human O +
T O -
- O -
cell O +
leukemia O +
virus O +
type O +
1 O +
( O +
HTLV-1 O +
) O +
is O +
an O +
etiological O +
agent O +
of O +
adult O +
T O -
- O -
cell O +
leukemia O +
( O +
ATL O +
) O +
. O +

We O +
showed O +
here O +
by O +
mobility O -
- O -
shift O +
assay O +
that O +
T O -
- O -
cell O +
lines O +
transformed O +
with O +
the O +
virus O +
contained O +
high O +
levels O +
of O +
AP-1 B-Gene +
activities O +
. O +

Consistent O +
with O +
this O +
result O +
, O +
these O +
cell O +
lines O +
expressed O +
increased O +
levels O +
of O +
mRNAs O +
encoding O +
the O +
AP-1 B-Gene +
proteins I-Gene +
, O +
c B-Gene -
- I-Gene -
Fos I-Gene +
, O +
Fra-1 B-Gene +
, O +
c B-Gene -
- I-Gene -
Jun I-Gene +
, O +
JunB B-Gene +
, O +
and O +
JunD B-Gene +
. O +

Previously O +
, O +
transcription O +
of O +
the O +
c O -
- O -
fos O +
gene O +
has O +
been O +
reported O +
to O +
be O +
transactivated O +
by O +
the O +
viral B-Gene +
transcription I-Gene +
factor I-Gene +
, O +
Tax1 B-Gene +
. O +

By O +
using O +
the O +
human O +
T O -
- O -
cell O +
line O +
( O +
JPX-9 O +
) O +
, O +
in O +
which O +
expression O +
of O +
the O +
Tax1 B-Gene +
is O +
inducible O +
, O +
we O +
showed O +
that O +
expression O +
of O +
mRNAs O +
for O +
Fra-1 B-Gene +
, O +
c B-Gene -
- I-Gene -
Jun I-Gene +
, O +
and O +
JunD B-Gene +
was O +
also O +
transactivated O +
by O +
Tax1 B-Gene +
. O +

Moreover O +
, O +
Tax1 B-Gene +
activated O +
expression O +
of O +
two O +
other O +
transcription B-Gene +
factors I-Gene +
having O +
zinc B-Gene +
finger I-Gene +
motifs I-Gene +
, O +
Egr-1 B-Gene +
and O +
Egr-2 B-Gene +
, O +
in O +
the O +
same O +
cells O +
. O +

The O +
Tax1-inducible B-Gene +
transcription I-Gene +
factors I-Gene +
identified O +
here O +
are O +
encoded O +
by O +
the O +
members O +
of O +
immediate O +
early O +
genes O +
under O +
the O +
control O +
of O +
growth O +
signals O +
. O +

Thus O +
, O +
Tax1 B-Gene +
was O +
suggested O +
to O +
replace O +
growth O +
signals O +
, O +
at O +
least O +
in O +
part O +
, O +
by O +
this O +
mechanism O +
. O +

Lymphocyte O +
glucocorticoid B-Gene +
receptor I-Gene +
binding O +
during O +
depression O +
and O +
after O +
clinical O +
recovery O +
. O +

Lymphocyte B-Gene +
glucocorticoid I-Gene +
receptor I-Gene +
binding O +
parameters O +
were O +
studied O +
in O +
15 O +
severely O +
depressed O +
patients O +
during O +
depression O +
and O +
after O +
clinical O +
recovery O +
, O +
and O +
in O +
15 O +
healthy O +
controls O +
. O +

There O +
was O +
no O +
difference O +
in O +
glucocorticoid B-Gene +
receptor I-Gene +
number O +
or O +
affinity O +
between O +
depressed O +
patients O +
and O +
recovered O +
or O +
control O +
subjects O +
. O +

Afternoon O +
ACTH O +
and O +
cortisol O +
concentrations O +
did O +
not O +
differ O +
significantly O +
between O +
the O +
three O +
groups O +
. O +

No O +
relationship O +
could O +
be O +
established O +
between O +
glucocorticoid B-Gene +
receptor I-Gene +
binding O +
and O +
antidepressant O +
medication O +
. O +

These O +
data O +
support O +
the O +
view O +
of O +
an O +
impaired O +
ligand O -
- O -
induced O +
plasticity O +
of O +
glucocorticoid B-Gene +
receptor I-Gene +
regulation O +
rather O +
than O +
the O +
hypothesis O +
of O +
decreased O +
glucocorticoid B-Gene +
receptor I-Gene +
numbers O +
during O +
depression O +
. O +

Glucocorticoid B-Gene +
receptors I-Gene +
in O +
normal O +
leukocytes O +
: O +
effects O +
of O +
age O +
, O +
gender O +
, O +
season O +
, O +
and O +
plasma O +
cortisol O +
concentrations O +
. O +

We O +
measured O +
glucocorticoid B-Gene +
receptors I-Gene +
( O +
GR B-Gene +
) O +
in O +
mononuclear O +
leukocytes O +
( O +
MNL O +
) O +
isolated O +
from O +
peripheral O +
blood O +
of O +
145 O +
apparently O +
healthy O +
volunteers O +
( O +
86 O +
men O +
and O +
59 O +
women O +
) O +
. O +

An O +
age O -
- O -
related O +
decrease O +
in O +
the O +
number O +
of O +
GR B-Gene +
was O +
suggested O +
between O +
subjects O +
younger O +
than O +
20 O +
years O +
and O +
elderly O +
subjects O +
; O +
there O +
was O +
no O +
apparent O +
seasonal O +
variation O +
in O +
GR B-Gene +
. O +

Gender O +
difference O +
in O +
the O +
number O +
of O +
GR B-Gene +
was O +
not O +
significant O +
, O +
although O +
women O +
showed O +
slightly O +
fewer O +
GR B-Gene +
. O +

Eight O +
patients O +
with O +
dermatomyositis O -
/ O -
polymyositis O +
were O +
examined O +
to O +
determine O +
whether O +
the O +
number O +
of O +
GR B-Gene +
in O +
MNL O +
could O +
be O +
down O -
- O -
regulated O +
by O +
their O +
cognate O +
ligands O +
. O +

The O +
number O +
of O +
GR B-Gene +
in O +
MNL O +
from O +
these O +
patients O +
was O +
significantly O +
decreased O +
one O +
month O +
after O +
the O +
initiation O +
of O +
prednisolone O +
therapy O +
. O +

However O +
, O +
in O +
normal O +
subjects O +
, O +
the O +
GR B-Gene +
in O +
MNL O +
did O +
not O +
demonstrate O +
circadian O +
variation O +
, O +
in O +
contrast O +
to O +
concentrations O +
of O +
plasma O +
cortisol O +
. O +

A O +
human O +
putative O +
lymphocyte O +
G0 O -
/ O -
G1 O +
switch O +
gene O +
containing O +
a O +
CpG O -
- O -
rich O +
island O +
encodes O +
a O +
small B-Gene +
basic I-Gene +
protein I-Gene +
with O +
the O +
potential O +
to O +
be O +
phosphorylated O +
. O +

Genes O +
actively O +
involved O +
in O +
the O +
G0 O -
/ O -
G1 O +
switch O +
( O +
G0S O +
genes O +
) O +
may O +
be O +
differentially O +
expressed O +
during O +
the O +
lectin B-Gene +
-induced O +
switch O +
of O +
lymphocytes O +
from O +
the O +
G0 O +
to O +
the O +
G1 O +
phases O +
of O +
the O +
cell O +
cycle O +
. O +

This O +
paper O +
presents O +
studies O +
of O +
G0S2 O +
, O +
a O +
member O +
of O +
a O +
set O +
of O +
putative O +
G0S O +
genes O +
, O +
for O +
which O +
cDNAs O +
were O +
cloned O +
and O +
selected O +
on O +
the O +
basis O +
of O +
differential O +
cDNA O +
hybridization O +
. O +

G0S2 O +
mRNA O +
increases O +
transiently O +
within O +
1 O -
- O -
2 O +
hr O +
of O +
the O +
addition O +
of O +
lectin B-Gene +
or O +
cycloheximide O +
to O +
cultured O +
blood O +
mononuclear O +
cells O +
. O +

Comparison O +
of O +
a O +
nearly O +
full O -
- O -
length O +
cDNA O +
sequence O +
with O +
the O +
corresponding O +
genomic O +
sequence O +
reveals O +
one O +
small O +
intron O +
and O +
an O +
open O +
reading O +
frame O +
in O +
the O +
second O +
exon O +
. O +

The O +
derived O +
103-amino B-Gene -
- I-Gene -
acid I-Gene +
basic I-Gene +
protein I-Gene +
has O +
two O +
potential O +
alpha B-Gene -
- I-Gene -
helical I-Gene +
domains I-Gene +
separated O +
by O +
a O +
hydrophobic B-Gene +
region I-Gene +
with O +
the O +
potential O +
to O +
generate O +
turns O +
and O +
assume O +
a O +
beta O -
- O -
sheet O +
conformation O +
. O +

Consistent O +
with O +
involvement O +
in O +
the O +
G0 O -
/ O -
G1 O +
switch O +
, O +
the O +
protein O +
contains O +
potential O +
sites O +
for O +
phosphorylation O +
by O +
protein B-Gene +
kinase I-Gene +
C I-Gene +
and O +
casein B-Gene +
kinase I-Gene +
II I-Gene +
. O +

The O +
gene O +
contains O +
a O +
CpG B-Gene -
- I-Gene -
rich I-Gene +
island I-Gene +
suggesting O +
expression O +
in O +
the O +
germ O +
line O +
. O +

An O +
upstream O +
segment O +
contains O +
tandem O +
dinucleotide O +
repeats O +
( O +
CT O +
) O +
19 O -
/ O +
( O +
CA O +
) O +
16 O +
. O +

There O +
is O +
a O +
suitably O +
located O +
TATA O +
box O +
, O +
but O +
potential O +
sites O +
for O +
CCAAT B-Gene -
- I-Gene -
box I-Gene +
binding I-Gene +
factors I-Gene +
are O +
far O +
upstream O +
, O +
embedded O +
in O +
a O +
42-nucleotide O +
repeat O +
element O +
. O +

Potential O +
sites O +
for O +
transcription B-Gene +
factors I-Gene +
AP1 B-Gene +
, O +
AP2 B-Gene +
, O +
and O +
AP3 B-Gene +
are O +
consistent O +
with O +
rapid O +
transcriptional O +
activation O +
in O +
response O +
to O +
inducing O +
agents O +
. O +

Activity O +
of O +
the O +
kappa O +
B O +
enhancer O +
of O +
the O +
interleukin-2 B-Gene +
receptor I-Gene +
alpha I-Gene +
chain I-Gene +
in O +
somatic O +
cell O +
hybrids O +
is O +
accompanied O +
by O +
the O +
nuclear O +
localization O +
of O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
. O +

The O +
two B-Gene +
nuclear I-Gene +
proteins I-Gene +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
( O +
consisting O +
of O +
subunits O +
p50 B-Gene +
an O +
dp65 B-Gene +
) O +
and O +
the O +
DNA B-Gene -
- I-Gene -
binding I-Gene +
subunit I-Gene +
of O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
( O +
p50 B-Gene +
) O +
by O +
itself O +
, O +
also O +
called O +
KBF1 B-Gene +
, O +
are O +
constitutively O +
expressed O +
and O +
localized O +
in O +
the O +
nucleus O +
of O +
the O +
human O +
T O -
- O -
cell O +
line O +
IARC O +
301.5 O +
. O +

In O +
order O +
to O +
define O +
the O +
roles O +
of O +
these O +
two O +
factors B-Gene +
, O +
which O +
bind O +
to O +
the O +
same O +
kappa O +
B O +
enhancers O +
, O +
in O +
transcription O +
activation O +
we O +
have O +
prepared O +
somatic O +
cell O +
hybrids O +
between O +
IARC O +
301.5 O +
and O +
a O +
murine O +
myeloma O +
. O +

Most O +
hybrids O +
express O +
both O +
KBF1 B-Gene +
and O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
in O +
their O +
nuclei O +
, O +
but O +
one O +
hybrid O +
expresses O +
only O +
KBF1 B-Gene +
. O +

The O +
kappa O +
B O +
enhancer O +
of O +
the O +
gene O +
encoding O +
the O +
interleukin-2 B-Gene +
( I-Gene +
IL-2 I-Gene +
) I-Gene +
receptor I-Gene +
alpha I-Gene +
chain I-Gene +
( O +
IL-2R B-Gene +
alpha I-Gene +
) O +
is O +
functional O +
only O +
in O +
the O +
hybrids O +
expressing O +
nuclear B-Gene +
NF I-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
. O +

These O +
findings O +
show O +
that O +
nuclear B-Gene +
NF I-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
is O +
necessary O +
to O +
activate O +
the O +
kappa O +
B O +
enhancer O +
, O +
while O +
KBF1 B-Gene +
by O +
itself O +
is O +
not O +
sufficient O +
. O +

We O +
propose O +
that O +
KBF1 B-Gene +
is O +
a O +
competitive O +
inhibitor O +
of O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
and O +
discuss O +
how O +
these O +
factors O +
may O +
be O +
involved O +
in O +
the O +
transient O +
expression O +
of O +
IL-2 B-Gene +
and O +
IL-2 B-Gene +
alpha I-Gene +
genes O +
during O +
the O +
immune O +
response O +
. O +

Binding O +
of O +
erythroid B-Gene +
and I-Gene +
non I-Gene -
- I-Gene -
erythroid I-Gene +
nuclear I-Gene +
proteins I-Gene +
to O +
the O +
silencer O +
of O +
the O +
human O +
epsilon O -
- O -
globin O -
- O -
encoding O +
gene O +
. O +

To O +
clarify O +
the O +
molecular O +
mechanisms O +
involved O +
in O +
the O +
developmental O +
control O +
of O +
hemoglobin O -
- O -
encoding O +
genes O +
we O +
have O +
been O +
studying O +
the O +
expression O +
of O +
these O +
genes O +
in O +
human O +
cells O +
in O +
continuous O +
culture O +
. O +

We O +
have O +
previously O +
reported O +
the O +
presence O +
of O +
a O +
transcriptional O +
control O +
element O +
with O +
the O +
properties O +
of O +
a O +
silencer O +
extending O +
from O +
-392 O +
to O +
-177 O +
bp O +
relative O +
to O +
the O +
cap O +
site O +
of O +
the O +
human O +
epsilon O -
- O -
globin O -
- O -
encoding O +
gene O +
[ O +
Cao O +
et O +
al. O +
, O +
Proc O -
. O -
Natl O -
. O -
Acad O -
. O -
Sci O -
. O -
USA O +
86 O +
( O +
1989 O +
) O +
5306 O -
- O -
5309 O +
] O +
. O +

We O +
also O +
showed O +
that O +
this O +
silencer O +
has O +
stronger O +
inhibitory O +
activity O +
in O +
HeLa O +
cells O +
, O +
as O +
compared O +
to O +
K562 O +
human O +
erythroleukemia O +
cells O +
. O +

Using O +
deletion O +
mutants O +
and O +
cis O -
- O -
cloned O +
synthetic O +
oligodeoxyribonucleotides O +
in O +
transient O +
expression O +
assays O +
, O +
nucleotide O +
sequences O +
responsible O +
for O +
this O +
effect O +
have O +
now O +
been O +
further O +
delimited O +
to O +
44 O +
bp O +
located O +
from O +
-294 O +
to O +
-251 O +
bp O +
. O +

Gel O +
electrophoresis O +
mobility O +
shift O +
assays O +
and O +
DNaseI B-Gene +
footprinting O +
assays O +
demonstrate O +
that O +
these O +
negative O +
regulatory O +
sequences O +
are O +
recognized O +
differently O +
by O +
proteins O +
present O +
in O +
nuclear O +
extracts O +
obtained O +
from O +
HeLa O +
and O +
K562 O +
cells O +
. O +

Two O +
binding O +
proteins O +
are O +
detected O +
in O +
K562 O +
nuclear O +
extracts O +
, O +
while O +
only O +
one O +
is O +
found O +
in O +
extracts O +
from O +
HeLa O +
cells O +
. O +

Possible O +
mechanisms O +
by O +
which O +
these O +
proteins O +
may O +
regulate O +
transcription O +
of O +
the O +
epsilon O -
- O -
globin O -
- O -
encoding O +
gene O +
in O +
erythroid O +
and O +
non O -
- O -
erythroid O +
cells O +
are O +
discussed O +
. O +

In O +
vivo O +
and O +
in O +
vitro O +
effects O +
of O +
glucocorticoids O +
on O +
lymphocyte O +
proliferation O +
in O +
man O +
: O +
relationship O +
to O +
glucocorticoid B-Gene +
receptors I-Gene +
. O +

Interrelations O +
between O +
the O +
hypothalamic O -
- O -
pituitary O -
- O -
adrenal O +
system O +
( O +
HPA O +
) O +
and O +
the O +
immune O +
system O +
represent O +
a O +
well O -
- O -
documented O +
biological O +
phenomenon O +
. O +

While O +
in O +
vitro O +
administration O +
of O +
glucocorticoids O +
may O +
inhibit O +
concanavalin O +
A O +
( O +
Con O +
A O +
) O +
- O +
and O +
phytohemagglutinin O +
( O +
PHA O +
) O +
-induced O +
T O -
- O -
cell O +
proliferation O +
, O +
pokeweed B-Gene +
mitogen I-Gene +
( O +
PWM B-Gene +
) O +
-driven O +
B O -
- O -
cell O +
mitogenesis O +
is O +
relatively O +
resistant O +
to O +
glucocorticoids O +
. O +

To O +
further O +
explore O +
the O +
link O +
between O +
the O +
HPA O +
and O +
the O +
immune O +
system O +
in O +
relation O +
to O +
glucocorticoid B-Gene +
receptor I-Gene +
function O +
, O +
dose O -
- O -
response O +
curves O +
were O +
obtained O +
for O +
Con O +
A O +
-and O +
PHA B-Gene +
-induced O +
T O -
- O -
cell O +
mitogenesis O +
, O +
PWM B-Gene +
-generated O +
B O -
- O -
cell O +
mitogenesis O +
and O +
spontaneous O +
lymphocyte O +
proliferation O +
in O +
13 O +
healthy O +
controls O +
. O +

Glucocorticoid O +
effects O +
were O +
assessed O +
in O +
vivo O +
by O +
depletion O +
of O +
endogenous O +
glucocorticoids O +
after O +
oral O +
administration O +
of O +
1.5 O +
g O +
metyrapone O +
( O +
MET O +
) O +
and O +
subsequent O +
glucocorticoid O +
replacement O +
, O +
and O +
in O +
vitro O +
by O +
incubation O +
of O +
the O +
cells O +
with O +
different O +
doses O +
of O +
dexamethasone O +
( O +
DEX O +
) O +
. O +

There O +
was O +
a O +
significant O +
decrease O +
in O +
PWM B-Gene +
-induced O +
B O -
- O -
cell O +
mitogenesis O +
and O +
a O +
more O +
pronounced O +
effect O +
of O +
DEX O +
administered O +
in O +
vitro O +
on O +
spontaneous O +
lymphocyte O +
proliferation O +
after O +
MET O +
treatment O +
when O +
compared O +
with O +
the O +
DEX O +
plus O +
MET O +
pretreated O +
condition O +
in O +
vivo O +
. O +

These O +
data O +
suggest O +
that O +
the O +
inhibition O +
of O +
spontaneous O +
lymphocyte O +
proliferation O +
by O +
glucocorticoids O +
in O +
vitro O +
is O +
related O +
to O +
glucocorticoid B-Gene +
receptor I-Gene +
function O +
. O +

The O +
decrease O +
in O +
PWM B-Gene +
-generated O +
B O -
- O -
cell O +
proliferation O +
following O +
cortisol O +
depletion O +
by O +
MET O +
may O +
be O +
seen O +
in O +
connection O +
with O +
impaired O +
glucocorticoid O -
- O -
mediated O +
induction O +
of O +
interleukin-1 B-Gene +
receptor I-Gene +
synthesis O +
. O +

Leukotriene O +
B4 O +
stimulates O +
c O -
- O -
fos O +
and O +
c O -
- O -
jun O +
gene O +
transcription O +
and O +
AP-1 B-Gene +
binding O +
activity O +
in O +
human O +
monocytes O +
. O +

We O +
have O +
examined O +
the O +
effect O +
of O +
leukotriene O +
B4 O +
( O +
LTB4 O +
) O +
, O +
a O +
potent O +
lipid O +
proinflammatory B-Gene +
mediator I-Gene +
, O +
on O +
the O +
expression O +
of O +
the O +
proto O -
- O -
oncogenes O +
c O -
- O -
jun O +
and O +
c O -
- O -
fos O +
. O +

In O +
addition O +
, O +
we O +
looked O +
at O +
the O +
modulation O +
of O +
nuclear B-Gene +
factors I-Gene +
binding O +
specifically O +
to O +
the O +
AP-1 O +
element O +
after O +
LTB4 O +
stimulation O +
. O +

LTB4 O +
increased O +
the O +
expression O +
of O +
the O +
c O -
- O -
fos O +
gene O +
in O +
a O +
time- O +
and O +
concentration O -
- O -
dependent O +
manner O +
. O +

The O +
c O -
- O -
jun O +
mRNA O +
, O +
which O +
is O +
constitutively O +
expressed O +
in O +
human O +
peripheral O -
- O -
blood O +
monocytes O +
at O +
relatively O +
high O +
levels O +
, O +
was O +
also O +
slightly O +
augmented O +
by O +
LTB4 O +
, O +
although O +
to O +
a O +
much O +
lower O +
extent O +
than O +
c O -
- O -
fos O +
. O +

The O +
kinetics O +
of O +
expression O +
of O +
the O +
two O +
genes O +
were O +
also O +
slightly O +
different O +
, O +
with O +
c O -
- O -
fos O +
mRNA O +
reaching O +
a O +
peak O +
at O +
15 O +
min O +
after O +
stimulation O +
and O +
c O -
- O -
jun O +
at O +
30 O +
min O +
. O +

Both O +
messages O +
rapidly O +
declined O +
thereafter O +
. O +

Stability O +
of O +
the O +
c O -
- O -
fos O +
and O +
c O -
- O -
jun O +
mRNA O +
was O +
not O +
affected O +
by O +
LTB4 O +
, O +
as O +
assessed O +
after O +
actinomycin O +
D O +
treatment O +
. O +

Nuclear O +
transcription O +
studies O +
in O +
vitro O +
showed O +
that O +
LTB4 O +
increased O +
the O +
transcription O +
of O +
the O +
c O -
- O -
fos O +
gene O +
7-fold O +
and O +
the O +
c O -
- O -
jun O +
gene O +
1.4-fold O +
. O +

Resting O +
monocytes O +
contained O +
nuclear B-Gene +
factors I-Gene +
binding O +
to O +
the O +
AP-1 O +
element O +
, O +
but O +
stimulation O +
of O +
monocytes O +
with O +
LTB4 O +
induced O +
greater O +
AP-1 B-Gene +
-binding O +
activity O +
of O +
nuclear B-Gene +
proteins I-Gene +
. O +

These O +
results O +
indicate O +
that O +
LTB4 O +
may O +
regulate O +
the O +
production O +
of O +
different O +
cytokines B-Gene +
by O +
modulating O +
the O +
yield O +
and/or O +
the O +
function O +
of O +
transcription B-Gene +
factors I-Gene +
such O +
as O +
AP-1 B-Gene +
-binding O +
proto B-Gene -
- I-Gene -
oncogene I-Gene +
products I-Gene +
. O +

Kinetics O +
of O +
nuclear O +
translocation O +
and O +
turnover O +
of O +
the O +
vitamin B-Gene +
D I-Gene +
receptor I-Gene +
in O +
human O +
HL60 O +
leukemia O +
cells O +
and O +
peripheral O +
blood O +
lymphocytes O +
-- O +
coincident O +
rise O +
of O +
DNA O -
- O -
relaxing O +
activity O +
in O +
nuclear O +
extracts O +
. O +

High B-Gene +
affinity I-Gene +
receptors I-Gene +
( O +
VDR B-Gene +
) O +
for O +
1 O +
, O +
25-dihydroxycholecalciferol O +
( O +
calcitriol O +
) O +
are O +
expressed O +
in O +
HL60 O +
human O +
leukemia O +
cells O +
and O +
in O +
low O +
numbers O +
in O +
peripheral O +
blood O +
lymphocytes O +
( O +
PBL O +
) O +
. O +

HL60 O +
cells O +
, O +
expressing O +
some O +
characteristics O +
of O +
promyelocytes O +
, O +
can O +
be O +
induced O +
to O +
monocytoid O +
differentiation O +
by O +
calcitriol O +
. O +

Specific O +
nuclear O +
translocation O +
of O +
[ B-Gene +
3H I-Gene +
] I-Gene +
calcitriol I-Gene -
/ I-Gene -
VDR I-Gene +
was O +
examined O +
after O +
exposure O +
of O +
whole O +
cells O +
to O +
10 O +
( O +
-9 O +
) O +
M O -
/ O -
l O +
calcitriol O +
in O +
the O +
presence O +
and O +
absence O +
of O +
a O +
500-fold O +
excess O +
of O +
unlabeled O +
ligand O +
and O +
subsequent O +
isolation O +
of O +
nuclei O +
. O +

Specific O +
nuclear O +
translocation O +
of O +
[ B-Gene +
3H I-Gene +
] I-Gene +
calcitriol I-Gene -
/ I-Gene -
VDR I-Gene +
was O +
found O +
to O +
be O +
time O +
dependent O +
reaching O +
a O +
maximum O +
of O +
approximately O +
2100 O +
binding O +
sites O -
/ O -
nucleus O +
after O +
3 O +
h O +
of O +
incubation O +
in O +
HL60 O +
cells O +
, O +
whereas O +
a O +
maximum O +
of O +
approximately O +
310 O +
binding O +
sites O -
/ O -
nucleus O +
was O +
found O +
after O +
3 O +
h O +
in O +
PBL O +
. O +

Pulse O +
exposure O +
of O +
HL60 O +
to O +
radiolabeled O +
hormone O +
for O +
3 O +
h O +
followed O +
by O +
culture O +
in O +
medium O +
without O +
serum O +
and O +
calcitriol O +
lead O +
to O +
nuclear O +
retention O +
of O +
approximately O +
1600 B-Gene +
radiolabeled I-Gene +
VDR I-Gene +
by O +
8 O +
h O +
and O +
approximately O +
1000 O +
VDR B-Gene +
by O +
24 O +
h O +
. O +

Radiolabeled B-Gene +
VDR I-Gene +
disappeared O +
from O +
the O +
nuclear O +
compartment O +
with O +
a O +
halflife O +
of O +
approximately O +
30 O +
min O +
if O +
cells O +
were O +
cultured O +
with O +
identical O +
concentrations O +
of O +
unlabeled O +
hormone O +
after O +
the O +
pulse O +
( O +
pulse O -
/ O -
chase O -
- O -
experiments O +
) O +
. O +

No O +
difference O +
of O +
VDR B-Gene +
retention O +
in O +
pulse O +
and O +
pulse O -
/ O -
chase O -
- O -
experiments O +
was O +
seen O +
in O +
PBL O +
, O +
where O +
VDR B-Gene +
halflife O +
was O +
approximately O +
30 O +
min O +
. O +

No O +
specific O +
translocation O +
into O +
the O +
nuclear O +
compartment O +
was O +
seen O +
when O +
isolated O +
nuclei O +
were O +
incubated O +
in O +
[ O +
3H O +
] O +
calcitriol O +
. O +

Radiolabeled B-Gene +
hormone I-Gene -
/ I-Gene -
receptor I-Gene +
complexes I-Gene +
of O +
nuclei O +
isolated O +
from O +
cells O +
exposed O +
for O +
3 O +
h O +
to O +
radiolabeled O +
hormone O +
-- O +
in O +
contrast O +
to O +
identical O +
experiments O +
with O +
intact O +
cells O +
-- O +
did O +
not O +
disappear O +
from O +
the O +
nuclear O +
compartment O +
upon O +
incubation O +
of O +
nuclei O +
with O +
identical O +
concentrations O +
of O +
the O +
unlabeled O +
compound O +
. O +

The O +
activity O +
of O +
DNA B-Gene +
relaxing I-Gene +
enzymes I-Gene +
( O +
e.g O +
. O +
topoisomerases B-Gene +
I I-Gene +
and I-Gene +
II I-Gene +
) O +
in O +
nuclear O +
extracts O +
was O +
measured O +
using O +
a O +
PBR O +
322-relaxation O -
- O -
assay O +
. O +

Enhanced O +
overall O +
enzyme O +
activity O +
was O +
found O +
in O +
nuclear O +
extracts O +
by O +
1 O +
h O +
after O +
incubation O +
with O +
calcitriol O +
( O +
final O +
ethanol O +
concentration O +
0.0001 O +
% O +
v O -
/ O -
v O +
) O +
in O +
HL60 O +
and O +
PBL O +
. O +

The O +
enhanced O +
activity O +
disappeared O +
after O +
2 O +
h O +
in O +
PBL O +
, O +
whereas O +
it O +
was O +
still O +
enhanced O +
by O +
4 O +
h O +
in O +
HL60 O +
. O +

No O +
effect O +
was O +
seen O +
in O +
ethanol O +
treated O +
controls O +
. O +

We O +
conclude O +
that O +
a O +
specific O +
nuclear O +
translocation O +
mechanism O +
exists O +
for O +
calcitriol O +
in O +
both O +
cell O +
types O +
examined O +
, O +
most O +
likely O +
due O +
to O +
translocation O +
of O +
receptor B-Gene +
proteins I-Gene +
after O +
hormone O +
binding O +
. O +

Translocated B-Gene +
hormone I-Gene -
/ I-Gene -
receptor I-Gene +
complexes I-Gene +
compete O +
for O +
a O +
limited O +
number O +
of O +
specific O +
nuclear O +
binding O +
sites O +
. O +

Enhanced O +
activity O +
of O +
topoisomerases B-Gene +
in O +
nuclear O +
extracts O +
upon O +
translocation O +
of O +
VDR B-Gene +
might O +
reflect O +
interaction O +
of O +
both O +
within O +
the O +
nuclear O +
compartment O +
, O +
thus O +
initiating O +
DNA O -
- O -
unwinding O +
, O +
a O +
prerequisite O +
of O +
transcription O +
initiation O +
. O +

Specific O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
subunits I-Gene +
act O +
in O +
concert O +
with O +
Tat B-Gene +
to O +
stimulate O +
human O +
immunodeficiency O +
virus O +
type O +
1 O +
transcription O +
. O +

NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
is O +
a O +
protein B-Gene +
complex I-Gene +
which O +
functions O +
in O +
concert O +
with O +
the O +
tat B-Gene -
- I-Gene -
I I-Gene +
gene I-Gene +
product I-Gene +
to O +
stimulate O +
human O +
immunodeficiency O +
virus O +
( O +
HIV O +
) O +
transcription O +
. O +

To O +
determine O +
whether O +
specific O +
members O +
of O +
the O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
family I-Gene +
contribute O +
to O +
this O +
effect O +
, O +
we O +
have O +
examined O +
the O +
abilities O +
of O +
different O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
subunits I-Gene +
to O +
act O +
with O +
Tat B-Gene -
- I-Gene -
I I-Gene +
to O +
stimulate O +
transcription O +
of O +
HIV O +
in O +
Jurkat O +
T O -
- O -
leukemia O +
cells O +
. O +

We O +
have O +
found O +
that O +
the O +
p49 B-Gene +
( I-Gene +
100 I-Gene +
) I-Gene +
DNA I-Gene +
binding I-Gene +
subunit I-Gene +
, O +
together O +
with O +
p65 B-Gene +
, O +
can O +
act O +
in O +
concert O +
with O +
Tat B-Gene -
- I-Gene -
I I-Gene +
to O +
stimulate O +
the O +
expression O +
of O +
HIV O -
- O -
CAT O +
plasmid O +
. O +

Little O +
effect O +
was O +
observed O +
with O +
50-kDa B-Gene +
forms I-Gene +
of O +
p105 B-Gene +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
or O +
rel B-Gene +
, O +
in O +
combination O +
with O +
p65 B-Gene +
or O +
full B-Gene -
- I-Gene -
length I-Gene +
c I-Gene -
- I-Gene -
rel I-Gene +
, O +
which O +
do O +
not O +
stimulate O +
the O +
HIV O +
enhancer O +
in O +
these O +
cells O +
. O +

These O +
findings O +
suggest O +
that O +
the O +
combination O +
of O +
p49 B-Gene +
( I-Gene +
100 I-Gene +
) I-Gene +
and O +
p65 B-Gene +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
can O +
act O +
in O +
concert O +
with O +
the O +
tat B-Gene -
- I-Gene -
I I-Gene +
gene I-Gene +
product I-Gene +
to O +
stimulate O +
the O +
synthesis O +
of O +
HIV O +
RNA O +
. O +

Every O +
enhancer O +
works O +
with O +
every O +
promoter O +
for O +
all O +
the O +
combinations O +
tested O +
: O +
could O +
new O +
regulatory O +
pathways O +
evolve O +
by O +
enhancer O +
shuffling O +
? O +

The O +
promoters O +
and O +
enhancers O +
of O +
cell O +
type O -
- O -
specific O +
genes O +
are O +
often O +
conserved O +
in O +
evolution O +
, O +
and O +
hence O +
one O +
might O +
expect O +
that O +
a O +
given O +
enhancer O +
has O +
evolved O +
to O +
work O +
best O +
with O +
its O +
own O +
promoter O +
. O +

While O +
this O +
expectation O +
may O +
be O +
realized O +
in O +
some O +
cases O +
, O +
we O +
have O +
not O +
found O +
evidence O +
for O +
it O +
. O +

A O +
total O +
of O +
27 O +
combinations O +
of O +
different O +
promoters O +
and O +
enhancers O +
were O +
tested O +
by O +
transfection O +
into O +
cultured O +
cells O +
. O +

We O +
found O +
that O +
the O +
relative O +
efficiency O +
of O +
the O +
enhancers O +
is O +
approximately O +
the O +
same O +
, O +
irrespective O +
of O +
the O +
type O +
of O +
promoter O +
used O +
, O +
i.e. O +
, O +
there O +
was O +
no O +
strong O +
preference O +
for O +
any O +
given O +
enhancer O -
/ O +
promoter O +
combination O +
. O +

Notably O +
, O +
we O +
do O +
not O +
see O +
particularly O +
strong O +
transcription O +
when O +
the O +
immunoglobulin O +
kappa O +
enhancer O +
( O +
or O +
the O +
immunoglobulin O +
heavy O +
chain O +
enhancer O +
) O +
is O +
used O +
to O +
activate O +
a O +
kappa O +
gene O +
promoter O +
. O +

We O +
propose O +
that O +
a O +
generally O +
permissive O +
enhancer O -
/ O +
promoter O +
interaction O +
is O +
of O +
evolutionary O +
benefit O +
for O +
higher O +
eukaryotes O +
: O +
by O +
enhancer O +
shuffling O +
, O +
genes O +
could O +
be O +
easily O +
brought O +
under O +
a O +
new O +
type O +
of O +
inducibility O -
/ O -
cell O +
type O +
specificity O +
. O +

Oct2 B-Gene +
transactivation O +
from O +
a O +
remote O +
enhancer O +
position O +
requires O +
a O +
B O -
- O -
cell O -
- O -
restricted O +
activity O +
. O +

Previous O +
cotransfection O +
experiments O +
had O +
demonstrated O +
that O +
ectopic O +
expression O +
of O +
the O +
lymphocyte B-Gene -
- I-Gene -
specific I-Gene +
transcription I-Gene +
factor I-Gene +
Oct2 B-Gene +
could O +
efficiently O +
activate O +
a O +
promoter O +
containing O +
an O +
octamer O +
motif O +
. O +

Oct2 B-Gene +
expression O +
was O +
unable O +
to O +
stimulate O +
a O +
multimerized O +
octamer O +
enhancer O +
element O +
in O +
HeLa O +
cells O +
, O +
however O +
. O +

We O +
have O +
tested O +
a O +
variety O +
of O +
Oct2 B-Gene +
isoforms I-Gene +
generated O +
by O +
alternative O +
splicing O +
for O +
the O +
capability O +
to O +
activate O +
an O +
octamer O +
enhancer O +
in O +
nonlymphoid O +
cells O +
and O +
a O +
B O -
- O -
cell O +
line O +
. O +

Our O +
analyses O +
show O +
that O +
several O +
Oct2 B-Gene +
isoforms I-Gene +
can O +
stimulate O +
from O +
a O +
remote O +
position O +
but O +
that O +
this O +
stimulation O +
is O +
restricted O +
to O +
B O +
cells O +
. O +

This O +
result O +
indicates O +
the O +
involvement O +
of O +
either O +
a O +
B B-Gene -
- I-Gene -
cell I-Gene -
- I-Gene -
specific I-Gene +
cofactor I-Gene +
or O +
a O +
specific O +
modification O +
of O +
a O +
cofactor B-Gene +
or O +
the O +
Oct2 B-Gene +
protein I-Gene +
in O +
Oct2 B-Gene +
-mediated O +
enhancer O +
activation O +
. O +

Mutational O +
analyses O +
indicate O +
that O +
the O +
carboxy B-Gene -
- I-Gene -
terminal I-Gene +
domain I-Gene +
of O +
Oct2 B-Gene +
is O +
critical O +
for O +
enhancer O +
activation O +
. O +

Moreover O +
, O +
this O +
domain O +
conferred O +
enhancing O +
activity O +
when O +
fused O +
to O +
the O +
Oct1 B-Gene +
protein I-Gene +
, O +
which O +
by O +
itself O +
was O +
unable O +
to O +
stimulate O +
from O +
a O +
remote O +
position O +
. O +

The O +
glutamine B-Gene -
- I-Gene -
rich I-Gene +
activation I-Gene +
domain I-Gene +
present O +
in O +
the O +
amino B-Gene -
- I-Gene -
terminal I-Gene +
portion I-Gene +
of I-Gene +
Oct2 I-Gene +
and O +
the O +
POU B-Gene +
domain I-Gene +
contribute O +
only O +
marginally O +
to O +
the O +
transactivation O +
function O +
from O +
a O +
distal O +
position O +
. O +

TAR O +
-independent O +
transactivation O +
by O +
Tat B-Gene +
in O +
cells O +
derived O +
from O +
the O +
CNS O +
: O +
a O +
novel O +
mechanism O +
of O +
HIV-1 O +
gene O +
regulation O +
. O +

The O +
Tat B-Gene +
protein I-Gene +
of O +
human O +
immunodeficiency O +
virus O +
type O +
1 O +
( O +
HIV-1 O +
) O +
is O +
essential O +
for O +
productive O +
infection O +
and O +
is O +
a O +
potential O +
target O +
for O +
antiviral O +
therapy O +
. O +

Tat B-Gene +
, O +
a O +
potent O +
activator O +
of O +
HIV-1 O +
gene O +
expression O +
, O +
serves O +
to O +
greatly O +
increase O +
the O +
rate O +
of O +
transcription O +
directed O +
by O +
the O +
viral O +
promoter O +
. O +

This O +
induction O +
, O +
which O +
seems O +
to O +
be O +
an O +
important O +
component O +
in O +
the O +
progression O +
of O +
acquired O +
immune O +
deficiency O +
syndrome O +
( O +
AIDS O +
) O +
, O +
may O +
be O +
due O +
to O +
increased O +
transcriptional O +
initiation O +
, O +
increased O +
transcriptional O +
elongation O +
, O +
or O +
a O +
combination O +
of O +
these O +
processes O +
. O +

Much O +
attention O +
has O +
been O +
focused O +
on O +
the O +
interaction O +
of O +
Tat B-Gene +
with O +
a O +
specific O +
RNA O +
target O +
termed O +
TAR O +
( O +
transactivation O +
responsive O +
) O +
which O +
is O +
present O +
in O +
the O +
leader O +
sequence O +
of O +
all O +
HIV-1 O +
mRNAs O +
. O +

This O +
interaction O +
is O +
believed O +
to O +
be O +
an O +
important O +
component O +
of O +
the O +
mechanism O +
of O +
transactivation O +
. O +

In O +
this O +
report O +
we O +
demonstrate O +
that O +
in O +
certain O +
CNS O -
- O -
derived O +
cells O +
Tat B-Gene +
is O +
capable O +
of O +
activating O +
HIV-1 O +
through O +
a O +
TAR O +
-independent O +
pathway O +
. O +

A O +
Tat O -
- O -
responsive O +
element O +
is O +
found O +
upstream O +
within O +
the O +
viral O +
promoter O +
that O +
in O +
glial O -
- O -
derived O +
cell O +
lines O +
allows O +
transactivation O +
in O +
the O +
absence O +
of O +
TAR O +
. O +

Deletion O +
mapping O +
and O +
hybrid O +
promoter O +
constructs O +
demonstrate O +
that O +
the O +
newly O +
identified O +
Tat O -
- O -
responsive O +
element O +
corresponds O +
to O +
a O +
sequence O +
within O +
the O +
viral O +
long O +
terminal O +
repeat O +
( O +
LTR O +
) O +
previously O +
identified O +
as O +
the O +
HIV-1 O +
enhancer O +
, O +
or O +
NF O -
- O -
kappa O +
B O +
domain O +
. O +

DNA O +
band O -
- O -
shift O +
analysis O +
reveals O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
binding O +
activity O +
in O +
glial O +
cells O +
that O +
differs O +
from O +
that O +
present O +
in O +
T O +
lymphoid O +
cells O +
. O +

Further O +
, O +
we O +
observe O +
that O +
TAR O -
- O -
deleted O +
mutants O +
of O +
HIV-1 O +
demonstrate O +
normal O +
late O +
gene O +
expression O +
in O +
glial O +
cells O +
as O +
evidenced O +
by O +
syncytia O +
formation O +
and O +
production O +
of O +
viral B-Gene +
p24 I-Gene +
antigen I-Gene +
. O +

( O +
ABSTRACT O +
TRUNCATED O +
AT O +
250 O +
WORDS O +
) O +

Natural O +
variants O +
of O +
the O +
HIV-1 O +
long O +
terminal O +
repeat O +
: O +
analysis O +
of O +
promoters O +
with O +
duplicated O +
DNA O +
regulatory O +
motifs O +
. O +

Sequence O +
variation O +
in O +
the O +
long O +
terminal O +
repeat O +
( O +
LTR O +
) O +
region O +
of O +
HIV-1 O +
was O +
analyzed O +
in O +
viral O +
isolates O +
of O +
17 O +
infected O +
individuals O +
. O +

Two O +
classes O +
of O +
LTR O +
size O +
variants O +
were O +
found O +
. O +

One O +
HIV-1 O +
variant O +
was O +
detected O +
containing O +
an O +
additional O +
binding O +
site O +
for O +
the O +
transcription O +
factor O +
Sp1 O +
. O +

Another O +
LTR O +
size O +
variation O +
was O +
observed O +
in O +
four O +
patients O +
in O +
a O +
region O +
just O +
upstream O +
of O +
the O +
NF O -
- O -
kappa O +
B O +
enhancer O +
. O +

This O +
variation O +
was O +
the O +
result O +
of O +
a O +
duplication O +
of O +
a O +
short O +
DNA O +
sequence O +
( O +
CTG O -
- O -
motif O +
) O +
. O +

Cell O +
culture O +
experiments O +
demonstrated O +
that O +
the O +
natural O +
variant O +
with O +
four O +
Sp1 O +
sites O +
had O +
a O +
slightly O +
higher O +
promoter O +
activity O +
and O +
viral O +
replication O +
rate O +
than O +
the O +
isogenic O +
control O +
LTR O +
with O +
three O +
Sp1 O +
sites O +
. O +

No O +
positive O +
effect O +
of O +
the O +
duplicated O +
CTG O -
- O -
motif O +
could O +
be O +
detected O +
. O +

In O +
order O +
to O +
measure O +
small O +
differences O +
in O +
virus O +
production O +
more O +
accurately O +
, O +
equal O +
amounts O +
of O +
a O +
size O +
variant O +
and O +
the O +
wild O -
- O -
type O +
plasmid O +
were O +
cotransfected O +
into O +
T O -
- O -
cells O +
. O +

The O +
virus O +
with O +
four O +
Sp1 O +
sites O +
did O +
outgrow O +
the O +
three O +
Sp1 O +
virus O +
in O +
35 O +
days O +
of O +
culture O +
and O +
CTG O -
- O -
monomer O +
virus O +
outcompeted O +
the O +
CTG O -
- O -
dimer O +
virus O +
in O +
42 O +
days O +
. O +

Based O +
on O +
these O +
results O +
we O +
estimate O +
a O +
5 O -
- O -
10 O +
% O +
difference O +
in O +
virus O +
production O +
of O +
the O +
LTR O +
variants O +
when O +
compared O +
to O +
that O +
of O +
wild O -
- O -
type O +
. O +

Tyrosine O +
phosphorylation O +
is O +
a O +
mandatory O +
proximal O +
step O +
in O +
radiation O -
- O -
induced O +
activation O +
of O +
the O +
protein B-Gene +
kinase I-Gene +
C I-Gene +
signaling O +
pathway O +
in O +
human O +
B O -
- O -
lymphocyte O +
precursors O +
[ O +
published O +
erratum O +
appears O +
in O +
Proc O +
Natl O +
Acad O +
Sci O +
U O +
S O +
A O +
1993 O +
Apr O +
15 O +
; O +
90 O +
( O +
8 O +
) O +
: O +
3775 O +
] O +

Ionizing O +
radiation O +
triggers O +
a O +
signal O +
in O +
human O +
B O -
- O -
lymphocyte O +
precursors O +
that O +
is O +
intimately O +
linked O +
to O +
an O +
active O +
protein B-Gene -
- I-Gene -
tyrosine I-Gene +
kinase I-Gene +
regulatory O +
pathway O +
. O +

We O +
show O +
that O +
in O +
B O -
- O -
lymphocyte O +
precursors O +
, O +
irradiation O +
with O +
gamma O -
- O -
rays O +
leads O +
to O +
( O +
i O +
) O +
stimulation O +
of O +
phosphatidylinositol O +
turnover O +
; O +
( O +
ii O +
) O +
downstream O +
activation O +
by O +
covalent O +
modification O +
of O +
multiple O +
serine B-Gene -
- I-Gene -
specific I-Gene +
protein I-Gene +
kinases I-Gene +
, O +
including O +
protein B-Gene +
kinase I-Gene +
C I-Gene +
; O +
and O +
( O +
iii O +
) O +
activation O +
of O +
nuclear B-Gene +
factor I-Gene +
kappa I-Gene +
B I-Gene +
. O +

All O +
of O +
the O +
radiation O -
- O -
induced O +
signals O +
were O +
effectively O +
prevented O +
by O +
the O +
protein B-Gene -
- I-Gene -
tyrosine I-Gene +
kinase I-Gene +
inhibitors I-Gene +
genistein I-Gene +
and I-Gene +
herbimycin I-Gene +
A I-Gene +
. O +

Thus O +
, O +
tyrosine O +
phosphorylation O +
is O +
an O +
important O +
and O +
perhaps O +
mandatory O +
proximal O +
step O +
in O +
the O +
activation O +
of O +
the O +
protein B-Gene +
kinase I-Gene +
C I-Gene +
signaling O +
cascade O +
in O +
human O +
B O -
- O -
lymphocyte O +
precursors O +
. O +

Our O +
report O +
expands O +
current O +
knowledge O +
of O +
the O +
radiation O -
- O -
induced O +
signaling O +
cascade O +
by O +
clarifying O +
the O +
chronological O +
sequence O +
of O +
biochemical O +
events O +
that O +
follow O +
irradiation O +
. O +

The O +
zinc B-Gene +
finger I-Gene +
transcription I-Gene +
factor I-Gene +
Egr-1 B-Gene +
is O +
essential O +
for O +
and O +
restricts O +
differentiation O +
along O +
the O +
macrophage O +
lineage O +
. O +

We O +
have O +
isolated O +
cDNA O +
clones O +
of O +
myeloid O +
differentiation O +
primary O +
response O +
( O +
MyD O +
) O +
genes O +
, O +
activated O +
in O +
the O +
absence O +
of O +
de O +
novo O +
protein O +
synthesis O +
following O +
induction O +
for O +
differentiation O +
along O +
either O +
the O +
macrophage O +
or O +
granulocyte O +
lineage O +
in O +
human O +
myeloblastic O +
leukemia O +
HL-60 O +
cells O +
. O +

One O +
cDNA O +
clone O +
of O +
a O +
primary O +
response O +
gene O +
, O +
expressed O +
upon O +
macrophage O +
differentiation O +
, O +
encoded O +
for O +
Egr-1 B-Gene +
, O +
a O +
zinc B-Gene +
finger I-Gene +
transcription I-Gene +
factor I-Gene +
. O +

The O +
Egr-1 O +
gene O +
was O +
observed O +
to O +
be O +
transcriptionally O +
silent O +
in O +
HL-60 O +
cells O +
, O +
but O +
active O +
in O +
U-937 O +
and O +
M1 O +
cells O +
, O +
the O +
latter O +
two O +
being O +
predetermined O +
for O +
macrophage O +
differentiation O +
. O +

Egr-1 B-Gene +
antisense O +
oligomers O +
in O +
the O +
culture O +
media O +
blocked O +
macrophage O +
differentiation O +
in O +
both O +
myeloid O +
leukemia O +
cell O +
lines O +
and O +
normal O +
myeloblasts O +
. O +

HL-60 O +
cells O +
constitutively O +
expressing O +
an O +
Egr-1 O +
transgene O +
( O +
HL-60Egr-1 O +
) O +
could O +
be O +
induced O +
for O +
macrophage O +
, O +
but O +
not O +
granulocyte O +
, O +
differentiation O +
. O +

These O +
observations O +
indicate O +
that O +
expression O +
of O +
Egr-1 B-Gene +
is O +
essential O +
for O +
and O +
restricts O +
differentiation O +
of O +
myeloblasts O +
along O +
the O +
macrophage O +
lineage O +
. O +

Replication O +
of O +
type O +
1 O +
human O +
immunodeficiency O +
viruses O +
containing O +
linker O +
substitution O +
mutations O +
in O +
the O +
-201 O +
to O +
-130 O +
region O +
of O +
the O +
long O +
terminal O +
repeat O +
. O +

In O +
previous O +
transfection O +
analyses O +
using O +
the O +
chloramphenicol B-Gene +
acetyltransferase I-Gene +
reporter O +
gene O +
system O +
, O +
we O +
determined O +
that O +
linker O +
substitution O +
( O +
LS O +
) O +
mutations O +
between O +
-201 O +
and O +
-130 O +
( O +
relative O +
to O +
the O +
transcription O +
start O +
site O +
) O +
of O +
the O +
human O +
immunodeficiency O +
virus O +
type O +
1 O +
long O +
terminal O +
repeat O +
( O +
LTR O +
) O +
caused O +
moderate O +
decreases O +
in O +
LTR O +
transcriptional O +
activity O +
in O +
a O +
T O -
- O -
cell O +
line O +
( O +
S.L.Zeichner O +
, O +
J.Y.H. O +
Kim O +
, O +
and O +
J.C.Alwine O +
, O +
J.Virol.65 O +
: O +
2436 O -
- O -
2444 O +
, O +
1991 O +
) O +
. O +

In O +
order O +
to O +
confirm O +
the O +
significance O +
of O +
this O +
region O +
in O +
the O +
context O +
of O +
viral O +
replication O +
, O +
we O +
constructed O +
several O +
of O +
these O +
LS O +
mutations O +
( O +
-201 O +
to O +
- O +
184 O +
, O +
-183 O +
to O +
-166 O +
, O +
-165 O +
to O +
-148 O +
, O +
and O +
-148 O +
to O +
-130 O +
) O +
in O +
proviruses O +
and O +
prepared O +
viral O +
stocks O +
by O +
cocultivation O +
of O +
transfected O +
RD O +
cells O +
with O +
CEMx174 O +
cells O +
. O +

In O +
addition O +
, O +
two O +
mutations O +
between O +
-93 O +
and O +
-76 O +
and O +
between O +
-75 O +
and O +
-58 O +
were O +
utilized O +
, O +
since O +
they O +
affect O +
the O +
nuclear O +
factor O +
kappa O +
B O +
( O +
NF O -
- O -
kappa O +
B O +
) O +
- O +
and O +
Sp1-binding O +
sites O +
and O +
were O +
expected O +
to O +
diminish O +
viral O +
replication O +
. O +

Our O +
results O +
suggest O +
that O +
while O +
transfection O +
analyses O +
offer O +
an O +
adequate O +
approximation O +
of O +
the O +
effects O +
of O +
the O +
LS O +
mutations O +
, O +
the O +
analysis O +
of O +
viral O +
replication O +
using O +
a O +
mutant O +
viral O +
stock O +
presents O +
a O +
more O +
accurate O +
picture O +
, O +
which O +
is O +
sometimes O +
at O +
variance O +
with O +
the O +
transfection O +
results O +
. O +

Three O +
mutants O +
( O +
-201 O -
/ O -
-184 O +
NXS O +
, O +
-165 O -
/ O -
-148 O +
NXS O +
, O +
and O +
-147 O -
/ O -
-130 O +
NXS O +
) O +
had O +
effects O +
on O +
viral O +
replication O +
that O +
were O +
much O +
more O +
severe O +
than O +
the O +
effects O +
predicted O +
from O +
their O +
performance O +
in O +
transfection O +
analyses O +
, O +
and O +
the O +
effects O +
of O +
two O +
LS O +
mutations O +
( O +
-201 O -
/ O -
-184 O +
NXS O +
and O +
-183 O -
/ O -
-166 O +
NXS O +
) O +
were O +
not O +
predicted O +
by O +
their O +
effects O +
in O +
transfection O +
. O +

In O +
addition O +
, O +
we O +
observed O +
cell O +
type O -
- O -
specific O +
permissiveness O +
to O +
replication O +
of O +
some O +
mutant O +
viruses O +
. O +

In O +
the O +
cell O +
types O +
tested O +
, O +
the O +
LS O +
mutations O +
indicated O +
an O +
apparent O +
requirement O +
not O +
only O +
for O +
the O +
intact O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
and O +
SP1-binding O +
sites O +
but O +
also O +
for O +
several O +
regions O +
between O +
-201 O +
and O +
-130 O +
not O +
previously O +
associated O +
with O +
viral O +
infectivity O +
. O +

Human O +
CD4 O +
lymphocytes O +
specifically O +
recognize O +
a O +
peptide O +
representing O +
the O +
fusion O +
region O +
of O +
the O +
hybrid B-Gene +
protein I-Gene +
pml B-Gene -
/ I-Gene -
RAR I-Gene +
alpha I-Gene +
present O +
in O +
acute O +
promyelocytic O +
leukemia O +
cells O +
. O +

Fusion O +
proteins O +
present O +
in O +
leukemic O +
cells O +
frequently O +
contain O +
a O +
new O +
amino O +
acid O +
at O +
the O +
fusion B-Gene +
point I-Gene +
. O +

We O +
tested O +
whether O +
a O +
peptide O +
( O +
BCR1 O -
/ O -
25 O +
) O +
encompassing O +
the O +
fusion B-Gene +
region I-Gene +
of O +
the O +
hybrid O +
molecule O +
pml B-Gene -
/ I-Gene -
RAR I-Gene +
alpha I-Gene +
, O +
which O +
is O +
selectively O +
expressed O +
by O +
acute O +
promyelocytic O +
leukemia O +
( O +
APL O +
) O +
cells O +
, O +
can O +
be O +
recognized O +
by O +
human O +
T O +
lymphocytes O +
in O +
vitro O +
. O +

CD4 O -
+ O +
lymphocytes O +
, O +
at O +
both O +
polyclonal O +
and O +
clonal O +
level O +
, O +
recognized O +
peptide O +
BCR1 O -
/ O -
25 O +
in O +
an O +
HLA B-Gene -
- I-Gene -
DR I-Gene +
-- O +
restricted O +
fashion O +
on O +
presentation O +
by O +
autologous O +
antigen O -
- O -
presenting O +
cell O +
( O +
APC O +
) O +
or O +
by O +
APC O +
expressing O +
the O +
HLA B-Gene -
- I-Gene -
DR11 I-Gene +
restricting I-Gene +
molecule I-Gene +
. O +

Control O +
peptides O +
corresponding O +
to O +
the O +
normal O +
pml B-Gene +
and O +
RAR B-Gene +
alpha I-Gene +
proteins I-Gene +
were O +
not O +
recognized O +
. O +

One O +
clone O +
( O +
DEG5 O +
) O +
also O +
exerted O +
a O +
high O +
and O +
specific O +
cytotoxicity O +
against O +
autologous O +
cells O +
pulsed O +
with O +
BCR1 O -
/ O -
25 O +
. O +

The O +
autologous O +
DE O +
LCL O +
containing O +
a O +
transduced O +
pml O -
/ O -
RAR O +
alpha O +
fusion O +
gene O +
and O +
expressing O +
a O +
bcr1 O +
type O +
of O +
the O +
pml B-Gene -
/ I-Gene -
RAR I-Gene +
alpha I-Gene +
hybrid O +
protein O +
induced O +
the O +
proliferation O +
of O +
DE O +
anti O -
- O -
BCR1 O -
/ O -
25 O +
T O +
cell O +
clones O +
. O +

It O +
is O +
concluded O +
that O +
the O +
bcr1 B-Gene +
type I-Gene -
- I-Gene -
pml I-Gene -
/ I-Gene -
RAR I-Gene +
alpha I-Gene +
fusion I-Gene +
protein I-Gene +
of O +
APL O +
contains O +
an O +
antigenic O +
site O +
, O +
absent O +
from O +
the O +
normal O +
parent O +
molecules O +
and O +
recognized O +
by O +
human O +
CD4 O -
+ O +
lymphocytes O +
. O +

Transcriptional O +
regulation O +
of O +
the O +
pyruvate O +
kinase O +
erythroid O -
- O -
specific O +
promoter O +
. O +

Mammal B-Gene +
pyruvate I-Gene +
kinases I-Gene +
are O +
encoded O +
by O +
two O +
genes O +
. O +

The O +
L O +
gene O +
produces O +
the O +
erythroid B-Gene +
( O +
R B-Gene -
- I-Gene -
PK I-Gene +
) O +
or O +
the O +
hepatic B-Gene +
( I-Gene +
L I-Gene -
- I-Gene -
PK I-Gene +
) I-Gene +
isozymes I-Gene +
by O +
the O +
alternative O +
use O +
of O +
two O +
promoters O +
. O +

We O +
report O +
the O +
characterization O +
of O +
the O +
cis- O +
and O +
trans O -
- O -
acting O +
elements O +
involved O +
in O +
the O +
tissue O -
- O -
specific O +
activity O +
of O +
the O +
L O +
gene O +
erythroid O +
promoter O +
. O +

A O +
R O -
- O -
PK O +
DNA O +
fragment O +
extending O +
from O +
-870 O +
to O +
+ O -
54 O +
relative O +
to O +
the O +
cap O +
site O +
confers O +
erythroid O +
specificity O +
to O +
a O +
reporter O +
gene O +
. O +

Within O +
this O +
region O +
, O +
we O +
define O +
a O +
minimal O +
promoter O +
( O +
-62 O +
to O +
+ O -
54 O +
) O +
that O +
displays O +
erythroid O -
- O -
specific O +
activity O +
and O +
contains O +
two O +
DNA O +
binding O +
sites O +
. O +

One O +
, O +
located O +
at O +
-50 O +
, O +
binds O +
members O +
of O +
the O +
CCACC B-Gene -
/ I-Gene -
Sp1 I-Gene +
family I-Gene +
and O +
the O +
other O +
, O +
located O +
at O +
-20 O +
, O +
binds O +
the O +
erythroid B-Gene +
factor I-Gene +
GATA-1 I-Gene +
. O +

Although O +
the O +
-20 O +
GATA O +
binding O +
site O +
( O +
AGATAA O +
) O +
is O +
also O +
a O +
potential O +
TFIID O +
binding O +
site O +
, O +
it O +
does O +
not O +
bind O +
TFIID B-Gene +
. O +

Furthermore O +
, O +
the O +
substitution O +
of O +
this O +
GATA O +
binding O +
site O +
by O +
a O +
canonical O +
TFIID O +
binding O +
site O +
suppresses O +
the O +
promoter O +
activity O +
. O +

Mutations O +
and O +
deletions O +
of O +
both O +
sites O +
indicate O +
that O +
only O +
the O +
association O +
of O +
CCACC B-Gene -
/ I-Gene -
Sp1 I-Gene +
and O +
GATA O +
binding O +
sites O +
can O +
drive O +
efficient O +
and O +
tissue O -
- O -
specific O +
expression O +
of O +
this O +
R B-Gene -
- I-Gene -
PK I-Gene +
minimal O +
promoter O +
. O +

Finally O +
, O +
by O +
co O -
- O -
transfection O +
experiments O +
, O +
we O +
study O +
the O +
elements O +
involved O +
in O +
the O +
hGATA-1 O +
transactivation O +
of O +
the O +
R O -
- O -
PK O +
promoter O +
in O +
HeLa O +
cells O +
. O +

Cell O +
type- O +
and O +
stage O -
- O -
specific O +
expression O +
of O +
the O +
CD20 B-Gene -
/ I-Gene -
B1 I-Gene +
antigen I-Gene +
correlates O +
with O +
the O +
activity O +
of O +
a O +
diverged O +
octamer O +
DNA O +
motif O +
present O +
in O +
its O +
promoter O +
. O +

The O +
CD20 O +
( O +
B1 O +
) O +
gene O +
encodes O +
a O +
B B-Gene +
cell I-Gene -
- I-Gene -
specific I-Gene +
protein I-Gene +
involved O +
in O +
the O +
regulation O +
of O +
human O +
B O +
cell O +
proliferation O +
and O +
differentiation O +
. O +

Studies O +
with O +
5 O +
' O +
deletion O +
CD20 O +
promoter O -
- O -
CAT O +
constructs O +
have O +
previously O +
revealed O +
two O +
regions O +
of O +
the O +
promoter O +
between O +
bases O +
-186 O +
and O +
-280 O +
and O +
between O +
bases O +
-280 O +
and O +
-454 O +
which O +
contained O +
positive O +
regulatory O +
elements O +
. O +

In O +
this O +
study O +
we O +
identified O +
a O +
sequence O +
element O +
present O +
in O +
the O +
most O +
proximal O +
region O +
located O +
between O +
bases O +
-214 O +
and O +
-201 O +
, O +
TTCTTCTAATTAA O +
, O +
which O +
is O +
important O +
in O +
the O +
high O +
constitutive O +
expression O +
of O +
CD20 B-Gene +
in O +
mature O +
B O +
cells O +
and O +
the O +
induction O +
of O +
CD20 B-Gene +
in O +
pre O -
- O -
B O +
cells O +
. O +

This O +
sequence O +
element O +
was O +
referred O +
to O +
as O +
the O +
BAT O +
box O +
and O +
its O +
deletion O +
significantly O +
reduced O +
the O +
activity O +
of O +
a O +
CD20 O +
promoter O -
- O -
CAT O +
construct O +
in O +
B O +
cells O +
. O +

Mobility O +
shift O +
assays O +
with O +
various O +
mutant O +
probes O +
and O +
B O +
cell O +
nuclear O +
extracts O +
demonstrated O +
that O +
the O +
core O +
sequence O +
TAAT O +
was O +
essential O +
for O +
binding O +
to O +
this O +
site O +
. O +

Cross O +
competition O +
experiments O +
with O +
an O +
octamer O +
sequence O +
from O +
the O +
Ig O +
heavy O +
chain O +
promoter O +
, O +
the O +
BAT O +
box O +
, O +
and O +
a O +
TA O -
- O -
rich O +
sequence O +
present O +
in O +
the O +
CD21 O +
promoter O +
revealed O +
that O +
all O +
three O +
sequences O +
bound O +
the O +
same O +
nuclear B-Gene +
proteins I-Gene +
suggesting O +
that O +
the O +
BAT B-Gene +
box I-Gene +
binding I-Gene +
proteins I-Gene +
were O +
Oct-1 B-Gene +
and O +
Oct-2 B-Gene +
. O +

Southwestern O +
blotting O +
and O +
UV O +
cross O -
- O -
linking O +
studies O +
confirmed O +
that O +
the O +
BAT B-Gene +
box I-Gene +
binding I-Gene +
proteins I-Gene +
were O +
Oct-1 B-Gene +
and O +
Oct-2 B-Gene +
. O +

The O +
affinity O +
of O +
the O +
BAT B-Gene +
box I-Gene +
binding I-Gene +
proteins I-Gene +
for O +
the O +
BAT O +
box O +
was O +
approximately O +
25-fold O +
less O +
than O +
for O +
the O +
octamer O +
sequence O +
and O +
the O +
BAT B-Gene +
box I-Gene +
binding I-Gene +
proteins I-Gene +
dissociated O +
from O +
the O +
BAT O +
box O +
10-fold O +
more O +
rapidly O +
than O +
from O +
the O +
octamer O +
sequence O +
. O +

Despite O +
this O +
lower O +
affinity O +
, O +
a O +
trimer O +
of O +
the O +
BAT O +
box O +
sequence O +
was O +
as O +
efficiently O +
transactivated O +
by O +
an O +
Oct-2 O +
expression O +
vector O +
as O +
was O +
a O +
trimer O +
of O +
the O +
octamer O +
sequence O +
in O +
HeLa O +
cells O +
. O +

The O +
BAT O +
box O +
and O +
Oct-2 B-Gene +
were O +
also O +
implicated O +
in O +
the O +
induction O +
of O +
CD20 B-Gene +
in O +
the O +
pre O -
- O -
B O +
cell O +
line O +
, O +
PB-697 O +
, O +
via O +
phorbol O +
esters O +
. O +

The O +
induction O +
of O +
CD20 O +
mRNA O +
was O +
temporally O +
associated O +
with O +
induction O +
of O +
Oct-2 O +
mRNA O +
and O +
a O +
BAT O +
box O -
- O -
deleted O +
CD20-CAT O +
construct O +
, O +
in O +
contrast O +
to O +
the O +
wild O +
type O +
, O +
was O +
poorly O +
induced O +
by O +
phorbol O +
esters O +
. O +

Together O +
these O +
results O +
suggest O +
that O +
the O +
BAT B-Gene +
box I-Gene +
binding I-Gene +
proteins I-Gene +
are O +
important O +
in O +
the O +
B O +
cell O +
specific O +
expression O +
of O +
CD20 B-Gene +
and O +
perhaps O +
CD21 B-Gene +
. O +

NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
controls O +
expression O +
of O +
inhibitor O +
I B-Gene +
kappa I-Gene +
B I-Gene +
alpha I-Gene +
: O +
evidence O +
for O +
an O +
inducible O +
autoregulatory O +
pathway O +
. O +

The O +
eukaryotic O +
transcription B-Gene +
factor I-Gene +
nuclear B-Gene +
factor I-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
( O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
) O +
participates O +
in O +
many O +
parts O +
of O +
the O +
genetic O +
program O +
mediating O +
T O +
lymphocyte O +
activation O +
and O +
growth O +
. O +

Nuclear O +
expression O +
of O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
occurs O +
after O +
its O +
induced O +
dissociation O +
from O +
its O +
cytoplasmic O +
inhibitor O +
I B-Gene +
kappa I-Gene +
B I-Gene +
alpha I-Gene +
. O +

Phorbol O +
ester O +
and O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene -
- I-Gene -
alpha I-Gene +
induction O +
of O +
nuclear B-Gene +
NF I-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
is O +
associated O +
with O +
both O +
the O +
degradation O +
of O +
performed O +
I B-Gene +
kappa I-Gene +
B I-Gene +
alpha I-Gene +
and O +
the O +
activation O +
of O +
I B-Gene +
kappa I-Gene +
B I-Gene +
alpha O +
gene O +
expression O +
. O +

Transfection O +
studies O +
indicate O +
that O +
the O +
I O +
kappa O +
B O +
alpha O +
gene O +
is O +
specifically O +
induced O +
by O +
the O +
65-kilodalton B-Gene +
transactivating I-Gene +
subunit I-Gene +
of O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
. O +

Association O +
of O +
the O +
newly O +
synthesized O +
I B-Gene +
kappa I-Gene +
B I-Gene +
alpha I-Gene +
with O +
p65 B-Gene +
restores O +
intracellular O +
inhibition O +
of O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
DNA O +
binding O +
activity O +
and O +
prolongs O +
the O +
survival O +
of O +
this O +
labile O +
inhibitor O +
. O +

Together O +
, O +
these O +
results O +
show O +
that O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
controls O +
the O +
expression O +
of O +
I B-Gene +
kappa I-Gene +
B I-Gene +
alpha O +
by O +
means O +
of O +
an O +
inducible O +
autoregulatory O +
pathway O +
. O +

The O +
lytic O +
transition O +
of O +
Epstein O -
- O -
Barr O +
virus O +
is O +
imitated O +
by O +
recombinant O +
B O -
- O -
cells O +
. O +

Lytic O +
transition O +
of O +
Epstein O -
- O -
Barr O +
virus O +
( O +
EBV O +
) O +
is O +
initiated O +
by O +
distinct O +
immediate O +
early O +
regulators O +
of O +
the O +
viral O +
cycle O +
, O +
in O +
synchronization O +
to O +
temporary O +
, O +
permissive O +
conditions O +
during O +
host O +
cell O +
differentiation O +
. O +

We O +
developed O +
eukaryotic O +
vectors O +
suitable O +
to O +
imitate O +
the O +
processes O +
involved O +
in O +
lytic O +
transition O +
in O +
cell O +
culture O +
systems O +
. O +

Two O +
stable O +
B O +
cell O +
lines O +
were O +
established O +
: O +
R59Z O +
activator O +
cells O +
were O +
used O +
to O +
induce O +
lytic O +
EBV O +
expression O +
in O +
a O +
constitutive O +
manner O +
by O +
the O +
production O +
of O +
the O +
BZLF B-Gene +
1 I-Gene +
trans I-Gene -
- I-Gene -
activator I-Gene +
( O +
Zta B-Gene +
) O +
. O +

R7 O -
- O -
57 O +
reporter O +
cells O +
, O +
on O +
the O +
other O +
hand O +
, O +
signaled O +
induced O +
activity O +
of O +
the O +
lytic O +
origin O +
of O +
EBV O +
replication O +
( O +
ori O +
Lyt O +
) O +
. O +

Different O +
modes O +
, O +
like O +
chemical O +
induction O +
, O +
lytic O +
superinfection O +
with O +
EBV O +
and O +
single O +
gene O +
trans O -
- O -
activation O +
converted O +
the O +
recombinant O +
ori O +
Lyt O +
element O +
in O +
R7 O -
- O -
57 O +
reporter O +
cells O +
. O +

BZLF B-Gene +
1 I-Gene +
, O +
transiently O +
expressed O +
in O +
R7 O -
- O -
57 O +
reporter O +
cells O +
, O +
was O +
the O +
only O +
EBV B-Gene +
trans I-Gene -
- I-Gene -
activator I-Gene +
found O +
, O +
sufficient O +
in O +
inducing O +
the O +
viral O +
lytic O +
cycle O +
. O +

Basing O +
on O +
these O +
experiments O +
, O +
trans O -
- O -
cellular O +
activation O +
of O +
EBV O +
was O +
tested O +
by O +
cocultivation O +
of O +
BZLF O +
1-expressing O +
R59Z O +
activator O +
cells O +
with O +
the O +
R7 O -
- O -
57 O +
reporter O +
line O +
. O +

No O +
lytic O +
effect O +
on O +
the O +
reporter O +
cells O +
could O +
be O +
measured O +
, O +
neither O +
by O +
cocultivation O +
of O +
activator O +
cells O +
nor O +
by O +
coincubation O +
of O +
BZLF B-Gene +
1 I-Gene +
-containing O +
cell O +
lysates O +
. O +

Latency O +
breaking O +
activity O +
, O +
however O +
, O +
was O +
transferred O +
from O +
activator O +
to O +
reporter O +
cells O +
when O +
active O +
, O +
exogenous O +
virus O +
was O +
added O +
. O +

The O +
cell O +
system O +
described O +
in O +
these O +
experiments O +
provides O +
a O +
tool O +
for O +
the O +
detection O +
of O +
EBV O +
reactivation O +
and O +
demonstrates O +
the O +
potential O +
of O +
the O +
lytic O +
regulatory O +
gene O +
BZLF O +
1 O +

Immobilization O +
and O +
recovery O +
of O +
fusion B-Gene +
proteins I-Gene +
and O +
B O -
- O -
lymphocyte O +
cells O +
using O +
magnetic O +
separation O +
. O +

A O +
new O +
approach O +
to O +
facilitate O +
immobilization O +
and O +
affinity O +
purification O +
of O +
recombinant B-Gene +
proteins I-Gene +
and O +
selected O +
human O +
B O +
lymphocytes O +
has O +
been O +
developed O +
. O +

Using O +
magnetic O +
beads O +
with O +
attached O +
DNA O +
containing O +
the O +
Escherichia O +
coli O +
lac O +
operator O +
, O +
fusion B-Gene +
proteins I-Gene +
comprising O +
the O +
DNA O -
- O -
binding O +
lac O +
repressor O +
could O +
be O +
affinity O -
- O -
purified O +
and O +
recovered O +
by O +
gentle O +
elution O +
conditions O +
, O +
such O +
as O +
with O +
a O +
lactose O +
analogue O +
or O +
by O +
enzymatic O +
means O +
using O +
either O +
deoxyribonuclease B-Gene +
( O +
DNase B-Gene +
) O +
or O +
restriction B-Gene +
endonucleases I-Gene +
. O +

The O +
results O +
show O +
for O +
the O +
first O +
time O +
that O +
a O +
DNA B-Gene -
- I-Gene -
binding I-Gene +
protein I-Gene +
can O +
be O +
used O +
for O +
affinity O +
purification O +
of O +
fusion B-Gene +
proteins I-Gene +
as O +
exemplified O +
by O +
the O +
specific O +
and O +
gentle O +
recovery O +
of O +
beta B-Gene -
- I-Gene -
galactosidase I-Gene +
and O +
alkaline B-Gene +
phosphatase I-Gene +
from O +
bacterial O +
lysates O +
using O +
immunomagnetic O +
separation O +
. O +

The O +
approach O +
was O +
further O +
extended O +
to O +
cell O +
separation O +
by O +
the O +
efficient O +
recovery O +
and O +
elution O +
of O +
human O +
CD37 O +
B O +
lymphocytes O +
from O +
peripheral O +
blood O +
. O +

[ O +
The O +
trend O +
of O +
molecular O +
biology O +
study O +
on O +
eosinophils O +
] O +

Recently O +
, O +
many O +
investigators O +
have O +
been O +
interested O +
in O +
the O +
study O +
on O +
eosinophil O +
biology O +
since O +
genes O +
association O +
with O +
eosinophils O +
such O +
as O +
interleukin-5 B-Gene +
or O +
eosinophil B-Gene +
granule I-Gene +
proteins I-Gene +
( O +
EPO B-Gene +
, O +
ECP B-Gene +
, O +
EDN B-Gene +
, O +
MBP B-Gene +
, O +
and O +
CLC B-Gene +
) O +
, O +
were O +
isolated O +
. O +

However O +
, O +
the O +
molecular O +
basis O +
for O +
the O +
commitment O +
of O +
progenitors O +
to O +
the O +
eosinophil O +
lineage O +
has O +
not O +
been O +
determined O +
. O +

The O +
mechanism O +
by O +
which O +
eosinophil O -
- O -
specific O +
genes O +
encoding O +
primary O +
and O +
secondary B-Gene +
granule I-Gene +
proteins I-Gene +
( O +
e.g O +
. O +
ECP B-Gene +
, O +
EDN B-Gene +
, O +
EPO B-Gene +
, O +
MBP B-Gene +
, O +
and O +
CLC B-Gene +
) O +
are O +
expressed O +
and O +
regulated O +
during O +
eosinophilopoiesis O +
is O +
also O +
unknown O +
. O +

In O +
this O +
paper O +
, O +
I O +
described O +
the O +
characterization O +
of O +
genes O +
encoding O +
eosinophil B-Gene +
granule I-Gene +
proteins I-Gene +
and O +
the O +
mRNA O +
expression O +
of O +
GATA-1 B-Gene +
binding I-Gene +
transcription I-Gene +
factor I-Gene +
during O +
eosinophil O +
differentiation O +
. O +

Lipopolysaccharide O +
induces O +
phosphorylation O +
of O +
MAD3 B-Gene +
and O +
activation O +
of O +
c B-Gene -
- I-Gene -
Rel I-Gene +
and O +
related O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
proteins O +
in O +
human O +
monocytic O +
THP-1 O +
cells O +
. O +

Many O +
effects O +
of O +
lipopolysaccharide O +
( O +
LPS O +
) O +
on O +
gene O +
expression O +
, O +
including O +
that O +
of O +
human O +
immunodeficiency O +
virus O +
( O +
HIV O +
) O +
, O +
in O +
monocytic O +
cells O +
are O +
mediated O +
by O +
activation O +
of O +
kappa O +
B O +
DNA O -
- O -
binding O +
proteins O +
. O +

However O +
, O +
the O +
specific O +
members O +
of O +
the O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene -
/ I-Gene -
Rel I-Gene +
transcription I-Gene +
factor I-Gene +
family I-Gene +
involved O +
in O +
the O +
LPS O +
response O +
, O +
and O +
the O +
mechanisms O +
through O +
which O +
LPS O -
- O -
generated O +
signals O +
are O +
transduced O +
remain O +
unclear O +
. O +

Here O +
we O +
show O +
that O +
LPS O +
induces O +
nuclear O +
expression O +
of O +
c B-Gene -
- I-Gene -
Rel I-Gene -
/ I-Gene -
p50 I-Gene +
heterodimers I-Gene +
as O +
well O +
as O +
p50 B-Gene -
/ I-Gene -
p65 I-Gene +
( O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
) O +
kappa O +
B O +
DNA O -
- O -
binding O +
complexes O +
in O +
human O +
monocytic O +
THP-1 O +
cells O +
. O +

Nuclear O +
localization O +
of O +
these O +
proteins O +
occurred O +
concomitantly O +
with O +
a O +
rapid O +
decrease O +
in O +
their O +
cytosolic O +
levels O +
and O +
was O +
independent O +
of O +
phorbol B-Gene +
ester I-Gene -
- I-Gene -
sensitive I-Gene +
protein I-Gene +
kinase I-Gene +
C I-Gene +
. O +

Within O +
24 O +
h O +
following O +
LPS O +
stimulation O +
there O +
was O +
a O +
striking O +
increase O +
in O +
the O +
levels O +
of O +
c B-Gene -
- I-Gene -
Rel I-Gene +
, O +
p105 B-Gene +
, O +
and O +
p50 B-Gene +
in O +
the O +
cytosol O +
. O +

The O +
increased O +
levels O +
of O +
these O +
proteins O +
correlated O +
with O +
increases O +
in O +
the O +
amounts O +
of O +
their O +
mRNAs O +
during O +
LPS O +
activation O +
of O +
THP-1 O +
cells O +
. O +

LPS O +
activation O +
of O +
THP-1 O +
cells O +
resulted O +
in O +
phosphorylation O +
of O +
MAD3 B-Gene +
( O +
an O +
I B-Gene +
kappa I-Gene +
B I-Gene +
-like O +
protein O +
) O +
, O +
a O +
rapid O +
increase O +
in O +
MAD3 O +
mRNA O +
, O +
and O +
an O +
increase O +
in O +
MAD3 B-Gene +
protein O +
by O +
2 O +
h O +
. O +

Thus O +
, O +
LPS O +
activation O +
of O +
human O +
monocytic O +
cells O +
results O +
in O +
nuclear O +
expression O +
of O +
c B-Gene -
- I-Gene -
Rel I-Gene -
/ I-Gene -
p50 I-Gene +
and O +
p50 B-Gene -
/ I-Gene -
p65 I-Gene +
( O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
) O +
and O +
induces O +
phosphorylation O +
of O +
MAD3 B-Gene +
. O +

Regulation O +
of O +
lymphoid O -
- O -
specific O +
immunoglobulin O +
mu O +
heavy O +
chain O +
gene O +
enhancer O +
by O +
ETS O -
- O -
domain O +
proteins O +
. O +

The O +
enhancer O +
for O +
the O +
immunoglobulin O +
mu O +
heavy O +
chain O +
gene O +
( O +
IgH B-Gene +
) O +
activates O +
a O +
heterologous O +
gene O +
at O +
the O +
pre O -
- O -
B O +
cell O +
stage O +
of O +
B O +
lymphocyte O +
differentiation O +
. O +

A O +
lymphoid O -
- O -
specific O +
element O +
, O +
microB O +
, O +
is O +
necessary O +
for O +
enhancer O +
function O +
in O +
pre O -
- O -
B O +
cells O +
. O +

A O +
microB B-Gene +
binding I-Gene +
protein I-Gene +
is O +
encoded O +
by O +
the O +
PU.1 O -
/ O -
Spi-1 O +
proto O -
- O -
oncogene O +
. O +

Another O +
sequence O +
element O +
, O +
microA O +
, O +
was O +
identified O +
in O +
the O +
mu O +
enhancer O +
that O +
binds O +
the O +
product O +
of O +
the O +
ets-1 O +
proto O -
- O -
oncogene O +
. O +

The O +
microA O +
motif O +
was O +
required O +
for O +
microB O -
- O -
dependent O +
enhancer O +
activity O +
, O +
which O +
suggests O +
that O +
a O +
minimal O +
B O +
cell O -
- O -
specific O +
enhancer O +
is O +
composed O +
of O +
both O +
the O +
PU.1 O +
and O +
Ets-1 O +
binding O +
sites O +
. O +

Co O -
- O -
expression O +
of O +
both O +
PU.1 B-Gene +
and O +
Ets-1 B-Gene +
in O +
nonlymphoid O +
cells O +
trans O -
- O -
activated O +
reporter O +
plasmids O +
that O +
contained O +
the O +
minimal O +
mu O +
enhancer O +
. O +

These O +
results O +
implicate O +
two O +
members O +
of O +
the O +
Ets B-Gene +
family I-Gene +
in O +
the O +
activation O +
of O +
IgH O +
gene O +
expression O +
. O +

FK506 O +
and O +
ciclosporin O +
: O +
molecular O +
probes O +
for O +
studying O +
intracellular O +
signal O +
transduction O +
. O +

The O +
immunosuppressants O +
ciclosporin O +
and O +
FK506 O +
block O +
the O +
Ca O +
( O +
2 O -
+ O +
) O +
-dependent O +
signal O -
- O -
transduction O +
pathway O +
emanating O +
from O +
the O +
T B-Gene -
- I-Gene -
cell I-Gene +
receptor I-Gene +
, O +
thereby O +
inhibiting O +
the O +
activation O +
of O +
helper O +
T O +
cells O +
. O +

Using O +
these O +
drugs O +
as O +
probes O +
, O +
chemists O +
and O +
biologists O +
have O +
uncovered O +
several O +
intracellular O +
signalling O +
molecules O +
bridging O +
the O +
generation O +
of O +
second O -
- O -
messenger O +
Ca2 O -
+ O +
ions O +
and O +
the O +
transcriptional O +
activation O +
of O +
IL-2 B-Gene +
, O +
among O +
which O +
are O +
calmodulin B-Gene +
, O +
calcineurin B-Gene +
and O +
the O +
nuclear B-Gene +
factor I-Gene +
of I-Gene +
activated I-Gene +
T I-Gene +
cells I-Gene +
( O +
NF B-Gene -
- I-Gene -
AT I-Gene +
) O +
. O +

Hence O +
, O +
Ca2 O -
+ O +
binds O +
to O +
calmodulin B-Gene +
, O +
leading O +
to O +
the O +
binding O +
of O +
calmodulin B-Gene +
to O +
calcineurin B-Gene +
; O +
the O +
activated O +
calcineurin B-Gene +
, O +
in O +
turn O +
, O +
may O +
dephosphorylate O +
the O +
cytoplasmic B-Gene +
subunit I-Gene +
of I-Gene +
NF I-Gene -
- I-Gene -
AT I-Gene +
, O +
resulting O +
in O +
its O +
translocation O +
from O +
the O +
cytoplasm O +
into O +
the O +
nucleus O +
to O +
form O +
a O +
competent B-Gene +
transcriptional I-Gene +
activator I-Gene +
. O +

As O +
described O +
by O +
Jun B-Gene +
Liu O +
, O +
these O +
drugs O +
manifest O +
their O +
effects O +
in O +
an O +
unprecedented O +
fashion O +
. O +

They O +
do O +
not O +
directly O +
intercept O +
intracellular O +
signalling O +
molecules O +
. O +

Instead O +
, O +
they O +
form O +
tight O +
complexes O +
with O +
two O +
different O +
classes O +
of O +
abundant O +
cytosolic B-Gene +
receptors I-Gene +
called O +
immunophilins B-Gene +
upon O +
entering O +
the O +
cell O +
, O +
and O +
consequently O +
inhibit O +
their O +
peptidyl B-Gene +
prolyl I-Gene +
cis I-Gene -
- I-Gene -
trans I-Gene +
isomerase I-Gene +
activities O +
. O +

The O +
two O +
structurally O +
distinct O +
immunophilin B-Gene -
- I-Gene -
drug I-Gene +
complexes I-Gene +
bind O +
to O +
, O +
and O +
inhibit O +
, O +
the O +
phosphatase B-Gene +
activity O +
of O +
calcineurin B-Gene +
. O +

Rhabdomyosarcomas O +
do O +
not O +
contain O +
mutations O +
in O +
the O +
DNA O +
binding O +
domains O +
of O +
myogenic O +
transcription B-Gene +
factors I-Gene +
. O +

Skeletal O +
myogenesis O +
is O +
regulated O +
by O +
a O +
group O +
of O +
transcription B-Gene +
factors I-Gene +
( O +
MyoD B-Gene +
, O +
myogenin B-Gene +
, O +
myf5 B-Gene +
, O +
and O +
myf6 B-Gene +
) O +
that O +
are O +
` B-Gene -
` I-Gene +
basic I-Gene +
helix I-Gene -
- I-Gene -
loop I-Gene -
- I-Gene -
helix I-Gene +
'' I-Gene +
proteins I-Gene +
that O +
bind O +
to O +
the O +
promoters O +
of O +
muscle O -
- O -
specific O +
genes O +
and O +
promote O +
their O +
expression O +
. O +

We O +
have O +
previously O +
shown O +
that O +
after O +
a O +
mutation O +
of O +
Leu122 O +
to O +
Arg O +
the O +
DNA B-Gene +
binding I-Gene +
basic I-Gene +
domain I-Gene +
of O +
MyoD B-Gene +
confers O +
c O -
- O -
myc O +
-like O +
functional O +
characteristics O +
to O +
the O +
protein O +
. O +

In O +
this O +
study O +
we O +
used O +
single O -
- O -
strand O +
conformation O +
polymorphism O +
analysis O +
to O +
determine O +
whether O +
such O +
mutations O +
occur O +
naturally O +
in O +
rhabdomyosarcomas O +
. O +

We O +
have O +
found O +
that O +
the O +
basic B-Gene +
domains I-Gene +
of O +
all O +
the O +
myogenic B-Gene +
factors I-Gene +
remain O +
unaltered O +
in O +
rhabdomyosarcomas O +
. O +

Selection O +
against O +
such O +
mutations O +
may O +
be O +
the O +
result O +
of O +
functional O +
redundancy O +
of O +
these O +
myogenic B-Gene +
transcription I-Gene +
factors I-Gene +
. O +

The O +
SCL B-Gene +
protein I-Gene +
displays O +
cell O -
- O -
specific O +
heterogeneity O +
in O +
size O +
. O +

SCL B-Gene +
protein I-Gene +
production O +
was O +
examined O +
in O +
a O +
variety O +
of O +
hemopoietic O +
cell O +
lines O +
by O +
immunoblotting O +
using O +
specific O +
polyclonal O +
antisera O +
. O +

SCL B-Gene +
protein I-Gene +
was O +
detected O +
in O +
erythroid O +
, O +
megakaryocyte O +
, O +
mast O +
and O +
early O +
myeloid O +
cell O +
lines O +
, O +
as O +
well O +
as O +
in O +
several O +
lymphoid O +
leukemia O +
cell O +
lines O +
which O +
are O +
known O +
to O +
harbor O +
SCL O +
gene O +
rearrangements O +
. O +

In O +
most O +
cell O +
lines O +
, O +
proteins O +
of O +
molecular O +
weight O +
49 O +
and O +
44 O +
kDa O +
were O +
found O +
, O +
however O +
two O +
myeloid O +
cell O +
lines O +
expressed O +
only O +
lower O +
molecular B-Gene +
weight I-Gene +
species I-Gene +
of I-Gene +
24 I-Gene +
and I-Gene +
22 I-Gene +
kDa I-Gene +
. O +

This O +
size O +
discrepancy O +
appeared O +
to O +
be O +
due O +
to O +
cell O -
- O -
specific O +
translational O +
regulation O +
, O +
since O +
overexpression O +
of O +
a O +
retrovirally O +
transfected O +
SCL O +
gene O +
yielded O +
the O +
higher O +
molecular O +
weight O +
forms O +
in O +
most O +
cell O +
lines O +
( O +
GP+E-86 O +
, O +
AT2.5 O +
, O +
M1 O +
) O +
but O +
only O +
the O +
22 B-Gene +
kDa I-Gene +
form I-Gene +
in O +
the O +
myeloid O +
cell O +
line O +
, O +
WEHI-3B O -
/ O -
D+ O +
. O +

Overexpression O +
of O +
full O -
- O -
length O +
SCL B-Gene +
protein I-Gene +
in O +
the O +
lymphoid O +
cell O +
lines O +
, O +
SupT1 O +
and O +
Raji O +
, O +
did O +
not O +
alter O +
cell O +
phenotype O +
and O +
there O +
was O +
no O +
evidence O +
for O +
autoregulation O +
of O +
SCL B-Gene +
transcription O +
. O +

The O +
restricted O +
pattern O +
of O +
SCL B-Gene +
protein I-Gene +
synthesis O +
is O +
consistent O +
with O +
the O +
restricted O +
expression O +
of O +
SCL O +
mRNA O +
documented O +
previously O +
. O +

In O +
addition O +
, O +
the O +
present O +
results O +
indicate O +
that O +
SCL B-Gene +
protein I-Gene +
size O +
was O +
determined O +
by O +
regulation O +
of O +
translation O +
in O +
a O +
cell O -
- O -
specific O +
manner O +
. O +

Activation O +
of O +
the O +
granulocyte O -
- O -
macrophage O +
colony O -
- O -
stimulating O +
factor O +
promoter O +
in O +
T O +
cells O +
requires O +
cooperative O +
binding O +
of O +
Elf-1 B-Gene +
and O +
AP-1 B-Gene +
transcription B-Gene +
factors I-Gene +
. O +

The O +
granulocyte O -
- O -
macrophage O +
colony O -
- O -
stimulating O +
factor O +
( O +
GM O -
- O -
CSF O +
) O +
gene O +
has O +
been O +
studied O +
extensively O +
as O +
a O +
model O +
system O +
of O +
transcriptional O +
induction O +
during O +
T O -
- O -
lymphocyte O +
activation O +
. O +

The O +
GM O -
- O -
CSF O +
gene O +
is O +
not O +
expressed O +
in O +
resting O +
peripheral O +
blood O +
T O +
cells O +
but O +
is O +
rapidly O +
induced O +
at O +
the O +
transcriptional O +
level O +
following O +
activation O +
through O +
the O +
cell B-Gene +
surface I-Gene +
T I-Gene -
- I-Gene -
cell I-Gene +
receptor I-Gene +
. O +

A O +
highly O +
conserved O +
19-bp O +
element O +
located O +
immediately O +
5 O +
' O +
of O +
the O +
human O +
GM O -
- O -
CSF O +
TATA O +
box O +
( O +
bp O +
-34 O +
to O +
-52 O +
) O +
, O +
herein O +
called O +
purine O +
box O +
1 O +
( O +
PB1 O +
) O +
, O +
has O +
been O +
shown O +
to O +
bind O +
a O +
T B-Gene -
- I-Gene -
cell I-Gene +
nuclear I-Gene +
protein I-Gene +
complex I-Gene +
and O +
to O +
be O +
required O +
for O +
transcriptional O +
induction O +
of O +
the O +
GM O -
- O -
CSF O +
gene O +
following O +
T O -
- O -
cell O +
activation O +
. O +

The O +
PB1 O +
sequence O +
motif O +
is O +
highly O +
conserved O +
in O +
both O +
human O +
and O +
murine O +
GM O -
- O -
CSF O +
genes O +
. O +

In O +
this O +
report O +
, O +
we O +
demonstrate O +
that O +
the O +
PB1 O +
element O +
alone O +
confers O +
inducibility O +
on O +
a O +
heterologous O +
promoter O +
following O +
transfection O +
into O +
human O +
Jurkat O +
T O +
cells O +
. O +

In O +
addition O +
, O +
we O +
identify O +
a O +
major O +
PB1 B-Gene +
nuclear I-Gene +
protein I-Gene -
- I-Gene -
binding I-Gene +
complex I-Gene +
that O +
is O +
not O +
present O +
in O +
resting O +
peripheral O +
blood O +
T O +
cells O +
but O +
is O +
rapidly O +
induced O +
following O +
T O -
- O -
cell O +
activation O +
. O +

Sequence O +
analysis O +
revealed O +
that O +
PB1 O +
is O +
composed O +
of O +
adjacent O +
binding O +
sites O +
for O +
Ets B-Gene +
and O +
AP-1 B-Gene +
transcription B-Gene +
factors I-Gene +
. O +

In O +
vitro O +
mutagenesis O +
experiments O +
demonstrated O +
that O +
both O +
the O +
Ets O +
and O +
AP-1 O +
sites O +
are O +
required O +
for O +
binding O +
of O +
the O +
inducible O +
PB1 B-Gene +
nuclear I-Gene +
protein I-Gene +
complex I-Gene +
and O +
for O +
the O +
transcriptional O +
activity O +
of O +
this O +
element O +
and O +
the O +
GM O -
- O -
CSF O +
promoter O +
in O +
activated O +
T O +
cells O +
. O +

( O +
ABSTRACT O +
TRUNCATED O +
AT O +
250 O +
WORDS O +
) O +

Stress O +
response O +
of O +
senescent O +
T O +
lymphocytes O +
: O +
reduced O +
hsp70 B-Gene +
is O +
independent O +
of O +
the O +
proliferative O +
block O +
. O +

Senescent O +
human O +
T O +
lymphocyte O +
cultures O +
are O +
unable O +
to O +
undergo O +
proliferation O +
, O +
but O +
show O +
no O +
difference O +
from O +
early O +
passage O +
cells O +
in O +
cytotoxic O +
function O +
or O +
surface O +
antigenic O +
profile O +
. O +

A O +
second O +
feature O +
of O +
senescent O +
T O +
cells O +
is O +
the O +
dramatic O +
reduction O +
in O +
hsp70 B-Gene +
production O +
in O +
response O +
to O +
heat O +
shock O +
. O +

This O +
decline O +
is O +
associated O +
with O +
a O +
decrease O +
in O +
binding O +
of O +
nuclear O +
extracts O +
to O +
the O +
consensus O +
heat O +
shock O +
element O +
. O +

Interestingly O +
, O +
the O +
progressive O +
decline O +
in O +
the O +
heat O +
shock O +
response O +
of O +
cultured O +
T O +
cells O +
correlates O +
with O +
the O +
percent O +
proliferative O +
life O +
span O +
completed O +
rather O +
than O +
with O +
the O +
actual O +
proliferative O +
activity O +
at O +
the O +
time O +
of O +
heat O +
shock O +
. O +

This O +
suggests O +
that O +
for O +
senescent O +
T O +
cells O +
the O +
reduced O +
ability O +
to O +
respond O +
to O +
heat O +
shock O +
by O +
producing O +
hsp70 B-Gene +
, O +
although O +
possibly O +
lying O +
at O +
the O +
level O +
of O +
transcriptional O +
control O +
, O +
may O +
nevertheless O +
be O +
unrelated O +
to O +
the O +
reduced O +
DNA O +
synthesis O +
or O +
the O +
diminished O +
proliferative O +
activity O +
also O +
manifested O +
by O +
these O +
cells O +
. O +

The O +
interleukin-8 O +
AP-1 O +
and O +
kappa O +
B O -
- O -
like O +
sites O +
are O +
genetic O +
end O +
targets O +
of O +
FK506-sensitive O +
pathway O +
accompanied O +
by O +
calcium O +
mobilization O +
. O +

FK506 O +
, O +
an O +
immunosuppressant O +
, O +
inhibits O +
the O +
production O +
of O +
several O +
cytokines B-Gene +
in O +
T O +
lymphocytes O +
. O +

We O +
observed O +
that O +
FK506 O +
suppressed O +
the O +
transcription O +
of O +
a O +
chemotactic B-Gene +
cytokine I-Gene +
, O +
interleukin-8 B-Gene +
( O +
IL-8 B-Gene +
) O +
in O +
a O +
human O +
T O +
cell O +
line O +
, O +
Jurkat O +
cells O +
, O +
activated O +
by O +
phorbol O +
12-myristate O +
13-acetate O +
( O +
PMA O +
) O +
and O +
calcium O +
( O +
Ca2 O -
+ O +
) O +
ionophore O +
( O +
ionomycin O +
) O +
. O +

By O +
deleted O +
and O +
mutated O +
analysis O +
of O +
the O +
IL-8 O +
promoters O +
, O +
the O +
AP-1 O +
and O +
kappa O +
B O -
- O -
like O +
sites O +
were O +
identified O +
as O +
the O +
responsive O +
elements O +
for O +
PMA O +
and O +
ionomycin O +
. O +

FK506 O +
suppressed O +
the O +
transcriptions O +
through O +
the O +
AP-1 O +
or O +
kappa O +
B O -
- O -
like O +
sites O +
induced O +
by O +
PMA O +
plus O +
Ca O +
( O +
2 O -
+ O +
) O +
-mobilizing O +
agents O +
, O +
but O +
not O +
those O +
induced O +
by O +
Ca O +
( O +
2 O -
+ O +
) O +
-independent O +
stimuli O +
. O +

In O +
gel O +
retardation O +
analysis O +
, O +
FK506 O +
had O +
little O +
effect O +
on O +
the O +
binding O +
to O +
the O +
AP-1 O +
site O +
of O +
PMA O -
/ O -
ionomycin O -
- O -
induced O +
nuclear O +
factors O +
, O +
which O +
were O +
recognized O +
with O +
anti B-Gene -
- I-Gene -
JunD I-Gene +
or O +
c B-Gene -
- I-Gene -
Fos I-Gene +
antibody I-Gene +
. O +

In O +
contrast O +
, O +
FK506 O +
or O +
EGTA O +
( O +
Ca2 O -
+ O +
chelator O +
) O +
similarly O +
affected O +
the O +
formation O +
of O +
kappa B-Gene +
B I-Gene -
- I-Gene -
like I-Gene +
site I-Gene +
binding I-Gene +
complexes I-Gene +
, O +
which O +
were O +
not O +
recognized O +
by O +
any O +
antibodies B-Gene +
against O +
the O +
human B-Gene +
Rel I-Gene +
family I-Gene +
proteins I-Gene +
( O +
c B-Gene -
- I-Gene -
Rel I-Gene +
, O +
p65 B-Gene +
, O +
p50 B-Gene +
, O +
and O +
p49 B-Gene +
) O +
. O +

Furthermore O +
, O +
we O +
confirmed O +
the O +
previous O +
report O +
that O +
FK506 O +
suppressed O +
the O +
PMA O -
/ O -
ionomycin O -
- O -
induced O +
activation O +
through O +
authentic O +
kappa O +
B O +
site O +
of O +
immunoglobulin O +
( O +
Ig O +
) O +
gene O +
, O +
to O +
which O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
binding O +
was O +
also O +
decreased O +
by O +
FK506 O +
, O +
indicating O +
that O +
both O +
IL-8 O +
kappa O +
B O -
- O -
like O +
site O +
and O +
Ig O +
kappa O +
B O +
site O +
are O +
FK506-sensitive O +
in O +
spite O +
of O +
the O +
difference O +
of O +
binding B-Gene +
factors I-Gene +
. O +

Our O +
results O +
indicate O +
that O +
not O +
only O +
the O +
reported O +
IL-2 O +
NF O -
- O -
AT O +
and O +
NFIL-2A O +
sites O +
and O +
Ig O +
kappa O +
B O +
site O +
, O +
but O +
also O +
the O +
IL-8 B-Gene +
AP-1 O +
and O +
kappa O +
B O -
- O -
like O +
sites O +
are O +
terminals O +
of O +
FK506-sensitive O +
pathway O +
involving O +
Ca2 O -
+ O +
mobilization O +
. O +

Activation O +
of O +
a O +
novel O +
serine B-Gene -
/ I-Gene -
threonine I-Gene +
kinase I-Gene +
that O +
phosphorylates O +
c B-Gene -
- I-Gene -
Fos I-Gene +
upon O +
stimulation O +
of O +
T O +
and O +
B O +
lymphocytes O +
via O +
antigen O +
and O +
cytokine B-Gene +
receptors I-Gene +
. O +

Ligation O +
of O +
Ag B-Gene +
receptors I-Gene +
in O +
T O +
and O +
B O +
lymphocytes O +
initiates O +
signal O +
transduction O +
cascades O +
which O +
alter O +
the O +
expression O +
of O +
genes O +
that O +
regulate O +
cellular O +
proliferation O +
and O +
differentiation O +
. O +

The O +
transmission O +
of O +
signals O +
from O +
the O +
membrane O +
to O +
the O +
nucleus O +
is O +
mediated O +
principally O +
through O +
the O +
action O +
of O +
protein B-Gene +
tyrosine I-Gene +
and I-Gene +
serine I-Gene -
/ I-Gene -
threonine I-Gene +
kinases I-Gene +
. O +

We O +
have O +
identified O +
and O +
characterized O +
a O +
novel O +
serine B-Gene -
/ I-Gene -
threonine I-Gene +
kinase I-Gene +
that O +
phosphorylated O +
the O +
proto B-Gene -
- I-Gene -
oncogene I-Gene +
product I-Gene +
, O +
c B-Gene -
- I-Gene -
Fos I-Gene +
, O +
and O +
is O +
termed O +
Fos B-Gene +
kinase I-Gene +
. O +

Fos B-Gene +
kinase I-Gene +
was O +
rapidly O +
activated O +
after O +
ligation O +
of O +
the O +
CD3 B-Gene +
and I-Gene +
CD2 I-Gene +
receptors I-Gene +
in O +
Jurkat O +
and O +
normal O +
human O +
T O +
lymphocytes O +
and O +
in O +
response O +
to O +
IL-6 B-Gene +
and O +
anti B-Gene -
- I-Gene -
IgM I-Gene +
in O +
the O +
human O +
B O +
cell O +
lines O +
AF10 O +
and O +
Ramos O +
, O +
respectively O +
. O +

The O +
phorbol O +
ester O +
, O +
PMA O +
, O +
was O +
also O +
a O +
potent O +
inducer O +
of O +
Fos B-Gene +
kinase I-Gene +
activity O +
in O +
all O +
of O +
the O +
above O +
populations O +
, O +
suggesting O +
that O +
PKC B-Gene +
plays O +
a O +
role O +
in O +
the O +
regulation O +
of O +
this O +
enzyme B-Gene +
. O +

Fos B-Gene +
kinase I-Gene +
phosphorylates O +
c B-Gene -
- I-Gene -
Fos I-Gene +
at O +
a O +
site O +
near O +
the O +
C B-Gene -
- I-Gene -
terminus I-Gene +
, O +
as O +
well O +
as O +
a O +
peptide O +
derived O +
from O +
this O +
region O +
( O +
residues B-Gene +
359 I-Gene -
- I-Gene -
370 I-Gene +
, O +
RKGSSSNEPSSD B-Gene +
) O +
, O +
and O +
Fos O +
peptide O +
competitively O +
inhibited O +
c B-Gene -
- I-Gene -
Fos I-Gene +
phosphorylation O +
. O +

Fos B-Gene +
kinase I-Gene +
was O +
shown O +
to O +
be O +
distinct O +
from O +
other O +
identified O +
serine B-Gene -
/ I-Gene -
threonine I-Gene +
kinases I-Gene +
, O +
including O +
protein B-Gene +
kinase I-Gene +
A I-Gene +
, O +
protein B-Gene +
kinase I-Gene +
C I-Gene +
, O +
casein B-Gene +
kinase I-Gene +
II I-Gene +
, O +
MAP B-Gene +
kinases I-Gene +
, O +
p70S6 B-Gene -
K I-Gene +
and O +
p90RSK B-Gene +
. O +

Fos B-Gene +
kinase I-Gene +
was O +
purified O +
by O +
anion O +
exchange O +
chromatography O +
and O +
exhibited O +
an O +
apparent O +
M O +
( O +
r O +
) O +
= O +
65 O +
, O +
000 O +
and O +
isoelectric O +
point O +
= O +
6.1 O +
. O +

Fos B-Gene +
kinase I-Gene +
may O +
play O +
a O +
role O +
in O +
transcriptional O +
regulation O +
through O +
its O +
capacity O +
to O +
phosphorylate O +
c B-Gene -
- I-Gene -
Fos I-Gene +
at O +
a O +
site O +
required O +
for O +
expression O +
of O +
the O +
transcriptional O +
transrepressive O +
activity O +
of O +
this O +
molecule O +
. O +

Moreover O +
, O +
its O +
rapid O +
activation O +
suggests O +
it O +
may O +
have O +
a O +
wider O +
role O +
within O +
signal O +
transduction O +
cascades O +
in O +
lymphocytes O +
. O +

A O +
novel O +
heterodimerization B-Gene +
partner I-Gene +
for O +
thyroid B-Gene +
hormone I-Gene +
receptor I-Gene +
. O +

Peroxisome B-Gene +
proliferator I-Gene -
- I-Gene -
activated I-Gene +
receptor I-Gene +
. O +

Retinoid B-Gene -
- I-Gene -
like I-Gene +
receptors I-Gene +
play O +
a O +
central O +
role O +
in O +
hormonal O +
responses O +
by O +
forming O +
heterodimers B-Gene +
with O +
other O +
nuclear B-Gene +
hormone I-Gene +
receptors I-Gene +
. O +

In O +
this O +
study O +
we O +
have O +
identified O +
the O +
peroxisome B-Gene +
proliferator I-Gene -
- I-Gene -
activated I-Gene +
receptor I-Gene +
( O +
PPAR B-Gene +
) O +
as O +
a O +
new O +
thyroid B-Gene +
hormone I-Gene +
receptor I-Gene +
( I-Gene +
THR I-Gene +
) I-Gene +
auxiliary I-Gene +
nuclear I-Gene +
protein I-Gene +
, O +
heterodimerizing O +
with O +
THR B-Gene +
in O +
solution O +
. O +

Although O +
these O +
heterodimers B-Gene +
do O +
not O +
recognize O +
a O +
classical O +
thyroid O +
hormone O +
response O +
element O +
( O +
TRE O +
) O +
characterized O +
by O +
direct O +
repeat O +
separated O +
by O +
four O +
nucleotides O +
( O +
DR+4 O +
) O +
, O +
PPAR B-Gene +
behaves O +
as O +
a O +
dominant O +
negative O +
regulator O +
of O +
thyroid O +
hormone O +
( O +
TH O +
) O +
action O +
. O +

However O +
, O +
a O +
TH O -
- O -
dependent O +
positive O +
effect O +
is O +
elicited O +
by O +
selective O +
interaction O +
of O +
the O +
THR B-Gene +
beta I-Gene -
- I-Gene -
PPAR I-Gene +
but O +
not O +
the O +
THR B-Gene +
alpha I-Gene -
- I-Gene -
PPAR I-Gene +
heterodimer I-Gene +
with O +
a O +
novel O +
TRE O +
( O +
DR+2 O +
) O +
. O +

The O +
critical O +
region O +
of O +
THR B-Gene +
beta O +
was O +
mapped O +
to O +
3 O +
amino O +
acids O +
in O +
the O +
distal B-Gene +
box I-Gene +
of O +
the O +
DNA B-Gene +
binding I-Gene +
domain I-Gene +
. O +

Hence O +
, O +
PPAR B-Gene +
can O +
positively O +
or O +
negatively O +
influence O +
TH O +
action O +
depending O +
on O +
TRE O +
structure O +
and O +
THR B-Gene +
isotype I-Gene +
. O +

Hypoxic O +
induction O +
of O +
interleukin-8 O +
gene O +
expression O +
in O +
human O +
endothelial O +
cells O +
. O +

Because O +
leukocyte O -
- O -
mediated O +
tissue O +
damage O +
is O +
an O +
important O +
component O +
of O +
the O +
pathologic O +
picture O +
in O +
ischemia O -
/ O -
reperfusion O +
, O +
we O +
have O +
sought O +
mechanisms O +
by O +
which O +
PMNs O +
are O +
directed O +
into O +
hypoxic O +
tissue O +
. O +

Incubation O +
of O +
human O +
endothelial O +
cells O +
( O +
ECs O +
) O +
in O +
hypoxia O +
, O +
PO2 O +
approximately O +
14 O -
- O -
18 O +
Torr O +
, O +
led O +
to O +
time O -
- O -
dependent O +
release O +
of O +
IL-8 B-Gene +
antigen O +
into O +
the O +
conditioned O +
medium O +
; O +
this O +
was O +
accompanied O +
by O +
increased O +
chemotactic O +
activity O +
for O +
PMNs O +
, O +
blocked O +
by O +
antibody O +
to O +
IL-8 B-Gene +
. O +

Production O +
of O +
IL-8 B-Gene +
by O +
hypoxic O +
ECs O +
occurred O +
concomitantly O +
with O +
both O +
increased O +
levels O +
of O +
IL-8 O +
mRNA O +
, O +
based O +
on O +
polymerase O +
chain O +
reaction O +
analysis O +
, O +
and O +
increased O +
IL-8 B-Gene +
transcription O +
, O +
based O +
on O +
nuclear O +
run O -
- O -
on O +
assays O +
. O +

Northern O +
analysis O +
of O +
mRNA O +
from O +
hypoxic O +
ECs O +
also O +
demonstrated O +
increased O +
levels O +
of O +
mRNA O +
for O +
macrophage B-Gene +
chemotactic I-Gene +
protein-1 I-Gene +
, O +
another O +
member O +
of O +
the O +
chemokine B-Gene +
superfamily I-Gene +
of O +
proinflammatory B-Gene +
cytokines I-Gene +
. O +

IL-8 O +
gene O +
induction O +
was O +
associated O +
with O +
the O +
presence O +
of O +
increased O +
binding O +
activity O +
in O +
nuclear O +
extracts O +
from O +
hypoxic O +
ECs O +
for O +
the O +
NF O -
- O -
kB O +
site O +
. O +

Studies O +
with O +
human O +
umbilical O +
vein O +
segments O +
exposed O +
to O +
hypoxia O +
also O +
demonstrated O +
increased O +
elaboration O +
of O +
IL-8 B-Gene +
antigen I-Gene +
compared O +
with O +
normoxic O +
controls O +
. O +

In O +
mice O +
exposed O +
to O +
hypoxia O +
( O +
PO2 O +
approximately O +
30 O -
- O -
40 O +
Torr O +
) O +
, O +
there O +
was O +
increased O +
pulmonary O +
leukostasis O +
, O +
as O +
evidenced O +
by O +
increased O +
myeloperoxidase B-Gene +
activity O +
in O +
tissue O +
homogenates O +
. O +

In O +
parallel O +
, O +
increased O +
levels O +
of O +
transcripts O +
for O +
IP-10 B-Gene +
, O +
a O +
murine O +
homologue O +
in O +
the O +
chemokine B-Gene +
family I-Gene +
related O +
to O +
IL-8 B-Gene +
, O +
were O +
observed O +
in O +
hypoxic O +
lung O +
tissue O +
. O +

Taken O +
together O +
, O +
these O +
data O +
suggest O +
that O +
hypoxia O +
constitutes O +
a O +
stimulus O +
for O +
leukocyte O +
chemotaxis O +
and O +
tissue O +
leukostasis O +
. O +

Patterns O +
of O +
Pan B-Gene +
expression O +
and O +
role O +
of O +
Pan B-Gene +
proteins I-Gene +
in O +
endocrine O +
cell O +
type O -
- O -
specific O +
complex O +
formation O +
. O +

The O +
Pan O +
gene O +
encodes O +
at O +
least O +
two O +
distinct O +
transcripts O +
, O +
Pan-1 B-Gene +
and O +
Pan-2 B-Gene +
( O +
also O +
known O +
as O +
E47 B-Gene +
and O +
E12 B-Gene +
, O +
respectively O +
) O +
, O +
by O +
the O +
mechanism O +
of O +
alternative O +
RNA O +
splicing O +
. O +

Northern O +
blot O +
analyses O +
performed O +
on O +
rat O +
and O +
mouse O +
tissues O +
have O +
detected O +
ubiquitously O +
expressed O +
Pan O +
transcripts O +
, O +
but O +
the O +
abundance O +
, O +
distribution O +
, O +
and O +
form O +
of O +
Pan B-Gene +
proteins I-Gene +
have O +
not O +
been O +
clearly O +
defined O +
. O +

Studies O +
of O +
cell O +
lines O +
representing O +
endocrine O +
, O +
fibroblast O +
, O +
and O +
lymphoid O +
lineages O +
using O +
polyclonal O +
antisera O +
to O +
detect O +
E2A B-Gene +
proteins I-Gene +
have O +
suggested O +
that O +
significant O +
E2A B-Gene +
protein I-Gene +
expression O +
is O +
restricted O +
to O +
B O -
- O -
lymphocytes O +
. O +

We O +
have O +
developed O +
a O +
monoclonal B-Gene +
antibody I-Gene +
, O +
Yae B-Gene +
, O +
which O +
is O +
specific O +
for O +
Pan B-Gene -
/ I-Gene -
E2A I-Gene +
proteins I-Gene +
, O +
and O +
have O +
used O +
the O +
Yae B-Gene +
antibody I-Gene +
to O +
examine O +
a O +
variety O +
of O +
endocrine O +
and O +
nonendocrine O +
cell O +
lineages O +
for O +
differences O +
in O +
Pan O -
/ O +
E2A B-Gene +
protein I-Gene +
expression O +
, O +
subcellular O +
localization O +
, O +
and O +
heteromeric O +
complex O +
formation O +
. O +

In O +
contrast O +
to O +
previous O +
results O +
obtained O +
using O +
polyclonal O +
antiseras O +
to O +
detect O +
Pan O -
/ O +
E2A B-Gene +
proteins I-Gene +
, O +
we O +
report O +
comparable O +
levels O +
of O +
Pan B-Gene +
proteins I-Gene +
in O +
GH O -
/ O -
PRL- O +
and O +
insulin O -
- O -
producing O +
, O +
B- O +
and O +
T O -
- O -
lymphocyte O +
cells O +
. O +

IEF-1 B-Gene +
, O +
a O +
pancreatic O +
beta O -
- O -
cell O +
type O -
- O -
specific O +
complex O +
believed O +
to O +
regulate O +
insulin O +
expression O +
, O +
is O +
demonstrated O +
to O +
consist O +
of O +
at O +
least O +
two O +
distinct O +
species O +
, O +
one O +
of O +
which O +
does O +
not O +
contain O +
Pan B-Gene +
molecules I-Gene +
. O +

Although O +
it O +
has O +
been O +
postulated O +
that O +
pituitary O +
endocrine O +
cells O +
and O +
pancreatic O +
endocrine O +
beta O -
- O -
cells O +
share O +
identical O +
Pan B-Gene -
/ I-Gene -
E2A I-Gene +
complexes I-Gene +
, O +
native O -
- O -
Western O +
analyses O +
of O +
pituitary O +
and O +
endocrine O +
beta O -
- O -
cells O +
detect O +
Pan B-Gene +
proteins I-Gene +
in O +
distinct O +
cell B-Gene +
type I-Gene -
- I-Gene -
specific I-Gene +
complexes I-Gene +
. O +

Novel O +
aldosterone B-Gene +
receptors I-Gene +
: O +
specificity O -
- O -
conferring O +
mechanism O +
at O +
the O +
level O +
of O +
the O +
cell O +
membrane O +
. O +

Functional O +
studies O +
in O +
extra O -
- O -
renal O +
, O +
nonepithelial O +
cells O +
such O +
as O +
smooth O +
muscle O +
cells O +
and O +
more O +
recently O +
circulating O +
human O +
lymphocytes O +
have O +
provided O +
increasing O +
evidence O +
that O +
aldosterone O +
produces O +
not O +
only O +
classical O +
genomic O +
effects O +
, O +
but O +
also O +
rapid O +
non O -
- O -
genomic O +
effects O +
on O +
transmembrane O +
electrolyte O +
movements O +
. O +

These O +
involve O +
activation O +
of O +
the O +
sodium B-Gene -
/ I-Gene -
proton I-Gene -
- I-Gene -
exchanger I-Gene +
of O +
the O +
cell O +
membrane O +
at O +
very O +
low O +
, O +
physiological O +
concentrations O +
of O +
aldosterone O +
with O +
an O +
acute O +
onset O +
within O +
1 O -
- O -
2 O +
minutes O +
. O +

A O +
second O +
messenger O +
cascade O +
involved O +
is O +
the O +
inositol-1 O +
, O +
4 O +
, O +
5-trisphosphate O -
/ O -
calcium O +
pathway O +
which O +
responds O +
over O +
the O +
same O +
rapid O +
time O +
course O +
. O +

Such O +
changes O +
clearly O +
can O +
not O +
be O +
explained O +
by O +
genomic O +
mechanisms O +
, O +
which O +
are O +
responsible O +
for O +
later O +
effects O +
than O +
the O +
membrane O -
- O -
related O +
rapid O +
responses O +
. O +

In O +
addition O +
to O +
its O +
rapid O +
time O +
course O +
the O +
unique O +
characteristics O +
of O +
this O +
new O +
pathway O +
for O +
steroid O +
action O +
include O +
a O +
10000-fold O +
selectivity O +
for O +
aldosterone O +
over O +
cortisol O +
and O +
the O +
ineffectiveness O +
of O +
spironolactones O +
, O +
classical O +
mineralocorticoid O +
antagonists O +
, O +
as O +
antagonists O +
of O +
the O +
response O +
. O +

Subsequently O +
binding O +
sites O +
have O +
been O +
demonstrated O +
in O +
the O +
plasma O +
membrane O +
of O +
human O +
lymphocytes O +
which O +
show O +
pharmacological O +
( O +
aldosterone O +
specificity O +
) O +
and O +
kinetic O +
( O +
high O +
turnover O +
) O +
properties O +
identical O +
with O +
those O +
of O +
the O +
rapid O +
aldosterone O +
effects O +
in O +
the O +
same O +
cells O +
. O +

SDS O -
- O -
PAGE O +
analysis O +
of O +
the O +
receptor B-Gene +
protein I-Gene +
has O +
shown O +
a O +
molecular O +
weight O +
of O +
approximately O +
50 O +
kD O +
. O +

The O +
present O +
paper O +
reviews O +
the O +
data O +
supporting O +
a O +
new O +
, O +
two O -
- O -
step O +
model O +
for O +
non O -
- O -
genomic O +
and O +
genomic O +
aldosterone O +
effects O +
. O +

It O +
also O +
suggests O +
a O +
novel O +
specificity O -
- O -
conferring O +
mechanism O +
for O +
mineralocorticoid O +
action O +
at O +
the O +
membrane O +
level O +
. O +

Multiple O +
prolactin O -
- O -
responsive O +
elements O +
mediate O +
G1 O +
and O +
S O +
phase O +
expression O +
of O +
the O +
interferon O +
regulatory O +
factor-1 O +
gene O +
. O +

The O +
interferon O +
regulatory O +
factor-1 O +
( O +
IRF-1 O +
) O +
gene O +
is O +
both O +
an O +
immediate O -
- O -
early O +
G1 O +
phase O +
gene O +
and O +
an O +
S O +
phase O +
gene O +
inducible O +
by O +
PRL B-Gene +
in O +
rat O +
Nb2 O +
T O +
lymphocytes O +
. O +

To O +
understand O +
the O +
mechanism O +
by O +
which O +
PRL B-Gene +
regulates O +
the O +
biphasic O +
expression O +
of O +
IRF-1 B-Gene +
, O +
we O +
cloned O +
the O +
rat O +
IRF-1 O +
gene O +
and O +
functionally O +
characterized O +
the O +
IRF-1 O +
promoter O +
. O +

Upon O +
transfection O +
into O +
Nb2 O +
T O +
cells O +
, O +
1.7 O +
kilobases O +
( O +
kb O +
) O +
of O +
IRF-1 O +
5'-flanking O +
DNA O +
linked O +
to O +
a O +
chloramphenicol O +
acetyl O +
transferase O +
( O +
CAT O +
) O +
reporter O +
gene O +
mediated O +
a O +
30-fold O +
induction O +
of O +
CAT B-Gene +
enzyme I-Gene +
activity O +
in O +
response O +
to O +
24 O +
h O +
of O +
PRL B-Gene +
stimulation O +
. O +

Deletion O +
mutants O +
containing O +
1.3 O +
, O +
0.6 O +
, O +
and O +
0.2 O +
kb O +
5'-flanking O +
DNA O +
were O +
incrementally O +
less O +
transcriptionally O +
active O +
, O +
although O +
0.2 O +
kb O +
still O +
mediated O +
a O +
12-fold O +
induction O +
by O +
PRL B-Gene +
. O +

The O +
sequence O +
between O +
-1.7 O +
and O +
-0.2 O +
kb O +
linked O +
to O +
a O +
heterologous O +
thymidine O +
kinase O +
promoter O +
failed O +
to O +
respond O +
to O +
PRL B-Gene +
stimulation O +
, O +
suggesting O +
that O +
the O +
activity O +
of O +
upstream O +
PRL O +
response O +
elements O +
may O +
require O +
an O +
interaction O +
with O +
promoter O -
- O -
proximal O +
elements O +
. O +

By O +
assaying O +
CAT B-Gene +
enzyme I-Gene +
activity O +
across O +
a O +
24-h O +
PRL B-Gene +
induction O +
time O +
course O +
, O +
we O +
were O +
able O +
to O +
assign O +
G1 O +
vs. O +
S O +
phase O +
PRL B-Gene +
responses O +
of O +
the O +
IRF-1 O +
gene O +
to O +
different O +
regions O +
of O +
the O +
IRF-1 B-Gene +
5'-flanking O +
and O +
promoter O +
DNA O +
. O +

The O +
0.2-kb O +
IRF O -
- O -
CAT O +
construct O +
was O +
induced O +
by O +
PRL B-Gene +
stimulation O +
during O +
the O +
G1 O +
phase O +
of O +
the O +
cell O +
cycle O +
. O +

In O +
contrast O +
, O +
the O +
1.7-kb O +
IRF- O +
CAT B-Gene +
construct O +
was O +
inducible O +
by O +
PRL B-Gene +
during O +
both O +
G1 O +
and O +
S O +
phase O +
of O +
the O +
cell O +
cycle O +
. O +

Hence O +
, O +
the O +
PRL B-Gene +
-induced O +
biphasic O +
expression O +
of O +
the O +
IRF-1 O +
gene O +
appears O +
to O +
be O +
controlled O +
by O +
separate O +
PRL O -
- O -
responsive O +
elements O +
: O +
elements O +
in O +
the O +
first O +
0.2 O +
kb O +
of O +
the O +
IRF-1 O +
promoter O +
region O +
act O +
during O +
early O +
activation O +
, O +
and O +
elements O +
between O +
0.2 O +
and O +
1.7 O +
kb O +
act O +
in O +
concert O +
with O +
the O +
proximal O +
0.2-kb O +
region O +
during O +
S O +
phase O +
progression O +
. O +

HLA O -
- O -
DR- O +
, O +
CD33 O -
+ O +
, O +
CD56 O -
+ O +
, O +
CD16- O +
myeloid O -
/ O -
natural O +
killer O +
cell O +
acute O +
leukemia O +
: O +
a O +
previously O +
unrecognized O +
form O +
of O +
acute O +
leukemia O +
potentially O +
misdiagnosed O +
as O +
French O -
- O -
American O -
- O -
British O +
acute O +
myeloid O +
leukemia O -
- O -
M3 O +
[ O +
see O +
comments O +
] O +

We O +
have O +
identified O +
and O +
characterized O +
a O +
previously O +
unrecognized O +
form O +
of O +
acute O +
leukemia O +
that O +
shares O +
features O +
of O +
both O +
myeloid O +
and O +
natural O +
killer O +
( O +
NK O +
) O +
cells O +
. O +

From O +
a O +
consecutive O +
series O +
of O +
350 O +
cases O +
of O +
adult O +
de O +
novo O +
acute O +
myeloid O +
leukemia O +
( O +
AML O +
) O +
, O +
we O +
identified O +
20 O +
cases O +
( O +
6 O +
% O +
) O +
with O +
a O +
unique O +
immunophenotype O +
: O +
CD33 O -
+ O +
, O +
CD56 O -
+ O +
, O +
CD11a+ O +
, O +
CD13lo O +
, O +
CD15lo O +
, O +
CD34+ O -
/ O -
- O +
, O +
HLA B-Gene -
- I-Gene -
DR I-Gene +
- O +
, O +
CD16 B-Gene +
- O +
. O +

Multicolor O +
flow O +
cytometric O +
assays O +
confirmed O +
the O +
coexpression O +
of O +
myeloid B-Gene +
( I-Gene +
CD33 I-Gene +
, I-Gene +
CD13 I-Gene +
, I-Gene +
CD15 I-Gene +
) I-Gene +
and I-Gene +
NK I-Gene +
cell I-Gene -
- I-Gene -
associated I-Gene +
( I-Gene +
CD56 I-Gene +
) I-Gene +
antigens I-Gene +
in O +
each O +
case O +
, O +
whereas O +
reverse O +
transcription O +
polymerase O +
chain O +
reaction O +
( O +
RT O -
- O -
PCR O +
) O +
assays O +
confirmed O +
the O +
identity O +
of O +
CD56 B-Gene +
( O +
neural B-Gene +
cell I-Gene +
adhesion I-Gene +
molecule I-Gene +
) O +
in O +
leukemic O +
blasts O +
. O +

Although O +
two O +
cases O +
expressed O +
CD4 B-Gene +
, O +
no O +
case O +
expressed O +
CD2 B-Gene +
, O +
CD3 B-Gene +
, O +
or O +
CD8 B-Gene +
and O +
no O +
case O +
showed O +
clonal O +
rearrangement O +
of O +
genes O +
encoding O +
the O +
T B-Gene -
- I-Gene -
cell I-Gene +
receptor I-Gene +
( O +
TCR B-Gene +
beta I-Gene +
, I-Gene +
gamma I-Gene +
, I-Gene +
delta I-Gene +
) O +
. O +

Leukemic O +
blasts O +
in O +
the O +
majority O +
of O +
cases O +
shared O +
unique O +
morphologic O +
features O +
( O +
deeply O +
invaginated O +
nuclear O +
membranes O +
, O +
scant O +
cytoplasm O +
with O +
fine O +
azurophilic O +
granularity O +
, O +
and O +
finely O +
granular O +
Sudan O +
black O +
B O +
and O +
myeloperoxidase B-Gene +
cytochemical O +
reactivity O +
) O +
that O +
were O +
remarkably O +
similar O +
to O +
those O +
of O +
acute O +
promyelocytic O +
leukemia O +
( O +
APL O +
) O +
; O +
particularly O +
the O +
microgranular B-Gene +
variant I-Gene +
( O +
FAB B-Gene +
AML I-Gene -
- I-Gene -
M3v I-Gene +
) O +
. O +

However O +
, O +
all O +
20 O +
cases O +
lacked O +
the O +
t O +
( O +
15 O +
; O +
17 O +
) O +
and O +
17 O +
cases O +
tested O +
lacked O +
the O +
promyelocytic O -
/ O -
retinoic O +
acid O +
receptor O +
alpha O +
( O +
RAR O +
alpha O +
) O +
fusion O +
transcript O +
in O +
RT O -
- O -
PCR O +
assays O +
; O +
12 O +
cases O +
had O +
46 O +
, O +
XX O +
or O +
46 O +
, O +
XY O +
karyotypes O +
, O +
whereas O +
2 O +
cases O +
had O +
abnormalities O +
of O +
chromosome O +
17q O +
: O +
1 O +
with O +
del O +
( O +
17 O +
) O +
( O +
q25 O +
) O +
and O +
the O +
other O +
with O +
t O +
( O +
11 O +
; O +
17 O +
) O +
( O +
q23 O +
; O +
q21 O +
) O +
and O +
the O +
promyelocytic O +
leukemia O +
zinc O +
finger O -
/ O -
RAR O +
alpha O +
fusion O +
transcript O +
. O +

All O +
cases O +
tested O +
( O +
6 O -
/ O -
20 O +
) O +
, O +
including O +
the O +
case O +
with O +
t O +
( O +
11 O +
; O +
17 O +
) O +
, O +
failed O +
to O +
differentiate O +
in O +
vitro O +
in O +
response O +
to O +
all O -
- O -
trans O +
retinoic O +
acid O +
( O +
ATRA O +
) O +
, O +
suggesting O +
that O +
these O +
cases O +
may O +
account O +
for O +
some O +
APLs O +
that O +
have O +
not O +
shown O +
a O +
clinical O +
response O +
to O +
ATRA O +
. O +

Four O +
of O +
6 O +
cases O +
tested O +
showed O +
functional O +
NK O +
cell O -
- O -
mediated O +
cytotoxicity O +
, O +
suggesting O +
a O +
relationship O +
between O +
these O +
unique O +
CD33 O -
+ O +
, O +
CD56 O -
+ O +
, O +
CD16 B-Gene +
-acute O +
leukemias O +
and O +
normal O +
CD56 O -
+ O +
, O +
CD16- O +
NK O +
precursor O +
cells O +
. O +

Using O +
a O +
combination O +
of O +
panning O +
and O +
multiparameter O +
flow O +
cytometric O +
sorting O +
, O +
we O +
identified O +
a O +
normal O +
CD56 O -
+ O +
, O +
CD33 O -
+ O +
, O +
CD16- O +
counterpart O +
cell O +
at O +
a O +
frequency O +
of O +
1 O +
% O +
to O +
2 O +
% O +
in O +
the O +
peripheral O +
blood O +
of O +
healthy O +
individuals O +
. O +

Our O +
studies O +
suggest O +
that O +
this O +
form O +
of O +
acute O +
leukemia O +
may O +
arise O +
from O +
transformation O +
of O +
a O +
precursor O +
cell O +
common O +
to O +
both O +
the O +
myeloid O +
and O +
NK O +
cell O +
lineages O +
; O +
thus O +
we O +
propose O +
the O +
designation O +
myeloid O -
/ O -
NK O +
acute O +
leukemia O +
. O +

Recognition O +
of O +
this O +
new O +
leukemic O +
entity O +
will O +
be O +
important O +
in O +
distinguishing O +
these O +
ATRA O -
- O -
nonresponsive O +
cases O +
from O +
ATRA O -
- O -
responsive O +
true O +
APL O +
. O +

Upregulation O +
of O +
bcl-2 O +
by O +
the O +
Epstein B-Gene -
- I-Gene -
Barr I-Gene +
virus I-Gene +
latent I-Gene +
membrane I-Gene +
protein I-Gene +
LMP1 B-Gene +
: O +
a O +
B O -
- O -
cell O -
- O -
specific O +
response O +
that O +
is O +
delayed O +
relative O +
to O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
activation O +
and O +
to O +
induction O +
of O +
cell B-Gene +
surface I-Gene +
markers I-Gene +
. O +

An O +
ability O +
of O +
the O +
Epstein B-Gene -
- I-Gene -
Barr I-Gene +
virus I-Gene +
latent I-Gene +
membrane I-Gene +
protein I-Gene +
LMP1 B-Gene +
to O +
enhance O +
the O +
survival O +
of O +
infected O +
B O +
cells O +
through O +
upregulation O +
of O +
the O +
bcl-2 O +
oncogene O +
was O +
first O +
suggested O +
by O +
experiments O +
involving O +
gene O +
transfection O +
and O +
the O +
selection O +
of O +
stable O +
LMP1 O -
+ O +
clones O +
( O +
S.Henderson O +
, O +
M. O +
Rowe O +
, O +
C.Gregory O +
, O +
F.Wang O +
, O +
E.Kieff O +
, O +
and O +
A.Rickinson O +
, O +
Cell O +
65 O +
: O +
1107 O -
- O -
1115 O +
, O +
1991 O +
) O +
. O +

However O +
, O +
it O +
was O +
not O +
possible O +
to O +
ascertain O +
whether O +
Bcl-2 B-Gene +
upregulation O +
was O +
a O +
specific O +
consequence O +
of O +
LMP1 B-Gene +
expression O +
or O +
an O +
artifact O +
of O +
the O +
selection O +
procedure O +
whereby O +
rare O +
Bcl-2 O -
+ O +
cells O +
already O +
present O +
in O +
the O +
starting O +
population O +
might O +
best O +
be O +
able O +
to O +
tolerate O +
the O +
potentially O +
toxic O +
effects O +
of O +
LMP1 B-Gene +
. O +

We O +
therefore O +
reexamined O +
this O +
issue O +
by O +
using O +
two O +
different O +
experimental O +
approaches O +
that O +
allowed O +
LMP1 B-Gene +
-induced O +
effects O +
to O +
be O +
monitored O +
immediately O +
following O +
expression O +
of O +
the O +
viral O +
protein O +
and O +
in O +
the O +
absence O +
of O +
selective O +
pressures O +
; O +
activation O +
of O +
the O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
transcription B-Gene +
factor I-Gene +
and O +
upregulation O +
of O +
the O +
cell B-Gene +
adhesion I-Gene +
molecule I-Gene +
ICAM-1 B-Gene +
were O +
used O +
as O +
early O +
indices O +
of O +
LMP1 B-Gene +
function O +
. O +

In O +
the O +
first O +
approach O +
, O +
stable O +
clones O +
of O +
two O +
B O -
- O -
cell O +
lines O +
carrying O +
an O +
LMP1 B-Gene +
gene O +
under O +
the O +
control O +
of O +
an O +
inducible O +
metallothionein O +
promoter O +
were O +
induced O +
to O +
express O +
LMP1 B-Gene +
in O +
all O +
cells O +
. O +

Activation O +
of O +
NK B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
and O +
upregulation O +
of O +
ICAM-1 B-Gene +
occurred O +
within O +
24 O +
h O +
and O +
were O +
followed O +
at O +
48 O +
to O +
72 O +
h O +
by O +
upregulation O +
of O +
Bcl-2 B-Gene +
. O +

In O +
the O +
second O +
approach O +
, O +
we O +
tested O +
the O +
generality O +
of O +
this O +
phenomenon O +
by O +
transiently O +
expressing O +
LMP1 B-Gene +
from O +
a O +
strong O +
constitutively O +
active O +
promoter O +
in O +
a O +
range O +
of O +
different O +
cell O +
types O +
. O +

All O +
six O +
B O -
- O -
cell O +
lines O +
tested O +
showed O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
activation O +
in O +
response O +
to O +
LMP1 B-Gene +
expression O +
, O +
and O +
this O +
was O +
followed O +
in O +
five O +
of O +
six O +
lines O +
by O +
expression O +
of O +
ICAM-1 B-Gene +
and O +
Bcl-2 B-Gene +
. O +

In O +
the O +
same O +
experiments O +
, O +
all O +
three O +
non- O +
B O -
- O -
cell O +
lines O +
showed O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
activation O +
and O +
ICAM-1 B-Gene +
upregulation O +
but O +
never O +
any O +
effect O +
upon O +
Bcl-2 B-Gene +
. O +

We O +
therefore O +
conclude O +
that O +
Bcl-2 B-Gene +
upregulation O +
is O +
part O +
of O +
the O +
panoply O +
of O +
cellular O +
changes O +
induced O +
by O +
LMP1 B-Gene +
but O +
that O +
the O +
effect O +
is O +
cell O +
type O +
specific O +
. O +

Our O +
data O +
also O +
suggest O +
that O +
whilst O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
may O +
be O +
an O +
essential O +
component O +
of O +
LMP1 B-Gene +
signal O +
transduction O +
, O +
other O +
cell B-Gene -
- I-Gene -
specific I-Gene +
factors I-Gene +
may O +
be O +
required O +
to O +
effect O +
some O +
functions O +
of O +
the O +
viral B-Gene +
protein I-Gene +
. O +

Epstein O -
- O -
Barr O +
virus O +
( O +
EBV O +
) O +
replicative O +
gene O +
expression O +
in O +
tumour O +
cells O +
of O +
AIDS O -
- O -
related O +
non O -
- O -
Hodgkin O +
's O +
lymphoma O +
in O +
relation O +
to O +
CD4 B-Gene +
cell O +
number O +
and O +
antibody O +
titres O +
to O +
EBV O +
. O +

OBJECTIVE O +
: O +
To O +
determine O +
whether O +
activation O +
of O +
Epstein O -
- O -
Barr O +
virus O +
( O +
EBV O +
) O +
replication O +
in O +
tumour O +
cells O +
of O +
AIDS O -
- O -
related O +
non O -
- O -
Hodgkin O +
's O +
lymphoma O +
( O +
ARNHL O +
) O +
is O +
correlated O +
with O +
CD4 B-Gene -
+ I-Gene +
cell O +
counts O +
and O +
influences O +
antibody O +
response O +
to O +
EBV O +
[ O +
anti B-Gene -
- I-Gene -
Z I-Gene +
Epstein I-Gene -
- I-Gene -
Barr I-Gene +
replicative I-Gene +
activator I-Gene +
( O +
ZEBRA B-Gene +
) O +
, O +
anti B-Gene -
- I-Gene -
early I-Gene +
antigen I-Gene +
( O +
EA B-Gene +
) O +
, O +
anti B-Gene -
- I-Gene -
viral I-Gene +
capsid I-Gene +
antigen I-Gene +
( O +
VCA B-Gene +
) O +
] O +
. O +

DESIGN O +
: O +
Retrospective O +
study O +
based O +
on O +
immunohistochemistry O +
and O +
in O +
situ O +
hybridization O +
to O +
detect O +
EBV O +
replicative O +
gene O +
products O +
in O +
tissue O +
samples O +
from O +
patients O +
affected O +
by O +
ARNHL O +
and O +
correlation O +
with O +
CD4 B-Gene -
+ I-Gene +
cell O +
counts O +
and O +
results O +
of O +
EBV O +
serology O +
( O +
including O +
anti- O +
ZEBRA B-Gene +
activity O +
) O +
in O +
sera O +
from O +
the O +
same O +
patients O +
. O +

METHODS O +
: O +
Seventeen O +
out O +
of O +
22 O +
cases O +
of O +
ARNHL O +
were O +
selected O +
for O +
the O +
presence O +
of O +
EBV O +
[ O +
Epstein O -
- O -
Barr O +
early O +
region O +
( O +
EBER O +
) O +
RNA O -
- O -
positive O +
] O +
. O +

Immunohistochemistry O +
was O +
performed O +
with O +
anti B-Gene -
- I-Gene -
ZEBRA I-Gene +
, O +
anti B-Gene -
- I-Gene -
EA I-Gene -
- I-Gene -
restricted I-Gene +
, I-Gene +
anti I-Gene -
- I-Gene -
VCA I-Gene +
antibodies I-Gene +
and O +
in O +
situ O +
hybridization O +
with O +
BHLF1 O -
/ O -
NotI O +
oligoprobes O +
on O +
tumour O +
samples O +
. O +

Results O +
were O +
statistically O +
correlated O +
with O +
those O +
of O +
CD4 B-Gene -
+ I-Gene +
cell O +
counts O +
( O +
17 O +
out O +
of O +
17 O +
) O +
and O +
with O +
anti O -
- O -
EBV O +
antibody O +
titres O +
( O +
13 O +
out O +
of O +
17 O +
) O +
assessed O +
using O +
standard O +
immunofluorescence O +
method O +
and O +
enzyme O -
- O -
linked O +
immunosorbent O +
assay O +
procedure O +
using O +
recombinant B-Gene +
ZEBRA I-Gene +
protein I-Gene +
and O +
synthetic O +
peptides O +
as O +
antigens B-Gene +
. O +

RESULTS O +
: O +
BZLF1 B-Gene +
( O +
ZEBRA B-Gene +
) O +
or O +
early B-Gene +
gene I-Gene +
products I-Gene +
( O +
EA B-Gene -
- I-Gene -
R I-Gene +
and O +
EA B-Gene -
- I-Gene -
D I-Gene -
/ I-Gene -
BHLF1 I-Gene -
/ I-Gene -
NotI I-Gene +
) O +
were O +
detected O +
in O +
a O +
small O +
proportion O +
( O +
< O +
0.01 O -
- O -
5 O +
% O +
) O +
of O +
tumour O +
cells O +
in O +
eight O +
of O +
these O +
17 O +
cases O +
by O +
immunohistochemistry O +
and O +
in O +
situ O +
hybridization O +
. O +

Demonstration O +
of O +
replicative O +
gene O +
expression O +
did O +
not O +
correlate O +
with O +
either O +
low O +
CD4 B-Gene -
+ I-Gene +
cell O +
counts O +
( O +
P O +
> O +
0.05 O +
) O +
or O +
anti O -
- O -
EBV O +
antibody O +
titres O +
( O +
P O +
> O +
0.05 O +
) O +
. O +

Anti- O +
ZEBRA B-Gene +
activity O +
was O +
not O +
significantly O +
increased O +
in O +
patients O +
affected O +
with O +
ARNHL O +
, O +
the O +
cells O +
of O +
which O +
expressed O +
replicative O +
gene O +
products O +
( O +
P O +
> O +
0.05 O +
) O +
. O +

CONCLUSION O +
: O +
The O +
degree O +
of O +
immunodeficiency O +
does O +
not O +
clearly O +
enhance O +
replicative O +
gene O +
expression O +
in O +
tumour O +
cells O +
of O +
ARNHL O +
. O +

EBV O +
serology O +
, O +
including O +
anti- O +
ZEBRA B-Gene +
activity O +
, O +
is O +
not O +
a O +
reliable O +
tool O +
for O +
predicting O +
the O +
occurrence O +
of O +
such O +
proliferations O +
. O +

Displacement O +
of O +
an O +
E B-Gene -
- I-Gene -
box I-Gene -
- I-Gene -
binding I-Gene +
repressor I-Gene +
by O +
basic B-Gene +
helix I-Gene -
- I-Gene -
loop I-Gene -
- I-Gene -
helix I-Gene +
proteins I-Gene +
: O +
implications O +
for O +
B O -
- O -
cell O +
specificity O +
of O +
the O +
immunoglobulin O +
heavy O -
- O -
chain O +
enhancer O +
. O +

The O +
activity O +
of O +
the O +
immunoglobulin O +
heavy O -
- O -
chain O +
( O +
IgH O +
) O +
enhancer O +
is O +
restricted O +
to O +
B O +
cells O +
, O +
although O +
it O +
binds O +
both O +
B B-Gene -
- I-Gene -
cell I-Gene -
- I-Gene -
restricted I-Gene +
and I-Gene +
ubiquitous I-Gene +
transcription I-Gene +
factors I-Gene +
. O +

Activation O +
of O +
the O +
enhancer O +
in O +
non O -
- O -
B O +
cells O +
upon O +
overexpression O +
of O +
the O +
basic B-Gene +
helix I-Gene -
- I-Gene -
loop I-Gene -
- I-Gene -
helix I-Gene +
( I-Gene +
bHLH I-Gene +
) I-Gene +
protein I-Gene +
E2A B-Gene +
appears O +
to O +
be O +
mediated O +
not O +
only O +
by O +
the O +
binding O +
of O +
E2A B-Gene +
to O +
its O +
cognate O +
E O +
box O +
but O +
also O +
by O +
the O +
resulting O +
displacement O +
of O +
a O +
repressor B-Gene +
from O +
that O +
same O +
site O +
. O +

We O +
have O +
identified O +
a O +
` B-Gene -
` I-Gene +
two I-Gene -
- I-Gene -
handed I-Gene +
'' I-Gene +
zinc I-Gene +
finger I-Gene +
protein I-Gene +
, O +
denoted O +
ZEB B-Gene +
, O +
the O +
DNA O -
- O -
binding O +
specificity O +
of O +
which O +
mimics O +
that O +
of O +
the O +
cellular B-Gene +
repressor I-Gene +
. O +

By O +
employing O +
a O +
derivative O +
E O +
box O +
that O +
binds O +
ZEB B-Gene +
but O +
not O +
E2A B-Gene +
, O +
we O +
have O +
shown O +
that O +
the O +
repressor B-Gene +
is O +
active O +
in O +
B O +
cells O +
and O +
the O +
IgH O +
enhancer O +
is O +
silenced O +
in O +
the O +
absence O +
of O +
binding O +
competition O +
by O +
bHLH B-Gene +
proteins I-Gene +
. O +

Hence O +
, O +
we O +
propose O +
that O +
a O +
necessary O +
prerequisite O +
of O +
enhancer O +
activity O +
is O +
the O +
B O -
- O -
cell O -
- O -
specific O +
displacement O +
of O +
a O +
ZEB B-Gene -
- I-Gene -
like I-Gene +
repressor I-Gene +
by O +
bHLH B-Gene +
proteins I-Gene +
. O +

Appraisal O +
of O +
potential O +
therapeutic O +
index O +
of O +
antioxidants O +
on O +
the O +
basis O +
of O +
their O +
in O +
vitro O +
effects O +
on O +
HIV O +
replication O +
in O +
monocytes O +
and O +
interleukin B-Gene +
2 I-Gene +
-induced O +
lymphocyte O +
proliferation O +
. O +

Antioxidant O +
molecules O +
have O +
been O +
suggested O +
to O +
be O +
of O +
therapeutic O +
value O +
in O +
the O +
treatment O +
of O +
HIV O -
- O -
infected O +
patients O +
. O +

To O +
evaluate O +
this O +
possibility O +
, O +
we O +
examined O +
in O +
vitro O +
the O +
effects O +
of O +
two O +
types O +
of O +
antioxidant O +
molecules O +
in O +
terms O +
of O +
inhibition O +
of O +
HIV O +
replication O +
in O +
monocytes O +
, O +
one O +
of O +
the O +
main O +
reservoirs O +
of O +
HIV O +
, O +
and O +
also O +
in O +
terms O +
of O +
modulation O +
of O +
the O +
immune O +
competence O +
as O +
measured O +
by O +
PBMC O +
proliferation O +
. O +

We O +
tested O +
the O +
effects O +
of O +
BHA O +
, O +
a O +
phenolic O +
, O +
lipid O -
- O -
soluble O +
, O +
chain O -
- O -
breaking O +
antioxidant O +
, O +
and O +
NAC O +
, O +
a O +
known O +
glutathione O +
precursor O +
with O +
some O +
direct O +
free O -
- O -
radical O +
scavenging O +
properties O +
as O +
well O +
, O +
on O +
the O +
regulation O +
of O +
HIV-1 O +
expression O +
in O +
latently O +
infected O +
U1 O +
cells O +
and O +
in O +
productively O +
and O +
chronically O +
infected O +
U937 O +
cells O +
. O +

Both O +
antioxidants O +
inhibited O +
TNF B-Gene +
-or O +
PMA O -
- O -
induced O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
activity O +
in O +
U1 O +
cells O +
, O +
as O +
well O +
as O +
the O +
sustained O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
activity O +
permanently O +
induced O +
by O +
the O +
virus O +
itself O +
in O +
chronically O +
HIV O -
- O -
infected O +
U937 O +
cells O +
. O +

This O +
resulted O +
in O +
only O +
a O +
partial O +
inhibition O +
of O +
TNF B-Gene +
-or O +
PMA- O +
induced O +
HIV O +
replication O +
in O +
U1 O +
cells O +
, O +
and O +
no O +
detectable O +
effect O +
on O +
HIV O +
replication O +
in O +
chronically O +
infected O +
U937 O +
cells O +
. O +

This O +
may O +
be O +
the O +
first O +
limitation O +
to O +
potential O +
antiviral O +
effects O +
of O +
antioxidant O +
therapies O +
. O +

Another O +
limitation O +
is O +
that O +
antioxidant O +
concentrations O +
high O +
enough O +
to O +
block O +
NK B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
activation O +
were O +
shown O +
to O +
have O +
a O +
suppressive O +
effect O +
on O +
immune O +
functions O +
in O +
vitro O +
, O +
because O +
NAC O +
and O +
BHA O +
blocked O +
IL-2-induced O +
PBMC O +
proliferation O +
. O +

These O +
data O +
warrant O +
prudence O +
in O +
the O +
design O +
of O +
antioxidant O -
- O -
based O +
therapies O +
aimed O +
at O +
suppressing O +
HIV O +
replication O +
. O +

A O +
low O +
NM23.H1 O +
gene O +
expression O +
identifying O +
high O +
malignancy O +
human O +
melanomas O +
. O +

The O +
NM23 O +
gene O +
has O +
been O +
proposed O +
as O +
a O +
metastasis O -
- O -
suppressor O +
gene O +
, O +
and O +
its O +
use O +
has O +
been O +
suggested O +
as O +
prognostic O +
factor O +
. O +

NM23 B-Gene +
was O +
identified O +
in O +
a O +
system O +
of O +
murine O +
melanoma O +
cell O +
lines O +
, O +
in O +
which O +
an O +
inverse O +
relationship O +
was O +
found O +
between O +
NM23 B-Gene +
expression O +
and O +
metastatic O +
ability O +
. O +

In O +
a O +
human O +
malignant O +
melanoma O +
study O +
NM23 B-Gene +
expression O +
was O +
found O +
to O +
be O +
significantly O +
lower O +
in O +
metastases O +
that O +
developed O +
less O +
than O +
24 O +
months O +
after O +
diagnosis O +
of O +
the O +
primary O +
tumours O +
. O +

The O +
present O +
paper O +
studies O +
the O +
expression O +
of O +
the O +
NM23.H1 O +
gene O +
in O +
cell O +
lines O +
which O +
derive O +
from O +
primary O +
or O +
metastatic O +
human O +
malignant O +
melanomas O +
in O +
relation O +
to O +
staging O +
, O +
infiltration O +
degree O +
, O +
lymphocytic O +
infiltration O +
, O +
cell O +
morphology O +
, O +
cell O +
pigmentation O +
, O +
karyotype O +
, O +
and O +
disease O -
- O -
free O +
survival O +
. O +

The O +
level O +
of O +
mRNA O +
expression O +
of O +
the O +
NM23 O +
gene O +
is O +
significantly O +
lower O +
in O +
cell O +
lines O +
that O +
derive O +
from O +
more O +
infiltrating O +
primary O +
melanomas O +
than O +
in O +
cell O +
lines O +
obtained O +
from O +
less O +
infiltrating O +
tumours O +
. O +

Moreover O +
, O +
cell O +
lines O +
derived O +
from O +
tumours O +
of O +
patients O +
with O +
a O +
disease O -
- O -
free O +
survival O +
of O +
more O +
than O +
24 O +
months O +
( O +
24 O -
- O -
58 O +
months O +
) O +
express O +
the O +
NM23 O +
gene O +
at O +
higher O +
levels O +
than O +
cell O +
lines O +
obtained O +
from O +
melanomas O +
of O +
patients O +
with O +
a O +
disease O -
- O -
free O +
survival O +
of O +
less O +
than O +
24 O +
months O +
( O +
6 O -
- O -
15 O +
months O +
) O +
. O +

Glucocorticoid O -
- O -
induced O +
apoptosis O +
of O +
lymphoid O +
cells O +
. O +

The O +
induction O +
of O +
cell O +
death O +
in O +
lymphoid O +
cells O +
by O +
glucocorticoids O +
is O +
one O +
of O +
the O +
earliest O +
and O +
most O +
thoroughly O +
studied O +
models O +
of O +
apoptosis O +
. O +

Although O +
the O +
exact O +
mechanism O +
by O +
which O +
apoptosis O +
occurs O +
in O +
lymphocytes O +
is O +
unknown O +
many O +
biochemical O +
and O +
molecular O +
changes O +
have O +
been O +
shown O +
to O +
occur O +
in O +
these O +
cells O +
in O +
response O +
to O +
glucocorticoids O +
. O +

The O +
role O +
of O +
chromatin O +
degradation O +
and O +
endonucleases B-Gene +
in O +
the O +
apoptotic O +
process O +
has O +
been O +
closely O +
studied O +
, O +
as O +
well O +
as O +
the O +
involvement O +
of O +
several O +
oncogenes O +
in O +
glucocorticoid O -
- O -
induced O +
cell O +
lysis O +
. O +

In O +
addition O +
, O +
the O +
clinical O +
importance O +
of O +
glucocorticoid O -
- O -
induced O +
apoptosis O +
in O +
the O +
treatment O +
of O +
lymphoid O +
neoplasms O +
has O +
recently O +
received O +
increased O +
attention O +
. O +

Inhibition O +
of O +
human O +
immunodeficiency O +
virus O +
type O +
1 O +
replication O +
by O +
a O +
Tat O -
- O -
activated O +
, O +
transduced O +
interferon O +
gene O +
: O +
targeted O +
expression O +
to O +
human O +
immunodeficiency O +
virus O +
type O +
1-infected O +
cells O +
. O +

We O +
have O +
examined O +
the O +
feasibility O +
of O +
using O +
interferon B-Gene +
( O +
IFN B-Gene +
) O +
gene O +
transfer O +
as O +
a O +
novel O +
approach O +
to O +
anti O -
- O -
human O +
immunodeficiency O +
virus O +
type O +
1 O +
( O +
HIV-1 O +
) O +
therapy O +
in O +
this O +
study O +
. O +

To O +
limit O +
expression O +
of O +
a O +
transduced O +
HIV-1 O +
long O +
terminal O +
repeat O +
( O +
LTR O +
) O +
-IFNA2 O +
( O +
the O +
new O +
approved O +
nomenclature O +
for O +
IFN O +
genes O +
is O +
used O +
throughout O +
this O +
article O +
) O +
hybrid O +
gene O +
to O +
the O +
HIV-1-infected O +
cells O +
, O +
HIV-1 O +
LTR O +
was O +
modified O +
. O +

Deletion O +
of O +
the O +
NF O -
- O -
kappa O +
B O +
elements O +
of O +
the O +
HIV-1 O +
LTR O +
significantly O +
inhibited O +
Tat B-Gene +
-mediated O +
transactivation O +
in O +
T O -
- O -
cell O +
lines O +
, O +
as O +
well O +
as O +
in O +
a O +
monocyte O +
line O +
, O +
U937 O +
. O +

Replacement O +
of O +
the O +
NF O -
- O -
kappa O +
B O +
elements O +
in O +
the O +
HIV-1 O +
LTR O +
by O +
a O +
DNA O +
fragment O +
derived O +
from O +
the O +
5'-flanking O +
region O +
of O +
IFN O -
- O -
stimulated O +
gene O +
15 O +
( O +
ISG15 O +
) O +
, O +
containing O +
the O +
IFN O -
- O -
stimulated O +
response O +
element O +
, O +
partially O +
restored O +
Tat B-Gene +
-mediated O +
activation O +
of O +
LTR O +
in O +
T O +
cells O +
as O +
well O +
as O +
in O +
monocytes O +
. O +

Insertion O +
of O +
this O +
chimeric O +
promoter O +
( O +
ISG15 O +
LTR O +
) O +
upstream O +
of O +
the O +
human O +
IFNA2 O +
gene O +
directed O +
high O +
levels O +
of O +
IFN B-Gene +
synthesis O +
in O +
Tat O -
- O -
expressing O +
cells O +
, O +
while O +
this O +
promoter O +
was O +
not O +
responsive O +
to O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
alpha I-Gene +
-mediated O +
activation O +
. O +

ISG15-LTR O -
- O -
IFN O +
hybrid O +
gene O +
inserted O +
into O +
the O +
retrovirus O +
vector O +
was O +
transduced O +
into O +
Jurkat O +
and O +
U937 O +
cells O +
. O +

Selected O +
transfected O +
clones O +
produced O +
low O +
levels O +
of O +
IFN B-Gene +
A I-Gene +
( O +
IFNA B-Gene +
) O +
constitutively O +
, O +
and O +
their O +
abilities O +
to O +
express O +
interleukin-2 B-Gene +
and O +
interleukin-2 B-Gene +
receptor I-Gene +
upon O +
stimulation O +
with O +
phytohemagglutinin B-Gene +
and O +
phorbol O +
myristate O +
acetate O +
were O +
retained O +
. O +

Enhancement O +
of O +
IFNA B-Gene +
synthesis O +
observed O +
upon O +
HIV-1 O +
infection O +
resulted O +
in O +
significant O +
inhibition O +
of O +
HIV-1 O +
replication O +
for O +
a O +
period O +
of O +
at O +
least O +
30 O +
days O +
. O +

Virus O +
isolated O +
from O +
IFNA O -
- O -
producing O +
cells O +
was O +
able O +
to O +
replicate O +
in O +
the O +
U937 O +
cells O +
but O +
did O +
not O +
replicate O +
efficiently O +
in O +
U937 O +
cells O +
transduced O +
with O +
the O +
IFNA O +
gene O +
. O +

These O +
results O +
suggest O +
that O +
targeting O +
IFN B-Gene +
synthesis O +
to O +
HIV-1-infected O +
cells O +
is O +
an O +
attainable O +
goal O +
and O +
that O +
autocrine O +
IFN B-Gene +
synthesis O +
results O +
in O +
a O +
long O -
- O -
lasting O +
and O +
permanent O +
suppression O +
of O +
HIV-1 O +
replication O +
. O +

No O +
evidence O +
for O +
the O +
expression O +
of O +
the O +
progesterone B-Gene +
receptor I-Gene +
on O +
peripheral O +
blood O +
lymphocytes O +
during O +
pregnancy O +
[ O +
see O +
comments O +
] O +

The O +
expression O +
of O +
the O +
progesterone B-Gene +
receptor I-Gene +
in O +
human O +
peripheral O +
blood O +
lymphocytes O +
was O +
analysed O +
, O +
using O +
an O +
enzyme O +
linked O +
immunosorbent O +
assay O +
( O +
Abbott O +
PgR O -
- O -
EIA O +
monoclonal O +
) O +
, O +
in O +
order O +
to O +
evaluate O +
its O +
prognostic O +
character O +
in O +
the O +
context O +
of O +
spontaneous O +
abortion O +
. O +

Cytosols O +
were O +
prepared O +
from O +
lymphocytes O +
of O +
24 O +
healthy O +
pregnant O +
women O +
( O +
11 O +
first O +
, O +
10 O +
second O +
and O +
three O +
third O +
trimester O +
) O +
, O +
seven O +
healthy O +
non O -
- O -
pregnant O +
women O +
, O +
nine O +
women O +
with O +
recurrent O +
spontaneous O +
abortion O +
, O +
and O +
six O +
healthy O +
men O +
. O +

In O +
addition O +
, O +
a O +
human O +
breast O +
carcinoma O +
cell O +
line O +
( O +
ZR-75 O -
- O -
1 O +
) O +
, O +
which O +
expresses O +
the O +
progesterone B-Gene +
receptor I-Gene +
, O +
was O +
analysed O +
throughout O +
. O +

The O +
ZR-75 O -
- O -
1 O +
cell O +
line O +
showed O +
an O +
expression O +
of O +
642 O +
fmol O -
/ O -
mg O +
whereas O +
lymphocytes O +
of O +
pregnant O +
women O +
showed O +
an O +
expression O +
< O +
or O +
= O +
4 O +
fmol O -
/ O -
mg O +
. O +

Lymphocytes O +
of O +
non O -
- O -
pregnant O +
women O +
, O +
women O +
with O +
threatened O +
pre O -
- O -
term O +
delivery O +
, O +
and O +
men O +
showed O +
equivalent O +
levels O +
: O +
3 O +
+ O -
/- O +
1 O +
, O +
3 O +
+ O -
/- O +
2 O +
and O +
5 O +
+ O -
/- O +
4 O +
fmol O -
/ O -
mg O +
respectively O +
. O +

These O +
results O +
show O +
that O +
there O +
is O +
no O +
evidence O +
of O +
specific O +
expression O +
of O +
the O +
progesterone B-Gene +
receptor I-Gene +
in O +
pregnancy O +
and O +
exclude O +
any O +
prognostic O +
character O +
in O +
spontaneous O +
abortion O +
. O +

A O +
role O +
for O +
the O +
progesterone B-Gene +
receptor I-Gene +
in O +
the O +
mechanism O +
of O +
the O +
known O +
effect O +
of O +
progesterone O +
on O +
peripheral O +
blood O +
lymphocytes O +
is O +
also O +
excluded O +
. O +

Characterization O +
of O +
the O +
CD48 O +
gene O +
demonstrates O +
a O +
positive O +
element O +
that O +
is O +
specific O +
to O +
Epstein O -
- O -
Barr O +
virus O -
- O -
immortalized O +
B O -
- O -
cell O +
lines O +
and O +
contains O +
an O +
essential O +
NF O -
- O -
kappa O +
B O +
site O +
. O +

Epstein O -
- O -
Barr O +
virus O +
( O +
EBV O +
) O +
infection O +
of O +
mature O +
, O +
resting O +
B O +
cells O +
drives O +
them O +
to O +
become O +
lymphoblasts O +
expressing O +
high O +
levels O +
of O +
cell O +
surface O +
molecules O +
, O +
such O +
as O +
CD48 B-Gene +
, O +
characteristically O +
expressed O +
on O +
normal O +
activated O +
B O +
cells O +
. O +

Here O +
, O +
we O +
report O +
on O +
the O +
identification O +
of O +
an O +
enhancer O +
element O +
in O +
the O +
CD48 O +
gene O +
which O +
reproducibly O +
confers O +
strong O +
transcriptional O +
activity O +
only O +
in O +
EBV O -
- O -
positive O +
B O -
- O -
lymphoblastoid O +
cell O +
lines O +
. O +

The O +
element O +
is O +
not O +
activated O +
upon O +
infection O +
of O +
established O +
EBV O -
- O -
negative O +
B O -
- O -
cell O +
lines O +
, O +
indicating O +
that O +
EBV O +
fails O +
to O +
drive O +
these O +
cells O +
to O +
a O +
fully O +
lymphoblastoid O +
phenotype O +
. O +

An O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
binding O +
site O +
is O +
an O +
essential O +
component O +
of O +
the O +
element O +
but O +
alone O +
is O +
not O +
sufficient O +
to O +
account O +
for O +
the O +
activity O +
or O +
the O +
specificity O +
of O +
the O +
element O +
. O +

We O +
have O +
detected O +
a O +
specific O +
nuclear B-Gene +
protein I-Gene +
complex I-Gene +
that O +
binds O +
to O +
the O +
element O +
and O +
show O +
that O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B1 I-Gene +
( O +
p50 B-Gene +
) O +
is O +
a O +
part O +
of O +
this O +
complex O +
. O +

The O +
EBV B-Gene -
- I-Gene -
encoded I-Gene +
latent I-Gene +
membrane I-Gene +
protein I-Gene +
1 I-Gene +
is O +
capable O +
of O +
transactivating O +
the O +
isolated O +
CD48 B-Gene +
NF O -
- O -
kappa O +
B O +
site O +
but O +
not O +
the O +
intact O +
element O +
, O +
suggesting O +
that O +
the O +
latent B-Gene +
membrane I-Gene +
protein I-Gene +
1 I-Gene +
-driven O +
activation O +
of O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene -
/ I-Gene -
Rel I-Gene +
must O +
interact O +
with O +
other O +
regulatory O +
pathways O +
to O +
control O +
expression O +
of O +
cellular O +
genes O +
as O +
EBV O +
drives O +
resting O +
B O +
cells O +
into O +
the O +
cell O +
cycle O +
. O +

Activation O +
of O +
human O +
thymocytes O +
after O +
infection O +
by O +
EBV O +
. O +

The O +
discovery O +
of O +
EBV O +
in O +
certain O +
T O +
cell O +
malignancies O +
and O +
the O +
expression O +
of O +
the O +
EBV B-Gene +
receptor I-Gene +
, O +
CR2 B-Gene -
/ I-Gene -
CD21 I-Gene +
, O +
on O +
a O +
population O +
of O +
immature O +
thymocytes O +
, O +
T O +
lymphoblastoid O +
cell O +
lines O +
, O +
and O +
childhood O +
acute O +
T O +
lymphoblastic O +
leukemia O +
cells O +
suggested O +
that O +
EBV O -
- O -
receptor O +
interactions O +
on O +
T O +
cells O +
may O +
be O +
of O +
importance O +
. O +

We O +
have O +
shown O +
that O +
, O +
within O +
the O +
thymus O +
, O +
a O +
population O +
of O +
large O +
, O +
immature O +
cells O +
expresses O +
CD21 B-Gene +
. O +

EBV O +
altered O +
the O +
activation O +
responses O +
of O +
immature O +
thymocytes O +
in O +
vitro O +
. O +

Triggering O +
through O +
CD2 B-Gene +
is O +
mitogenic O +
for O +
mature O +
, O +
but O +
not O +
immature O +
, O +
T O +
cells O +
. O +

However O +
, O +
during O +
infection O +
by O +
EBV O +
, O +
ligation O +
of O +
CD2 B-Gene +
caused O +
thymocytes O +
to O +
proliferate O +
in O +
the O +
absence O +
of O +
exogenous B-Gene +
cytokines I-Gene +
. O +

This O +
function O +
was O +
a O +
result O +
of O +
the O +
interaction O +
of O +
EBV O +
with O +
its O +
receptor O +
, O +
CD21 B-Gene +
, O +
but O +
was O +
caused O +
by O +
infection O +
rather O +
than O +
surface O +
signaling O +
, O +
because O +
neither O +
specific B-Gene +
mAb I-Gene +
nor O +
the O +
P3HR-1 O +
strain O +
of O +
virus O +
mimicked O +
the O +
effect O +
of O +
B95 O -
- O -
8 O +
. O +

Immature O +
thymocytes O +
were O +
infected O +
by O +
EBV O +
, O +
as O +
determined O +
by O +
the O +
internalization O +
of O +
the O +
viral O +
genome O +
and O +
its O +
transcriptional O +
activity O +
. O +

Consistent O +
with O +
the O +
activity O +
of O +
B95 B-Gene -
- I-Gene -
8 I-Gene +
, O +
EBNA-2 O +
transcripts O +
were O +
identified O +
within O +
infected O +
thymocyte O +
populations O +
. O +

In O +
addition O +
, O +
components O +
of O +
the O +
viral O +
replicative O +
pathway O +
were O +
expressed O +
during O +
infection O +
of O +
thymocytes O +
. O +

These O +
components O +
included O +
transcription O +
of O +
BZLF-1 O +
, O +
an O +
early O +
gene O +
that O +
characterizes O +
EBV O -
- O -
infected O +
B O +
cells O +
after O +
disruption O +
of O +
latency O +
. O +

A O +
second O +
transcript O +
was O +
identified O +
as O +
encoding O +
the O +
recently O +
characterized O +
RAZ B-Gene +
, O +
which O +
also O +
is O +
associated O +
with O +
replicative O +
infection O +
. O +

The O +
consequences O +
of O +
EBV O +
infection O +
of O +
T O +
cells O +
at O +
an O +
early O +
stage O +
of O +
differentiation O +
may O +
lead O +
to O +
failure O +
of O +
normal O +
T O +
cell O +
repertoire O +
development O +
, O +
autoimmunity O +
, O +
or O +
malignancy O +
. O +

Protein B-Gene +
kinase I-Gene +
C I-Gene +
is O +
not O +
a O +
downstream O +
effector O +
of O +
p21ras O +
in O +
activated O +
T O +
cells O +
. O +

The O +
aim O +
of O +
this O +
present O +
study O +
was O +
to O +
investigate O +
the O +
role O +
of O +
protein B-Gene +
kinase I-Gene +
C I-Gene +
( O +
PKC B-Gene +
) O +
, O +
downstream O +
of O +
p21ras O +
, O +
in O +
activating O +
interleukin-2 O +
( O +
IL-2 O +
) O +
gene O +
expression O +
. O +

It O +
has O +
been O +
reported O +
that O +
PKC B-Gene +
is O +
an O +
effector B-Gene +
of O +
p21ras O +
in O +
T O +
cells O +
. O +

Data O +
is O +
presented O +
, O +
using O +
the O +
potent O +
and O +
selective O +
PKC B-Gene +
inhibitor O +
Ro O +
31 O -
- O -
8425 O +
and O +
transient O +
expression O +
of O +
a O +
constitutively O +
active O +
ras O +
mutant O +
, O +
which O +
clearly O +
shows O +
that O +
PKC B-Gene +
is O +
not O +
downstream O +
of O +
p21ras O +
in O +
the O +
induction O +
of O +
NF B-Gene -
- I-Gene -
AT I-Gene +
and O +
AP-1 B-Gene +
transcriptional O +
activity O +
and O +
in O +
the O +
expression O +
of O +
IL-2 B-Gene +
in O +
human O +
Jurkat O +
T O +
cells O +
. O +

Reporter O +
gene O +
experiments O +
demonstrated O +
that O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
transcriptional O +
activity O +
is O +
not O +
affected O +
by O +
expression O +
of O +
activated O +
p21ras O +
. O +

The O +
signaling O +
pathways O +
involving O +
PKC B-Gene +
activation O +
, O +
calcium O +
mobilization O +
and O +
ras B-Gene +
activation O +
combine O +
to O +
provide O +
the O +
necessary O +
components O +
for O +
production O +
of O +
IL-2 B-Gene +
during O +
T O +
cell O +
activation O +
. O +

Detection O +
of O +
the O +
chromosome O +
16 O +
CBF O +
beta O -
- O -
MYH11 O +
fusion O +
transcript O +
in O +
myelomonocytic O +
leukemias O +
. O +

Karyotypic O +
detection O +
of O +
chromosomal O +
16 O +
abnormalities O +
classically O +
associated O +
with O +
AML O +
M4Eo O +
can O +
be O +
difficult O +
. O +

Characterization O +
of O +
the O +
two O +
genes O +
involved O +
in O +
the O +
inv O +
( O +
16 O +
) O +
( O +
p13q22 O +
) O +
, O +
CBF O +
beta O +
and O +
MYH11 O +
, O +
has O +
allowed O +
the O +
detection O +
of O +
fusion O +
transcripts O +
by O +
reverse O -
- O -
transcriptase O +
polymerase O +
chain O +
reaction O +
( O +
RT O -
- O -
PCR O +
) O +
. O +

We O +
have O +
analyzed O +
CBF O +
beta O -
- O -
MYH11 O +
fusion O +
transcripts O +
by O +
RT O -
- O -
PCR O +
in O +
myelomonocytic O +
leukemias O +
, O +
with O +
or O +
without O +
eosinophilia O +
, O +
to O +
determine O +
whether O +
their O +
presence O +
correlates O +
with O +
morphology O +
. O +

Fifty O -
- O -
three O +
cases O +
( O +
11 O +
AML O +
M4Eo O +
; O +
1 O +
AML O +
M4 O +
with O +
atypical O +
abnormal O +
eosinophils O +
( O +
AML O +
M4 O +
` O -
` O +
Eo O +
'' O +
) O +
; O +
29 O +
AML O +
M4 O +
; O +
8 O +
AML O +
M5 O +
; O +
3 O +
CMML O +
; O +
and O +
1 O +
AML O +
M2 O +
with O +
eosinophilia O +
) O +
were O +
analyzed O +
. O +

All O +
11 O +
typical O +
AML O +
M4Eo O +
were O +
CBF O +
beta O +
-MYH11 O +
positive O +
. O +

The O +
single O +
case O +
of O +
AML O +
M4 O +
with O +
distinctive O +
eosinophil O +
abnormalities O +
was O +
negative O +
by O +
karyotype O +
, O +
RT O -
- O -
PCR O +
and O +
fluorescent O +
in O +
situ O +
hybridization O +
( O +
FISH O +
) O +
. O +

Three O +
of O +
29 O +
( O +
10 O +
% O +
) O +
AML O +
M4 O +
without O +
abnormal O +
eosinophils O +
were O +
CBF O +
beta O +
-MYH11 O +
positive O +
, O +
1 O +
of O +
which O +
did O +
not O +
show O +
any O +
apparent O +
chromosome O +
16 O +
abnormalities O +
by O +
classical O +
metaphase O +
analysis O +
( O +
2 O +
not O +
tested O +
) O +
. O +

Both O +
cases O +
tested O +
also O +
showed O +
MYH11 O +
genomic O +
rearrangement O +
. O +

None O +
of O +
the O +
other O +
leukemias O +
were O +
RT O -
- O -
PCR O +
positive O +
. O +

Follow O -
- O -
up O +
of O +
three O +
patient O +
showed O +
residual O +
positivity O +
in O +
apparent O +
complete O +
remission O +
. O +

These O +
data O +
show O +
that O +
CBF O +
beta O -
- O -
MYH11 O +
fusion O +
transcripts O +
occur O +
not O +
only O +
in O +
the O +
vast O +
majority O +
of O +
typical O +
AML O +
M4Eo O +
, O +
but O +
also O +
in O +
approximately O +
10 O +
% O +
of O +
AML O +
M4 O +
without O +
eosinophilic O +
abnormalities O +
, O +
a O +
much O +
higher O +
incidence O +
than O +
the O +
sporadic O +
reports O +
of O +
chromosome O +
16 O +
abnormalities O +
in O +
AML O +
M4 O +
would O +
suggest O +
. O +

Taken O +
together O +
with O +
the O +
detection O +
of O +
CBF O +
beta O +
- O +
MYH11 O +
transcripts O +
in O +
the O +
absence O +
of O +
apparent O +
chromosome O +
16 O +
abnormalities O +
by O +
classical O +
banding O +
techniques O +
, O +
these O +
data O +
show O +
that O +
additional O +
screening O +
by O +
either O +
RT O -
- O -
PCR O +
or O +
FISH O +
should O +
be O +
performed O +
in O +
all O +
AML O +
M4 O +
, O +
regardless O +
of O +
morphologic O +
features O +
, O +
to O +
allow O +
accurate O +
evaluation O +
of O +
the O +
prognostic O +
importance O +
of O +
this O +
fusion O +
transcript O +
. O +

Expression O +
and O +
genomic O +
configuration O +
of O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
, O +
IL-3 B-Gene +
, O +
M B-Gene -
- I-Gene -
CSF I-Gene +
receptor I-Gene +
( O +
C B-Gene -
- I-Gene -
FMS I-Gene +
) O +
, O +
early O +
growth O +
response O +
gene-1 O +
( O +
EGR-1 O +
) O +
and O +
M O -
- O -
CSF O +
genes O +
in O +
primary O +
myelodysplastic O +
syndromes O +
. O +

Peripheral O +
blood O +
mononuclear O +
cells O +
from O +
seventeen O +
patients O +
with O +
primary O +
myelodysplastic O +
syndromes O +
( O +
MDS O +
) O +
in O +
advanced O +
stage O +
were O +
enriched O +
for O +
blasts O +
and O +
tested O +
for O +
( O +
1 O +
) O +
karyotype O +
, O +
( O +
2 O +
) O +
genomic O +
configuration O +
and O +
( O +
3 O +
) O +
expression O +
of O +
IL-3 O +
, O +
GM O -
- O -
CSF O +
, O +
FMS O +
and O +
EGR-1 O +
genes O +
which O +
are O +
all O +
located O +
on O +
the O +
long O +
arm O +
of O +
chromosome O +
5 O +
. O +

The O +
expression O +
of O +
the O +
M O -
- O -
CSF O +
gene O +
, O +
that O +
has O +
been O +
recently O +
reassigned O +
to O +
the O +
short O +
arm O +
of O +
chromosome O +
1 O +
( O +
lp O +
) O +
, O +
was O +
also O +
investigated O +
. O +

Aims O +
of O +
the O +
study O +
were O +
to O +
( O +
1 O +
) O +
assess O +
the O +
potential O +
role O +
of O +
the O +
expression O +
of O +
these O +
genes O +
in O +
the O +
maintenance O +
and O +
expansion O +
of O +
the O +
neoplastic O +
clones O +
and O +
( O +
2 O +
) O +
search O +
for O +
constitutional O +
losses O +
or O +
rearrangements O +
of O +
one O +
allele O +
followed O +
by O +
a O +
deletion O +
of O +
the O +
second O +
allele O +
of O +
the O +
same O +
genes O +
in O +
the O +
leukemic O +
cells O +
. O +

The O +
latter O +
issue O +
was O +
investigated O +
by O +
comparing O +
, O +
in O +
8 O +
cases O +
, O +
constitutive O +
DNA O +
from O +
skin O +
fibroblasts O +
with O +
leukemic O +
DNA O +
. O +

Eleven O +
of O +
the O +
17 O +
patients O +
had O +
abnormal O +
karyotypes O +
. O +

The O +
M O -
- O -
CSF O +
gene O +
was O +
expressed O +
in O +
6 O +
cases O +
and O +
the O +
FMS O +
and O +
the O +
EGR-1 O +
genes O +
were O +
expressed O +
in O +
2 O +
of O +
the O +
latter O +
cases O +
. O +

An O +
autocrine O +
mechanism O +
of O +
growth O +
could O +
be O +
hypothesized O +
only O +
for O +
the O +
2 O +
patients O +
whose O +
cells O +
expressed O +
both O +
the O +
M O -
- O -
CSF O +
and O +
FMS O +
genes O +
. O +

No O +
germline O +
changes O +
or O +
rearrangements O +
were O +
observed O +
in O +
any O +
of O +
the O +
genes O +
studied O +
. O +

Thus O +
, O +
deregulation O +
of O +
genes O +
encoding O +
for O +
certain O +
hemopoietic B-Gene +
growth I-Gene +
factors I-Gene +
or O +
receptors O +
does O +
not O +
seem O +
to O +
represent O +
a O +
major O +
mechanism O +
of O +
MDS O +
progression O +
. O +

A O +
germline O +
TaqI O +
restriction O +
fragment O +
length O +
polymorphism O +
in O +
the O +
progesterone O +
receptor O +
gene O +
in O +
ovarian O +
carcinoma O +
[ O +
see O +
comments O +
] O +

Clinical O +
outcome O +
in O +
ovarian O +
carcinoma O +
is O +
predicted O +
by O +
progesterone B-Gene +
receptor I-Gene +
status O +
, O +
indicating O +
an O +
endocrine O +
aspect O +
to O +
this O +
disease O +
. O +

Peripheral O +
leucocyte O +
genomic O +
DNAs O +
were O +
obtained O +
from O +
41 O +
patients O +
with O +
primary O +
ovarian O +
carcinoma O +
and O +
83 O +
controls O +
from O +
Ireland O +
, O +
as O +
well O +
as O +
from O +
26 O +
primary O +
ovarian O +
carcinoma O +
patients O +
and O +
101 O +
controls O +
in O +
Germany O +
. O +

Southern O +
analysis O +
using O +
a O +
human O +
progesterone O +
receptor O +
( O +
hPR O +
) O +
cDNA O +
probe O +
identified O +
a O +
germline O +
TaqI O +
restriction O +
fragment O +
length O +
polymorphism O +
( O +
RFLP O +
) O +
defined O +
by O +
two O +
alleles O +
: O +
T1 O +
, O +
represented O +
by O +
a O +
2.7 O +
kb O +
fragment O +
; O +
and O +
T2 O +
, O +
represented O +
by O +
a O +
1.9 O +
kb O +
fragment O +
and O +
characterised O +
by O +
an O +
additional O +
TaqI O +
restriction O +
site O +
with O +
respect O +
to O +
T1 O +
. O +

An O +
over O -
- O -
representation O +
of O +
T2 O +
in O +
ovarian O +
cancer O +
patients O +
compared O +
with O +
controls O +
in O +
the O +
pooled O +
Irish O -
/ O -
German O +
population O +
( O +
P O +
< O +
0.025 O +
) O +
was O +
observed O +
. O +

A O +
difference O +
( O +
P O +
< O +
0.02 O +
) O +
in O +
the O +
distribution O +
of O +
the O +
RFLP O +
genotypes O +
between O +
Irish O +
and O +
German O +
control O +
populations O +
was O +
also O +
observed O +
. O +

The O +
allele O +
distributions O +
could O +
not O +
be O +
shown O +
to O +
differ O +
significantly O +
from O +
Hardy O -
- O -
Weinberg O +
distribution O +
in O +
any O +
subgroup O +
. O +

Using O +
hPR O +
cDNA O +
region O -
- O -
specific O +
probes O +
, O +
the O +
extra O +
TaqI O +
restriction O +
site O +
was O +
mapped O +
to O +
intron O +
G O +
of O +
the O +
hPR O +
gene O +
. O +

IL-1 B-Gene +
receptor I-Gene +
and O +
TCR B-Gene +
signals O +
synergize O +
to O +
activate O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
-mediated O +
gene O +
transcription O +
. O +

Previous O +
studies O +
have O +
demonstrated O +
that O +
IL-1 B-Gene +
receptor I-Gene +
( O +
IL-1R B-Gene +
) O +
- O +
and O +
TCR B-Gene +
-initiated O +
signals O +
can O +
interact O +
synergistically O +
to O +
increase O +
the O +
rate O +
of O +
transcription O +
of O +
several O +
lymphokine O +
and O +
lymphokine O +
receptor O +
genes O +
during O +
the O +
competence O +
phase O +
of O +
the O +
activation O +
program O +
in O +
T O +
helper O +
lymphocytes O +
. O +

In O +
this O +
report O +
we O +
describe O +
how O +
signals O +
initiated O +
through O +
the O +
type B-Gene +
I I-Gene +
IL-1R I-Gene +
interact O +
with O +
signals O +
from O +
the O +
antigen O +
receptor O +
to O +
synergistically O +
augment O +
the O +
transactivating O +
properties O +
of O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
. O +

The O +
synergistic O +
antigen B-Gene +
receptor I-Gene +
initiated O +
signals O +
are O +
mediated O +
through O +
protein B-Gene +
kinase I-Gene +
C I-Gene +
because O +
they O +
can O +
be O +
mimicked O +
by O +
the O +
phorbol O +
ester O +
, O +
12-O O -
- O -
tetradecanoylphorbol-13-acetate O +
, O +
but O +
not O +
with O +
calcium O +
ionophores O +
; O +
and O +
are O +
staurosporine O +
sensitive O +
but O +
cyclosporine O +
resistant O +
. O +

Gel O +
shift O +
analyses O +
demonstrate O +
that O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
nuclear O +
translocation O +
is O +
stimulated O +
primarily O +
by O +
IL-1 B-Gene +
rather O +
than O +
by O +
antigen B-Gene +
receptor I-Gene +
signals O +
. O +

Western O +
blot O +
and O +
phosphorylation O +
analyses O +
demonstrate O +
that O +
the O +
synergistic O +
effect O +
on O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
functional O +
activity O +
is O +
independent O +
of O +
I B-Gene +
kappa I-Gene +
B I-Gene +
alpha I-Gene +
( O +
MAD3 B-Gene +
) O +
- O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
dissociation O +
in O +
the O +
cytosol O +
and O +
is O +
not O +
associated O +
with O +
I B-Gene +
kappa I-Gene +
B I-Gene +
nuclear O +
translocation O +
. O +

The O +
IL-1 B-Gene +
-induced O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
DNA O +
nuclear O +
localization O +
is O +
transient O +
and O +
can O +
be O +
prolonged O +
either O +
by O +
an O +
antigen O +
receptor O -
- O -
initiated O +
signal O +
or O +
by O +
inhibiting O +
protein O +
synthesis O +
. O +

These O +
results O +
suggest O +
that O +
IL-1 B-Gene +
induces O +
both O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
nuclear O +
translocation O +
and O +
the O +
synthesis O +
of O +
a O +
protein O +
( O +
s O +
) O +
responsible O +
for O +
terminating O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
-DNA O +
interaction O +
in O +
the O +
nucleus O +
. O +

Antigen O +
receptor O +
signals O +
prolong O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
-DNA O +
interaction O +
, O +
probably O +
by O +
functionally O +
antagonizing O +
the O +
IL-1 B-Gene +
-induced O +
synthesis O +
of O +
a O +
protein O +
( O +
s O +
) O +
responsible O +
for O +
the O +
transient O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
-DNA O +
interaction O +
and O +
consequently O +
synergistically O +
enhance O +
IL-1 B-Gene +
-induced O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
-dependent O +
gene O +
transcription O +
. O +

Analysis O +
of O +
the O +
role O +
of O +
protein B-Gene +
kinase I-Gene +
C I-Gene -
- I-Gene -
alpha I-Gene +
, I-Gene +
-epsilon I-Gene +
, I-Gene +
and I-Gene +
-zeta I-Gene +
in O +
T O +
cell O +
activation O +
. O +

T O +
cells O +
express O +
multiple O +
isotypes O +
of O +
protein B-Gene +
kinase I-Gene +
C I-Gene +
( O +
PKC B-Gene +
) O +
and O +
although O +
it O +
is O +
well O +
accepted O +
that O +
PKCs B-Gene +
have O +
an O +
important O +
role O +
in O +
T O +
cell O +
activation O +
, O +
little O +
is O +
known O +
about O +
the O +
function O +
of O +
individual O +
PKC B-Gene +
isotypes I-Gene +
. O +

To O +
address O +
this O +
issue O +
, O +
mutationally O +
active O +
PKC B-Gene -
- I-Gene -
alpha I-Gene +
, I-Gene +
-epsilon I-Gene +
, I-Gene +
or I-Gene +
-zeta I-Gene +
have O +
been O +
transfected O +
into O +
T O +
cells O +
and O +
the O +
consequences O +
for O +
T O +
cell O +
activation O +
determined O +
. O +

p21ras B-Gene +
plays O +
an O +
essential O +
role O +
in O +
T O +
cell O +
activation O +
. O +

Accordingly O +
, O +
the O +
effects O +
of O +
the O +
constitutively B-Gene +
active I-Gene +
PKCs I-Gene +
were O +
compared O +
to O +
the O +
effects O +
of O +
mutationally O +
activated O +
p21ras B-Gene +
. O +

The O +
data O +
indicate O +
that O +
PKC B-Gene -
- I-Gene -
epsilon I-Gene +
and O +
, O +
to O +
a O +
lesser O +
extent O +
PKC B-Gene -
- I-Gene -
alpha I-Gene +
but O +
not O +
-zeta B-Gene +
, O +
can O +
regulate O +
the O +
transcription B-Gene +
factors I-Gene +
AP-1 B-Gene +
and O +
nuclear O +
factor B-Gene +
of I-Gene +
activated I-Gene +
T I-Gene +
cells I-Gene +
( O +
NF B-Gene -
- I-Gene -
AT-1 I-Gene +
) O +
. O +

The O +
ability O +
of O +
PKC B-Gene -
- I-Gene -
epsilon I-Gene +
to O +
induce O +
transactivation O +
of O +
NF B-Gene -
- I-Gene -
AT-1 I-Gene +
and O +
AP-1 B-Gene +
was O +
similar O +
to O +
the O +
stimulatory O +
effect O +
of O +
a O +
constitutively B-Gene +
activated I-Gene +
p21ras I-Gene +
. O +

PKC B-Gene -
- I-Gene -
epsilon I-Gene +
, O +
but O +
not O +
PKC B-Gene -
- I-Gene -
alpha I-Gene +
nor O +
activated O +
p21ras B-Gene +
, O +
was O +
able O +
to O +
induce O +
NF B-Gene -
- I-Gene -
KB I-Gene +
activity O +
. O +

Phorbol O +
esters O +
induce O +
expression O +
of O +
CD69 B-Gene +
whereas O +
none O +
of O +
the O +
activated B-Gene +
PKC I-Gene +
isotypes I-Gene +
tested O +
were O +
able O +
to O +
have O +
this O +
effect O +
. O +

Activated O +
Src B-Gene +
and O +
p21ras B-Gene +
were O +
able O +
to O +
induce O +
CD69 B-Gene +
expression O +
. O +

These O +
results O +
indicate O +
selective O +
functions O +
for O +
different O +
PKC B-Gene +
isotypes I-Gene +
in O +
T O +
cells O +
. O +

Moreover O +
, O +
the O +
data O +
comparing O +
the O +
effects O +
of O +
activated B-Gene +
Ras I-Gene +
and O +
PKC B-Gene +
mutants I-Gene +
suggest O +
that O +
PKC B-Gene -
- I-Gene -
alpha I-Gene +
, O +
p21ras B-Gene +
, O +
and O +
PKC B-Gene -
- I-Gene -
epsilon I-Gene +
are O +
not O +
positioned O +
linearly O +
on O +
a O +
single O +
signal O +
transduction O +
pathway O +
. O +

Identification O +
of O +
two O +
novel O +
regulatory O +
elements O +
within O +
the O +
5'-untranslated O +
region O +
of O +
the O +
human O +
A O +
gamma O -
- O -
globin O +
gene O +
. O +

Interaction O +
between O +
the O +
stage O +
selector O +
element O +
( O +
SSE O +
) O +
in O +
the O +
proximal O +
gamma O -
- O -
globin O +
promoter O +
and O +
hypersensitivity O +
site O +
2 O +
in O +
the O +
locus O +
control O +
region O +
partly O +
mediates O +
the O +
competitive O +
silencing O +
of O +
the O +
beta O -
- O -
globin O +
promoter O +
in O +
the O +
fetal O +
developmental O +
stage O +
. O +

We O +
have O +
now O +
demonstrated O +
that O +
a O +
second O +
SSE O -
- O -
like O +
element O +
in O +
the O +
5'-untranslated O +
region O +
of O +
the O +
gamma O -
- O -
gene O +
also O +
contributes O +
to O +
this O +
competitive O +
silencing O +
of O +
the O +
beta O -
- O -
gene O +
. O +

Utilizing O +
transient O +
transfection O +
assays O +
in O +
the O +
fetal O +
erythroid O +
cell O +
line O +
, O +
K562 O +
, O +
we O +
have O +
shown O +
that O +
the O +
core O +
enhancer O +
of O +
hypersensitivity O +
site O +
2 O +
can O +
preferentially O +
interact O +
with O +
the O +
proximal O +
gamma O -
- O -
promoter O +
in O +
the O +
absence O +
of O +
the O +
SSE O +
, O +
completely O +
silencing O +
a O +
linked O +
beta O -
- O -
promoter O +
. O +

Mutation O +
of O +
a O +
20-base O +
pair O +
sequence O +
of O +
the O +
gamma O -
- O -
gene O +
5'-untranslated O +
region O +
( O +
UTR O +
) O +
led O +
to O +
derepression O +
of O +
beta O -
- O -
promoter O +
activity O +
. O +

A O +
marked O +
activation O +
of O +
gamma O -
- O -
promoter O +
activity O +
was O +
also O +
observed O +
with O +
this O +
mutation O +
, O +
suggesting O +
the O +
presence O +
of O +
a O +
repressor O +
. O +

Fine O +
mutagenesis O +
dissected O +
these O +
activities O +
to O +
different O +
regions O +
of O +
the O +
5'-UTR O +
. O +

The O +
stage O +
selector O +
activity O +
was O +
localized O +
to O +
a O +
region O +
centered O +
on O +
nucleotides O +
+ O -
13 O +
to O +
+ O -
15 O +
. O +

Electromobility O +
shift O +
assays O +
utilizing O +
this O +
sequence O +
demonstrated O +
binding O +
of O +
a O +
fetal B-Gene +
and I-Gene +
erythroid I-Gene -
- I-Gene -
specific I-Gene +
protein I-Gene +
. O +

The O +
repressor O +
activity O +
of O +
the O +
5'-UTR O +
was O +
localized O +
to O +
tandem O +
GATA O -
- O -
like O +
sites O +
, O +
which O +
appear O +
to O +
bind O +
a O +
complex O +
of O +
two O +
proteins O +
, O +
one O +
of O +
which O +
is O +
the O +
erythroid B-Gene +
transcription I-Gene +
factor I-Gene +
GATA-1 B-Gene +
. O +

These O +
results O +
indicate O +
that O +
the O +
5'-UTR O +
of O +
the O +
gamma O -
- O -
gene O +
contains O +
sequences O +
that O +
may O +
be O +
important O +
for O +
its O +
transcriptional O +
and O +
developmental O +
regulation O +
. O +

MIP1 B-Gene +
alpha I-Gene +
nuclear I-Gene +
protein I-Gene +
( O +
MNP B-Gene +
) O +
, O +
a O +
novel O +
transcription B-Gene +
factor I-Gene +
expressed O +
in O +
hematopoietic O +
cells O +
that O +
is O +
crucial O +
for O +
transcription O +
of O +
the O +
human O +
MIP-1 O +
alpha O +
gene O +
. O +

Murine B-Gene +
macrophage I-Gene +
inflammatory I-Gene +
protein I-Gene +
1 I-Gene +
alpha I-Gene +
( O +
MIP-1 B-Gene +
alpha I-Gene +
) O +
and O +
its O +
human B-Gene +
equivalent I-Gene +
( O +
GOS19 B-Gene +
, O +
LD78 B-Gene +
, O +
or O +
AT464 B-Gene +
) O +
are O +
members O +
of O +
the O +
-C B-Gene -
- I-Gene -
C I-Gene +
family I-Gene +
of O +
low B-Gene -
- I-Gene -
molecular I-Gene -
- I-Gene -
weight I-Gene +
chemokines I-Gene +
. O +

Secreted O +
from O +
activated O +
T O +
cells O +
and O +
macrophages O +
, O +
bone O +
marrow B-Gene -
- I-Gene -
derived I-Gene +
MIP-1 I-Gene +
alpha I-Gene -
/ I-Gene -
GOS19 I-Gene +
inhibits O +
primitive O +
hematopoietic O +
stem O +
cells O +
and O +
appears O +
to O +
be O +
involved O +
in O +
the O +
homeostatic O +
control O +
of O +
stem O +
cell O +
proliferation O +
. O +

It O +
also O +
induces O +
chemotaxis O +
and O +
inflammatory O +
responses O +
in O +
mature O +
cell O +
types O +
. O +

Therefore O +
, O +
it O +
is O +
important O +
to O +
understand O +
the O +
mechanisms O +
which O +
control O +
the O +
expression O +
of O +
MIP-1 B-Gene +
alpha I-Gene +
/GOS19 B-Gene +
. O +

Previous O +
work O +
has O +
shown O +
that O +
in O +
Jurkat O +
T O +
cells O +
, O +
a O +
set O +
of O +
widely O +
expressed O +
transcription B-Gene +
factors I-Gene +
( O +
the O +
ICK-1 B-Gene +
family I-Gene +
) O +
affect O +
the O +
GOS19 O +
promoter O +
. O +

One O +
member O +
, O +
ICK-1A B-Gene +
, O +
behaves O +
as O +
a O +
strong B-Gene +
negative I-Gene +
regulator I-Gene +
. O +

In O +
this O +
communication O +
, O +
we O +
provide O +
evidence O +
that O +
the O +
pathway O +
of O +
induction O +
in O +
the O +
macrophage O +
cell O +
line O +
U937 O +
is O +
different O +
from O +
that O +
in O +
Jurkat O +
cells O +
. O +

Furthermore O +
, O +
we O +
show O +
that O +
the O +
ICK-1 O +
binding O +
site O +
does O +
not O +
confer O +
negative O +
regulation O +
in O +
U937 O +
cells O +
. O +

We O +
provide O +
evidence O +
for O +
an O +
additional O +
binding O +
site O +
, O +
the O +
MIP-1 O +
alpha O +
nuclear O +
protein O +
( O +
MNP O +
) O +
site O +
, O +
which O +
overlaps O +
the O +
ICK-1 O +
site O +
. O +

Interaction O +
of O +
nuclear O +
extracts O +
from O +
various O +
cell O +
lines O +
and O +
tissue O +
with O +
the O +
MNP O +
site O +
leads O +
to O +
the O +
formation O +
of O +
fast B-Gene -
- I-Gene -
migrating I-Gene +
protein I-Gene -
- I-Gene -
DNA I-Gene +
complexes I-Gene +
with O +
similar O +
but O +
distinct O +
electrophoretic O +
mobilities O +
. O +

A O +
mutation O +
of O +
the O +
MNP O +
site O +
which O +
does O +
not O +
abrogate O +
ICK-1 O +
binding O +
inactivates O +
the O +
GOS19.1 O +
promoter O +
in O +
U937 O +
cells O +
and O +
reduces O +
its O +
activity O +
by O +
fourfold O +
in O +
Jurkat O +
cells O +
. O +

We O +
propose O +
that O +
the O +
MNP B-Gene +
protein I-Gene +
( O +
s O +
) O +
binding O +
at O +
the O +
MNP O +
site O +
constitutes O +
a O +
novel O +
transcription B-Gene +
factor I-Gene +
( O +
s O +
) O +
expressed O +
in O +
hematopoietic O +
cells O +
. O +

The O +
transcription B-Gene +
factor I-Gene +
, O +
Nm23H2 B-Gene +
, O +
binds O +
to O +
and O +
activates O +
the O +
translocated O +
c O -
- O -
myc O +
allele O +
in O +
Burkitt O +
's O +
lymphoma O +
. O +

We O +
have O +
identified O +
an O +
in O +
vivo O +
footprint O +
over O +
the O +
PuF O +
site O +
on O +
the O +
translocated O +
c O -
- O -
myc O +
allele O +
in O +
Burkitt O +
's O +
lymphoma O +
cells O +
. O +

The O +
PuF O +
site O +
on O +
the O +
silent O +
normal O +
c O -
- O -
myc O +
allele O +
was O +
unoccupied O +
. O +

We O +
demonstrated O +
by O +
electrophoretic O +
mobility O +
shift O +
assay O +
, O +
electrophoretic O +
mobility O +
shift O +
assay O +
with O +
antibody O +
, O +
UV O +
cross O -
- O -
linking O +
followed O +
by O +
SDS O -
- O -
gel O +
electrophoresis O +
, O +
and O +
Western O +
analysis O +
that O +
Nm23H2 B-Gene +
in O +
B O +
cell O +
nuclear O +
extracts O +
bound O +
to O +
the O +
c O -
- O -
myc O +
PuF O +
site O +
. O +

Transfection O +
experiments O +
with O +
c O -
- O -
myc O +
promoter O +
constructs O +
in O +
both O +
DHL-9 O +
and O +
Raji O +
cells O +
revealed O +
that O +
the O +
PuF O +
site O +
functioned O +
as O +
a O +
positive O +
regulatory O +
element O +
in O +
B O +
cells O +
with O +
a O +
drop O +
in O +
activity O +
with O +
mutation O +
of O +
this O +
site O +
. O +

Access O +
to O +
this O +
site O +
is O +
blocked O +
in O +
the O +
normal O +
silent O +
c O -
- O -
myc O +
allele O +
; O +
these O +
data O +
suggest O +
that O +
the O +
Nm23H2 B-Gene +
protein O +
is O +
involved O +
in O +
deregulation O +
of O +
the O +
translocated O +
c O -
- O -
myc O +
allele O +
in O +
Burkitt O +
's O +
lymphoma O +
cells O +
. O +

Modulation O +
of O +
transcription B-Gene +
factor I-Gene +
NF I-Gene +
kappa I-Gene +
B I-Gene +
activity O +
by O +
intracellular O +
glutathione O +
levels O +
and O +
by O +
variations O +
of O +
the O +
extracellular O +
cysteine O +
supply O +
. O +

HIV O -
- O -
infected O +
individuals O +
and O +
SIV O -
- O -
infected O +
rhesus O +
macaques O +
have O +
, O +
on O +
the O +
average O +
, O +
decreased O +
plasma O +
cysteine O +
and O +
cystine O +
concentrations O +
and O +
decreased O +
intracellular O +
glutathione O +
levels O +
. O +

We O +
now O +
show O +
that O +
a O +
depletion O +
of O +
intracellular O +
glutathione O +
in O +
a O +
human O +
T O +
cell O +
line O +
( O +
Molt-4 O +
) O +
inhibits O +
the O +
activation O +
and O +
nuclear O +
translocation O +
of O +
the O +
transcription B-Gene +
factor I-Gene +
NF I-Gene +
kappa I-Gene +
B I-Gene +
, O +
whereas O +
incubation O +
with O +
increasing O +
extracellular O +
concentrations O +
of O +
cysteine O +
inhibits O +
the O +
DNA O -
- O -
binding O +
and O +
transactivating O +
activity O +
of O +
NF B-Gene +
kappa I-Gene +
B I-Gene +
. O +

Because O +
inhibition O +
of O +
DNA O -
- O -
binding O +
activity O +
is O +
associated O +
with O +
increasing O +
intracellular O +
glutathione O +
disulfide O +
levels O +
and O +
GSSG B-Gene +
can O +
be O +
shown O +
to O +
inhibit O +
the O +
DNA O -
- O -
binding O +
activity O +
directly O +
in O +
cell O -
- O -
free O +
systems O +
, O +
our O +
studies O +
suggest O +
that O +
GSSG B-Gene +
is O +
a O +
physiologically O +
relevant O +
inhibitor O +
in O +
intact O +
cells O +
also O +
. O +

NF B-Gene +
kappa I-Gene +
B I-Gene +
controls O +
many O +
immunologically O +
important O +
genes O +
, O +
so O +
our O +
studies O +
suggest O +
that O +
the O +
immune O +
system O +
may O +
be O +
sensitive O +
not O +
only O +
against O +
a O +
cysteine O +
and O +
glutathione O +
deficiency O +
but O +
also O +
against O +
an O +
excess O +
of O +
cysteine O +
. O +

Thapsigargin O +
induces O +
IL-2 B-Gene +
receptor I-Gene +
alpha I-Gene -
- I-Gene -
chain I-Gene +
in O +
human O +
peripheral O +
and O +
Jurkat O +
T O +
cells O +
via O +
a O +
protein B-Gene +
kinase I-Gene +
C I-Gene +
-independent O +
mechanism O +
. O +

Thapsigargin O +
( O +
TG O +
) O +
, O +
an O +
inhibitor O +
of O +
Ca B-Gene +
( I-Gene +
2 I-Gene -
+ I-Gene +
) I-Gene +
-ATPase I-Gene +
, O +
depletes O +
intracellular O +
Ca2 O -
+ O +
stores O +
and O +
induces O +
a O +
sustained O +
Ca2 O -
+ O +
influx O +
without O +
altering O +
phosphatidyl O +
inositol O +
levels O +
. O +

TG O +
plus O +
phorbol O +
myristate O +
acetate O +
( O +
PMA O +
) O +
but O +
not O +
TG O +
alone O +
induced O +
IL-2 B-Gene +
in O +
Jurkat O +
T O +
cells O +
, O +
suggesting O +
that O +
TG O +
had O +
no O +
effect O +
on O +
protein B-Gene +
kinase I-Gene +
C I-Gene +
( O +
PKC B-Gene +
) O +
. O +

However O +
, O +
TG O +
induced O +
increases O +
in O +
IL-2R B-Gene +
alpha I-Gene +
protein I-Gene +
as O +
well O +
as O +
IL-2R O +
alpha O +
mRNA O +
in O +
Jurkat O +
T O +
cells O +
in O +
a O +
dose O -
- O -
dependent O +
manner O +
. O +

A O +
similar O +
increase O +
in O +
IL-2R B-Gene +
alpha I-Gene +
by O +
TG O +
was O +
also O +
observed O +
in O +
human O +
peripheral O +
T O +
cells O +
. O +

Further O +
, O +
like O +
PMA O +
, O +
TG O +
markedly O +
induced O +
NF B-Gene +
kappa I-Gene +
B I-Gene +
in O +
Jurkat O +
T O +
cells O +
. O +

However O +
, O +
TG O +
and O +
PMA O +
exhibited O +
a O +
synergistic O +
action O +
on O +
IL-2R B-Gene +
alpha I-Gene +
expression O +
, O +
suggesting O +
that O +
TG O +
and O +
PMA O +
induce O +
IL-2R B-Gene +
alpha I-Gene +
through O +
distinct O +
pathways O +
. O +

PMA B-Gene +
-but I-Gene +
not I-Gene +
TG I-Gene -
- I-Gene -
induced I-Gene +
IL-2R I-Gene +
alpha I-Gene +
is O +
inhibited O +
by O +
the O +
PKC B-Gene +
inhibitor O +
H7 O +
, O +
whereas O +
TG B-Gene +
-but I-Gene +
not I-Gene +
PMA I-Gene -
- I-Gene -
induced I-Gene +
IL-2R I-Gene +
alpha I-Gene +
was O +
inhibited O +
by O +
cholera O +
toxin O +
, O +
forskolin O +
and O +
1 O +
, O +
9-dideoxy O +
forskolin O +
. O +

In O +
toto O +
, O +
these O +
results O +
suggest O +
that O +
TG O +
induces O +
IL-2R B-Gene +
alpha I-Gene +
in O +
human O +
T O +
cells O +
through O +
a O +
PKC B-Gene +
-independent O +
pathway O +
. O +

Interleukin B-Gene +
4 I-Gene +
activates O +
a O +
signal O +
transducer O +
and O +
activator O +
of O +
transcription B-Gene +
( I-Gene +
Stat I-Gene +
) I-Gene +
protein I-Gene +
which O +
interacts O +
with O +
an O +
interferon O -
- O -
gamma O +
activation O +
site O -
- O -
like O +
sequence O +
upstream O +
of O +
the O +
I O +
epsilon O +
exon O +
in O +
a O +
human O +
B O +
cell O +
line O +
. O +

Evidence O +
for O +
the O +
involvement O +
of O +
Janus B-Gene +
kinase I-Gene +
3 I-Gene +
and O +
interleukin-4 B-Gene +
Stat I-Gene +
. O +

Germ O +
line O +
C O +
transcripts O +
can O +
be O +
induced O +
by O +
IL-4 B-Gene +
in O +
the O +
human O +
B O +
cell O +
line O +
, O +
BL-2 O +
. O +

Utilizing O +
a O +
IFN O -
- O -
gamma O +
activation O +
site O -
- O -
like O +
DNA O +
sequence O +
element O +
located O +
upstream O +
of O +
the O +
I O +
epsilon O +
exon O +
, O +
we O +
demonstrated O +
by O +
gel O +
mobility O +
shift O +
assays O +
that O +
IL-4 B-Gene +
induced O +
a O +
binding O +
activity O +
in O +
the O +
cytosol O +
and O +
nucleus O +
of O +
BL-2 O +
cells O +
. O +

This O +
factor O +
was O +
designated O +
IL-4 B-Gene +
NAF I-Gene +
( O +
IL-4-induced B-Gene +
nuclear I-Gene -
- I-Gene -
activating I-Gene +
factors I-Gene +
) O +
and O +
was O +
identified O +
as O +
a O +
tyrosine B-Gene +
phosphoprotein I-Gene +
, O +
which O +
translocates O +
from O +
the O +
cytosol O +
to O +
the O +
nucleus O +
upon O +
IL-4 B-Gene +
treatment O +
. O +

Because O +
these O +
are O +
the O +
characteristics O +
of O +
a O +
signal B-Gene +
transducer I-Gene +
and I-Gene +
activator I-Gene +
of I-Gene +
transcription I-Gene +
( I-Gene +
Stat I-Gene +
) I-Gene +
protein I-Gene +
, O +
we O +
determined O +
whether O +
antibodies B-Gene +
to I-Gene +
Stat I-Gene +
proteins I-Gene +
will O +
interfere O +
with O +
gel O +
mobility O +
shift O +
and O +
found O +
that O +
antibodies B-Gene +
to I-Gene +
IL-4 I-Gene +
Stat I-Gene +
, O +
also O +
known O +
as O +
Stat6 B-Gene +
, O +
but O +
not O +
antibodies B-Gene +
to O +
other O +
Stat B-Gene +
proteins I-Gene +
, O +
interfere O +
with O +
the O +
formation O +
of O +
the O +
IL-4 B-Gene +
NAF I-Gene +
complex I-Gene +
. O +

Congruous O +
with O +
the O +
involvement O +
of O +
a O +
Stat B-Gene +
protein I-Gene +
, O +
IL-4 B-Gene +
induced O +
robust O +
Janus B-Gene +
kinase I-Gene +
3 I-Gene +
( O +
JAK3 B-Gene +
) O +
activity O +
in O +
BL-2 O +
cells O +
. O +

Cotransfection O +
of O +
JAK3 B-Gene +
with O +
IL-4 B-Gene +
Stat I-Gene +
into O +
COS-7 O +
cells O +
produced O +
an O +
intracellular O +
activity O +
which O +
bound O +
the O +
same O +
IFN O -
- O -
gamma O +
activation O +
site O -
- O -
like O +
sequence O +
and O +
comigrated O +
with O +
IL-4 B-Gene +
NAF I-Gene +
in O +
electrophoretic O +
mobility O +
shift O +
assay O +
. O +

These O +
results O +
show O +
that O +
IL-4 B-Gene +
NAF I-Gene +
is O +
IL-4 B-Gene +
Stat I-Gene +
, O +
which O +
is O +
activated O +
by O +
JAK3 B-Gene +
in O +
response O +
to O +
IL-4 B-Gene +
receptor O +
engagement O +
. O +

Interleukin B-Gene +
12 I-Gene +
induces O +
tyrosine O +
phosphorylation O +
and O +
activation O +
of O +
STAT4 B-Gene +
in O +
human O +
lymphocytes O +
. O +

Interleukin B-Gene +
12 I-Gene +
( O +
IL-12 B-Gene +
) O +
is O +
an O +
important O +
immunoregulatory B-Gene +
cytokine I-Gene +
whose O +
receptor O +
is O +
a O +
member O +
of O +
the O +
hematopoietin B-Gene +
receptor I-Gene +
superfamily I-Gene +
. O +

We O +
have O +
recently O +
demonstrated O +
that O +
stimulation O +
of O +
human O +
T O +
and O +
natural O +
killer O +
cells O +
with O +
IL-12 B-Gene +
induces O +
tyrosine O +
phosphorylation O +
of O +
the O +
Janus B-Gene +
family I-Gene +
tyrosine I-Gene +
kinase I-Gene +
JAK2 B-Gene +
and O +
Tyk2 B-Gene +
, O +
implicating O +
these O +
kinases B-Gene +
in O +
the O +
immediate O +
biochemical O +
response O +
to O +
IL-12 B-Gene +
. O +

Recently O +
, O +
transcription B-Gene +
factors I-Gene +
known O +
as O +
STATs B-Gene +
( O +
signal B-Gene +
transducers I-Gene +
and I-Gene +
activators I-Gene +
of I-Gene +
transcription I-Gene +
) O +
have O +
been O +
shown O +
to O +
be O +
tyrosine O +
phosphorylated O +
and O +
activated O +
in O +
response O +
to O +
a O +
number O +
of O +
cytokines B-Gene +
that O +
bind O +
hematopoietin B-Gene +
receptors I-Gene +
and O +
activate O +
JAK B-Gene +
kinases I-Gene +
. O +

In O +
this O +
report O +
we O +
demonstrate O +
that O +
IL-12 B-Gene +
induces O +
tyrosine O +
phosphorylation O +
of O +
a O +
recently O +
identified O +
STAT B-Gene +
family I-Gene +
member I-Gene +
, O +
STAT4 B-Gene +
, O +
and O +
show O +
that O +
STAT4 B-Gene +
expression O +
is O +
regulated O +
by O +
T O -
- O -
cell O +
activation O +
. O +

Furthermore O +
, O +
we O +
show O +
that O +
IL-12 B-Gene +
stimulates O +
formation O +
of O +
a O +
DNA B-Gene -
- I-Gene -
binding I-Gene +
complex I-Gene +
that O +
recognizes O +
a O +
DNA O +
sequence O +
previously O +
shown O +
to O +
bind O +
STAT B-Gene +
proteins I-Gene +
and O +
that O +
this O +
complex O +
contains O +
STAT4 B-Gene +
. O +

These O +
data O +
, O +
and O +
the O +
recent O +
demonstration O +
of O +
JAK B-Gene +
phosphorylation O +
by O +
IL-12 B-Gene +
, O +
identify O +
a O +
rapid O +
signal O -
- O -
transduction O +
pathway O +
likely O +
to O +
mediate O +
IL-12 B-Gene +
-induced O +
gene O +
expression O +
. O +

Overexpression O +
of O +
DR B-Gene -
- I-Gene -
nm23 I-Gene +
, O +
a O +
protein O +
encoded O +
by O +
a O +
member O +
of O +
the O +
nm23 O +
gene O +
family O +
, O +
inhibits O +
granulocyte O +
differentiation O +
and O +
induces O +
apoptosis O +
in O +
32Dc13 O +
myeloid O +
cells O +
. O +

Chronic O +
myelogenous O +
leukemia O +
evolves O +
in O +
two O +
clinically O +
distinct O +
stages O +
: O +
a O +
chronic O +
and O +
a O +
blast O +
crisis O +
phase O +
. O +

The O +
molecular O +
changes O +
associated O +
with O +
chronic O +
phase O +
to O +
blast O +
crisis O +
transition O +
are O +
largely O +
unknown O +
. O +

We O +
have O +
identified O +
a O +
cDNA O +
clone O +
, O +
DR B-Gene -
- I-Gene -
nm23 I-Gene +
, O +
differentially O +
expressed O +
in O +
a O +
blast O -
- O -
crisis O +
cDNA O +
library O +
, O +
which O +
has O +
approximately O +
70 O +
% O +
sequence O +
similarity O +
to O +
the O +
putative O +
metastatic O +
suppressor O +
genes O +
, O +
nm23-H1 O +
and O +
nm23-H2 O +
. O +

The O +
deduced O +
amino O +
acid O +
sequence O +
similarity O +
to O +
the O +
proteins O +
encoded O +
by O +
these O +
two O +
latter O +
genes O +
is O +
approximately O +
65 O +
% O +
and O +
includes O +
domains O +
and O +
amino O +
acid O +
residues O +
( O +
the O +
leucine B-Gene +
zipper I-Gene -
- I-Gene -
like I-Gene +
and O +
the O +
RGD B-Gene +
domain I-Gene +
, O +
a O +
serine O +
and O +
a O +
histidine O +
residue O +
in O +
the O +
NH2- B-Gene +
and O +
in O +
the O +
COOH B-Gene -
- I-Gene -
terminal I-Gene +
portion I-Gene +
of O +
the O +
protein O +
, O +
respectively O +
) O +
postulated O +
to O +
be O +
important O +
for O +
nm23 B-Gene +
function O +
. O +

DR O -
- O -
nm23 O +
mRNA O +
is O +
preferentially O +
expressed O +
at O +
early O +
stages O +
of O +
myeloid O +
differentiation O +
of O +
highly O +
purified O +
CD34 O -
+ O +
cells O +
. O +

Its O +
constitutive O +
expression O +
in O +
the O +
myeloid O +
precursor O +
32Dc13 O +
cell O +
line O +
, O +
which O +
is O +
growth O -
- O -
factor O +
dependent O +
for O +
both O +
proliferation O +
and O +
differentiation O +
, O +
results O +
in O +
inhibition O +
of O +
granulocytic O +
differentiation O +
induced O +
by O +
granulocyte B-Gene +
colony I-Gene -
- I-Gene -
stimulating I-Gene +
factor I-Gene +
and O +
causes O +
apoptotic O +
cell O +
death O +
. O +

These O +
results O +
are O +
consistent O +
with O +
a O +
role O +
for O +
DR B-Gene -
- I-Gene -
nm23 I-Gene +
in O +
normal O +
hematopoiesis O +
and O +
raise O +
the O +
possibility O +
that O +
its O +
overexpression O +
contributes O +
to O +
differentiation O +
arrest O +
, O +
a O +
feature O +
of O +
blastic O +
transformation O +
in O +
chronic O +
myelogenous O +
leukemia O +
. O +

Transcription B-Gene +
factors I-Gene +
as O +
targets O +
for O +
oxidative O +
signalling O +
during O +
lymphocyte O +
activation O +
. O +

We O +
previously O +
have O +
demonstrated O +
a O +
requirement O +
for O +
oxidative O +
events O +
during O +
cell O +
cycle O +
entry O +
in O +
T O +
lymphocytes O +
and O +
have O +
hypothesised O +
that O +
reactive O +
oxygen O +
species O +
may O +
act O +
as O +
intracellular O +
signalling O +
agents O +
during O +
lymphocyte O +
activation O +
. O +

In O +
the O +
current O +
study O +
, O +
cysteamine O +
, O +
an O +
aminothiol O +
compound O +
with O +
antioxidant O +
activity O +
, O +
has O +
been O +
used O +
to O +
further O +
investigate O +
the O +
role O +
of O +
oxidative O +
signalling O +
during O +
lymphocyte O +
activation O +
. O +

Treatment O +
of O +
normal O +
human O +
peripheral O +
blood O +
lymphocytes O +
with O +
cysteamine O +
in O +
vitro O +
was O +
found O +
to O +
inhibit O +
proliferation O +
in O +
a O +
dose O -
- O -
dependent O +
manner O +
, O +
with O +
essentially O +
complete O +
inhibition O +
occurring O +
at O +
a O +
dose O +
of O +
400 O +
microM O +
. O +

This O +
inhibitory O +
effect O +
was O +
limited O +
to O +
the O +
first O +
2 O +
h O +
after O +
mitogenic O +
activation O +
, O +
localizing O +
the O +
time O -
- O -
frame O +
of O +
action O +
of O +
cysteamine O +
to O +
within O +
the O +
commitment O +
period O +
. O +

It O +
therefore O +
was O +
of O +
interest O +
to O +
establish O +
which O +
, O +
if O +
any O +
, O +
commitment O +
events O +
were O +
affected O +
by O +
oxidative O +
signalling O +
during O +
cell O +
cycle O +
entry O +
. O +

Taking O +
the O +
IL-2 O +
gene O +
as O +
a O +
candidate O +
, O +
we O +
examined O +
the O +
effect O +
of O +
cysteamine O +
treatment O +
on O +
early O +
gene O +
expression O +
during O +
lymphocyte O +
activation O +
, O +
and O +
on O +
the O +
activity O +
of O +
transcription B-Gene +
factors I-Gene +
AP-1 B-Gene +
, O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
, O +
NF B-Gene -
- I-Gene -
AT I-Gene +
and O +
Oct1 B-Gene +
, O +
whose O +
functions O +
are O +
required O +
for O +
expression O +
of O +
the O +
IL-2 B-Gene +
mRNA O +
. O +

Cysteamine O +
treatment O +
inhibited O +
both O +
expression O +
of O +
the O +
IL-2 O +
mRNA O +
and O +
secretion O +
of O +
IL-2 B-Gene +
into O +
the O +
culture O +
medium O +
. O +

The O +
inhibitory O +
effect O +
of O +
cysteamine O +
may O +
be O +
mediated O +
at O +
least O +
in O +
part O +
by O +
an O +
effect O +
on O +
transcription B-Gene +
factor I-Gene +
function O +
, O +
as O +
the O +
DNA O +
binding O +
activities O +
of O +
AP-1 B-Gene +
and O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
extracted O +
from O +
mitogen O -
- O -
stimulated O +
cells O +
were O +
significantly O +
inhibited O +
by O +
cysteamine O +
treatment O +
. O +

Interestingly O +
, O +
Oct1 O +
and O +
NF O -
- O -
AT O +
DNA O +
binding O +
activity O +
were O +
not O +
affected O +
by O +
cysteamine O +
treatment O +
, O +
suggesting O +
that O +
oxidative O +
signalling O +
processes O +
operate O +
in O +
a O +
selective O +
manner O +
. O +

The O +
identification O +
of O +
regulatory B-Gene +
proteins I-Gene +
, O +
such O +
as O +
transcription B-Gene +
factors I-Gene +
, O +
as O +
molecular O +
targets O +
for O +
oxidative O +
signalling O +
provides O +
further O +
evidence O +
to O +
implicate O +
oxidative O +
signalling O +
as O +
being O +
intimately O +
involved O +
in O +
the O +
G0 O +
to O +
G1 O +
phase O +
transition O +
in O +
T O +
lymphocytes O +
. O +

Cellular O +
and O +
molecular O +
mechanisms O +
of O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
production O +
induced O +
by O +
IL-2 B-Gene +
and O +
IL-12 B-Gene +
in O +
a O +
human O +
NK O +
cell O +
line O +
. O +

Interferon B-Gene -
- I-Gene -
gamma I-Gene +
( O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
) O +
is O +
an O +
important O +
immunoregulatory B-Gene +
protein I-Gene +
produced O +
predominantly O +
by O +
T O +
cells O +
and O +
large O +
granular O +
lymphocytes O +
( O +
LGL O +
) O +
in O +
response O +
to O +
different O +
extracellular O +
signals O +
. O +

In O +
particular O +
, O +
two O +
interleukins B-Gene +
( O +
ILs B-Gene +
) O +
, O +
IL-2 B-Gene +
and O +
IL-12 B-Gene +
, O +
have O +
been O +
shown O +
to O +
be O +
potent O +
inducers O +
of O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
gene O +
expression O +
in O +
both O +
T O +
cells O +
and O +
LGL O +
. O +

Although O +
it O +
has O +
been O +
reported O +
that O +
there O +
are O +
some O +
T O +
cell O +
lines O +
that O +
produce O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
in O +
response O +
to O +
IL-2 O +
and O +
IL-12 O +
stimulation O +
, O +
there O +
has O +
as O +
yet O +
been O +
no O +
report O +
of O +
a O +
natural O +
killer O +
( O +
NK O +
) O +
cell O +
line O +
that O +
responds O +
in O +
a O +
similar O +
manner O +
. O +

In O +
this O +
report O +
we O +
present O +
evidence O +
that O +
the O +
cell O +
line O +
NK3.3 O +
derived O +
from O +
human O +
NK O +
cells O +
, O +
responds O +
to O +
both O +
IL-2 B-Gene +
and O +
IL-12 B-Gene +
, O +
as O +
measured O +
by O +
increases O +
in O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
and O +
granulocyte B-Gene -
- I-Gene -
macrophage I-Gene +
colony I-Gene -
- I-Gene -
stimulating I-Gene +
factor I-Gene +
( O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
) O +
cytoplasmic O +
mRNA O +
and O +
protein O +
expression O +
. O +

In O +
addition O +
, O +
when O +
used O +
together O +
IL-2 B-Gene +
and O +
IL-12 B-Gene +
synergized O +
in O +
the O +
induction O +
of O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
and O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
and O +
this O +
synergy O +
was O +
attributed O +
to O +
an O +
increased O +
accumulation O +
and O +
stability O +
of O +
the O +
IFN O -
- O -
gamma O +
and O +
GM O -
- O -
CSF O +
mRNAs O +
. O +

To O +
investigate O +
the O +
signaling O +
pathways O +
involved O +
in O +
the O +
gene O +
induction O +
, O +
five O +
inhibitors O +
, O +
cyclosporin O +
A O +
( O +
CsA O +
) O +
, O +
transforming B-Gene +
growth I-Gene +
factor I-Gene -
- I-Gene -
beta I-Gene +
, O +
cycloheximide O +
, O +
genistein O +
, O +
and O +
staurosporine O +
A O +
, O +
were O +
used O +
in O +
analyzing O +
the O +
effects O +
of O +
IL-2 B-Gene +
and O +
IL-12 B-Gene +
on O +
NK3.3 O +
cells O +
. O +

The O +
results O +
suggest O +
that O +
activation O +
of O +
protein B-Gene +
kinase I-Gene +
C I-Gene +
, O +
but O +
not O +
new O +
protein O +
synthesis O +
, O +
is O +
required O +
for O +
IL-2 B-Gene +
induction O +
of O +
IFN O -
- O -
gamma O +
and O +
GM O -
- O -
CSF O +
cytoplasmic O +
mRNA O +
. O +

In O +
contrast O +
, O +
IL-12 B-Gene +
induction O +
of O +
IFN O -
- O -
gamma O +
cytoplasmic O +
mRNA O +
appears O +
to O +
only O +
partially O +
depend O +
on O +
activation O +
of O +
protein B-Gene +
kinase I-Gene +
C I-Gene +
. O +

Furthermore O +
, O +
both O +
transforming B-Gene +
growth I-Gene +
factor I-Gene -
- I-Gene -
beta I-Gene +
and O +
genistein O +
, O +
a O +
tyrosine O +
kinase O +
inhibitor O +
, O +
could O +
suppress O +
IL-2 B-Gene +
and O +
IL-12 B-Gene +
signaling O +
but O +
CsA O +
was O +
generally O +
inactive O +
. O +

It O +
also O +
was O +
observed O +
that O +
suppression O +
of O +
cytokine O +
gene O +
expression O +
by O +
these O +
agents O +
was O +
independent O +
of O +
the O +
inhibition O +
of O +
proliferation O +
. O +

In O +
addition O +
, O +
IL-2 B-Gene +
but O +
not O +
IL-12 B-Gene +
induced O +
nuclear B-Gene +
factors I-Gene +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
and O +
AP1 B-Gene +
, O +
and O +
regulation O +
of O +
the O +
nuclear O +
levels O +
of O +
these O +
two O +
DNA B-Gene +
binding I-Gene +
protein I-Gene +
complexes I-Gene +
is O +
correlated O +
with O +
IFN O -
- O -
gamma O +
and O +
GM O -
- O -
CSF O +
gene O +
expression O +
. O +

These O +
data O +
indicate O +
that O +
IL-2 B-Gene +
and O +
IL-12 B-Gene +
may O +
have O +
distinct O +
signaling O +
pathways O +
leading O +
to O +
the O +
induction O +
of O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
and O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
gene O +
expression O +
, O +
and O +
that O +
the O +
NK3.3 O +
cell O +
line O +
may O +
serve O +
as O +
a O +
novel O +
model O +
for O +
dissecting O +
the O +
biochemical O +
and O +
molecular O +
events O +
involved O +
in O +
these O +
pathways O +
. O +

Restoration O +
of O +
the O +
Epstein B-Gene -
- I-Gene -
Barr I-Gene +
virus I-Gene +
ZEBRA I-Gene +
protein I-Gene +
's O +
capacity O +
to O +
disrupt O +
latency O +
by O +
the O +
addition O +
of O +
heterologous B-Gene +
activation I-Gene +
regions I-Gene +
. O +

The O +
ZEBRA B-Gene +
protein I-Gene +
has O +
a O +
unique O +
biological O +
function O +
among O +
herpesviral B-Gene +
proteins I-Gene +
. O +

It O +
is O +
responsible O +
for O +
the O +
disruption O +
of O +
Epstein O -
- O -
Barr O +
virus O +
( O +
EBV O +
) O +
latency O +
and O +
the O +
induction O +
of O +
the O +
lytic O +
cycle O +
. O +

ZEBRA B-Gene +
is O +
a O +
bZIP B-Gene +
transcriptional I-Gene +
activator I-Gene +
which O +
binds O +
as O +
a O +
dimer O +
to O +
7-bp O +
response O +
elements O +
within O +
EBV O +
promoters O +
and O +
is O +
directly O +
involved O +
in O +
the O +
stimulation O +
of O +
virus O +
replication O +
at O +
the O +
EBV O +
lytic O +
origin O +
. O +

We O +
have O +
employed O +
the O +
ZEBRA B-Gene +
/EBV O +
biological O +
system O +
to O +
test O +
whether O +
a O +
heterologous B-Gene +
activation I-Gene +
domain I-Gene +
can O +
substitute O +
for O +
another O +
activation O +
domain O +
( O +
the O +
ZEBRA B-Gene +
domain I-Gene +
) O +
. O +

The O +
ZEBRA B-Gene +
activation I-Gene +
region I-Gene +
was O +
replaced O +
with O +
the O +
potent O +
acid B-Gene +
activation I-Gene +
region I-Gene +
from O +
the O +
herpes B-Gene +
simplex I-Gene +
virus I-Gene +
VP16 I-Gene +
protein I-Gene +
or O +
with O +
the O +
activation B-Gene +
region I-Gene +
of O +
the O +
EBV B-Gene +
R I-Gene +
protein I-Gene +
. O +

Both O +
chimeras O +
were O +
found O +
to O +
transactivate O +
model O +
and O +
native O +
promoters O +
at O +
equivalent O +
or O +
better O +
levels O +
than O +
ZEBRA B-Gene +
itself O +
. O +

Activation O +
was O +
not O +
target- O +
or O +
cell O -
- O -
type O +
dependent O +
, O +
nor O +
was O +
it O +
dependent O +
on O +
the O +
presence O +
of O +
virus O +
. O +

These O +
activation O +
domains O +
restored O +
ZEBRA B-Gene +
's O +
ability O +
to O +
induce O +
early B-Gene +
antigen I-Gene +
and O +
to O +
stimulate O +
origin O +
replication O +
to O +
levels O +
that O +
were O +
equal O +
to O +
or O +
greater O +
than O +
those O +
of O +
wild O +
type O +
. O +

These O +
studies O +
suggest O +
that O +
the O +
specificities O +
of O +
some O +
of O +
the O +
known O +
biological O +
functions O +
of O +
ZEBRA B-Gene +
are O +
not O +
dependent O +
upon O +
the O +
nature O +
of O +
the O +
activation B-Gene +
domain I-Gene +
present I-Gene +
within O +
ZEBRA B-Gene +
. O +

Activation O +
and O +
expression O +
of O +
the O +
nuclear B-Gene +
factors I-Gene +
of O +
activated O +
T O +
cells O +
, O +
NFATp B-Gene +
and O +
NFATc B-Gene +
, O +
in O +
human O +
natural O +
killer O +
cells O +
: O +
regulation O +
upon O +
CD16 B-Gene +
ligand O +
binding O +
. O +

The O +
putative O +
factors O +
that O +
couple O +
the O +
signal O +
transduction O +
from O +
surface O +
receptors O +
to O +
the O +
activation O +
of O +
cytokine B-Gene +
synthesis O +
in O +
natural O +
killer O +
( O +
NK O +
) O +
cells O +
have O +
not O +
been O +
elucidated O +
. O +

We O +
report O +
here O +
that O +
the O +
nuclear B-Gene +
factor I-Gene +
of O +
activated O +
T O +
cells O +
( O +
NFATp B-Gene +
) O +
, O +
a O +
cyclosporin B-Gene +
A I-Gene +
( I-Gene +
CsA I-Gene +
) I-Gene +
-sensitive I-Gene +
factor I-Gene +
that O +
regulates O +
the O +
transcription O +
of O +
several O +
cytokines B-Gene +
, O +
mediates O +
CD16 B-Gene +
-induced O +
activation O +
of O +
cytokine B-Gene +
genes I-Gene +
in O +
human O +
NK O +
cells O +
. O +

CD16 B-Gene +
( O +
Fc B-Gene +
gamma I-Gene +
RIIIA I-Gene +
) O +
-induced O +
expression O +
of O +
cytokine O +
mRNA O +
in O +
NK O +
cells O +
occurs O +
via O +
a O +
CsA O -
- O -
sensitive O +
and O +
Ca O +
( O +
2 O -
+ O +
) O +
-dependent O +
mechanism O +
. O +

Stimulation O +
of O +
NK O +
cells O +
with O +
CD16 B-Gene +
ligands O +
induces O +
NFAT B-Gene +
-like O +
DNA O +
binding O +
activity O +
in O +
the O +
nuclear O +
extracts O +
from O +
these O +
cells O +
, O +
as O +
detected O +
in O +
electrophoretic O +
mobility O +
shift O +
assays O +
. O +

This O +
occurs O +
with O +
fast O +
kinetics O +
after O +
stimulation O +
, O +
via O +
a O +
CsA O -
- O -
sensitive O +
and O +
Ca O +
( O +
2 O -
+ O +
) O +
-dependent O +
mechanism O +
that O +
does O +
not O +
require O +
de O +
novo O +
protein O +
synthesis O +
. O +

NK B-Gene +
cell I-Gene +
NFAT I-Gene +
is O +
present O +
in O +
the O +
cytosol O +
of O +
nonstimulated O +
cells O +
, O +
migrates O +
to O +
the O +
nucleus O +
upon O +
stimulation O +
, O +
and O +
can O +
associate O +
with O +
AP-1 B-Gene +
. O +

Two O +
distinct O +
molecules O +
, O +
NFATp B-Gene +
and O +
NFATc B-Gene +
, O +
have O +
been O +
reported O +
to O +
mediate O +
NFAT B-Gene +
activity O +
. O +

The O +
results O +
of O +
supershift O +
assays O +
using O +
NFATp- B-Gene +
and I-Gene +
NFATc- I-Gene +
specific I-Gene +
antibodies I-Gene +
indicate O +
that O +
NK O +
cell O +
activation O +
early O +
after O +
CD16 B-Gene +
ligand O +
binding O +
involves O +
primarily O +
, O +
if O +
not O +
exclusively O +
, O +
NFATp B-Gene +
, O +
and O +
Western O +
blot O +
analysis O +
shows O +
that O +
this O +
has O +
the O +
same O +
electrophoretic O +
mobility O +
( O +
approximately O +
120 O +
kD O +
) O +
as O +
that O +
of O +
T O +
lymphocytes O +
. O +

NK O +
cells O +
do O +
not O +
express O +
NFATc B-Gene +
constitutively O +
, O +
but O +
NFATc O +
mRNA O +
accumulation O +
is O +
induced O +
in O +
these O +
cells O +
within O +
2 O +
h O +
of O +
stimulation O +
with O +
CD16 O +
ligands O +
. O +

However O +
, O +
supershift O +
assays O +
using O +
the O +
available O +
mAb B-Gene +
recognizing O +
the O +
T B-Gene +
cell I-Gene +
NFATc I-Gene +
revealed O +
no O +
detectable O +
NFATc B-Gene +
protein O +
in O +
nuclear O +
and O +
cytoplasmic O +
extracts O +
from O +
CD16- O +
or O +
phorbol O +
ester O -
- O -
stimulated O +
cells O +
at O +
any O +
time O +
tested O +
, O +
up O +
to O +
4 O +
h O +
. O +

These O +
results O +
provide O +
the O +
first O +
direct O +
evidence O +
that O +
both O +
CsA B-Gene -
- I-Gene -
sensitive I-Gene +
transcription I-Gene +
factors I-Gene +
, O +
NFATp B-Gene +
and O +
NFATc B-Gene +
, O +
are O +
expressed O +
in O +
human O +
NK O +
cells O +
, O +
and O +
that O +
their O +
activation O +
and/or O +
expression O +
can O +
be O +
regulated O +
in O +
primary O +
cells O +
by O +
a O +
single O +
stimulus O +
, O +
that O +
, O +
in O +
the O +
case O +
of O +
CD16 O +
in O +
NK O +
cells O +
, O +
results O +
in O +
early O +
activation O +
of O +
NFATp B-Gene +
and O +
subsequently O +
induced O +
expression O +
of O +
NFATc O +
mRNA O +
. O +

Nonradioactive O +
quantification O +
of O +
glucocorticoid B-Gene +
receptor I-Gene +
expression O +
during O +
differentiation O +
of O +
human O +
monocytic O +
cells O +
( O +
U937 O +
) O +
. O +

We O +
describe O +
a O +
method O +
for O +
relative O +
quantification O +
of O +
specific O +
mRNA O +
using O +
a O +
nonradioactive O +
assay O +
based O +
on O +
DNA O +
strand O +
competition O +
between O +
identical O +
sequences O +
of O +
biotin- O +
and O +
fluorescein O -
- O -
labeled O +
amplicon O +
( O +
probe O +
) O +
and O +
unlabeled O +
amplicon O +
( O +
target O +
) O +
during O +
hybridization O +
. O +

As O +
the O +
target O +
quantity O +
increased O +
, O +
that O +
of O +
the O +
double O -
- O -
labeled O +
probe O +
decreased O +
in O +
accordance O +
with O +
the O +
mass O +
action O +
law O +
. O +

This O +
technique O +
was O +
successfully O +
applied O +
to O +
evaluate O +
differences O +
in O +
glucocorticoid B-Gene +
receptor I-Gene +
expression O +
in O +
U937 O +
cells O +
before O +
and O +
after O +
the O +
addition O +
of O +
potent O +
differentiation O +
inducers O +
: O +
12-O O -
- O -
tetradecanoylphorbol O +
13-acetate O +
( O +
TPA O +
) O +
and O +
a O +
combination O +
of O +
all O -
- O -
trans O +
retinoic O +
acid O +
( O +
RA O +
) O +
and O +
1 O +
, O +
25-dihydroxyvitamin O +
D2 O +
( O +
VD O +
) O +
. O +

We O +
observed O +
that O +
TPA O +
treatment O +
was O +
associated O +
with O +
an O +
increase O +
in O +
specific O +
binding O +
of O +
[ O +
3H O +
] O +
dexamethasone O +
and O +
up O -
- O -
regulation O +
of O +
GR O +
mRNA O +
while O +
no O +
enhanced O +
GR B-Gene +
expression O +
was O +
perceived O +
with O +
RA O -
/ O -
VD O +
treatment O +
. O +

Up O -
- O -
regulation O +
of O +
high O -
- O -
affinity O +
dehydroepiandrosterone O +
binding O +
activity O +
by O +
dehydroepiandrosterone O +
in O +
activated O +
human O +
T O +
lymphocytes O +
. O +

Although O +
evidence O +
indicates O +
that O +
dehydroepiandrosterone O +
( O +
DHEA O +
) O +
exerts O +
direct O +
physiological O +
effects O +
, O +
its O +
mechanism O +
of O +
action O +
remains O +
unknown O +
. O +

DHEA O +
binding O +
sites O +
were O +
examined O +
using O +
a O +
whole O -
- O -
cell O +
binding O +
assay O +
in O +
a O +
human O +
T O +
lymphoid O +
cell O +
line O +
, O +
PEER O +
, O +
revealing O +
that O +
a O +
single O +
class O +
of O +
high O -
- O -
affinity O +
binding O +
sites O +
for O +
DHEA O +
( O +
dissociation O +
constant O +
= O +
7.4 O +
+ O -
/- O +
0.53 O +
nmol O -
/ O -
L O +
, O +
mean O +
+ O -
/- O +
SE O +
, O +
n O +
= O +
4 O +
) O +
was O +
greatly O +
increased O +
when O +
treated O +
with O +
DHEA O +
, O +
phorbol-12-myristate-13-acetate O +
, O +
and O +
the O +
Ca2 O -
+ O +
ionophore O +
A23187 O +
. O +

Bound O +
[ O +
3H O +
] O +
DHEA O +
was O +
displaced O +
sensitively O +
by O +
DHEA O +
and O +
secondarily O +
by O +
dihydrotestosterone O +
, O +
but O +
not O +
effectively O +
by O +
other O +
steroids O +
, O +
including O +
DHEA O +
sulfate O +
. O +

These O +
results O +
not O +
only O +
indicate O +
the O +
existence O +
of O +
a O +
DHEA B-Gene +
receptor I-Gene +
, O +
but O +
also O +
suggest O +
that O +
T O +
cells O +
become O +
susceptible O +
to O +
regulation O +
by O +
DHEA O +
during O +
the O +
process O +
of O +
signal O -
- O -
induced O +
activation O +
. O +

Attenuation O +
of O +
gamma B-Gene +
interferon I-Gene +
-induced O +
tyrosine O +
phosphorylation O +
in O +
mononuclear O +
phagocytes O +
infected O +
with O +
Leishmania O +
donovani O +
: O +
selective O +
inhibition O +
of O +
signaling O +
through O +
Janus B-Gene +
kinases I-Gene +
and O +
Stat1 B-Gene +
. O +

The O +
induction O +
of O +
gene O +
transcription O +
in O +
response O +
to O +
gamma B-Gene +
interferon I-Gene +
is O +
impaired O +
in O +
mononuclear O +
phagocytes O +
infected O +
with O +
Leishmania O +
donovani O +
, O +
and O +
the O +
mechanisms O +
involved O +
are O +
not O +
fully O +
understood O +
. O +

The O +
changes O +
in O +
gene O +
expression O +
brought O +
about O +
by O +
gamma B-Gene +
interferon I-Gene +
are O +
thought O +
to O +
involve O +
transient O +
increases O +
in O +
the O +
activities O +
of O +
cellular B-Gene +
protein I-Gene +
tyrosine I-Gene +
kinases I-Gene +
, O +
including O +
the O +
Janus B-Gene +
kinases I-Gene +
Jak1 B-Gene +
and O +
Jak2 B-Gene +
, O +
leading O +
to O +
tyrosine O +
phosphorylation O +
of O +
the O +
transcription B-Gene +
factor I-Gene +
Stat1 I-Gene +
. O +

To O +
investigate O +
the O +
mechanisms O +
accounting O +
for O +
the O +
impaired O +
responses O +
to O +
gamma B-Gene +
interferon I-Gene +
, O +
a O +
model O +
system O +
for O +
examining O +
overall O +
changes O +
in O +
protein O +
tyrosine O +
phosphorylation O +
, O +
activation O +
of O +
Jak1 B-Gene +
and O +
Jak2 B-Gene +
and O +
phosphorylation O +
of O +
Stat1 B-Gene +
was O +
developed O +
in O +
phorbol O +
12-myristate O +
13-acetate O -
- O -
differentiated O +
U-937 O +
cells O +
. O +

Analysis O +
of O +
whole O -
- O -
cell O +
lysates O +
by O +
antiphosphotyrosine O +
immunoblotting O +
showed O +
that O +
incubation O +
with O +
gamma B-Gene +
interferon I-Gene +
brought O +
about O +
specific O +
increases O +
in O +
phosphotyrosine O +
labeling O +
of O +
several O +
proteins O +
. O +

Increased O +
labeling O +
of O +
these O +
proteins O +
occurred O +
to O +
similar O +
extents O +
in O +
control O +
cells O +
and O +
in O +
cells O +
that O +
had O +
been O +
infected O +
with O +
L. O +
donovani O +
for O +
16 O +
h O +
. O +

Jak1 B-Gene +
, O +
Jak2 B-Gene +
, O +
and O +
Stat1 B-Gene +
were O +
immunoprecipitated O +
from O +
control O +
and O +
interferon O -
- O -
treated O +
cells O +
, O +
and O +
tyrosine O +
phosphorylation O +
of O +
these O +
proteins O +
, O +
detected O +
by O +
antiphosphotyrosine O +
immunoblotting O +
was O +
used O +
to O +
measured O +
their O +
activation O +
. O +

Tyrosine O +
phosphorylation O +
of O +
Jak1 B-Gene +
, O +
Jak2 B-Gene +
, O +
and O +
Stat1 B-Gene +
increased O +
markedly O +
, O +
in O +
a O +
dose O -
- O -
dependent O +
manner O +
, O +
in O +
U-937 O +
cells O +
incubated O +
with O +
gamma B-Gene +
interferon I-Gene +
. O +

In O +
contrast O +
, O +
in O +
cells O +
infected O +
with O +
L. O +
donovani O +
, O +
tyrosine O +
phosphorylation O +
of O +
Jak1 B-Gene +
, O +
Jak2 B-Gene +
, O +
and O +
Stat1 B-Gene +
was O +
markedly O +
impaired O +
. O +

This O +
effect O +
was O +
dependent O +
upon O +
the O +
duration O +
of O +
exposure O +
to O +
L. O +
donovani O +
and O +
was O +
maximal O +
and O +
complete O +
at O +
16 O +
h O +
. O +

Results O +
similar O +
to O +
those O +
observed O +
with O +
U-937 O +
cells O +
were O +
also O +
obtained O +
with O +
human O +
peripheral O +
blood O +
monocytes O +
. O +

These O +
findings O +
indicate O +
that O +
infection O +
of O +
human O +
mononuclear O +
phagocytes O +
with O +
L. O +
donovani O +
leads O +
to O +
impaired O +
gamma B-Gene +
interferon I-Gene +
-mediated O +
tyrosine O +
phosphorylation O +
and O +
selective O +
effects O +
on O +
the O +
Jak- O +
Stat1 B-Gene +
pathway O +
. O +

Unresponsiveness O +
to O +
gamma B-Gene +
interferon I-Gene +
for O +
activation O +
of O +
this O +
pathway O +
may O +
explain O +
impaired O +
transcriptional O +
responses O +
in O +
leishmania O -
- O -
infected O +
cells O +
. O +

Regulation O +
of O +
IkB B-Gene +
alpha I-Gene +
phosphorylation O +
by O +
PKC- O +
and O +
Ca O +
( O +
2 O -
+ O +
) O +
-dependent O +
signal O +
transduction O +
pathways O +
. O +

The O +
Ca B-Gene +
( I-Gene +
2 I-Gene -
+ I-Gene +
) I-Gene +
-dependent I-Gene +
phosphatase I-Gene +
calcineurin B-Gene +
, O +
a O +
target O +
of O +
FK506 O +
and O +
CsA O +
, O +
synergizes O +
with O +
PKC B-Gene +
-induced O +
activation O +
of O +
nuclear B-Gene +
factor I-Gene +
( I-Gene +
NF I-Gene +
) I-Gene +
-kappa I-Gene +
B I-Gene +
in O +
T O +
cell O +
lines O +
. O +

We O +
have O +
investigated O +
whether O +
this O +
synergy O +
is O +
present O +
in O +
other O +
cell O +
types O +
and O +
the O +
mechanism O +
( O +
s O +
) O +
by O +
which O +
these O +
two O +
pathways O +
lead O +
to O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
activation O +
. O +

While O +
this O +
synergy O +
is O +
present O +
in O +
other O +
cell O +
types O +
, O +
in O +
the O +
monocytic O +
cell O +
line O +
U937 O +
calcineurin B-Gene +
is O +
also O +
sufficient O +
to O +
activate O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
. O +

Having O +
previously O +
shown O +
that O +
Ca O +
( O +
2 O -
+ O +
) O +
- O +
and O +
PKC O -
- O -
dependent O +
pathways O +
synergize O +
by O +
accelerating O +
the O +
degradation O +
of O +
IkB B-Gene +
alpha I-Gene +
, O +
we O +
focused O +
on O +
the O +
regulation O +
of O +
IkB B-Gene +
alpha I-Gene +
phosphorylation O +
. O +

While O +
PKC B-Gene +
-dependent O +
pathways O +
sequentially O +
result O +
in O +
the O +
phosphorylation O +
and O +
in O +
an O +
incomplete O +
degradation O +
of O +
IkB B-Gene +
alpha I-Gene +
in O +
T O +
cell O +
lines O +
, O +
co O -
- O -
activation O +
of O +
Ca O +
( O +
2 O -
+ O +
) O +
-dependent O +
pathways O +
accelerates O +
the O +
rate O +
of O +
IkB B-Gene +
alpha I-Gene +
phosphorylation O +
and O +
results O +
in O +
its O +
complete O +
degradation O +
. O +

Activation O +
of O +
Ca O +
( O +
2 O -
+ O +
) O +
-dependent O +
pathways O +
alone O +
do O +
not O +
result O +
in O +
the O +
phosphorylation O +
and/or O +
degradation O +
of O +
IkB B-Gene +
alpha I-Gene +
in O +
Jurkat O +
T O +
or O +
in O +
U937 O +
cells O +
. O +

Treatment O +
of O +
T O +
cells O +
with O +
the O +
selective O +
PKC B-Gene +
inhibitor O +
GF109203X O +
abrogates O +
the O +
PMA O -
- O -
induced O +
IkB B-Gene +
alpha I-Gene +
phosphorylation O -
/ O -
degradation O +
irrespective O +
of O +
activation O +
of O +
Ca O +
( O +
2 O -
+ O +
) O +
-dependent O +
pathways O +
, O +
but O +
not O +
the O +
phosphorylation O +
and O +
degradation O +
of O +
IkB B-Gene +
alpha I-Gene +
induced O +
by O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
, O +
a O +
PKC B-Gene +
-independent O +
stimulus O +
. O +

Contrary O +
to O +
the O +
interaction O +
with O +
PKC B-Gene +
, O +
Ca O +
( O +
2 O -
+ O +
) O +
-dependent O +
pathways O +
synergize O +
with O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
not O +
at O +
the O +
level O +
of O +
IkB B-Gene +
alpha I-Gene +
phosphorylation O +
, O +
but O +
at O +
the O +
level O +
of O +
its O +
degradation O +
. O +

These O +
results O +
indicate O +
that O +
Ca O +
( O +
2 O -
+ O +
) O +
-dependent O +
pathways O +
, O +
including O +
the O +
phosphatase B-Gene +
calcineurin B-Gene +
, O +
participate O +
in O +
the O +
regulation O +
of O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
in O +
a O +
cell O +
specific O +
fashion O +
and O +
synergize O +
with O +
PKC B-Gene +
-dependent O +
and O +
-independent O +
pathways O +
at O +
the O +
level O +
of O +
IkB B-Gene +
alpha I-Gene +
phosphorylation O +
and O +
degradation O +
. O +

Cupric O +
ion O +
blocks O +
NF B-Gene +
kappa I-Gene +
B I-Gene +
activation O +
through O +
inhibiting O +
the O +
signal O -
- O -
induced O +
phosphorylation O +
of O +
I B-Gene +
kappa I-Gene +
B I-Gene +
alpha I-Gene +
. O +

A O +
transcription B-Gene +
factor I-Gene +
NF B-Gene +
kappa I-Gene +
B I-Gene +
, O +
which O +
regulates O +
expression O +
of O +
various O +
cellular O +
genes O +
involved O +
in O +
immune O +
responses O +
and O +
viral O +
genes O +
including O +
HIV O +
, O +
is O +
sequestered O +
in O +
the O +
cytoplasm O +
as O +
a O +
complex O +
with O +
an O +
inhibitory B-Gene +
protein I-Gene +
I I-Gene +
kappa I-Gene +
B I-Gene +
. O +

Various O +
extracellular O +
signals O +
induce O +
phosphorylation O +
and O +
rapid O +
degradation O +
of O +
I B-Gene +
kappa I-Gene +
B I-Gene +
alpha I-Gene +
to O +
release O +
NF B-Gene +
kappa I-Gene +
B I-Gene +
. O +

Cu2 O -
+ O +
was O +
found O +
to O +
inhibit O +
the O +
activation O +
of O +
NF B-Gene +
kappa I-Gene +
B I-Gene +
induced O +
by O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
, O +
TPA O +
, O +
or O +
H2O2 O +
. O +

Deoxycholate O +
treatment O +
of O +
the O +
cytoplasmic O +
extract O +
prepared O +
from O +
cells O +
stimulated O +
by O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
in O +
the O +
presence O +
of O +
Cu2 O -
+ O +
resulted O +
in O +
the O +
release O +
of O +
NF B-Gene +
kappa I-Gene +
B I-Gene +
from O +
I B-Gene +
kappa I-Gene +
B I-Gene +
alpha I-Gene +
, O +
indicating O +
that O +
Cu2 O -
+ O +
interferes O +
with O +
the O +
dissociation O +
of O +
the O +
NF B-Gene +
kappa I-Gene +
B I-Gene -
- I-Gene -
I I-Gene +
kappa I-Gene +
B I-Gene +
complex I-Gene +
. O +

Neither O +
phosphorylation O +
nor O +
degradation O +
of O +
I B-Gene +
kappa I-Gene +
B I-Gene +
alpha I-Gene +
was O +
observed O +
upon O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
stimulation O +
in O +
the O +
presence O +
of O +
Cu2 O -
+ O +
. O +

These O +
results O +
indicate O +
that O +
Cu2 O -
+ O +
inhibits O +
the O +
release O +
of O +
NF B-Gene +
kappa I-Gene +
B I-Gene +
by O +
blockade O +
of O +
a O +
signal O +
leading O +
to O +
the O +
phosphorylation O +
of O +
I B-Gene +
kappa I-Gene +
B I-Gene +
alpha I-Gene +
. O +

ETS1 B-Gene +
transactivates O +
the O +
human O +
GM O -
- O -
CSF O +
promoter O +
in O +
Jurkat O +
T O +
cells O +
stimulated O +
with O +
PMA O +
and O +
ionomycin O +
. O +

Activation O +
of O +
T O +
helper O +
cells O +
results O +
in O +
coordinate O +
expression O +
of O +
a O +
number O +
of O +
cytokines B-Gene +
involved O +
in O +
differentiation O +
, O +
proliferation O +
and O +
activation O +
of O +
the O +
haematopoietic O +
system O +
. O +

Granulocyte B-Gene -
- I-Gene -
macrophage I-Gene +
colony I-Gene -
- I-Gene -
stimulating I-Gene +
factor I-Gene +
( O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
) O +
is O +
one O +
such O +
cytokine B-Gene +
whose O +
increased O +
expression O +
results O +
partly O +
from O +
increases O +
in O +
transcription O +
. O +

Cis O -
- O -
acting O +
elements O +
with O +
NF B-Gene +
kappa I-Gene +
B I-Gene +
, O +
AP-1 B-Gene +
and O +
ETS O -
- O -
like O +
motifs O +
have O +
been O +
identified O +
in O +
the O +
promoter O +
region O +
of O +
the O +
GM O -
- O -
CSF O +
gene O +
, O +
which O +
are O +
important O +
for O +
transcriptional O +
activity O +
following O +
PMA O +
and O +
ionomycin O +
stimulation O +
. O +

A O +
number O +
of O +
the O +
ETS B-Gene +
family I-Gene +
of O +
transcription B-Gene +
factors I-Gene +
are O +
expressed O +
in O +
T O +
cells O +
, O +
including O +
ETS1 B-Gene +
and O +
ELF1 B-Gene +
. O +

Here O +
we O +
describe O +
the O +
ability O +
of O +
these O +
factors O +
to O +
interact O +
with O +
a O +
site O +
( O +
GM5 O +
) O +
, O +
located O +
within O +
the O +
CLE0 O +
element O +
, O +
-47 O +
to O +
-40 O +
upstream O +
of O +
the O +
GM O -
- O -
CSF O +
transcription O +
initiation O +
site O +
. O +

Exogenous O +
ETS1 B-Gene +
, O +
but O +
not O +
ELF1 B-Gene +
, O +
can O +
transactivate O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
, O +
through O +
the O +
GM5 O +
site O +
, O +
in O +
a O +
PMA O -
/ O -
ionomycin O +
dependent O +
manner O +
. O +

Other O +
unidentified O +
ETS B-Gene -
- I-Gene -
like I-Gene +
factors I-Gene +
present O +
in O +
Jurkat O +
cells O +
are O +
also O +
capable O +
of O +
binding O +
GM5 O +
. O +

Mutation O +
of O +
the O +
core O +
ETS O +
binding O +
site O +
from O +
-GGAA- O +
to O +
-GGAT- O +
prevents O +
the O +
binding O +
of O +
ETS B-Gene -
- I-Gene -
like I-Gene +
factors I-Gene +
with O +
the O +
exception O +
of O +
ETS1 B-Gene +
. O +

The O +
GM O -
- O -
CSF O +
promoter O +
, O +
modified O +
in O +
this O +
way O +
to O +
be O +
ETS1 B-Gene +
specific O +
, O +
is O +
fully O +
responsive O +
to O +
PMA O -
/ O -
ionomycin O +
induction O +
, O +
in O +
addition O +
to O +
ETS1 B-Gene +
transactivation O +
in O +
the O +
presence O +
of O +
PMA O +
and O +
ionomycin O +
. O +

Together O +
these O +
data O +
suggest O +
that O +
ETS1 B-Gene +
may O +
be O +
involved O +
in O +
mediating O +
the O +
increased O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
production O +
associated O +
with O +
T O +
cell O +
activation O +
. O +

Regulation O +
of O +
the O +
balance O +
of O +
cytokine B-Gene +
production O +
and O +
the O +
signal O +
transducer O +
and O +
activator O +
of O +
transcription O +
( O +
STAT B-Gene +
) O +
transcription O +
factor O +
activity O +
by O +
cytokines B-Gene +
and O +
inflammatory O +
synovial O +
fluids O +
. O +

The O +
balance O +
between O +
type O +
1 O +
and O +
2 O +
T O +
helper O +
cell O +
cytokine O +
production O +
plays O +
an O +
important O +
role O +
in O +
several O +
animal O +
models O +
of O +
autoimmunity O +
, O +
and O +
skewed O +
patterns O +
of O +
cytokine B-Gene +
expression O +
have O +
been O +
described O +
in O +
human O +
inflammatory O +
diseases O +
. O +

Many O +
cytokines B-Gene +
activate O +
signal B-Gene +
transducer I-Gene +
and I-Gene +
activation I-Gene +
of I-Gene +
transcription I-Gene +
( I-Gene +
STAT I-Gene +
) I-Gene +
transcription I-Gene +
factors I-Gene +
, O +
which O +
, O +
in O +
turn O +
, O +
activate O +
transcription O +
of O +
inflammatory O +
effector O +
genes O +
. O +

We O +
used O +
mononuclear O +
cell O +
priming O +
cultures O +
and O +
inflammatory O +
synovial O +
fluids O +
( O +
SFs O +
) O +
derived O +
from O +
arthritis O +
patients O +
to O +
examine O +
the O +
regulation O +
of O +
cytokine B-Gene +
production O +
and O +
STAT B-Gene +
activity O +
by O +
an O +
inflammatory O +
synovial O +
microenvironment O +
. O +

Exposure O +
to O +
SFs O +
during O +
priming O +
resulted O +
in O +
an O +
81 O +
% O +
inhibition O +
of O +
interferon B-Gene +
( I-Gene +
IFN I-Gene +
) I-Gene +
-gamma I-Gene +
, O +
but O +
not O +
interleukin B-Gene +
( I-Gene +
IL I-Gene +
) I-Gene +
4 I-Gene +
, O +
production O +
by O +
effector O +
cells O +
generated O +
in O +
priming O +
cultures O +
. O +

SF O +
suppression O +
was O +
mediated O +
by O +
IL-4 B-Gene +
and O +
IL-10 B-Gene +
and O +
inhibition O +
of O +
IL-12 B-Gene +
expression O +
, O +
and O +
it O +
was O +
reversed O +
in O +
a O +
dominant O +
fashion O +
by O +
exogenous O +
IL-12 O +
. O +

SFs O +
blocked O +
the O +
sustained O +
activity O +
of O +
transcription B-Gene +
factor I-Gene +
Stat1 I-Gene +
, O +
but O +
not O +
Stat3 B-Gene +
, O +
during O +
the O +
priming O +
period O +
, O +
and O +
Stat1 B-Gene +
activity O +
was O +
differentially O +
regulated O +
by O +
cytokines B-Gene +
in O +
parallel O +
with O +
their O +
positive O +
or O +
negative O +
regulation O +
of O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
production O +
. O +

Active O +
Stat3 B-Gene +
, O +
but O +
not O +
Stat1 B-Gene +
, O +
was O +
detected O +
in O +
cells O +
from O +
inflamed O +
joints O +
. O +

These O +
results O +
suggest O +
a O +
role O +
for O +
altered O +
balance O +
of O +
Stat1 O +
and O +
Stat3 O +
transcriptional O +
activity O +
in O +
the O +
regulation O +
of O +
T O +
cell O +
differentiation O +
and O +
in O +
the O +
pathogenesis O +
of O +
inflammatory O +
synovitis O +
. O +

MEK1 B-Gene +
and O +
the O +
extracellular B-Gene +
signal I-Gene -
- I-Gene -
regulated I-Gene +
kinases I-Gene +
are O +
required O +
for O +
the O +
stimulation O +
of O +
IL-2 O +
gene O +
transcription O +
in O +
T O +
cells O +
. O +

TCR B-Gene +
engagement O +
stimulates O +
the O +
activation O +
of O +
the O +
protein B-Gene +
kinase I-Gene +
Raf-1 B-Gene +
. O +

Active O +
Raf-1 B-Gene +
phosphorylates O +
and O +
activates O +
the O +
mitogen B-Gene -
- I-Gene -
activated I-Gene +
protein I-Gene +
( I-Gene +
MAP I-Gene +
) I-Gene +
kinase I-Gene -
/ I-Gene -
extracellular I-Gene +
signal I-Gene -
- I-Gene -
regulated I-Gene +
kinase I-Gene +
kinase I-Gene +
1 I-Gene +
( O +
MEK1 B-Gene +
) O +
, O +
which O +
in O +
turn O +
phosphorylates O +
and O +
activates O +
the O +
MAP B-Gene +
kinases I-Gene -
/ I-Gene -
extracellular I-Gene +
signal I-Gene +
regulated I-Gene +
kinases I-Gene +
, O +
ERK1 B-Gene +
and O +
ERK2 B-Gene +
. O +

Raf-1 B-Gene +
activity O +
promotes O +
IL-2 O +
production O +
in O +
activated O +
T O +
lymphocytes O +
. O +

Therefore O +
, O +
we O +
sought O +
to O +
determine O +
whether O +
MEK1 B-Gene +
and O +
ERK B-Gene +
activities O +
also O +
stimulate O +
IL-2 O +
gene O +
transcription O +
. O +

Expression O +
of O +
constitutively O +
active O +
Raf-1 B-Gene +
or O +
MEK1 B-Gene +
in O +
Jurkat O +
T O +
cells O +
enhanced O +
the O +
stimulation O +
of O +
IL-2 O +
promoter O +
-driven O +
transcription O +
stimulated O +
by O +
a O +
calcium O +
ionophore O +
and O +
PMA O +
, O +
and O +
together O +
with O +
a O +
calcium O +
ionophore O +
the O +
expression O +
of O +
each O +
protein O +
was O +
sufficient O +
to O +
stimulate O +
NF B-Gene -
- I-Gene -
AT I-Gene +
activity O +
. O +

Expression O +
of O +
MEK1-interfering B-Gene +
mutants I-Gene +
inhibited O +
the O +
stimulation O +
of O +
IL-2 O +
promoter O +
-driven O +
transcription O +
and O +
blocked O +
the O +
ability O +
of O +
constitutively O +
active O +
Ras B-Gene +
and O +
Raf-1 B-Gene +
to O +
costimulate O +
NF B-Gene -
- I-Gene -
AT I-Gene +
activity O +
with O +
a O +
calcium O +
ionophore O +
. O +

Expression O +
of O +
the O +
MAP B-Gene +
kinase I-Gene -
- I-Gene -
specific I-Gene +
phosphatase I-Gene +
, O +
MKP-1 B-Gene +
, O +
which O +
blocks O +
ERK B-Gene +
activation O +
, O +
inhibited O +
IL-2 O +
promoter O +
and O +
NF B-Gene -
- I-Gene -
AT I-Gene +
-driven O +
transcription O +
stimulated O +
by O +
a O +
calcium O +
ionophore O +
and O +
PMA O +
, O +
and O +
in O +
addition O +
, O +
MKP-1 B-Gene +
neutralized O +
the O +
transcriptional O +
enhancement O +
caused O +
by O +
active O +
Raf-1 O +
and O +
MEK1 O +
expression O +
. O +

We O +
conclude O +
that O +
the O +
MAP B-Gene +
kinase I-Gene +
signal O +
transduction O +
pathway O +
consisting O +
of O +
Raf-1 B-Gene +
, O +
MEK1 B-Gene +
, O +
and O +
ERK1 B-Gene +
and O +
ERK2 B-Gene +
functions O +
in O +
the O +
stimulation O +
IL-2 O +
gene O +
transcription O +
in O +
activated O +
T O +
lymphocytes O +
. O +

Inhibition O +
of O +
NF B-Gene -
- I-Gene -
AT I-Gene +
signal O +
transduction O +
events O +
by O +
a O +
dominant O -
- O -
negative O +
form O +
of O +
calcineurin B-Gene +
. O +

An O +
inhibitory O +
, O +
` O -
` O +
dominant O -
- O -
negative O +
, O +
'' O +
form O +
of O +
the O +
calcineurin B-Gene +
catalytic I-Gene +
( I-Gene +
A I-Gene +
) I-Gene +
subunit I-Gene +
was O +
prepared O +
, O +
which O +
lacks O +
the O +
calmodulin B-Gene -
- I-Gene -
binding I-Gene +
domain I-Gene +
, O +
autoinhibitory B-Gene +
domain I-Gene +
and O +
most O +
of O +
its O +
catalytic O +
core O +
but O +
possesses O +
the O +
regulatory B-Gene +
( I-Gene +
B I-Gene +
) I-Gene +
subunit I-Gene +
binding O +
domain O +
. O +

When O +
tested O +
for O +
its O +
ability O +
to O +
block O +
calcineurin B-Gene +
-dependent O +
signaling O +
in O +
Jurkat O +
cells O +
, O +
expression O +
of O +
this O +
` O -
` O +
B O -
- O -
subunit O +
knock O -
- O -
out O +
'' O +
( O +
BKO O +
) O +
construct O +
suppressed O +
reporter O +
gene O +
activity O +
driven O +
by O +
NF B-Gene -
- I-Gene -
AT I-Gene +
, O +
the O +
pivotal O +
promoter O +
element O +
for O +
interleukin O +
( O +
IL O +
) O +
-2 O +
gene O +
induction O +
. O +

Immunoprecipitation O +
of O +
epitope B-Gene -
- I-Gene -
labeled I-Gene +
BKO I-Gene +
demonstrated O +
for O +
the O +
formation O +
of O +
a O +
tight O +
complex O +
with O +
endogenous B-Gene +
B I-Gene +
subunit I-Gene +
in O +
Jurkat O +
cells O +
, O +
consistent O +
with O +
an O +
inhibitory O +
mechanism O +
that O +
involves O +
the O +
sequestration O +
of O +
the O +
B B-Gene +
subunit I-Gene +
. O +

Furthermore O +
, O +
the O +
sharply O +
reduced O +
NF B-Gene -
- I-Gene -
AT I-Gene +
activity O +
produced O +
by O +
co O -
- O -
transfecting O +
BKO O +
could O +
be O +
` O -
` O +
rescued O +
'' O +
by O +
overexpression O +
of O +
transfected O +
B B-Gene +
subunit I-Gene +
, O +
suggesting O +
that O +
depletion O +
of O +
this O +
subunit O +
was O +
responsible O +
for O +
the O +
inhibition O +
. O +

These O +
data O +
suggest O +
the O +
potential O +
utility O +
of O +
agents O +
that O +
disrupt O +
calcineurin B-Gene +
-mediated O +
signal O +
transduction O +
pathways O +
by O +
blocking O +
formation O +
of O +
the O +
catalytically B-Gene +
active I-Gene +
dimer I-Gene +
of O +
calcineurin B-Gene +
A I-Gene +
and I-Gene +
B I-Gene +
subunits I-Gene +
. O +

Inhibition O +
of O +
vitamin B-Gene +
D I-Gene +
receptor I-Gene -
- I-Gene -
retinoid I-Gene +
X I-Gene +
receptor I-Gene -
- I-Gene -
vitamin I-Gene +
D I-Gene +
response I-Gene +
element I-Gene +
complex I-Gene +
formation O +
by O +
nuclear O +
extracts O +
of O +
vitamin O +
D O -
- O -
resistant O +
New O +
World O +
primate O +
cells O +
. O +

Most O +
New O +
World O +
primate O +
( O +
NWP O +
) O +
genera O +
evolved O +
to O +
require O +
high O +
circulating O +
levels O +
of O +
steroid O +
hormones O +
and O +
vitamin O +
D O +
. O +

We O +
hypothesized O +
that O +
an O +
intracellular B-Gene +
vitamin I-Gene +
D I-Gene +
binding I-Gene +
protein I-Gene +
( O +
IDBP B-Gene +
) O +
, O +
present O +
in O +
both O +
nuclear O +
and O +
cytoplasmic O +
fractions O +
of O +
NWP O +
cells O +
, O +
or O +
another O +
protein O +
( O +
s O +
) O +
may O +
cause O +
or O +
contribute O +
to O +
the O +
steroid O +
hormone O -
- O -
resistant O +
state O +
in O +
NWP O +
by O +
disruption O +
of O +
the O +
receptor O +
dimerization O +
process O +
and/or O +
by O +
interference O +
of O +
receptor B-Gene +
complex I-Gene +
binding O +
to O +
the O +
consensus O +
response O +
elements O +
present O +
in O +
the O +
enhancer O +
regions O +
of O +
steroid O -
- O -
responsive O +
genes O +
. O +

We O +
employed O +
electromobility O +
shift O +
assay O +
( O +
EMSA O +
) O +
to O +
screen O +
for O +
the O +
presence O +
of O +
proteins O +
capable O +
of O +
binding O +
to O +
the O +
vitamin O +
D O +
response O +
element O +
( O +
VDRE O +
) O +
. O +

Nuclear O +
and O +
post O -
- O -
nuclear O +
extracts O +
were O +
prepared O +
from O +
two O +
B O -
- O -
lymphoblastoid O +
cell O +
lines O +
known O +
to O +
be O +
representative O +
of O +
the O +
vitamin O +
D O -
- O -
resistant O +
and O +
wild O +
type O +
phenotypes O +
, O +
respectively O +
. O +

The O +
extracts O +
were O +
compared O +
for O +
their O +
ability O +
to O +
retard O +
the O +
migration O +
of O +
radiolabeled O +
double O +
stranded O +
oligomers O +
representative O +
of O +
the O +
VDREs O +
of O +
the O +
human O +
osteocalcin O +
and O +
the O +
mouse O +
osteopontin O +
gene O +
promoters O +
. O +

A O +
specific O +
, O +
retarded O +
band O +
containing O +
VDR B-Gene -
- I-Gene -
RXR I-Gene +
was O +
identified O +
when O +
wild O +
type O +
cell O +
but O +
not O +
when O +
vitamin O +
D O -
- O -
resistant O +
cell O +
nuclear O +
extract O +
was O +
used O +
in O +
the O +
binding O +
reaction O +
with O +
either O +
probe O +
. O +

In O +
addition O +
, O +
vitamin O +
D O -
- O -
resistant O +
cell O +
nuclear O +
extract O +
contained O +
a O +
protein O +
( O +
s O +
) O +
which O +
was O +
bound O +
specifically O +
to O +
the O +
VDRE O +
and O +
was O +
capable O +
of O +
completely O +
inhibiting O +
VDR B-Gene -
- I-Gene -
RXR I-Gene -
- I-Gene -
VDRE I-Gene +
complex I-Gene +
formation O +
; O +
these O +
effects O +
were O +
not O +
demonstrated O +
with O +
nuclear O +
extract O +
from O +
the O +
wild O +
type O +
cell O +
line O +
or O +
with O +
the O +
post O -
- O -
nuclear O +
extract O +
of O +
the O +
vitamin O +
D O -
- O -
resistant O +
cell O +
line O +
. O +

We O +
conclude O +
that O +
a O +
VDRE B-Gene -
- I-Gene -
binding I-Gene +
protein I-Gene +
( O +
s O +
) O +
, O +
distinct O +
from O +
IDBP B-Gene +
and O +
present O +
in O +
nuclear O +
extract O +
of O +
cells O +
from O +
a O +
prototypical O +
vitamin O +
D O -
- O -
resistant O +
NWP O +
, O +
is O +
capable O +
of O +
inhibiting O +
normal O +
VDR B-Gene -
- I-Gene -
RXR I-Gene +
heterodimer O +
binding O +
to O +
the O +
VDRE O +
. O +

Glucocorticoids O +
induced O +
down O -
- O -
regulation O +
of O +
glucocorticoid B-Gene +
receptor I-Gene +
mRNA O +
expression O +
in O +
asthma O +
. O +

Although O +
their O +
precise O +
mechanism O +
of O +
action O +
remains O +
to O +
be O +
elucidated O +
, O +
glucocorticoids O +
represent O +
the O +
most O +
effective O +
therapy O +
in O +
the O +
treatment O +
of O +
asthma O +
. O +

Interactions O +
between O +
the O +
glucocorticoid B-Gene +
receptor I-Gene +
and O +
the O +
AP-1 B-Gene +
complex I-Gene +
have O +
been O +
shown O +
to O +
regulate O +
the O +
transcription O +
of O +
some O +
genes O +
, O +
including O +
glucocorticoid B-Gene +
receptor I-Gene +
itself O +
. O +

The O +
aim O +
of O +
the O +
present O +
study O +
was O +
to O +
compare O +
the O +
expression O +
of O +
mRNA O +
for O +
glucocorticoid B-Gene +
receptor I-Gene +
in O +
human O +
blood O +
monocytes O +
obtained O +
from O +
seven O +
unstable O +
untreated O +
asthmatic O +
patients O +
who O +
were O +
subsequently O +
treated O +
with O +
high O +
doses O +
of O +
parenteral O +
corticosteroid O +
( O +
methyl O +
prednisolone O +
120 O +
mg O -
/ O -
day O +
) O +
for O +
10 O +
days O +
. O +

mRNA O +
expression O +
was O +
identified O +
after O +
RNA O +
extraction O +
using O +
RNAzol O +
and O +
analysed O +
after O +
reverse B-Gene +
transcriptase I-Gene +
, O +
by O +
polymerase O +
chain O +
reaction O +
using O +
a O +
semiquantitative O +
competitive O +
hybridization O +
assay O +
. O +

All O +
asthmatic O +
patients O +
showed O +
an O +
improvement O +
in O +
their O +
FEV1 O +
values O +
after O +
corticosteroid O +
treatment O +
( O +
per O +
cent O +
of O +
predicted O +
value O +
68.28 O +
+ O -
/- O +
4.93 O +
versus O +
95.57 O +
+ O -
/- O +
6.41 O +
, O +
P O +
< O +
0.02 O +
) O +
, O +
and O +
a O +
significant O +
decrease O +
for O +
glucocorticoid B-Gene +
receptor I-Gene +
mRNA O +
expression O +
( O +
P O +
< O +
0.02 O +
) O +
was O +
observed O +
in O +
their O +
monocytes O +
. O +

This O +
is O +
the O +
first O +
report O +
of O +
an O +
ex O +
vivo O +
down O -
- O -
regulation O +
for O +
the O +
glucocorticoid B-Gene +
receptor I-Gene +
mRNA O +
expression O +
, O +
following O +
corticosteroid O +
treatment O +
. O +

Differential O +
regulation O +
of O +
IL-6 O +
gene O +
transcription O +
and O +
expression O +
by O +
IL-4 B-Gene +
and O +
IL-10 B-Gene +
in O +
human O +
monocytic O +
cell O +
lines O +
. O +

IL-4 B-Gene +
and O +
IL-10 B-Gene +
inhibit O +
the O +
cytokine B-Gene +
production O +
and O +
mRNA O +
expression O +
by O +
monocytes O -
/ O -
macrophages O +
. O +

To O +
investigate O +
the O +
molecular O +
mechanism O +
of O +
the O +
inhibitory O +
effect O +
on O +
transcriptional O +
or O +
post O -
- O -
transcriptional O +
regulation O +
of O +
IL-6 O +
gene O +
expression O +
by O +
IL-4 B-Gene +
and O +
IL-10 B-Gene +
, O +
we O +
studied O +
IL-6 B-Gene +
production O +
, O +
expression O +
level O +
of O +
IL-6 O +
mRNA O +
, O +
IL-6 B-Gene +
promoter O +
activity O +
, O +
transcriptional O +
activity O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
and O +
NF B-Gene -
- I-Gene -
IL-6 I-Gene +
, O +
and O +
IL-6 O +
mRNA O +
stability O +
in O +
human O +
monocytic O +
cell O +
lines O +
, O +
THP-1 O +
and O +
U937 O +
, O +
stimulated O +
by O +
PMA O +
and O +
LPS O +
in O +
the O +
absence O +
or O +
the O +
presence O +
of O +
IL-4 B-Gene +
or O +
IL-10 B-Gene +
. O +

Both O +
IL-4 B-Gene +
and O +
IL-10 B-Gene +
were O +
seen O +
to O +
inhibit O +
IL-6 B-Gene +
production O +
and O +
the O +
expression O +
of O +
IL-6 O +
mRNA O +
in O +
both O +
monocytic O +
cell O +
lines O +
studied O +
. O +

In O +
chloramphenicol B-Gene +
acetyltransferase I-Gene +
assays O +
, O +
utilizing O +
the O +
transient O +
transfection O +
of O +
a O +
chloramphenicol O +
acetyltransferase O +
reporter O +
plasmid O +
containing O +
the O +
IL-6 O +
gene O +
promoter O +
, O +
IL-4 B-Gene +
, O +
but O +
not O +
IL-10 B-Gene +
, O +
suppressed O +
the O +
transcriptional O +
activity O +
of O +
the O +
IL-6 O +
gene O +
promoter O +
stimulated O +
by O +
PMA O +
and O +
LPS O +
. O +

Electrophoretic O +
mobility O +
shift O +
assays O +
showed O +
that O +
IL-4 B-Gene +
, O +
but O +
not O +
IL-10 B-Gene +
, O +
inhibited O +
nuclear O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
activity O +
, O +
and O +
that O +
IL-4 B-Gene +
and O +
IL-10 B-Gene +
did O +
not O +
affect O +
NF- O +
IL-6 B-Gene +
activity O +
. O +

On O +
the O +
other O +
hand O +
, O +
IL-10 B-Gene +
enhanced O +
the O +
degradation O +
of O +
IL-6 O +
mRNA O +
in O +
a O +
mRNA O +
stability O +
assay O +
. O +

These O +
results O +
suggest O +
that O +
IL-4 B-Gene +
may O +
inhibit O +
the O +
transcription O +
of O +
the O +
IL-6 O +
gene O +
by O +
affecting O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
binding O +
activity O +
, O +
while O +
IL-10 B-Gene +
may O +
inhibit O +
the O +
IL-6 O +
mRNA O +
levels O +
post O -
- O -
transcriptionally O +
, O +
without O +
suppressing O +
promoter O +
activity O +
. O +

Therefore O +
, O +
we O +
conclude O +
that O +
IL-4 B-Gene +
and O +
IL-10 B-Gene +
inhibit O +
IL-6 B-Gene +
production O +
by O +
different O +
mechanisms O +
in O +
human O +
monocytic O +
cell O +
lines O +
. O +

Cyclic O +
AMP O +
-responsive O +
element O +
-dependent O +
activation O +
of O +
Epstein O -
- O -
Barr O +
virus O +
zebra O +
promoter O +
by O +
human O +
herpesvirus O +
6 O +
. O +

We O +
have O +
recently O +
shown O +
that O +
infection O +
of O +
Epstein O -
- O -
Barr O +
virus O +
( O +
EBV O +
) O +
genome O -
- O -
positive O +
B O +
cells O +
by O +
human O +
herpesvirus O +
6 O +
( O +
HHV-6 O +
) O +
results O +
in O +
the O +
expression O +
of O +
the O +
immediate O -
- O -
early O +
EBV O +
Zebra O +
gene O +
, O +
followed O +
by O +
virus O +
replication O +
( O +
L.Flamand O +
, O +
I.Stefanescu O +
, O +
D.V.Ablashi O +
, O +
and O +
J.Menezes O +
, O +
J.Virol.67 O +
: O +
6768 O -
- O -
6777 O +
, O +
1993 O +
) O +
. O +

Here O +
we O +
show O +
that O +
HHV-6 O +
upregulates O +
Zebra O +
gene O +
transcription O +
through O +
a O +
cyclic O +
AMP O -
- O -
responsive O +
element O +
( O +
CRE O +
) O +
located O +
within O +
the O +
Zebra O +
promoter O +
( O +
Zp O +
) O +
. O +

Using O +
human O +
B- O +
or O +
T O -
- O -
cell O +
lines O +
transfected O +
with O +
ZpCat O +
reporter O +
gene O +
constructs O +
, O +
we O +
demonstrate O +
that O +
a O +
region O +
designated O +
the O +
ZII O +
domain O +
of O +
Zp O +
is O +
the O +
target O +
of O +
HHV-6 O +
transactivation O +
. O +

Mutation O +
of O +
the O +
consensus O +
AP-1 O -
/ O -
CRE O +
site O +
within O +
ZII O +
abolished O +
the O +
inducibility O +
of O +
Zp O +
by O +
HHV-6 O +
, O +
whereas O +
positioning O +
of O +
the O +
ZII O +
domain O +
upstream O +
of O +
the O +
beta O -
- O -
globin O +
minimal O +
promoter O +
conferred O +
responsiveness O +
following O +
HHV-6 O +
infection O +
. O +

Binding O +
of O +
these O +
factors O +
to O +
ZII O +
was O +
prevented O +
by O +
oligonucleotides O +
containing O +
CRE O +
but O +
not O +
by O +
AP-1 O +
consensus O +
sequences O +
. O +

Antibodies O +
against O +
CRE B-Gene -
- I-Gene -
binding I-Gene +
( I-Gene +
CREB I-Gene +
) I-Gene +
protein I-Gene +
but O +
not O +
against O +
c B-Gene -
- I-Gene -
Fos I-Gene +
or O +
c B-Gene -
- I-Gene -
Jun I-Gene +
were O +
able O +
to O +
supershift O +
the O +
DNA B-Gene -
- I-Gene -
protein I-Gene +
complex I-Gene +
, O +
identifying O +
the O +
nature O +
of O +
the O +
transcription B-Gene +
factor I-Gene +
which O +
binds O +
to O +
ZII O +
as O +
a O +
member O +
of O +
the O +
CREB B-Gene +
family I-Gene +
of I-Gene +
proteins I-Gene +
. O +

Finally O +
, O +
transfection O +
of O +
CREB B-Gene +
protein I-Gene +
and O +
protein O +
kinase O +
A O +
expression O +
vectors O +
were O +
found O +
to O +
activate O +
Zp O +
in O +
Jurkat O +
cells O +
, O +
suggesting O +
that O +
phosphorylated O +
form O +
of O +
CREB B-Gene +
protein I-Gene +
can O +
play O +
a O +
determining O +
role O +
in O +
the O +
EBV O +
reactivation O +
process O +
. O +

Expression O +
of O +
c B-Gene -
- I-Gene -
fos I-Gene +
and I-Gene +
c I-Gene -
- I-Gene -
jun I-Gene +
proteins I-Gene +
and O +
AP-1 B-Gene +
binding O +
activity O +
during O +
cell O +
cycle O +
progression O +
of O +
HL60 O +
cells O +
and O +
phytohemagglutinin O -
- O -
stimulated O +
lymphocytes O +
. O +

The O +
protein O +
products O +
of O +
the O +
c O -
- O -
fos O +
( O +
p62c B-Gene -
- I-Gene -
fos I-Gene +
) O +
and O +
c O -
- O -
jun O +
( O +
p39c B-Gene -
- I-Gene -
jun I-Gene +
) O +
genes O +
are O +
members O +
of O +
the O +
AP-1 B-Gene +
transcription I-Gene +
factor I-Gene +
family I-Gene +
and O +
are O +
thought O +
to O +
play O +
important O +
roles O +
in O +
the O +
regulation O +
of O +
gene O +
expression O +
during O +
the O +
cell O +
cycle O +
. O +

Most O +
studies O +
on O +
the O +
expression O +
of O +
these O +
proteins O +
in O +
relation O +
to O +
the O +
cell O +
cycle O +
have O +
been O +
performed O +
at O +
the O +
mRNA O +
level O +
, O +
and O +
therefore O +
do O +
not O +
give O +
direct O +
information O +
about O +
the O +
presence O +
of O +
the O +
proteins O +
during O +
the O +
cell O +
cycle O +
. O +

We O +
have O +
used O +
Western O +
blotting O +
to O +
investigate O +
the O +
presence O +
of O +
these O +
proteins O +
during O +
the O +
cell O +
cycles O +
of O +
two O +
different O +
cellular O +
systems O +
: O +
a O +
continuously O +
growing O +
myeloid O +
leukemic O +
cell O +
line O +
, O +
HL60 O +
, O +
and O +
normal O +
cells O +
stimulated O +
into O +
cycle O +
, O +
phyto- O +
hemagglutinin O +
( O +
PHA O +
) O +
-stimulated O +
normal O +
human O +
peripheral O +
blood O +
lymphocytes O +
( O +
PBL O +
) O +
. O +

The O +
binding O +
activity O +
of O +
transcription O +
factor O +
AP-1 B-Gene +
, O +
which O +
consists O +
of O +
dimers O +
of O +
Fos B-Gene +
and I-Gene +
Jun I-Gene +
family I-Gene +
proteins I-Gene +
, O +
was O +
also O +
studied O +
using O +
a O +
gel O +
shift O +
assay O +
. O +

We O +
found O +
nuclear O +
p62c B-Gene -
- I-Gene -
fos I-Gene +
, O +
p39c B-Gene -
- I-Gene -
jun I-Gene +
, O +
and O +
AP-1 B-Gene +
binding O +
activity O +
throughout O +
the O +
cell O +
cycle O +
both O +
in O +
HL60 O +
cells O +
and O +
in O +
PHA O -
- O -
stimulated O +
PBL O +
, O +
and O +
we O +
postulate O +
that O +
these O +
proteins O +
are O +
required O +
throughout O +
the O +
cell O +
cycle O +
and O +
not O +
transiently O +
in O +
the O +
G0 O +
to O +
G1 O +
transition O +
as O +
previous O +
mRNA O +
studies O +
have O +
indicated O +
. O +

We O +
demonstrated O +
an O +
uncoupling O +
of O +
AP-1 B-Gene +
binding O +
activity O +
from O +
p62c B-Gene -
- I-Gene -
fos I-Gene +
, O +
and O +
p39c B-Gene -
- I-Gene -
jun I-Gene +
AP-1 B-Gene +
activity O +
was O +
expressed O +
more O +
strongly O +
in O +
the O +
G1- O +
and O +
G2 O -
/ O -
M O -
- O -
phase O +
enriched O +
samples O +
than O +
in O +
the O +
S O -
- O -
phase O +
enriched O +
samples O +
of O +
HL60 O +
cells O +
, O +
while O +
levels O +
of O +
nuclear B-Gene +
p62c I-Gene -
- I-Gene -
fos I-Gene +
and I-Gene +
p39c I-Gene -
- I-Gene -
jun I-Gene +
were O +
constant O +
. O +

Nuclei O +
of O +
unstimulated O +
PBL O +
from O +
different O +
donors O +
expressed O +
p62c B-Gene -
- I-Gene -
fos I-Gene +
and O +
p39c B-Gene -
- I-Gene -
jun I-Gene +
, O +
but O +
AP-1 B-Gene +
was O +
not O +
detected O +
in O +
the O +
majority O +
of O +
samples O +
. O +

Following O +
PHA B-Gene +
stimulation O +
of O +
PBL O +
, O +
the O +
increase O +
in O +
AP-1 B-Gene +
activity O +
was O +
delayed O +
with O +
respect O +
to O +
the O +
augmentation O +
of O +
p39c B-Gene -
- I-Gene -
jun I-Gene +
expression O +
. O +

We O +
also O +
observed O +
that O +
cytoplasmic B-Gene +
p62c I-Gene -
- I-Gene -
fos I-Gene +
and I-Gene +
p39c I-Gene -
- I-Gene -
jun I-Gene +
were O +
present O +
in O +
HL60 O +
cells O +
and O +
PHA O -
- O -
stimulated O +
PBL O +
. O +

However O +
, O +
no O +
cytoplasmic B-Gene +
p62c I-Gene -
- I-Gene -
fos I-Gene +
was O +
detected O +
in O +
unstimulated O +
PBL O +
, O +
although O +
in O +
some O +
cases O +
cytoplasmic B-Gene +
p39c I-Gene -
- I-Gene -
jun I-Gene +
was O +
detected O +
, O +
suggesting O +
that O +
subcellular O +
compartmentalization O +
of O +
these O +
proteins B-Gene +
may O +
occur O +
under O +
certain O +
circumstances O +
. O +

Soluble B-Gene +
tumor I-Gene +
necrosis I-Gene +
factor I-Gene +
receptors I-Gene +
inhibit O +
phorbol O +
myristate O +
acetate O +
and O +
cytokine O -
- O -
induced O +
HIV-1 O +
expression O +
chronically O +
infected O +
U1 O +
cells O +
. O +

Recombinant B-Gene +
human I-Gene +
tumor I-Gene +
necrosis I-Gene +
factor I-Gene +
( I-Gene +
TNF I-Gene +
) I-Gene +
binding I-Gene +
protein-1 I-Gene +
( O +
r B-Gene -
- I-Gene -
h I-Gene +
TBP-1 I-Gene +
) O +
and O +
recombinant B-Gene +
human I-Gene +
soluble I-Gene +
dimeric I-Gene +
TNF I-Gene +
receptor I-Gene +
( O +
rhu B-Gene +
TNFR I-Gene +
: I-Gene +
Fc I-Gene +
) O +
were O +
used O +
to O +
determine O +
the O +
relative O +
contributions O +
of O +
TNF B-Gene +
to O +
phorbol O +
myristate O +
acetate O +
( O +
PMA O +
) O +
and O +
cytokine O -
- O -
induced O +
human O +
immunodeficiency O +
virus O +
type O +
1 O +
( O +
HIV-1 O +
) O +
replication O +
in O +
chronically O +
infected O +
cell O +
lines O +
. O +

Treatment O +
of O +
HIV-1-infected O +
promonocytic O +
U1 O +
cells O +
with O +
r B-Gene -
- I-Gene -
h I-Gene -
- I-Gene -
TBP-1 I-Gene +
or O +
rhu B-Gene +
TNFR I-Gene +
: I-Gene +
Fc I-Gene +
reduced O +
PMA O -
- O -
induced O +
HIV-1 B-Gene +
p24 I-Gene +
antigen I-Gene +
production O +
in O +
a O +
concentration O -
- O -
dependent O +
manner O +
, O +
with O +
a O +
maximal O +
inhibition O +
of O +
approximately O +
90 O +
% O +
. O +

Maximal O +
inhibition O +
of O +
p24 B-Gene +
antigen I-Gene +
production O +
in O +
T O -
- O -
lymphocytic O +
ACH-2 O +
cells O +
was O +
47 O +
% O +
with O +
r B-Gene -
- I-Gene -
hTBP-1 I-Gene +
and O +
42 O +
% O +
with O +
rhu B-Gene +
TNFR I-Gene +
: I-Gene +
Fc I-Gene +
. O +

r B-Gene -
- I-Gene -
hTBP-1 I-Gene +
and O +
rhu B-Gene +
TNFR I-Gene +
: I-Gene +
Fc I-Gene +
also O +
decreased O +
p24 B-Gene +
antigen I-Gene +
synthesized O +
by O +
U1 O +
cells O +
in O +
response O +
to O +
other O +
stimuli O +
, O +
including O +
phytohemagglutinin B-Gene +
( I-Gene +
PHA I-Gene +
) I-Gene +
-induced I-Gene +
supernatant I-Gene +
, O +
granulocyte B-Gene -
- I-Gene -
macrophage I-Gene +
colony I-Gene -
- I-Gene -
stimulating I-Gene +
factor I-Gene +
, O +
interleukin-6 B-Gene +
, O +
and O +
TNF B-Gene +
. O +

Addition O +
of O +
r B-Gene -
- I-Gene -
hTBP-1 I-Gene +
to O +
U1 O +
cells O +
during O +
the O +
last O +
4 O +
h O +
of O +
a O +
24 O +
h O +
incubation O +
with O +
PMA O +
still O +
inhibited O +
p24 B-Gene +
antigen I-Gene +
production O +
by O +
15 O +
% O +
. O +

U1 O +
cells O +
stimulated O +
with O +
10 O +
( O +
-7 O +
) O +
M O +
PMA O +
released O +
approximately O +
1 O +
ng O -
/ O -
ml O +
endogenous B-Gene +
TBP-1 I-Gene +
with O +
an O +
initial O +
peak O +
observed O +
at O +
1 O +
h O +
and O +
a O +
second O +
peak O +
at O +
24 O +
h O +
after O +
PMA O +
stimulation O +
. O +

r B-Gene -
- I-Gene -
hTBP-1 I-Gene +
also O +
partially O +
reversed O +
inhibition O +
of O +
U1 O +
cellular O +
proliferation O +
caused O +
by O +
PMA O +
. O +

Both O +
r B-Gene -
- I-Gene -
hTBP-1 I-Gene +
and O +
rhu B-Gene +
TNFR I-Gene +
: I-Gene +
Fc I-Gene +
blocked O +
PMA O +
induction O +
of O +
nuclear B-Gene +
factor I-Gene +
( I-Gene +
NK I-Gene +
) I-Gene +
- I-Gene +
kappa I-Gene +
B I-Gene +
DNA O -
- O -
binding O +
activity O +
in O +
U1 O +
cells O +
in O +
association O +
with O +
decreases O +
in O +
HIV-1 O +
replication O +
. O +

We O +
conclude O +
that O +
soluble O +
TNF O +
receptors O +
can O +
inhibit O +
stimuli O -
- O -
induced O +
HIV-1 O +
expression O +
and O +
NK- B-Gene +
kappa I-Gene +
B I-Gene +
DNA O -
- O -
binding O +
activity O +
in O +
chronically O +
infected O +
U1 O +
cells O +
. O +

Reversible O +
differentiation O +
of O +
human O +
monoblastic O +
leukemia O +
U937 O +
cells O +
by O +
ML-9 O +
, O +
an O +
inhibitor O +
of O +
myosin B-Gene +
light I-Gene +
chain I-Gene +
kinase I-Gene +
. O +

Human O +
monoblastic O +
leukemia O +
U937 O +
cells O +
are O +
induced O +
to O +
differentiate O +
into O +
monocytes O +
and O +
macrophages O +
by O +
various O +
agents O +
. O +

We O +
have O +
shown O +
that O +
1- O +
( O +
5-chloronaphthalene-1-sulfonyl O +
) O +
-1H O -
- O -
hexahydro-1 O +
, O +
4-diazepine O +
hydrochloride O +
( O +
ML-9 O +
) O +
, O +
an O +
inhibitor O +
of O +
myosin B-Gene +
light I-Gene +
chain I-Gene +
kinase I-Gene +
, O +
induces O +
differentiation O +
of O +
monocytoid O +
leukemia O +
cell O +
lines O +
U937 O +
and O +
THP-1 O +
but O +
not O +
of O +
myeloblastic O +
leukemic O +
ML-1 O +
cell O +
or O +
erythroleukemia O +
K562 O +
cells O +
. O +

In O +
the O +
present O +
study O +
, O +
we O +
further O +
analyzed O +
the O +
effect O +
of O +
ML-9 O +
in O +
comparison O +
with O +
that O +
of O +
1 O +
alpha O +
, O +
25-dihydroxyvitamin O +
D3 O +
( O +
VD3 O +
) O +
a O +
typical O +
inducer O +
of O +
monocytic O +
differentiation O +
. O +

ML-9 O +
induced O +
nitroblue O +
tetrazolium O +
( O +
NBT O +
) O +
-reducing O +
activity O +
of O +
U937 O +
cell O +
more O +
rapidly O +
than O +
VD3 O +
: O +
This O +
differentiation O +
marker O +
was O +
induced O +
significantly O +
after O +
incubation O +
with O +
ML-9 O +
and O +
VD3 O +
for O +
4 O +
hours O +
and O +
1 O +
day O +
, O +
respectively O +
. O +

ML-9 O +
also O +
induced O +
alpha B-Gene -
- I-Gene -
naphthyl I-Gene +
acetate I-Gene +
esterase I-Gene +
( O +
ANAE B-Gene +
) O +
activity O +
, O +
another O +
monocytic O +
differentiation O +
marker O +
, O +
more O +
rapidly O +
than O +
VD3 O +
. O +

The O +
maximum O +
levels O +
of O +
these O +
markers O +
induced O +
by O +
ML-9 O +
were O +
comparable O +
to O +
those O +
induced O +
by O +
VD3 O +
, O +
but O +
after O +
removal O +
of O +
ML-9 O +
from O +
the O +
medium O +
by O +
washing O +
the O +
cells O +
, O +
the O +
expressions O +
of O +
theses O +
markers O +
decreased O +
within O +
4 O +
hours O +
and O +
reached O +
basal O +
levels O +
in O +
1 O +
day O +
, O +
indicating O +
that O +
ML-9 O +
's O +
induction O +
of O +
expression O +
of O +
differentiation O -
- O -
associated O +
phenotypes O +
was O +
reversible O +
. O +

The O +
growth O +
inhibition O +
of O +
U937 O +
cells O +
by O +
ML-9 O +
was O +
also O +
reversible O +
. O +

Similar O +
effects O +
were O +
observed O +
in O +
another O +
line O +
of O +
human O +
monoblastic O +
cells O +
, O +
THP-1 O +
. O +

ML-9 O +
had O +
little O +
or O +
no O +
effect O +
on O +
the O +
morphology O +
of O +
U937 O +
cells O +
but O +
increased O +
the O +
expression O +
of O +
monocyte B-Gene -
- I-Gene -
macrophage I-Gene +
lineage I-Gene -
- I-Gene -
associated I-Gene +
surface I-Gene +
antigen I-Gene +
, O +
CD14 B-Gene +
, O +
to O +
some O +
extent O +
. O +

Irreversible O +
terminal O +
differentiation O +
induced O +
by O +
VD3 O +
is O +
associated O +
with O +
down O +
regulation O +
of O +
the O +
expression O +
of O +
c O -
- O -
myc O +
and O +
upregulation O +
of O +
the O +
expression O +
of O +
c O -
- O -
fos O +
and O +
c O -
- O -
jun O +
, O +
but O +
ML-9 O +
did O +
not O +
affect O +
the O +
expression O +
of O +
these O +
oncogenes O +
appreciably O +
. O +

ML-9-induced O +
differentiation O +
was O +
also O +
reversible O +
when O +
the O +
cells O +
were O +
cultured O +
with O +
cultured O +
with O +
ML-9 O +
plus O +
an O +
anti O -
- O -
cancer O +
drug O +
such O +
as O +
1-beta O -
- O -
D O -
- O -
arabino O -
- O -
furanosylcytosine O +
or O +
daunomycin O +
. O +

it O +
became O +
irreversible O +
, O +
however O +
, O +
upon O +
simultaneous O +
treatment O +
with O +
dexamethasone O +
and O +
transforming B-Gene +
growth I-Gene +
factor I-Gene -
- I-Gene -
beta I-Gene +
1 I-Gene +
( O +
TGF B-Gene -
- I-Gene -
beta I-Gene +
1 I-Gene +
) O +
, O +
which O +
did O +
not O +
induce O +
differentiation O +
of O +
U937 O +
cells O +
but O +
caused O +
growth O +
arrest O +
of O +
the O +
cells O +
in O +
the O +
G0 O -
/ O -
G1 O +
phase O +
of O +
the O +
cell O +
cycle O +
. O +

These O +
results O +
suggest O +
that O +
ML-9 O +
should O +
be O +
useful O +
for O +
studying O +
the O +
mechanisms O +
of O +
monocytic O +
differentiation O +
. O +

The O +
myeloid O -
- O -
cell O -
- O -
specific O +
c O -
- O -
fes O +
promoter O +
is O +
regulated O +
by O +
Sp1 B-Gene +
, O +
PU.1 B-Gene +
, O +
and O +
a O +
novel O +
transcription B-Gene +
factor I-Gene +
. O +

The O +
protein O +
product O +
of O +
the O +
c O -
- O -
fps O -
/ O -
fes O +
( O +
c O -
- O -
fes O +
) O +
proto O -
- O -
oncogene O +
has O +
been O +
implicated O +
in O +
the O +
normal O +
development O +
of O +
myeloid O +
cells O +
( O +
macrophages O +
and O +
neutrophils O +
) O +
. O +

mRNA O +
for O +
c O -
- O -
fes O +
has O +
been O +
detected O +
exclusively O +
in O +
myeloid O +
cells O +
and O +
vascular O +
endothelial O +
cells O +
in O +
adult O +
mammals O +
. O +

Although O +
a O +
13-kilobase O -
- O -
pair O +
( O +
kb O +
) O +
human O +
c O -
- O -
fes O +
transgene O +
exhibits O +
high O +
levels O +
of O +
expression O +
in O +
mice O +
, O +
the O +
sequences O +
that O +
confer O +
myeloid O -
- O -
cell O -
- O -
specific O +
expression O +
of O +
the O +
human O +
c O -
- O -
fes O +
gene O +
have O +
not O +
been O +
defined O +
. O +

Transient O -
- O -
transfection O +
experiments O +
demonstrated O +
that O +
plasmids O +
containing O +
446 O +
bp O +
of O +
c O -
- O -
fes O +
5'-flanking O +
sequences O +
linked O +
to O +
a O +
luciferase O +
reporter O +
gene O +
were O +
active O +
exclusively O +
in O +
myeloid O +
cells O +
. O +

No O +
other O +
DNA O +
element O +
within O +
the O +
13-kb O +
human O +
c O -
- O -
fes O +
locus O +
contained O +
positive O +
cis O -
- O -
acting O +
elements O +
, O +
with O +
the O +
exception O +
of O +
a O +
weakly O +
active O +
region O +
within O +
the O +
3'-flanking O +
sequences O +
. O +

DNase O +
I O +
footprinting O +
assays O +
revealed O +
four O +
distinct O +
sites O +
that O +
bind O +
myeloid B-Gene +
nuclear I-Gene +
proteins I-Gene +
( O +
-408 O +
to O +
-386 O +
, O +
-293 O +
to O +
-254 O +
, O +
-76 O +
to O +
-65 O +
, O +
and O +
-34 O +
to O +
+ O -
3 O +
) O +
. O +

However O +
, O +
the O +
first O +
two O +
footprints O +
resided O +
in O +
sequences O +
that O +
were O +
largely O +
dispensable O +
for O +
transient O +
activity O +
. O +

Plasmids O +
containing O +
151 O +
bp O +
of O +
5'-flanking O +
sequences O +
confer O +
myeloid O -
- O -
cell O -
- O -
specific O +
gene O +
expression O +
. O +

Electrophoretic O +
mobility O +
shift O +
analyses O +
demonstrated O +
that O +
the O +
151-bp O +
region O +
contains O +
nuclear O +
protein O +
binding O +
sites O +
for O +
Sp1 B-Gene +
, O +
PU.1 B-Gene +
, O +
and/or O +
Elf-1 B-Gene +
, O +
and O +
a O +
novel B-Gene +
factor I-Gene +
. O +

This O +
unidentified O +
factor O +
binds O +
immediately O +
3 O +
' O +
of O +
the O +
PU.1 O -
/ O -
Elf-1 O +
sites O +
and O +
appears O +
to O +
be O +
myeloid O +
cell O +
specific O +
. O +

Mutation O +
of O +
the O +
PU.1 B-Gene +
/Elf-1 B-Gene +
site O +
or O +
the O +
3 O +
' O +
site O +
( O +
FP4 O -
- O -
3 O +
' O +
) O +
within O +
the O +
context O +
of O +
the O +
c O -
- O -
fes O +
promoter O +
resulted O +
in O +
substantially O +
reduced O +
activity O +
in O +
transient O +
transfections O +
. O +

Furthermore O +
, O +
transient O -
- O -
cotransfection O +
assay O +
demonstrated O +
that O +
PU.1 B-Gene +
( O +
and O +
not O +
Elf-1 B-Gene +
) O +
can O +
transactivate O +
the O +
c O -
- O -
fes O +
promoter O +
in O +
nonmyeloid O +
cell O +
lines O +
. O +

We O +
conclude O +
that O +
the O +
human O +
c O -
- O -
fes O +
gene O +
contains O +
a O +
strong O +
myeloid O -
- O -
cell O -
- O -
specific O +
promoter O +
that O +
is O +
regulated O +
by O +
Sp1 B-Gene +
, O +
PU.1 B-Gene +
, O +
and O +
a O +
novel O +
transcription B-Gene +
factor I-Gene +
. O +

Transcriptional O +
activation O +
of O +
RNA O +
polymerase O +
III O -
- O -
dependent O +
genes O +
by O +
the O +
human B-Gene +
T I-Gene -
- I-Gene -
cell I-Gene +
leukemia I-Gene +
virus I-Gene +
type I-Gene +
1 I-Gene +
tax I-Gene +
protein I-Gene +
. O +

The O +
human B-Gene +
T I-Gene -
- I-Gene -
cell I-Gene +
leukemia I-Gene +
virus I-Gene -
- I-Gene -
encoded I-Gene +
tax I-Gene +
protein I-Gene +
is O +
a O +
potent O +
activator O +
of O +
many O +
viral O +
and O +
cellular O +
genes O +
transcribed O +
by O +
RNA B-Gene +
polymerase I-Gene +
II I-Gene +
. O +

We O +
find O +
that O +
both O +
chromatin O +
and O +
cell O +
extracts O +
derived O +
from O +
human O +
T O -
- O -
cell O +
leukemia O +
virus O +
type O +
1-infected O +
human O +
T O +
lymphocytes O +
support O +
higher O +
levels O +
of O +
5S O +
rRNA O +
and O +
tRNA O +
gene O +
transcription O +
than O +
chromatin O +
or O +
extracts O +
from O +
uninfected O +
T O +
lymphocytes O +
. O +

The O +
viral B-Gene +
protein I-Gene +
Tax I-Gene +
was O +
likely O +
responsible O +
for O +
this O +
higher O +
level O +
of O +
class O +
II O +
gene O +
transcription O +
, O +
as O +
purified B-Gene +
Tax I-Gene +
was O +
found O +
to O +
stimulate O +
both O +
genes O +
when O +
added O +
to O +
the O +
uninfected O +
cell O +
extract O +
or O +
in O +
reconstituted O +
systems O +
. O +

Both O +
limiting O -
- O -
component O +
transcription O +
assays O +
and O +
DNA O +
binding O +
assays O +
identified O +
the O +
class B-Gene +
III I-Gene +
gene I-Gene +
transcription I-Gene +
factor I-Gene +
TFIIIB B-Gene +
as O +
the O +
principle O +
target O +
of O +
Tax B-Gene +
activity O +
. O +

Surprisingly O +
, O +
we O +
find O +
that O +
Tax B-Gene +
increases O +
the O +
effective O +
concentration O +
of O +
active B-Gene +
TFIIIB I-Gene +
molecules I-Gene +
. O +

These O +
data O +
suggest O +
that O +
Tax B-Gene +
stimulates O +
RNA O +
polymerase O +
III O -
- O -
dependent O +
gene O +
expression O +
by O +
accelerating O +
the O +
rate O +
and/or O +
extent O +
of O +
transcription B-Gene +
initiation I-Gene +
complex I-Gene +
assembly O +
. O +

Induction O +
of O +
CIITA B-Gene +
and O +
modification O +
of O +
in O +
vivo O +
HLA O -
- O -
DR O +
promoter O +
occupancy O +
in O +
normal O +
thymic O +
epithelial O +
cells O +
treated O +
with O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
: O +
similarities O +
and O +
distinctions O +
with O +
respect O +
to O +
HLA O -
- O -
DR O -
- O -
constitutive O +
B O +
cells O +
. O +

In O +
this O +
study O +
, O +
the O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
induction O +
of O +
MHC O +
class O +
II O +
gene O +
expression O +
in O +
primary O +
cultures O +
of O +
thymic O +
epithelial O +
cells O +
( O +
TEC O +
) O +
was O +
analyzed O +
. O +

This O +
cellular O +
system O +
offers O +
the O +
advantage O +
that O +
MHC B-Gene +
class I-Gene +
II I-Gene +
induction O +
is O +
studied O +
in O +
a O +
` O -
` O +
physiologic O +
'' O +
cell O +
lineage O +
that O +
, O +
as O +
a O +
result O +
of O +
this O +
expression O +
within O +
the O +
thymus O +
, O +
is O +
thought O +
to O +
participate O +
to O +
the O +
selection O +
and O +
maturation O +
of O +
the O +
T O +
cells O +
. O +

It O +
was O +
found O +
that O +
the O +
MHC O +
class O +
II O +
gene O +
expression O +
was O +
associated O +
with O +
the O +
de O +
novo O +
transcription O +
of O +
the O +
gene O +
encoding O +
the O +
CIITA B-Gene +
trans I-Gene -
- I-Gene -
activator I-Gene +
, O +
a O +
crucial O +
MHC B-Gene +
class I-Gene +
II I-Gene +
gene I-Gene +
regulatory I-Gene +
factor I-Gene +
. O +

Furthermore O +
, O +
the O +
anatomy O +
of O +
interaction O +
between O +
the O +
MHC O +
class O +
II O +
DRA O +
promoter O +
and O +
corresponding O +
binding B-Gene +
factors I-Gene +
was O +
analyzed O +
by O +
in O +
vivo O +
DNAse B-Gene +
I I-Gene +
footprint O +
. O +

It O +
was O +
found O +
that O +
treatment O +
with O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
induces O +
changes O +
in O +
the O +
occupancy O +
of O +
the O +
DRA O +
gene O +
regulatory O +
sequences O +
by O +
nuclear B-Gene +
factors I-Gene +
. O +

The O +
resulting O +
occupancy O +
displays O +
strong O +
similarities O +
with O +
the O +
one O +
observed O +
in O +
the O +
MHC O +
class O +
II O -
- O -
constitutive O +
B O +
cells O +
, O +
represented O +
by O +
both O +
the O +
Burkitt O +
lymphoma O +
line O +
Raji O +
and O +
normal O +
tonsil- O +
derived O +
B O +
cells O +
. O +

However O +
, O +
some O +
peculiar O +
differences O +
were O +
observed O +
between O +
the O +
TEC O +
, O +
either O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
-induced O +
or O +
not O +
, O +
and O +
the O +
constitutive O +
B O +
cells O +
. O +

These O +
results O +
suggest O +
that O +
both O +
common O +
mechanisms O +
, O +
such O +
as O +
the O +
one O +
mediated O +
by O +
the O +
CIITA B-Gene +
trans I-Gene -
- I-Gene -
activator I-Gene +
, O +
and O +
distinct O +
tissue O -
- O -
specific O +
constraints O +
contribute O +
to O +
the O +
transcriptional O +
control O +
of O +
constitutive O +
and O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
-induced O +
MHC O +
class O +
II O +
gene O +
expression O +
. O +

Sublethal O +
levels O +
of O +
oxidative O +
stress O +
stimulate O +
transcriptional O +
activation O +
of O +
c O -
- O -
jun O +
and O +
suppress O +
IL-2 O +
promoter O +
activation O +
in O +
Jurkat O +
T O +
cells O +
. O +

Sublethal O +
levels O +
of O +
oxidative O +
stress O +
are O +
well O +
known O +
to O +
alter O +
T O +
cell O +
functional O +
responses O +
, O +
but O +
the O +
underlying O +
mechanisms O +
are O +
unknown O +
. O +

The O +
current O +
study O +
examined O +
the O +
effects O +
of O +
oxidative O +
stress O +
on O +
transcriptional O +
activities O +
mediated O +
by O +
c B-Gene -
- I-Gene -
Fos I-Gene -
/ I-Gene -
c I-Gene -
- I-Gene -
Jun I-Gene +
AP-1 B-Gene +
and O +
the O +
nuclear B-Gene +
factor I-Gene +
of I-Gene +
activated I-Gene +
T I-Gene +
cells I-Gene +
( O +
NF B-Gene -
- I-Gene -
AT I-Gene +
) O +
. O +

The O +
present O +
results O +
show O +
that O +
Jurkat O +
T O +
cells O +
acutely O +
exposed O +
to O +
micromolar O +
concentrations O +
of O +
H2O2 O +
exhibit O +
substantial O +
increases O +
in O +
AP-1 B-Gene +
binding O +
activity O +
and O +
the O +
expression O +
of O +
c O -
- O -
jun O +
but O +
not O +
c O -
- O -
fos O +
mRNA O +
. O +

The O +
preferential O +
induction O +
of O +
c O -
- O -
jun O +
by O +
H2O2 O +
did O +
not O +
represent O +
redox O +
stabilization O +
of O +
mRNA O +
transcripts O +
, O +
and O +
oxidative O +
signals O +
closely O +
resembled O +
PHA O -
/ O -
PMA O +
stimulation O +
by O +
effectively O +
transactivating O +
the O +
full O +
length O +
c O -
- O -
jun O +
promoter O +
via O +
the O +
proximal O +
jun1 O +
tumor O +
promoter O -
- O -
responsive O +
element O +
( O +
TRE O +
) O +
-like O +
promoter O +
element O +
. O +

Similarly O +
, O +
the O +
complexes O +
binding O +
the O +
consensus O +
AP-1 O +
TRE O +
and O +
jun O +
TRE O -
- O -
like O +
motifs O +
in O +
cells O +
exposed O +
to O +
oxidative O +
signals O +
or O +
PHA O -
/ O -
PMA O +
were O +
indistinguishable O +
, O +
being O +
composed O +
of O +
c B-Gene -
- I-Gene -
Fos I-Gene +
, O +
c B-Gene -
- I-Gene -
Jun I-Gene +
, O +
and O +
JunD B-Gene +
. O +

However O +
, O +
PHA O -
/ O -
PMA O +
but O +
not O +
oxidative O +
signals O +
induced O +
the O +
coordinate O +
activation O +
of O +
reporter O +
constructs O +
containing O +
the O +
AP-1-TRE O +
, O +
NF O -
- O -
AT O +
, O +
and O +
IL-2 O +
promoter O +
regions O +
along O +
with O +
IL-2 O +
mRNA O +
expression O +
. O +

Furthermore O +
, O +
sublethal O +
levels O +
of O +
H2O2 O +
actively O +
suppressed O +
the O +
transcriptional O +
activation O +
of O +
NF B-Gene -
- I-Gene -
AT I-Gene +
and O +
IL-2 O +
reporters O +
as O +
well O +
as O +
the O +
expression O +
of O +
IL-2 O +
mRNA O +
in O +
cells O +
stimulated O +
with O +
PHA O -
/ O -
PMA O +
. O +

Gel O +
shift O +
analysis O +
revealed O +
that O +
oxidative O +
suppression O +
of O +
NF B-Gene -
- I-Gene -
AT I-Gene +
represented O +
inhibition O +
in O +
the O +
early O +
generation O +
of O +
NFAT B-Gene +
complexes I-Gene +
rather O +
than O +
the O +
binding O +
of O +
preformed O +
NF B-Gene -
- I-Gene -
AT I-Gene +
complexes I-Gene +
. O +

These O +
results O +
suggest O +
that O +
oxidative O +
signals O +
can O +
positively O +
and O +
negatively O +
regulate O +
T O +
cell O +
transcriptional O +
events O +
and O +
that O +
changes O +
in O +
cellular O +
redox O +
can O +
uncouple O +
AP-1 B-Gene +
regulation O +
of O +
c O -
- O -
jun O +
from O +
transcriptional O +
up O -
- O -
regulation O +
of O +
IL-2 B-Gene +
via O +
NF B-Gene -
- I-Gene -
AT I-Gene +
. O +

HIV-1 B-Gene +
tat I-Gene +
induces O +
the O +
expression O +
of O +
a O +
new O +
hematopoietic B-Gene +
cell I-Gene -
- I-Gene -
specific I-Gene +
transcription I-Gene +
factor I-Gene +
and O +
downregulates O +
MIP-1 O +
alpha O +
gene O +
expression O +
in O +
activated O +
T O -
- O -
cells O +
. O +

MIP-1 B-Gene +
alpha I-Gene +
is O +
a O +
secreted O +
chemokine B-Gene +
which O +
can O +
inhibit O +
hematopoietic O +
stem O +
cells O +
and O +
modulate O +
inflammatory O +
responses O +
. O +

It O +
is O +
also O +
an O +
inhibitor O +
of O +
HIV O +
replication O +
in O +
CD8 O -
+ O +
T O -
- O -
cells O +
. O +

The O +
expression O +
of O +
MIP-1 B-Gene +
alpha I-Gene +
is O +
induced O +
during O +
cellular O +
activation O +
of O +
CD4 O -
+ O +
T O -
- O -
cells O +
and O +
monocytes O +
. O +

It O +
is O +
also O +
expressed O +
in O +
transformed O +
B O -
- O -
cells O +
. O +

We O +
have O +
previously O +
identified O +
a O +
new O +
transcription B-Gene +
factor I-Gene +
family I-Gene +
( O +
the O +
MNP B-Gene +
family I-Gene +
) O +
whose O +
expression O +
is O +
crucial O +
for O +
the O +
induction O +
of O +
MIP-1 B-Gene +
alpha I-Gene +
transcription O +
during O +
cellular O +
activation O +
and O +
in O +
transformed O +
B O +
cells O +
. O +

Monocytes O +
and O +
transformed O +
B O -
- O -
cells O +
normally O +
express O +
MNP-1 B-Gene +
strongly O +
and O +
MNP-2 B-Gene +
weakly O +
, O +
while O +
T O -
- O -
cells O +
strongly O +
express O +
only O +
MNP-2 B-Gene +
. O +

Recently O +
, O +
we O +
reported O +
that O +
HIV-1 B-Gene +
tat I-Gene +
downregulates O +
MIP-1 B-Gene +
alpha I-Gene +
expression O +
in O +
Jurkat O +
T O -
- O -
cells O +
. O +

In O +
this O +
report O +
we O +
show O +
induction O +
of O +
MNP-1 B-Gene +
in O +
Jurkat O +
T O -
- O -
cells O +
expressing O +
HIV-1 B-Gene +
tat I-Gene +
. O +

Expression O +
of O +
neither O +
HTLV-1 B-Gene +
tax I-Gene +
in O +
Jurkat O +
T O -
- O -
cells O +
nor O +
EBV O +
in O +
B O -
- O -
cells O +
had O +
any O +
effect O +
on O +
MNP-1 B-Gene +
or O +
MNP-2 B-Gene +
expression O +
, O +
showing O +
that O +
the O +
effect O +
is O +
specific O +
for O +
HIV-1 B-Gene +
tat I-Gene +
. O +

We O +
propose O +
that O +
HIV-1 B-Gene +
tat I-Gene +
may O +
inhibit O +
MIP-1 B-Gene +
alpha I-Gene +
expression O +
by O +
inducing O +
MNP-1 B-Gene +
expression O +
in O +
T O -
- O -
cells O +
, O +
probably O +
by O +
either O +
competing O +
with O +
MNP-2 B-Gene +
for O +
binding O +
to O +
the O +
MIP-1 O +
alpha O +
promoter O +
or O +
by O +
sequestering O +
it O +
into O +
inactive O +
forms O +
. O +

Cooperation O +
between O +
core B-Gene +
binding I-Gene +
factor I-Gene +
and O +
adjacent O +
promoter O +
elements O +
contributes O +
to O +
the O +
tissue O -
- O -
specific O +
expression O +
of O +
interleukin-3 B-Gene +
. O +

Tissue O -
- O -
specific O +
expression O +
of O +
interleukin-3 B-Gene +
( O +
IL-3 B-Gene +
) O +
is O +
mediated O +
via O +
cis O -
- O -
acting O +
elements O +
located O +
within O +
315 O +
base O +
pairs O +
of O +
the O +
transcription O +
start O +
. O +

This O +
is O +
achieved O +
in O +
part O +
through O +
the O +
positive O +
activities O +
of O +
the O +
AP-1 O +
and O +
Elf-1 O +
sites O +
in O +
the O +
IL-3 O +
promoter O +
. O +

The O +
contribution O +
to O +
T O +
cell O -
- O -
specific O +
expression O +
by O +
other O +
promoter O +
sites O +
was O +
assessed O +
in O +
a O +
transient O +
expression O +
assay O +
with O +
IL-3 O +
promoter O +
constructs O +
linked O +
to O +
a O +
luciferase O +
gene O +
, O +
focusing O +
initially O +
on O +
the O +
core O +
binding O +
factor O +
( O +
CBF O +
) O +
site O +
, O +
which O +
is O +
footprinted O +
in O +
vivo O +
upon O +
T O +
cell O +
activation O +
. O +

Activity O +
of O +
the O +
CBF O +
site O +
is O +
shown O +
to O +
be O +
critically O +
dependent O +
on O +
the O +
adjacent O +
activator O +
site O +
Act-1 O +
. O +

Together O +
the O +
Act-1 O +
and O +
CBF O +
sites O +
form O +
a O +
functional O +
unit O +
( O +
AC O +
unit O +
) O +
with O +
dual O +
activity O +
. O +

The O +
AC O +
unit O +
is O +
demonstrated O +
to O +
enhance O +
basal O +
activity O +
of O +
promoters O +
both O +
in O +
fibroblasts O +
and O +
T O +
cells O +
. O +

This O +
activity O +
is O +
further O +
inducible O +
in O +
activated O +
T O +
cells O +
, O +
but O +
not O +
in O +
fibroblasts O +
. O +

In O +
addition O +
to O +
the O +
already O +
identified O +
NIP O +
repressor O +
site O +
, O +
evidence O +
is O +
presented O +
for O +
a O +
second O +
repressor O +
region O +
that O +
restricts O +
promoter O +
activity O +
in O +
fibroblasts O +
. O +

Finally O +
, O +
a O +
novel O +
positive O +
regulatory O +
element O +
has O +
been O +
mapped O +
in O +
the O +
IL-3 O +
promoter O +
between O +
nucleotide O +
-180 O +
and O +
-210 O +
that O +
leads O +
to O +
increased O +
expression O +
in O +
T O +
cells O +
. O +

Together O +
these O +
results O +
demonstrate O +
that O +
T O +
cell O +
expression O +
of O +
IL-3 B-Gene +
is O +
not O +
specified O +
by O +
the O +
activity O +
of O +
a O +
single O +
tissue O -
- O -
specific O +
element O +
, O +
but O +
instead O +
involves O +
multiple O +
interacting O +
elements O +
that O +
provide O +
both O +
specific O +
positive O +
regulation O +
in O +
T O +
cells O +
and O +
specific O +
negative O +
regulation O +
in O +
fibroblasts O +
. O +

Gene O +
transcription O +
through O +
activation O +
of O +
G B-Gene -
- I-Gene -
protein I-Gene -
- I-Gene -
coupled I-Gene +
chemoattractant I-Gene +
receptors I-Gene +
. O +

Receptors O +
for O +
leukocyte B-Gene +
chemoattractants I-Gene +
, O +
including O +
chemokines B-Gene +
, O +
are O +
traditionally O +
considered O +
to O +
be O +
responsible O +
for O +
the O +
activation O +
of O +
special O +
leukocyte O +
functions O +
such O +
as O +
chemotaxis O +
, O +
degranulation O +
, O +
and O +
the O +
release O +
of O +
superoxide O +
anions O +
. O +

Recently O +
, O +
these O +
G B-Gene -
- I-Gene -
protein I-Gene -
- I-Gene -
coupled I-Gene +
serpentine I-Gene +
receptors I-Gene +
have O +
been O +
found O +
to O +
transduce O +
signals O +
leading O +
to O +
gene O +
transcription O +
and O +
translation O +
in O +
leukocytes O +
. O +

Transcription B-Gene +
factors I-Gene +
, O +
such O +
as O +
NF B-Gene +
kappa I-Gene +
B I-Gene +
and O +
AP-1 B-Gene +
, O +
are O +
activated O +
upon O +
stimulation O +
of O +
the O +
cells O +
with O +
several O +
chemoattractants O +
at O +
physiologically O +
relevant O +
concentrations O +
. O +

Activation O +
of O +
transcription O +
factors O +
through O +
these O +
receptors O +
involves O +
G B-Gene -
- I-Gene -
protein I-Gene +
coupling O +
and O +
the O +
activation O +
of O +
protein B-Gene +
kinases I-Gene +
. O +

The O +
underlying O +
signaling O +
pathways O +
appear O +
to O +
be O +
different O +
from O +
those O +
utilized O +
by O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
, O +
a O +
better O +
characterized O +
cytokine O +
that O +
induces O +
the O +
transcription O +
of O +
immediate O -
- O -
early O +
genes O +
. O +

Chemoattractants O +
stimulate O +
the O +
expression O +
of O +
several O +
inflammatory B-Gene +
cytokines I-Gene +
and O +
chemokines B-Gene +
, O +
which O +
in O +
turn O +
may O +
activate O +
their O +
respective O +
receptors O +
and O +
initiate O +
an O +
autocrine O +
regulatory O +
mechanism O +
for O +
persistent O +
cytokine B-Gene +
and O +
chemokine B-Gene +
gene O +
expression O +
. O +

Peptide O +
vaccination O +
can O +
lead O +
to O +
enhanced O +
tumor O +
growth O +
through O +
specific O +
T O -
- O -
cell O +
tolerance O +
induction O +
. O +

Vaccination O +
with O +
synthetic O +
peptides O +
representing O +
cytotoxic O +
T O +
lymphocyte O +
( O +
CTL O +
) O +
epitopes O +
can O +
lead O +
to O +
a O +
protective O +
CTL O -
- O -
mediated O +
immunity O +
against O +
tumors O +
or O +
viruses O +
. O +

We O +
now O +
report O +
that O +
vaccination O +
with O +
a O +
CTL O +
epitope O +
derived O +
from O +
the O +
human O +
adenovirus O +
type O +
5 O +
E1A O -
- O -
region O +
( O +
Ad5E1A234 O -
- O -
243 O +
) O +
, O +
which O +
can O +
serve O +
as O +
a O +
target O +
for O +
tumor O -
- O -
eradicating O +
CTL O +
, O +
enhances O +
rather O +
than O +
inhibits O +
the O +
growth O +
of O +
Ad5E1A O -
- O -
expressing O +
tumors O +
. O +

This O +
adverse O +
effect O +
of O +
peptide O +
vaccination O +
was O +
rapidly O +
evoked O +
, O +
required O +
low O +
doses O +
of O +
peptide O +
( O +
10 O +
micrograms O +
) O +
, O +
and O +
was O +
achieved O +
by O +
a O +
mode O +
of O +
peptide O +
delivery O +
that O +
induces O +
protective O +
T O -
- O -
cell O -
- O -
mediated O +
immunity O +
in O +
other O +
models O +
. O +

Ad5E1A B-Gene +
-specific O +
CTL O +
activity O +
could O +
no O +
longer O +
be O +
isolated O +
from O +
mice O +
after O +
injection O +
of O +
Ad5E1A O -
- O -
peptide O +
, O +
indicating O +
that O +
tolerization O +
of O +
Ad5E1A B-Gene +
-specific O +
CTL O +
activity O +
causes O +
the O +
enhanced O +
tumor O +
outgrowth O +
. O +

In O +
contrast O +
to O +
peptide O +
vaccination O +
, O +
immunization O +
with O +
adenovirus O +
, O +
expressing O +
Ad5E1A B-Gene +
, O +
induced O +
Ad5E1A B-Gene +
-specific O +
immunity O +
and O +
prevented O +
the O +
outgrowth O +
of O +
Ad5E1A B-Gene +
-expressing O +
tumors O +
. O +

These O +
results O +
show O +
that O +
immunization O +
with O +
synthetic O +
peptides O +
can O +
lead O +
to O +
the O +
elimination O +
of O +
anti O -
- O -
tumor O +
CTL O +
responses O +
. O +

These O +
findings O +
are O +
important O +
for O +
the O +
design O +
of O +
safe O +
peptide O -
- O -
based O +
vaccines O +
against O +
tumors O +
, O +
allogeneic O +
organ O +
transplants O +
, O +
and O +
T O -
- O -
cell O -
- O -
mediated O +
autoimmune O +
diseases O +
. O +

Defective O +
transcription O +
of O +
the O +
IL-2 O +
gene O +
is O +
associated O +
with O +
impaired O +
expression O +
of O +
c B-Gene -
- I-Gene -
Fos I-Gene +
, O +
FosB B-Gene +
, O +
and O +
JunB B-Gene +
in O +
anergic O +
T O +
helper O +
1 O +
cells O +
. O +

Anergic O +
CD4 O -
+ O +
Th O +
cells O +
do O +
not O +
produce O +
IL-2 B-Gene +
when O +
challenged O +
with O +
Ag O -
- O -
pulsed O +
accessory O +
cells O +
because O +
of O +
a O +
transcriptional O +
defect O +
. O +

In O +
this O +
work O +
, O +
we O +
report O +
that O +
these O +
anergic O +
T O +
cells O +
are O +
defective O +
in O +
their O +
ability O +
to O +
up O -
- O -
regulate O +
protein O +
binding O +
and O +
transactivation O +
at O +
two O +
critical O +
IL-2 O +
DNA O +
enhancer O +
elements O +
: O +
NF B-Gene -
- I-Gene -
AT I-Gene +
( O +
nuclear B-Gene +
factor I-Gene +
of I-Gene +
activated I-Gene +
T I-Gene +
cells I-Gene +
; O +
a O +
sequence O +
that O +
binds O +
a O +
heterotrimeric B-Gene +
NFATp I-Gene +
, I-Gene +
Fos I-Gene +
, I-Gene +
and I-Gene +
Jun I-Gene +
protein I-Gene +
complex I-Gene +
) O +
and O +
Activator B-Gene +
Protein-1 I-Gene +
( O +
AP-1 B-Gene +
) O +
( O +
that O +
binds O +
Fos B-Gene +
and I-Gene +
Jun I-Gene +
heterodimers I-Gene +
) O +
. O +

Western O +
blot O +
analysis O +
of O +
nuclear O +
extracts O +
showed O +
that O +
the O +
impaired O +
DNA O -
- O -
protein O +
interactions O +
in O +
anergic O +
T O +
cells O +
were O +
associated O +
with O +
poor O +
expression O +
of O +
the O +
inducible O +
AP-1 B-Gene +
family O +
members O +
c B-Gene -
- I-Gene -
Fos I-Gene +
, O +
FosB B-Gene +
, O +
and O +
JunB B-Gene +
. O +

However O +
, O +
the O +
reduced O +
expression O +
of O +
these O +
proteins O +
was O +
not O +
the O +
result O +
of O +
a O +
global O +
TCR B-Gene -
/ I-Gene -
CD3 I-Gene +
-signaling O +
defect O +
because O +
CD3 B-Gene +
cross O -
- O -
linking O +
induced O +
an O +
equivalent O +
increase O +
in O +
intracellular O -
- O -
free O +
calcium O +
ions O +
, O +
as O +
well O +
as O +
NFATp B-Gene +
dephosphorylation O +
, O +
translocation O +
to O +
the O +
nucleus O +
, O +
and O +
DNA O +
binding O +
in O +
both O +
normal O +
and O +
anergic O +
T O +
cells O +
. O +

Thus O +
, O +
defective O +
IL-2 O +
gene O +
transcription O +
appears O +
to O +
be O +
due O +
, O +
at O +
least O +
in O +
part O +
, O +
to O +
a O +
selective O +
block O +
in O +
the O +
expression O +
of O +
the O +
AP-1 B-Gene +
Fos I-Gene +
and I-Gene +
Jun I-Gene +
family I-Gene +
members I-Gene +
in O +
anergic O +
T O +
cells O +
. O +

Characterization O +
of O +
a O +
new O +
isoform O +
of O +
the O +
NFAT B-Gene +
( O +
nuclear B-Gene +
factor I-Gene +
of I-Gene +
activated I-Gene +
T I-Gene +
cells I-Gene +
) O +
gene O +
family O +
member O +
NFATc B-Gene +
[ O +
published O +
erratum O +
appears O +
in O +
J O +
Biol O +
Chem O +
1996 O +
Dec O +
27 O +
; O +
271 O +
( O +
52 O +
) O +
: O +
33705 O +
] O +

The O +
cyclosporin B-Gene +
A I-Gene +
( I-Gene +
CsA I-Gene +
) I-Gene +
/FK506-sensitive I-Gene +
nuclear I-Gene +
factor I-Gene +
of I-Gene +
activated I-Gene +
T I-Gene +
cells I-Gene +
( O +
NFAT B-Gene +
) O +
plays O +
a O +
key O +
role O +
in O +
the O +
inducible O +
expression O +
of O +
cytokine O +
genes O +
in O +
T O +
cells O +
. O +

Although O +
NFAT B-Gene +
has O +
been O +
recently O +
shown O +
to O +
be O +
inducible O +
in O +
several O +
non O -
- O -
T O +
immune O +
cells O +
, O +
the O +
NFAT O +
gene O +
family O +
members O +
characterized O +
to O +
date O +
have O +
been O +
isolated O +
only O +
from O +
T O +
cells O +
. O +

To O +
further O +
characterize O +
NFAT B-Gene +
function O +
in O +
human O +
B O +
cells O +
and O +
to O +
demonstrate O +
cytokine O +
gene O +
specificity O +
of O +
NFAT B-Gene +
proteins I-Gene +
, O +
we O +
report O +
here O +
the O +
isolation O +
and O +
characterization O +
of O +
a O +
cDNA O +
clone O +
from O +
the O +
Raji O +
B O +
cell O +
line O +
. O +

The O +
cDNA O +
clone O +
encodes O +
a O +
new O +
isoform O +
, O +
NFATc.beta B-Gene +
, O +
of O +
the O +
NFAT B-Gene +
gene I-Gene +
family I-Gene +
member I-Gene +
NFATc B-Gene +
( O +
designated O +
here O +
NFATc.alpha B-Gene +
) O +
. O +

The O +
amino B-Gene +
acid I-Gene +
sequence I-Gene +
of O +
NFATc.beta B-Gene +
differs O +
from O +
that O +
of O +
NFATc B-Gene +
. O +

alpha O +
in O +
the O +
first O +
NH2-terminal B-Gene +
29 I-Gene +
residues I-Gene +
and O +
contains O +
an O +
additional O +
region O +
of O +
142 B-Gene +
residues I-Gene +
at O +
the O +
COOH B-Gene +
terminus I-Gene +
. O +

Northern O +
analysis O +
using O +
a O +
probe O +
encompassing O +
a O +
common O +
region O +
of O +
both O +
isoforms O +
showed O +
two O +
mRNA O +
species O +
of O +
2.7 O +
and O +
4.5 O +
kilobase O +
pairs O +
, O +
while O +
an O +
NFATc.beta O -
- O -
specific O +
probe O +
detected O +
only O +
the O +
4.5-kilobase O +
pair O +
mRNA O +
which O +
was O +
preferentially O +
expressed O +
in O +
the O +
spleen O +
. O +

Transient O +
expression O +
of O +
NFATc.beta B-Gene +
was O +
capable O +
of O +
activating O +
an O +
interleukin-2 O +
NFAT O -
- O -
driven O +
reporter O +
gene O +
in O +
stimulated O +
Jurkat O +
cells O +
in O +
a O +
CsA O -
- O -
sensitive O +
manner O +
. O +

However O +
, O +
NFATc.beta B-Gene +
neither O +
bound O +
to O +
the O +
kappa3 O +
element O +
( O +
an O +
NFAT O -
- O -
binding O +
site O +
) O +
in O +
the O +
tumor O +
necrosis O +
factor O -
- O -
alpha O +
promoter O +
nor O +
activated O +
the O +
tumor O +
necrosis O +
factor O -
- O -
alpha O +
promoter O +
in O +
cotransfection O +
assays O +
. O +

These O +
data O +
suggest O +
that O +
different O +
members O +
or O +
isoforms O +
of O +
NFAT O +
gene O +
family O +
may O +
regulate O +
inducible O +
expression O +
of O +
different O +
cytokine O +
genes O +
. O +

JNK B-Gene +
( O +
c B-Gene -
- I-Gene -
Jun I-Gene +
NH2-terminal I-Gene +
kinase I-Gene +
) O +
is O +
a O +
target O +
for O +
antioxidants O +
in O +
T O +
lymphocytes O +
. O +

AP-1 B-Gene +
has O +
been O +
shown O +
to O +
behave O +
as O +
a O +
redox B-Gene -
- I-Gene -
sensitive I-Gene +
transcription I-Gene +
factor I-Gene +
that O +
can O +
be O +
activated O +
by O +
both O +
oxidant O +
and O +
antioxidant O +
stimuli O +
. O +

However O +
, O +
the O +
mechanisms O +
involved O +
in O +
the O +
activation O +
of O +
AP-1 B-Gene +
by O +
antioxidants O +
are O +
largely O +
unknown O +
. O +

In O +
this O +
study O +
we O +
show O +
that O +
the O +
structurally O +
unrelated O +
antioxidant O +
agents O +
pyrrolidine O +
dithiocarbamate O +
( O +
PDTC O +
) O +
, O +
butylated O +
hydroxyanisole O +
, O +
and O +
Nacetylcysteine O +
activated O +
JNK B-Gene +
( O +
c B-Gene -
- I-Gene -
Jun I-Gene +
NH2-terminal I-Gene +
kinase I-Gene +
) O +
in O +
Jurkat O +
T O +
cells O +
. O +

This O +
activation O +
differed O +
substantially O +
from O +
that O +
mediated O +
by O +
phorbol O +
12-myristate O +
13-acetate O +
( O +
PMA O +
) O +
and O +
Ca2 O -
+ O +
ionophore O +
or O +
produced O +
by O +
costimulation O +
with O +
antibodies B-Gene +
against O +
the O +
T B-Gene +
cell I-Gene +
receptor I-Gene -
- I-Gene -
CD3 I-Gene +
complex I-Gene +
and O +
to O +
CD28 B-Gene +
. O +

The O +
activation O +
of O +
JNK B-Gene +
by O +
classical O +
T O +
cell O +
stimuli O +
was O +
transient O +
, O +
whereas O +
that O +
mediated O +
by O +
PDTC O +
and O +
butylated O +
hydroxyanisole O +
( O +
but O +
not O +
N O -
- O -
acetylcysteine O +
) O +
was O +
sustained O +
. O +

The O +
kinetics O +
of O +
JNK B-Gene +
activation O +
correlated O +
with O +
the O +
expression O +
of O +
c O -
- O -
jun O +
which O +
was O +
transient O +
after O +
stimulation O +
with O +
PMA O +
plus O +
ionophore O +
and O +
prolonged O +
in O +
response O +
to O +
PDTC O +
, O +
which O +
also O +
transiently O +
induced O +
c O -
- O -
fos O +
. O +

In O +
addition O +
, O +
JNK B-Gene +
activation O +
by O +
PMA O +
plus O +
ionophore O +
was O +
sensitive O +
to O +
inhibitors O +
of O +
signaling O +
pathways O +
involving O +
Ca2 O -
+ O +
, O +
protein B-Gene +
kinase I-Gene +
C I-Gene +
, O +
and O +
tyrosine O +
phosphorylation O +
, O +
which O +
failed O +
to O +
inhibit O +
the O +
activation O +
mediated O +
by O +
PDTC O +
. O +

Transfection O +
of O +
trans O -
- O -
dominant O +
negative O +
expression O +
vectors O +
of O +
ras O +
and O +
raf O +
, O +
together O +
with O +
AP-1-dependent O +
reporter O +
constructs O +
, O +
as O +
well O +
as O +
Western O +
blot O +
analysis O +
using O +
anti B-Gene -
- I-Gene -
ERK I-Gene +
( I-Gene +
extracellular I-Gene +
signal I-Gene -
- I-Gene -
regulated I-Gene +
kinase I-Gene +
) I-Gene +
antibodies I-Gene +
, O +
indicated O +
that O +
the O +
Ras O -
/ O -
Raf O -
/ O -
ERK O +
pathway O +
did O +
not O +
appear O +
to O +
mediate O +
the O +
effect O +
of O +
the O +
antioxidant O +
. O +

However O +
, O +
the O +
combined O +
treatment O +
with O +
PDTC O +
and O +
PMA O +
, O +
two O +
agents O +
that O +
synergize O +
on O +
AP-1 B-Gene +
activation O +
, O +
resulted O +
in O +
the O +
persistent O +
phosphorylation O +
of O +
ERK-2 B-Gene +
. O +

In O +
conclusion O +
, O +
our O +
results O +
identify O +
JNK B-Gene +
as O +
a O +
target O +
of O +
antioxidant O +
agents O +
which O +
can O +
be O +
regulated O +
differentially O +
under O +
oxidant O +
and O +
antioxidant O +
conditions O +
. O +

Cloning O +
and O +
characterization O +
of O +
the O +
murine B-Gene +
B I-Gene -
- I-Gene -
cell I-Gene +
specific I-Gene +
transcriptional I-Gene +
coactivator I-Gene +
Bob1 B-Gene +
. O +

From O +
a O +
murine O +
B O -
- O -
cell O +
cDNA O -
- O -
library O +
we O +
have O +
cloned O +
a O +
cDNA O +
encoding O +
the O +
murine B-Gene +
B I-Gene -
- I-Gene -
cell I-Gene +
specific I-Gene +
coactivator I-Gene +
mBob1 B-Gene +
. O +

The O +
protein O +
is O +
the O +
murine O +
homologue O +
to O +
the O +
recently O +
described O +
human B-Gene +
coactivator I-Gene +
Bob1 I-Gene +
( O +
hBob1 B-Gene +
) O +
, O +
also O +
referred O +
to O +
as O +
OBF-1 B-Gene +
or O +
OCA B-Gene -
- I-Gene -
B I-Gene +
. O +

We O +
have O +
also O +
characterized O +
the O +
genomic B-Gene +
mBob1 I-Gene +
clone I-Gene +
. O +

Analysis O +
of O +
its O +
intron O -
- O -
exon O +
structure O +
has O +
allowed O +
identification O +
of O +
a O +
C B-Gene -
- I-Gene -
terminal I-Gene +
splice I-Gene +
variant I-Gene +
. O +

mBob1 B-Gene +
is O +
B O -
- O -
cell O +
restricted O +
, O +
and O +
is O +
found O +
in O +
all O +
B O -
- O -
cell O +
lines O +
representing O +
different O +
stages O +
of O +
B O -
- O -
cell O +
differentiation O +
. O +

mBob1 B-Gene +
interacts O +
with O +
the O +
octamer B-Gene +
transcription I-Gene +
factors I-Gene +
Oct-1 B-Gene +
and O +
Oct-2 B-Gene +
and O +
stimulates O +
transcription O +
mediated O +
by O +
these O +
factors O +
. O +

Dual O +
action O +
of O +
retinoic O +
acid O +
on O +
human O +
embryonic O -
/ O -
fetal O +
hematopoiesis O +
: O +
blockade O +
of O +
primitive O +
progenitor O +
proliferation O +
and O +
shift O +
from O +
multipotent O -
/ O -
erythroid O -
/ O -
monocytic O +
to O +
granulocytic O +
differentiation O +
program O +
. O +

In O +
preliminary O +
studies O +
, O +
we O +
have O +
analyzed O +
the O +
hematopoietic B-Gene +
growth I-Gene +
factor I-Gene +
( O +
HGF B-Gene +
) O +
requirement O +
of O +
hematopoietic O +
progenitor O +
cells O +
( O +
HPCs O +
) O +
purified O +
from O +
embryonic O -
- O -
fetal O +
liver O +
( O +
FL O +
) O +
and O +
grown O +
in O +
fetal O +
calf O +
serum O -
- O -
supplemented O +
( O +
FCS+ O +
) O +
clonogenic O +
culture O +
. O +

The O +
key O +
role O +
of O +
erythropoietin B-Gene +
( O +
Epo B-Gene +
) O +
for O +
colony O +
formation O +
by O +
early O +
erythroid O +
progenitors O +
( O +
burst O -
- O -
forming O +
units O -
- O -
erythroid O +
[ O +
BFU O -
- O -
E O +
] O +
) O +
has O +
been O +
confirmed O +
. O +

Furthermore O +
, O +
in O +
the O +
absence O +
of O +
exogenous O +
HGFs B-Gene +
, O +
FL O +
monocytic O +
progenitors O +
( O +
colony O -
- O -
forming O +
unit O +
monocyte O +
[ O +
CFU O -
- O -
M O +
] O +
) O +
generate O +
large O +
colonies O +
exclusively O +
composed O +
of O +
monocytes O -
- O -
macrophages O +
; O +
these O +
colonies O +
are O +
absent O +
in O +
FCS- O +
clonogenic O +
culture O +
. O +

On O +
this O +
basis O +
, O +
we O +
have O +
investigated O +
the O +
role O +
of O +
all O -
- O -
trans O +
retinoic O +
acid O +
( O +
ATRA O +
) O +
and O +
its O +
isomer O +
9-cis O +
RA O +
in O +
FL O +
hematopoiesis O +
. O +

Both O +
compounds O +
modulate O +
the O +
growth O +
of O +
purified O +
FL O +
HPCs O +
, O +
which O +
show O +
a O +
dose O -
- O -
dependent O +
shift O +
from O +
mixed O -
/ O -
erythroid O -
/ O -
monocytic O +
to O +
granulocytic O +
colony O +
formation O +
. O +

Studies O +
on O +
unicellular O +
and O +
paired O +
daughter O +
cell O +
culture O +
unequivocally O +
indicate O +
that O +
the O +
shift O +
is O +
mediated O +
by O +
modulation O +
of O +
the O +
HPC O +
differentiation O +
program O +
to O +
the O +
granulopoietic O +
pathway O +
( O +
rather O +
than O +
RA O -
- O -
induced O +
down O -
- O -
modulation O +
of O +
multipotent O +
/erythroid O -
/ O -
monocytic O +
HPC O +
growth O +
coupled O +
with O +
recruitment O +
of O +
granulocytic O +
HPCs O +
) O +
. O +

ATRA O +
and O +
9-cis O +
RA O +
also O +
exert O +
their O +
effect O +
on O +
the O +
proliferation O +
of O +
primitive O +
HPCs O +
( O +
high O -
- O -
proliferative O +
potential O +
colony O -
- O -
forming O +
cells O +
[ O +
HPP O -
- O -
CFCs O +
] O +
) O +
and O +
putative O +
hematopoietic O +
stem O +
cells O +
( O +
HSCs O +
; O +
assayed O +
in O +
Dexter O -
- O -
type O +
long O -
- O -
term O +
culture O +
) O +
. O +

High O +
concentrations O +
of O +
either O +
compound O +
( O +
1 O +
) O +
drastically O +
reduced O +
the O +
number O +
of O +
primary O +
HPP O -
- O -
CFC O +
colonies O +
and O +
totally O +
abolished O +
their O +
recloning O +
capacity O +
and O +
( O +
2 O +
) O +
inhibited O +
HSC O +
proliferation O +
. O +

It O +
is O +
crucial O +
that O +
these O +
results O +
mirror O +
recent O +
observations O +
indicating O +
that O +
murine O +
adult O +
HPCs O +
transduced O +
with O +
dominant O +
negative O +
ATRA O +
receptor O +
( O +
RAR O +
) O +
gene O +
are O +
immortalized O +
and O +
show O +
a O +
selective O +
blockade O +
of O +
granulocytic O +
differentiation O +
. O +

Altogether O +
, O +
these O +
results O +
suggest O +
that O +
ATRA O -
/ O -
9-cis O +
RA O +
may O +
play O +
a O +
key O +
role O +
in O +
FL O +
hematopoiesis O +
via O +
a O +
dual O +
effect O +
hypothetically O +
mediated O +
by O +
interaction O +
with O +
the O +
RAR B-Gene -
/ I-Gene -
RXR I-Gene +
heterodimer I-Gene +
, O +
ie O +
, O +
inhibition O +
of O +
HSC O -
/ O +
primitive O +
HPC O +
proliferation O +
and O +
induction O +
of O +
CFU O -
- O -
GEMM O -
/ O +
BFU O -
- O -
E O -
/ O -
CFU O -
- O -
M O +
shift O +
from O +
the O +
multipotent O -
/ O -
erythroid O -
/ O -
monocytic O +
to O +
the O +
granulocytic O -
- O -
neutrophilic O +
differentiation O +
program O +
. O +

The O +
catalytic B-Gene +
domain I-Gene +
of O +
pp56 B-Gene +
( I-Gene +
lck I-Gene +
) I-Gene +
, O +
but O +
not O +
its O +
regulatory B-Gene +
domain I-Gene +
, O +
is O +
sufficient O +
for O +
inducing O +
IL-2 B-Gene +
production O +
. O +

The O +
lymphoid B-Gene +
src I-Gene +
kinase I-Gene +
pp56 B-Gene +
( I-Gene +
lck I-Gene +
) I-Gene +
has O +
been O +
shown O +
to O +
be O +
essential O +
for O +
the O +
induction O +
of O +
different O +
T O +
lymphocyte O +
responses O +
, O +
including O +
CD4 B-Gene +
-mediated O +
enhancement O +
of O +
Ag O -
- O -
induced O +
T O +
cell O +
activation O +
, O +
early O +
T O +
cell O +
differentiation O +
, O +
induction O +
of O +
IL-2 B-Gene +
production O +
, O +
and O +
cytotoxicity O +
. O +

It O +
is O +
assumed O +
that O +
pp56 B-Gene +
( I-Gene +
lck I-Gene +
) I-Gene +
acts O +
on O +
these O +
processes O +
by O +
phosphorylating O +
substrates O +
. O +

However O +
, O +
it O +
has O +
been O +
recently O +
reported O +
that O +
the O +
NH2 B-Gene +
regulatory B-Gene +
domain I-Gene +
is O +
sufficient O +
to O +
mediate O +
CD4 B-Gene +
accessory O +
function O +
. O +

In O +
this O +
report O +
we O +
address O +
the O +
contribution O +
of O +
the O +
regulatory B-Gene +
and I-Gene +
catalytic I-Gene +
domains I-Gene +
of O +
pp56 B-Gene +
( I-Gene +
lck I-Gene +
) I-Gene +
to O +
another O +
function O +
of O +
this O +
enzyme O +
independent O +
of O +
CD4 B-Gene +
: O +
TCR O -
- O -
induced O +
IL-2 B-Gene +
production O +
. O +

Two O +
pp56 B-Gene +
( I-Gene +
lck I-Gene +
) I-Gene +
mutants I-Gene +
lacking O +
either O +
the O +
entire O +
catalytic B-Gene +
domain I-Gene +
or O +
the O +
entire O +
NH2 B-Gene +
regulatory B-Gene +
domain I-Gene +
were O +
generated O +
, O +
and O +
their O +
abilities O +
to O +
trigger O +
transactivation O +
of O +
the O +
TCR O -
- O -
regulated O +
nuclear O +
factor O +
of O +
activated O +
T O +
cells O +
( O +
NF O -
- O -
AT O +
) O +
region O +
of O +
the O +
IL-2 O +
promoter O +
were O +
compared O +
. O +

Only O +
the O +
catalytic O +
, O +
but O +
not O +
the O +
NH2 B-Gene +
regulatory O +
, O +
domain O +
of O +
pp56 B-Gene +
( I-Gene +
lck I-Gene +
) I-Gene +
was O +
able O +
to O +
induce O +
NF B-Gene -
- I-Gene -
AT I-Gene +
region O +
transactivation O +
on O +
its O +
own O +
and O +
to O +
cooperate O +
with O +
other O +
intracellular O +
signals O +
to O +
trigger O +
this O +
response O +
. O +

Moreover O +
, O +
the O +
catalytic B-Gene +
domain I-Gene +
of O +
pp56 B-Gene +
( I-Gene +
lck I-Gene +
) I-Gene +
was O +
able O +
to O +
induce O +
IL-2 B-Gene +
cytokine B-Gene +
production O +
to O +
an O +
extent O +
similar O +
to O +
that O +
of O +
wild O -
- O -
type O +
pp56 B-Gene +
( I-Gene +
lck I-Gene +
) I-Gene +
. O +

We O +
conclude O +
that O +
different O +
domains O +
of O +
the O +
pp56 B-Gene +
( I-Gene +
lck I-Gene +
) I-Gene +
molecule O +
contribute O +
to O +
regulate O +
distinct O +
biologic O +
functions O +
. O +

In O +
fact O +
, O +
while O +
the O +
NH2 B-Gene +
regulatory B-Gene +
domain I-Gene +
is O +
sufficient O +
to O +
mediate O +
CD4 B-Gene +
accessory O +
function O +
, O +
we O +
show O +
here O +
that O +
the O +
catalytic B-Gene +
domain I-Gene +
of O +
pp56 B-Gene +
( I-Gene +
lck I-Gene +
) I-Gene +
is O +
sufficient O +
for O +
induction O +
of O +
IL-2 B-Gene +
production O +
, O +
mimicking O +
TCR B-Gene +
ligation O +
. O +

Lack O +
of O +
IL-12 B-Gene +
signaling O +
in O +
human O +
allergen O -
- O -
specific O +
Th2 O +
cells O +
. O +

IL-12 B-Gene +
is O +
a O +
powerful O +
skewer O +
of O +
CD4 O -
+ O +
T O +
cell O +
responses O +
toward O +
the O +
Th1 O +
phenotype O +
by O +
inducing O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
production O +
in O +
naive O +
Th O +
cells O +
. O +

In O +
the O +
present O +
study O +
we O +
addressed O +
the O +
question O +
of O +
whether O +
IL-12 B-Gene +
can O +
reverse O +
established O +
Th2 O +
responses O +
into O +
Th1 O -
/ O -
Th0 O +
responses O +
by O +
inducing O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
production O +
in O +
memory O +
Th2 O +
cells O +
. O +

To O +
this O +
aim O +
, O +
allergen O -
- O -
specific O +
CD4 O -
+ O +
T O +
cell O +
clones O +
( O +
TCC O +
) O +
were O +
generated O +
from O +
the O +
peripheral O +
blood O +
of O +
three O +
atopic O +
patients O +
, O +
and O +
their O +
cytokine B-Gene +
profiles O +
were O +
analyzed O +
. O +

The O +
majority O +
of O +
these O +
TCC O +
exhibited O +
a O +
strongly O +
polarized O +
Th2 O +
cytokine B-Gene +
profile O +
, O +
and O +
the O +
production O +
of O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
could O +
not O +
be O +
induced O +
by O +
exogenous O +
IL-12 B-Gene +
. O +

Only O +
those O +
TCC O +
with O +
low O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
levels O +
in O +
the O +
absence O +
of O +
IL-12 B-Gene +
responded O +
to O +
IL-12 B-Gene +
by O +
additional O +
enhancement O +
of O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
production O +
. O +

The O +
IL-12 B-Gene +
nonresponsiveness O +
of O +
the O +
Th2 O +
clones O +
was O +
further O +
evident O +
by O +
the O +
total O +
lack O +
of O +
IL-12 B-Gene +
-induced O +
phosphorylation O +
of O +
STAT4 B-Gene +
( O +
signal B-Gene +
transducer I-Gene +
and I-Gene +
activator I-Gene +
of I-Gene +
transcription-4 I-Gene +
) O +
, O +
a O +
transcription B-Gene +
factor I-Gene +
that O +
is O +
typically O +
involved O +
in O +
IL-12 B-Gene +
signaling O +
. O +

Consequently O +
, O +
IL-12 B-Gene +
also O +
failed O +
to O +
induce O +
the O +
DNA O -
- O -
binding O +
activity O +
of O +
STAT4-containing B-Gene +
complexes I-Gene +
in O +
the O +
nuclei O +
of O +
these O +
Th2 O +
clones O +
. O +

All O +
TCC O +
expressed O +
equal O +
levels O +
of O +
the O +
low B-Gene -
- I-Gene -
affinity I-Gene +
IL-12R I-Gene +
beta1 I-Gene +
subunit I-Gene +
. O +

Our O +
results O +
indicate O +
that O +
human O +
allergen O -
- O -
specific O +
Th O +
cells O +
with O +
strongly O +
polarized O +
Th2 O +
cytokine B-Gene +
profiles O +
do O +
not O +
respond O +
to O +
IL-12 B-Gene +
and O +
, O +
therefore O +
, O +
can O +
not O +
be O +
induced O +
to O +
produce O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
. O +

The O +
apparent O +
high O +
frequency O +
of O +
IL-12-nonresponsive O +
Th O +
cells O +
within O +
the O +
allergen O -
- O -
specific O +
populations O +
in O +
atopic O +
patients O +
predicts O +
a O +
limited O +
skewing O +
potential O +
of O +
IL-12 B-Gene +
in O +
the O +
case O +
of O +
established O +
Th2 O +
responses O +
, O +
but O +
only O +
affecting O +
newly O +
recruited O +
naive O +
Th O +
cells O +
. O +

Activation O +
of O +
nuclear B-Gene +
factor I-Gene -
- I-Gene -
kappaB I-Gene +
via O +
T B-Gene +
cell I-Gene +
receptor I-Gene +
requires O +
a O +
Raf B-Gene +
kinase I-Gene +
and O +
Ca2 O -
+ O +
influx O +
. O +

Functional O +
synergy O +
between O +
Raf B-Gene +
and O +
calcineurin B-Gene +
. O +

Signals O +
transduced O +
via O +
the O +
TCR B-Gene +
activate O +
the O +
transcription B-Gene +
factor I-Gene +
nuclear B-Gene +
factor I-Gene -
- I-Gene -
kappaB I-Gene +
( O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
) O +
, O +
which O +
, O +
in O +
turn O +
, O +
is O +
critical O +
to O +
the O +
transcriptional O +
induction O +
of O +
many O +
genes O +
important O +
for O +
the O +
proliferation O +
and O +
expression O +
of O +
a O +
differentiated O +
phenotype O +
. O +

Treatment O +
of O +
T O +
cells O +
with O +
the O +
protein B-Gene +
kinase I-Gene +
C I-Gene +
activator O +
PMA O +
in O +
combination O +
with O +
Ca2 O -
+ O +
ionophores O +
mimics O +
this O +
process O +
, O +
and O +
the O +
two O +
agents O +
are O +
often O +
substituted O +
for O +
TCR B-Gene +
stimulation O +
, O +
bypassing O +
the O +
TCR B-Gene +
. O +

Here O +
we O +
identify O +
intracellular O +
signaling O +
components O +
involved O +
in O +
activation O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
following O +
TCR B-Gene +
stimulation O +
. O +

TCR B-Gene +
signaling O +
was O +
triggered O +
by O +
treating O +
Jurkat O +
T O +
cells O +
with O +
PHA B-Gene +
or O +
anti B-Gene -
- I-Gene -
CD3 I-Gene +
Abs I-Gene +
, O +
and O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
activation O +
was O +
monitored O +
by O +
electrophoretic O +
mobility O +
shift O +
assays O +
and/or O +
by O +
kappaB B-Gene +
-dependent O +
reporter O +
assays O +
. O +

Contrary O +
to O +
the O +
idea O +
that O +
protein B-Gene +
kinase I-Gene +
C I-Gene +
is O +
involved O +
in O +
TCR B-Gene +
-mediated O +
activation O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
, O +
high O +
doses O +
of O +
staurosporine O +
did O +
not O +
interfere O +
with O +
activation O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
by O +
PHA B-Gene +
, O +
while O +
the O +
same O +
dose O +
of O +
staurosporine O +
completely O +
blocked O +
activation O +
by O +
PMA O +
. O +

PHA B-Gene +
-induced O +
kappaB O -
- O -
dependent O +
reporter O +
activity O +
was O +
, O +
however O +
, O +
effectively O +
blocked O +
by O +
a O +
dominant O +
negative O +
form O +
of O +
Raf-1 B-Gene +
, O +
suggesting O +
a O +
critical O +
role O +
for O +
a O +
Raf B-Gene +
kinase I-Gene +
. O +

The O +
TCR B-Gene +
-mediated O +
activation O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
was O +
also O +
dependent O +
on O +
a O +
Ca2 O -
+ O +
influx O +
, O +
because O +
the O +
Ca2 O -
+ O +
channel O +
blocker O +
, O +
SK O +
& O +
F O +
96365 O +
, O +
as O +
well O +
as O +
other O +
agents O +
that O +
prevented O +
the O +
Ca2 O -
+ O +
influx O +
, O +
inhibited O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
activation O +
. O +

Cotransfection O +
of O +
a O +
constitutively O +
active O +
form O +
of O +
calcineurin B-Gene +
largely O +
substituted O +
for O +
the O +
Ca2 O -
+ O +
requirement O +
and O +
reversed O +
the O +
blockade O +
by O +
SK O +
& O +
F O +
96365 O +
. O +

Consistent O +
with O +
these O +
observations O +
, O +
coexpression O +
of O +
constitutively O +
active O +
forms O +
of O +
Raf-1 B-Gene +
and O +
calcineurin B-Gene +
synergistically O +
induced O +
kappaB B-Gene +
-dependent O +
reporter O +
activity O +
, O +
suggesting O +
a O +
physiologically O +
relevant O +
functional O +
interaction O +
between O +
the O +
kinase B-Gene +
and O +
the O +
phosphatase B-Gene +
. O +

Differentiation O -
- O -
dependent O +
expression O +
of O +
a O +
human B-Gene +
carboxylesterase I-Gene +
in O +
monocytic O +
cells O +
and O +
transcription B-Gene +
factor I-Gene +
binding O +
to O +
the O +
promoter O +
. O +

Carboxylesterases B-Gene +
play O +
an O +
important O +
role O +
in O +
defense O +
and O +
clearance O +
mechanisms O +
of O +
the O +
monocyte O -
/ O -
macrophage O +
system O +
. O +

During O +
the O +
differentiation O +
process O +
of O +
cells O +
from O +
the O +
monocytic O +
cell O +
line O +
THP-1 O +
we O +
observed O +
a O +
transient O +
transcriptional O +
upregulation O +
of O +
a O +
human B-Gene +
carboxylesterase I-Gene +
analyzed O +
by O +
means O +
of O +
Northern O +
blots O +
. O +

In O +
PMA O -
- O -
treated O +
THP-1 O +
cells O +
we O +
could O +
detect O +
three O +
major O +
transcription O +
initiation O +
sites O +
as O +
revealed O +
by O +
Nuclease O +
Protection O +
Assay O +
carried O +
out O +
with O +
two O +
overlapping O +
antisense O +
RNA O +
probes O +
. O +

We O +
have O +
recently O +
cloned O +
the O +
carboxylesterase O +
upstream O +
sequence O +
and O +
showed O +
its O +
basal O +
promoter O +
activity O +
in O +
CHO O +
cells O +
. O +

Using O +
electrophoretic O +
mobility O +
shift O +
analysis O +
we O +
demonstrated O +
that O +
the O +
promoter O +
region O +
spanning O +
base O +
pairs O +
-1 O +
to O +
-275 O +
, O +
which O +
contains O +
several O +
putative O +
binding O +
sites O +
for O +
transcription B-Gene +
factors I-Gene +
, O +
is O +
bound O +
by O +
nuclear B-Gene +
factors I-Gene +
Sp1 B-Gene +
and O +
IRBP B-Gene +
but O +
not O +
by O +
C B-Gene -
/ I-Gene -
EBPs I-Gene +
. O +

Taken O +
together O +
these O +
data O +
indicate O +
that O +
carboxylesterase O +
gene O +
transcription O +
in O +
THP-1 O +
cells O +
starts O +
at O +
multiple O +
initiation O +
sites O +
and O +
that O +
Sp1 B-Gene +
and O +
IRBP B-Gene +
may O +
be O +
critical O +
factors O +
for O +
modulating O +
the O +
differentiation O -
- O -
dependent O +
transcription O +
of O +
this O +
human O +
carboxylesterase O +
gene O +
. O +

Identification O +
of O +
Bcd O +
, O +
a O +
novel O +
proto O -
- O -
oncogene O +
expressed O +
in O +
B O -
- O -
cells O +
. O +

A O +
novel O +
B O -
- O -
cell O +
derived O +
( O +
Bcd O +
) O +
oncogene O +
has O +
been O +
isolated O +
from O +
the O +
peripheral O +
blood O +
lymphocytes O +
of O +
one O +
B O -
- O -
cell O +
chronic O +
lymphocytic O +
leukemia O +
( O +
B O -
- O -
CLL O +
) O +
patient O +
using O +
DNA O +
transfer O +
and O +
a O +
mouse O +
tumorigenicity O +
assay O +
. O +

The O +
Bcd O +
proto O -
- O -
oncogene O +
was O +
activated O +
by O +
a O +
truncation O +
in O +
the O +
5 O +
' O +
UTR O +
. O +

It O +
predicts O +
for O +
two O +
open O +
reading O +
frames O +
( O +
ORFs O +
) O +
. O +

ORF1 O +
consists O +
of O +
240 O +
bp O +
that O +
would O +
encode O +
80 O +
amino O +
acids O +
, O +
while O +
the O +
major O +
ORF2 O +
consists O +
of O +
648 O +
bp O +
capable O +
of O +
coding O +
for O +
216 O +
amino O +
acids O +
. O +

Predicted B-Gene +
peptide I-Gene +
sequence I-Gene +
of O +
ORF2 O +
contained O +
a O +
zinc B-Gene +
finger I-Gene +
domain I-Gene +
which O +
showed O +
significant O +
homology O +
to O +
GC B-Gene +
box I-Gene +
binding I-Gene +
proteins I-Gene +
BTEB2 B-Gene +
and O +
SP1 B-Gene +
. O +

Transfection O +
of O +
an O +
expression O +
vector O +
containing O +
ORF2 O +
but O +
not O +
full O +
length O +
cDNA O +
was O +
able O +
to O +
transform O +
NIH3T3 O +
cells O +
and O +
induce O +
tumors O +
in O +
nude O +
mice O +
. O +

Bcd O +
mRNA O +
transcripts O +
of O +
< O +
or O +
= O +
2.6 O +
kb O +
were O +
selectively O +
expressed O +
in O +
PBL O +
and O +
testis O +
of O +
healthy O +
individuals O +
. O +

Within O +
the O +
PBL O +
, O +
Bcd O +
gene O +
expression O +
was O +
restricted O +
to O +
CD19 O -
+ O +
B O -
- O -
cells O +
and O +
absent O +
from O +
CD14 O -
+ O +
monocytes O +
and O +
T O -
- O -
cells O +
. O +

Bcd O +
transcripts O +
were O +
detected O +
in O +
all O +
normal O +
PBL O +
samples O +
tested O +
but O +
not O +
in O +
several O +
malignant O +
human O +
B O -
- O -
cell O +
lines O +
and O +
not O +
in O +
50 O +
% O +
of O +
B O -
- O -
cells O +
from O +
B O -
- O -
CLL O +
patients O +
. O +

However O +
, O +
stimulation O +
of O +
B O -
- O -
cells O +
from O +
B O -
- O -
CLL O +
patients O +
under O +
conditions O +
which O +
induced O +
differentiation O +
into O +
plasma O +
cells O +
was O +
associated O +
with O +
induction O +
of O +
Bcd O +
gene O +
expression O +
. O +

The O +
Bcd O +
gene O +
may O +
therefore O +
play O +
an O +
important O +
role O +
in O +
B O -
- O -
cell O +
growth O +
and O +
development O +
. O +

Shared O +
gamma B-Gene +
( I-Gene +
c I-Gene +
) I-Gene +
subunit I-Gene +
within O +
the O +
human B-Gene +
interleukin-7 I-Gene +
receptor I-Gene +
complex I-Gene +
. O +

A O +
molecular O +
basis O +
for O +
the O +
pathogenesis O +
of O +
X O -
- O -
linked O +
severe O +
combined O +
immunodeficiency O +
. O +

Genetic O +
evidence O +
suggests O +
that O +
mutations O +
in O +
the O +
gamma B-Gene +
( I-Gene +
c I-Gene +
) I-Gene +
receptor I-Gene +
subunit I-Gene +
cause O +
X O -
- O -
linked O +
severe O +
combined O +
immunodeficiency O +
( O +
X O -
- O -
SCID O +
) O +
. O +

The O +
gamma B-Gene +
( I-Gene +
c I-Gene +
) I-Gene +
subunit I-Gene +
can O +
be O +
employed O +
in O +
receptor B-Gene +
complexes I-Gene +
for O +
IL-2 B-Gene +
, I-Gene +
-4 I-Gene +
, I-Gene +
-7 I-Gene +
, I-Gene +
-9 I-Gene +
, I-Gene +
and I-Gene +
-15 I-Gene +
, O +
and O +
the O +
multiple O +
signaling O +
defects O +
that O +
would O +
result O +
from O +
a O +
defective O +
gamma B-Gene +
( I-Gene +
c I-Gene +
) I-Gene +
chain I-Gene +
in O +
these O +
receptors O +
are O +
proposed O +
to O +
cause O +
the O +
severe O +
phenotype O +
of O +
X O -
- O -
SCID O +
patients O +
. O +

Interestingly O +
, O +
gene O +
disruption O +
of O +
either O +
IL-7 B-Gene +
or O +
the O +
IL-7 B-Gene +
receptor I-Gene +
( I-Gene +
IL-7R I-Gene +
) I-Gene +
alpha I-Gene +
subunit I-Gene +
in O +
mice O +
leads O +
to O +
immunological O +
defects O +
that O +
are O +
similar O +
to O +
human O +
X O -
- O -
SCID O +
. O +

These O +
observations O +
suggest O +
the O +
functional O +
importance O +
of O +
gamma B-Gene +
( I-Gene +
c I-Gene +
) I-Gene +
in O +
the O +
IL-7R B-Gene +
complex I-Gene +
. O +

In O +
the O +
present O +
study O +
, O +
structure O -
/ O -
function O +
analyses O +
of O +
the O +
IL-7R B-Gene +
complex I-Gene +
using O +
a O +
chimeric B-Gene +
receptor I-Gene +
system O +
demonstrated O +
that O +
gamma B-Gene +
( I-Gene +
c I-Gene +
) I-Gene +
is O +
indeed O +
critical O +
for O +
IL-7R B-Gene +
function O +
. O +

Nonetheless O +
, O +
only O +
a O +
limited O +
portion O +
of O +
the O +
cytoplasmic B-Gene +
domain I-Gene +
of O +
gamma B-Gene +
( I-Gene +
c I-Gene +
) I-Gene +
is O +
necessary O +
for O +
IL-7R B-Gene +
signal O +
transduction O +
. O +

Furthermore O +
, O +
replacement O +
of O +
the O +
gamma B-Gene +
( I-Gene +
c I-Gene +
) I-Gene +
cytoplasmic B-Gene +
domain I-Gene +
by O +
a O +
severely B-Gene +
truncated I-Gene +
erythropoeitin I-Gene +
receptor I-Gene +
does O +
not O +
affect O +
measured O +
IL-7R B-Gene +
signaling O +
events O +
. O +

These O +
findings O +
support O +
a O +
model O +
in O +
which O +
gamma B-Gene +
( I-Gene +
c I-Gene +
) I-Gene +
serves O +
primarily O +
to O +
activate O +
signal O +
transduction O +
by O +
the O +
IL-7R B-Gene +
complex I-Gene +
, O +
while O +
IL-7R B-Gene +
alpha I-Gene +
determines O +
specific O +
signaling O +
events O +
through O +
its O +
association O +
with O +
cytoplasmic B-Gene +
signaling I-Gene +
molecules I-Gene +
. O +

Finally O +
, O +
these O +
studies O +
are O +
consistent O +
with O +
the O +
hypothesis O +
that O +
the O +
molecular O +
pathogenesis O +
of O +
X O -
- O -
SCID O +
is O +
due O +
primarily O +
to O +
gamma B-Gene +
( I-Gene +
c I-Gene +
) I-Gene +
-mediated O +
defects O +
in O +
the O +
IL-7 B-Gene +
/IL-7R B-Gene +
system O +

Generation O +
of O +
cytotoxic O +
T O +
lymphocytes O +
against O +
immunorecessive B-Gene +
epitopes I-Gene +
after O +
multiple O +
immunizations O +
with O +
adenovirus O +
vectors O +
is O +
dependent O +
on O +
haplotype O +
. O +

Currently O +
, O +
adenovirus O +
( O +
Ad O +
) O +
is O +
being O +
considered O +
as O +
a O +
vector O +
for O +
the O +
treatment O +
of O +
cystic O +
fibrosis O +
as O +
well O +
as O +
other O +
diseases O +
. O +

However O +
, O +
the O +
cytotoxic O +
T O +
lymphocyte O +
( O +
CTL O +
) O +
response O +
to O +
Ad O +
could O +
limit O +
the O +
effectiveness O +
of O +
such O +
approaches O +
. O +

Since O +
the O +
CTL O +
response O +
to O +
virus O +
infection O +
is O +
often O +
focused O +
on O +
one O +
or O +
a O +
few O +
immunodominant B-Gene +
epitopes I-Gene +
, O +
one O +
approach O +
to O +
circumvent O +
this O +
response O +
is O +
to O +
create O +
vectors O +
that O +
lack O +
these O +
immunodominant B-Gene +
epitopes I-Gene +
. O +

The O +
effectiveness O +
of O +
this O +
approach O +
was O +
tested O +
by O +
immunizing O +
mice O +
with O +
human O +
group O +
C O +
adenoviruses O +
. O +

Three O +
mouse O +
strains O +
( O +
C57BL O -
/ O -
10SnJ O +
[ O +
H-2b O +
] O +
, O +
C3HeB O -
/ O -
FeJ O +
[ O +
H-2k O +
] O +
, O +
and O +
BALB O -
/ O -
cByJ O +
[ O +
H-2d O +
] O +
) O +
were O +
immunized O +
with O +
wild O -
- O -
type O +
Ad O +
or O +
Ad O +
vectors O +
lacking O +
the O +
immunodominant B-Gene +
antigen I-Gene +
( O +
s O +
) O +
, O +
and O +
the O +
CTL O +
responses O +
were O +
measured O +
. O +

In O +
C57BL O -
/ O -
10 O +
( O +
B10 O +
) O +
mice O +
, O +
a O +
single O +
inoculation O +
intraperitoneally O +
( O +
i.p O -
. O +
) O +
led O +
to O +
the O +
recognition O +
of O +
an O +
immunodominant B-Gene +
antigen I-Gene +
in O +
E1A O +
. O +

When O +
B10 O +
mice O +
were O +
inoculated O +
multiple O +
times O +
either O +
i.p O +
. O +

or O +
intranasally O +
with O +
wild O -
- O -
type O +
Ad O +
or O +
an O +
Ad O +
vector O +
lacking O +
most O +
of O +
the O +
E1 O +
region O +
, O +
subdominant O +
epitopes O +
outside O +
this O +
region O +
were O +
recognized O +
. O +

In O +
contrast O +
, O +
C3H O +
mice O +
inoculated O +
with O +
wild O -
- O -
type O +
Ad O +
recognized O +
an O +
epitope O +
mapping O +
within O +
E1B O +
. O +
When O +
inoculated O +
twice O +
with O +
Ad O +
vectors O +
lacking O +
both O +
E1A O +
and O +
E1B O +
, O +
no O +
immunorecessive B-Gene +
epitopes I-Gene +
were O +
recognized O +
. O +

The O +
immune O +
response O +
to O +
Ad O +
in O +
BALB O -
/ O -
c O +
mice O +
was O +
more O +
complex O +
. O +

CTLs O +
from O +
BALB O -
/ O -
c O +
mice O +
inoculated O +
i.p O -
. O +
with O +
wild O -
- O -
type O +
Ad O +
recognized O +
E1B O +
in O +
the O +
context O +
of O +
the O +
major O +
histocompatibility O +
complex O +
( O +
MHC O +
) O +
class O +
I O +
Dd O +
allele O +
and O +
a O +
region O +
outside O +
E1 O +
associated O +
with O +
the O +
Kd O +
allele O +
. O +

When O +
BALB O -
/ O -
c O +
mice O +
were O +
inoculated O +
with O +
E1 O +
-deleted O +
Ad O +
vectors O +
, O +
only O +
the O +
immunodominant B-Gene +
Kd I-Gene -
- I-Gene -
restricted I-Gene +
epitope I-Gene +
was O +
recognized O +
, O +
and O +
Dd O -
- O -
restricted O +
CTLs O +
did O +
not O +
develop O +
. O +

This O +
report O +
indicates O +
that O +
the O +
emergence O +
of O +
CTLs O +
against O +
immunorecessive B-Gene +
epitopes I-Gene +
following O +
multiple O +
administrations O +
of O +
Ad O +
vectors O +
lacking O +
immunodominant O +
antigens O +
is O +
dependent O +
on O +
haplotype O +
and O +
could O +
present O +
an O +
obstacle O +
to O +
gene O +
therapy O +
in O +
an O +
MHC B-Gene +
-diverse O +
human O +
population O +
. O +

Involvement O +
of O +
Egr-1 B-Gene +
/RelA B-Gene +
synergy O +
in O +
distinguishing O +
T O +
cell O +
activation O +
from O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene -
- I-Gene -
alpha I-Gene +
-induced O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B1 I-Gene +
transcription O +
. O +

NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
is O +
an O +
important O +
transcription B-Gene +
factor I-Gene +
required O +
for O +
T O +
cell O +
proliferation O +
and O +
other O +
immunological O +
functions O +
. O +

The O +
NF O -
- O -
kappa O +
B1 O +
gene O +
encodes O +
a O +
105-kD B-Gene +
protein I-Gene +
that O +
is O +
the O +
precursor O +
of O +
the O +
p50 B-Gene +
component I-Gene +
of O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
. O +

Previously O +
, O +
we O +
and O +
others O +
have O +
demonstrated O +
that O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
regulates O +
the O +
NF O -
- O -
kappa O +
B1 O +
gene O +
. O +

In O +
this O +
manuscript O +
we O +
have O +
investigated O +
the O +
molecular O +
mechanisms O +
by O +
which O +
T O +
cell O +
lines O +
stimulated O +
with O +
phorbol O +
12-myristate O +
13-acetate O +
( O +
PMA O +
) O +
and O +
phytohemagglutin B-Gene +
( O +
PHA B-Gene +
) O +
display O +
significantly O +
higher O +
levels O +
of O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B1 I-Gene +
encoding O +
transcripts O +
than O +
cells O +
stimulated O +
with O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene -
- I-Gene -
alpha I-Gene +
, O +
despite O +
the O +
fact O +
that O +
both O +
stimuli O +
activate O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
. O +

Characterization O +
of O +
the O +
NF O -
- O -
kappa O +
B1 O +
promoter O +
identified O +
an O +
Egr-1 O +
site O +
which O +
was O +
found O +
to O +
be O +
essential O +
for O +
both O +
the O +
PMA O -
/ O +
PHA B-Gene +
-mediated O +
induction O +
as O +
well O +
as O +
the O +
synergistic O +
activation O +
observed O +
after O +
the O +
expression O +
of O +
the O +
RelA O +
subunit O +
of O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
and O +
Egr-1 B-Gene +
. O +

Furthermore O +
, O +
Egr-1 B-Gene +
induction O +
was O +
required O +
for O +
endogenous O +
NF O -
- O -
kappa O +
B1 O +
gene O +
expression O +
, O +
since O +
PMA O -
/ O +
PHA O -
- O -
stimulated O +
T O +
cell O +
lines O +
expressing O +
antisense O +
Egr-1 O +
RNA O +
were O +
inhibited O +
in O +
their O +
ability O +
to O +
upregulate O +
NF O -
- O -
kappa O +
B1 O +
transcription O +
. O +

Our O +
studies O +
indicate O +
that O +
transcriptional O +
synergy O +
mediated O +
by O +
activation O +
of O +
both O +
Egr-1 B-Gene +
and O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
may O +
have O +
important O +
ramifications O +
in O +
T O +
cell O +
development O +
by O +
upregulating O +
NF O -
- O -
kappa O +
B1 O +
gene O +
expression O +
. O +

Jak1 B-Gene +
expression O +
is O +
required O +
for O +
mediating O +
interleukin-4-induced O +
tyrosine O +
phosphorylation O +
of O +
insulin O +
receptor O +
substrate O +
and O +
Stat6 B-Gene +
signaling B-Gene +
molecules I-Gene +
. O +

The O +
Jak1 B-Gene +
, I-Gene +
Jak2 I-Gene +
, I-Gene +
Jak3 I-Gene +
, I-Gene +
and I-Gene +
Fes I-Gene +
tyrosine I-Gene +
kinases I-Gene +
have O +
been O +
demonstrated O +
to O +
undergo O +
tyrosine O +
phosphorylation O +
in O +
response O +
to O +
interleukin B-Gene +
( I-Gene +
IL I-Gene +
) I-Gene +
-4 I-Gene +
stimulation O +
in O +
different O +
cell O +
systems O +
. O +

However O +
, O +
it O +
is O +
not O +
clear O +
which O +
, O +
if O +
any O +
, O +
of O +
these O +
kinases O +
are O +
responsible O +
for O +
initiating O +
IL-4-induced O +
tyrosine O +
phosphorylation O +
of O +
intracellular B-Gene +
substrates I-Gene +
in O +
vivo O +
. O +

In O +
the O +
present O +
study O +
, O +
we O +
have O +
utilized O +
a O +
mutant O +
Jak1-deficient O +
HeLa O +
cell O +
line O +
, O +
E1C3 O +
, O +
and O +
its O +
parental O +
Jak1-expressing O +
counterpart O +
, O +
1D4 O +
, O +
to O +
analyze O +
the O +
role O +
of O +
Jak1 B-Gene +
in O +
mediating O +
IL-4-induced O +
tyrosine O +
phosphorylation O +
events O +
. O +

IL-4 O +
treatment O +
rapidly O +
induced O +
tyrosine O +
phosphorylation O +
of O +
insulin B-Gene +
receptor I-Gene +
substrate I-Gene +
( I-Gene +
IRS I-Gene +
) I-Gene +
-1 I-Gene +
and O +
IRS-2 B-Gene +
in O +
1D4 O +
but O +
not O +
in O +
E1C3 O +
cells O +
. O +

IL-4 B-Gene +
-mediated O +
tyrosine O +
phosphorylation O +
of O +
Stat6 B-Gene +
was O +
pronounced O +
in O +
1D4 O +
cells O +
, O +
while O +
no O +
IL-4 B-Gene +
-induced O +
Stat6 B-Gene +
phosphorylation O +
was O +
detected O +
in O +
E1C3 O +
cells O +
. O +

IL-4 B-Gene +
also O +
induced O +
Stat6 B-Gene +
DNA O +
binding O +
activity O +
from O +
lysates O +
of O +
1D4 O +
but O +
not O +
E1C3 O +
cells O +
utilizing O +
a O +
radiolabeled O +
immunoglobulin O +
heavy O +
chain O +
germline O +
epsilon O +
promotor O +
sequence O +
( O +
Iepsilon O +
) O +
in O +
an O +
electrophoretic O +
mobility O +
shift O +
assay O +
. O +

Reconstitution O +
of O +
Jak1 B-Gene +
expression O +
in O +
E1C3 O +
cells O +
restored O +
the O +
ability O +
of O +
IL-4 B-Gene +
to O +
induce O +
IRS O +
and O +
Stat6 B-Gene +
tyrosine O +
phosphorylation O +
. O +

These O +
results O +
provide O +
evidence O +
that O +
Jak1 B-Gene +
expression O +
is O +
required O +
for O +
mediating O +
tyrosine O +
phosphorylation O +
and O +
activation O +
of O +
crucial O +
molecules O +
involved O +
in O +
IL-4 B-Gene +
signal O +
transduction O +
. O +

Interleukin-4 B-Gene +
signaling O +
in O +
B O +
lymphocytes O +
from O +
patients O +
with O +
X O -
- O -
linked O +
severe O +
combined O +
immunodeficiency O +
. O +

Interleukin-4 B-Gene +
( O +
IL-4 B-Gene +
) O +
is O +
an O +
important O +
cytokine O +
for O +
B O +
and O +
T O +
lymphocyte O +
function O +
and O +
mediates O +
its O +
effects O +
via O +
a O +
receptor O +
that O +
contains O +
gammac B-Gene +
. O +

B O +
cells O +
derived O +
from O +
patients O +
with O +
X O -
- O -
linked O +
severe O +
combined O +
immunodeficiency O +
( O +
X O -
- O -
SCID O +
) O +
are O +
deficient O +
in O +
gammac O +
and O +
provide O +
a O +
useful O +
model O +
in O +
which O +
to O +
dissect O +
the O +
role O +
of O +
this O +
subunit O +
in O +
IL-4 B-Gene +
-mediated O +
signaling O +
. O +

We O +
found O +
that O +
although O +
IL-4 B-Gene +
stimulation O +
of O +
X O -
- O -
SCID O +
B O +
cells O +
did O +
not O +
result O +
in O +
Janus B-Gene +
tyrosine I-Gene +
kinase-3 I-Gene +
( O +
JAK3 B-Gene +
) O +
phosphorylation O +
, O +
other O +
IL-4 B-Gene +
substrates I-Gene +
including O +
JAK1 B-Gene +
and O +
IRS-1 B-Gene +
were O +
phosphorylated O +
. O +

Additionally O +
, O +
we O +
detected O +
signal B-Gene +
transducers I-Gene +
and I-Gene +
activators I-Gene +
of I-Gene +
transcription I-Gene +
6 I-Gene +
( O +
STAT6 B-Gene +
) O +
tyrosine O +
phosphorylation O +
and O +
DNA O +
binding O +
activity O +
in O +
X O -
- O -
SCID O +
B O +
cells O +
with O +
a O +
wide O +
range O +
of O +
gammac B-Gene +
mutations O +
. O +

However O +
, O +
reconstitution O +
of O +
these O +
X O -
- O -
SCID O +
B O +
cells O +
with O +
gammac B-Gene +
enhanced O +
IL-4 B-Gene +
-mediated O +
responses O +
including O +
STAT6 B-Gene +
phosphorylation O +
and O +
DNA O +
binding O +
activity O +
and O +
resulted O +
in O +
increased O +
CD23 B-Gene +
expression O +
. O +

Thus O +
, O +
gammac B-Gene +
is O +
not O +
necessary O +
to O +
trigger O +
IL-4 B-Gene +
-mediated O +
responses O +
in O +
B O +
cells O +
, O +
but O +
its O +
presence O +
is O +
important O +
for O +
optimal O +
IL-4 B-Gene +
-signaling O +
. O +

These O +
results O +
suggest O +
that O +
two O +
distinct O +
IL-4 B-Gene +
signaling O +
pathways O +
exist O +
. O +

Nuclear B-Gene +
Rel I-Gene -
- I-Gene -
A I-Gene +
and I-Gene +
c I-Gene -
- I-Gene -
Rel I-Gene +
protein I-Gene +
complexes I-Gene +
are O +
differentially O +
distributed O +
within O +
human O +
thymocytes O +
. O +

Nuclear B-Gene +
factor I-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
( I-Gene +
NF I-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
) I-Gene +
/Rel I-Gene +
proteins I-Gene +
are O +
inducible O +
transcriptional B-Gene +
regulators I-Gene +
of O +
numerous O +
cellular O +
genes O +
. O +

They O +
are O +
particularly O +
abundant O +
in O +
lymphoid O +
tissues O +
and O +
are O +
thought O +
to O +
be O +
critical O +
for O +
the O +
transcription O +
of O +
genes O +
involved O +
in O +
immune O +
and O +
inflammatory O +
responses O +
. O +

We O +
have O +
reported O +
previously O +
that O +
a O +
nuclear O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
activity O +
was O +
present O +
in O +
freshly O +
extracted O +
human O +
thymocytes O +
in O +
the O +
absence O +
of O +
in O +
vitro O +
treatment O +
of O +
these O +
cells O +
. O +

In O +
the O +
present O +
report O +
, O +
we O +
identified O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
proteins I-Gene +
extracted O +
from O +
human O +
thymocyte O +
nuclei O +
as O +
being O +
p50 B-Gene -
/ I-Gene -
p65 I-Gene +
and I-Gene +
p50 I-Gene -
/ I-Gene -
c I-Gene -
- I-Gene -
Rel I-Gene +
complexes I-Gene +
. O +

Immunochemical O +
and O +
immunofluorescent O +
staining O +
of O +
thymus O +
sections O +
using O +
specific B-Gene +
Abs I-Gene +
allowed O +
visualization O +
of O +
nuclear B-Gene +
NF I-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
proteins I-Gene +
in O +
both O +
thymocytes O +
and O +
nonthymocyte O +
cells O +
. O +

This O +
detection O +
suggested O +
a O +
preferential O +
activation O +
of O +
p50 B-Gene -
/ I-Gene -
c I-Gene -
- I-Gene -
Rel I-Gene +
in O +
medullary O +
thymocytes O +
, O +
whereas O +
p50 B-Gene -
/ I-Gene -
p65 I-Gene +
was O +
present O +
in O +
both O +
cortical O +
and O +
medullary O +
regions O +
of O +
human O +
thymus O +
lobules O +
. O +

However O +
, O +
the O +
intensity O +
of O +
p65 B-Gene +
labeling O +
was O +
much O +
higher O +
in O +
several O +
thymocytes O +
from O +
the O +
medulla O +
. O +

p65 O +
, O +
p50 O +
, O +
and O +
c O -
- O -
Rel O +
activities O +
were O +
found O +
in O +
both O +
CD4- O +
and O +
CD8-positive O +
thymocytes O +
. O +

These O +
observations O +
suggest O +
that O +
p65 B-Gene +
and I-Gene +
c I-Gene -
- I-Gene -
Rel I-Gene +
complexes I-Gene +
play O +
distinct O +
roles O +
in O +
gene O +
expression O +
and O +
that O +
both O +
forms O +
of O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
play O +
critical O +
roles O +
during O +
late O +
stages O +
of O +
the O +
intrathymic O +
maturation O +
of O +
T O +
cells O +
. O +

Common O +
and O +
distinct O +
intracellular O +
signaling O +
pathways O +
in O +
human O +
neutrophils O +
utilized O +
by O +
platelet B-Gene +
activating I-Gene +
factor I-Gene +
and O +
FMLP B-Gene +
. O +

Stimulation O +
of O +
human O +
neutrophils O +
with O +
chemoattractants B-Gene +
FMLP B-Gene +
or O +
platelet B-Gene +
activating I-Gene +
factor I-Gene +
( O +
PAF B-Gene +
) O +
results O +
in O +
different O +
but O +
overlapping O +
functional O +
responses O +
. O +

We O +
questioned O +
whether O +
these O +
differences O +
might O +
reflect O +
patterns O +
of O +
intracellular O +
signal O +
transduction O +
. O +

Stimulation O +
with O +
either O +
PAF B-Gene +
or O +
FMLP B-Gene +
resulted O +
in O +
equivalent O +
phosphorylation O +
and O +
activation O +
of O +
the O +
mitogen B-Gene -
- I-Gene -
activated I-Gene +
protein I-Gene +
kinase I-Gene +
( I-Gene +
MAPk I-Gene +
) I-Gene +
homologue I-Gene +
38-kD B-Gene +
murine I-Gene +
MAP I-Gene +
kinase I-Gene +
homologous O +
to O +
HOG-1 B-Gene +
( I-Gene +
p38 I-Gene +
) I-Gene +
MAPk I-Gene +
. O +

Neither O +
FMLP B-Gene +
nor O +
PAF B-Gene +
activated O +
c B-Gene -
- I-Gene -
jun I-Gene +
NH2-terminal I-Gene +
MAPk I-Gene +
( O +
JNKs B-Gene +
) O +
. O +

Under O +
identical O +
conditions O +
, O +
FMLP B-Gene +
but O +
not O +
PAF B-Gene +
, O +
resulted O +
in O +
significant O +
p42 B-Gene -
/ I-Gene -
44 I-Gene +
( I-Gene +
ERK I-Gene +
) I-Gene +
MAPk I-Gene +
activation O +
. O +

Both O +
FMLP B-Gene +
and O +
PAF B-Gene +
activated I-Gene +
MAP I-Gene +
kinase I-Gene +
kinase-3 I-Gene +
( O +
MKK3 B-Gene +
) O +
, O +
a O +
known O +
activator O +
of O +
p38 B-Gene +
MAPk I-Gene +
. O +

Both O +
MAP B-Gene +
ERK I-Gene +
kinase I-Gene +
kinase-1 I-Gene +
( O +
MEKK1 B-Gene +
) O +
and O +
Raf B-Gene +
are O +
activated O +
strongly O +
by O +
FMLP B-Gene +
, O +
but O +
minimally O +
by O +
PAF B-Gene +
. O +

Pertussis B-Gene +
toxin I-Gene +
blocked O +
FMLP B-Gene +
-induced O +
activation O +
of O +
the O +
p42 B-Gene -
/ I-Gene -
44 I-Gene +
( I-Gene +
ERK I-Gene +
) I-Gene +
MAPk I-Gene +
cascade O +
, O +
but O +
not O +
that O +
of O +
p38 B-Gene +
MAPk I-Gene +
. O +

A O +
specific O +
p38 B-Gene +
MAPk I-Gene +
inhibitor O +
( O +
SK O +
& O +
F O +
86002 O +
) O +
blocked O +
superoxide O +
anion O +
production O +
in O +
response O +
to O +
FMLP B-Gene +
and O +
reduced O +
adhesion O +
and O +
chemotaxis O +
in O +
response O +
to O +
PAF B-Gene +
or O +
FMLP B-Gene +
. O +

These O +
results O +
demonstrate O +
distinct O +
patterns O +
of O +
intracellular O +
signaling O +
for O +
two O +
chemoattractants B-Gene +
and O +
suggest O +
that O +
selective O +
activation O +
of O +
intracellular O +
signaling O +
cascades O +
may O +
underlie O +
different O +
patterns O +
of O +
functional O +
responses O +
. O +

Pivotal O +
role O +
for O +
the O +
NFIL3 B-Gene -
/ I-Gene -
E4BP4 I-Gene +
transcription I-Gene +
factor I-Gene +
in O +
interleukin B-Gene +
3 I-Gene +
-mediated O +
survival O +
of O +
pro O -
- O -
B O +
lymphocytes O +
. O +

The O +
E2A B-Gene -
- I-Gene -
HLF I-Gene +
( I-Gene +
hepatic I-Gene +
leukemia I-Gene +
factor I-Gene +
) I-Gene +
oncoprotein I-Gene +
, O +
generated O +
in O +
pro O -
- O -
B O +
lymphocytes O +
by O +
fusion O +
of O +
the O +
trans B-Gene -
- I-Gene -
activation I-Gene +
domain I-Gene +
of O +
E2A B-Gene +
to O +
the O +
basic B-Gene +
region I-Gene -
/ I-Gene -
leucine I-Gene +
zipper I-Gene +
( I-Gene +
bZIP I-Gene +
) I-Gene +
domain I-Gene +
of O +
HLF B-Gene +
, O +
functions O +
as O +
an O +
anti B-Gene -
- I-Gene -
apoptotic I-Gene +
transcription I-Gene +
factor I-Gene +
in O +
leukemic O +
cell O +
transformation O +
. O +

When O +
introduced O +
into O +
interleukin B-Gene +
3 I-Gene +
( O +
IL-3 B-Gene +
) O +
-dependent O +
mouse O +
pro O -
- O -
B O +
lymphocytes O +
, O +
E2A B-Gene -
- I-Gene -
HLF I-Gene +
prevents O +
apoptosis O +
induced O +
by O +
growth B-Gene +
factor I-Gene +
deprivation O +
, O +
suggesting O +
that O +
IL-3 B-Gene +
mediates O +
cell O +
survival O +
through O +
activation O +
of O +
a O +
transcription B-Gene +
factor I-Gene +
whose O +
activity O +
can O +
be O +
constitutively O +
replaced O +
by O +
the O +
chimeric B-Gene +
oncoprotein I-Gene +
. O +

We O +
considered O +
four O +
bZIP B-Gene +
transcription I-Gene +
factors I-Gene +
as O +
candidates O +
for O +
this O +
putative O +
IL-3-regulated B-Gene +
factor I-Gene +
, O +
each O +
of O +
which O +
binds O +
avidly O +
to O +
the O +
DNA O +
consensus O +
sequence O +
recognized O +
by O +
E2A B-Gene -
- I-Gene -
HLF I-Gene +
and O +
is O +
related O +
to O +
the O +
Caenorhabditis B-Gene +
elegans I-Gene +
CES-2 I-Gene +
( O +
cell B-Gene +
death I-Gene +
specification I-Gene +
protein I-Gene +
) O +
neuron B-Gene -
- I-Gene -
specific I-Gene +
mediator I-Gene +
of I-Gene +
cell I-Gene +
death I-Gene +
. O +

The O +
expression O +
and O +
binding O +
activity O +
of O +
the O +
Nfil3 B-Gene +
protein I-Gene +
( O +
also O +
called O +
E4bp4 B-Gene +
) O +
, O +
but O +
not O +
of O +
Hlf B-Gene +
, O +
Dbp B-Gene +
, O +
or O +
Tef B-Gene +
, O +
was O +
found O +
to O +
be O +
regulated O +
by O +
IL-3 B-Gene +
in O +
mouse O +
pro O -
- O -
B O +
cell O +
lines O +
( O +
Baf-3 O +
and O +
FL5.12 O +
) O +
. O +

Northern O +
blot O +
analysis O +
showed O +
that O +
Nfil3 B-Gene -
/ I-Gene -
E4bp4 I-Gene +
is O +
regulated O +
as O +
a O +
` O -
` O +
delayed O -
- O -
early O +
'' O +
IL-3-responsive O +
gene O +
, O +
requiring O +
de O +
novo O +
protein O +
synthesis O +
. O +

In O +
the O +
absence O +
of O +
IL-3 B-Gene +
, O +
enforced O +
expression O +
of O +
the O +
human O +
NFIL3 O -
/ O -
E4BP4 O +
cDNA O +
promoted O +
the O +
survival O +
but O +
not O +
the O +
growth O +
of O +
IL-3-dependent O +
pro O -
- O -
B O +
cells O +
. O +

Our O +
results O +
implicate O +
NFIL3 B-Gene -
/ I-Gene -
E4BP4 I-Gene +
( O +
nuclear B-Gene +
factor I-Gene +
regulated I-Gene +
by I-Gene +
IL-3 I-Gene -
/ I-Gene -
adenovirus I-Gene +
E4 I-Gene +
promoter I-Gene +
binding I-Gene +
protein I-Gene +
) O +
in O +
a O +
distinct O +
growth O +
factor O -
- O -
regulated O +
signaling O +
pathway O +
that O +
is O +
responsible O +
for O +
the O +
survival O +
of O +
early O +
B O -
- O -
cell O +
progenitors O +
, O +
and O +
whose O +
alteration O +
by O +
E2A B-Gene -
- I-Gene -
HLF I-Gene +
leads O +
to O +
childhood O +
B O +
lineage O +
leukemia O +
. O +

ALY B-Gene +
, O +
a O +
context B-Gene -
- I-Gene -
dependent I-Gene +
coactivator I-Gene +
of O +
LEF-1 B-Gene +
and O +
AML-1 B-Gene +
, O +
is O +
required O +
for O +
TCRalpha O +
enhancer O +
function O +
. O +

LEF-1 B-Gene +
is O +
a O +
transcription O +
factor O +
that O +
participates O +
in O +
the O +
regulation O +
of O +
the O +
T O -
- O -
cell O +
receptor O +
alpha O +
( O +
TCR O +
alpha O +
) O +
enhancer O +
by O +
facilitating O +
the O +
assembly O +
of O +
multiple B-Gene +
proteins I-Gene +
into O +
a O +
higher O +
order O +
nucleoprotein B-Gene +
complex I-Gene +
. O +

The O +
function O +
of O +
LEF-1 B-Gene +
is O +
dependent O +
, O +
in O +
part O +
, O +
on O +
the O +
HMG B-Gene +
domain I-Gene +
that O +
induces O +
a O +
sharp O +
bend O +
in O +
the O +
DNA O +
helix O +
, O +
and O +
on O +
an O +
activation B-Gene +
domain I-Gene +
that O +
stimulates O +
transcription O +
only O +
in O +
a O +
specific O +
context O +
of O +
other O +
enhancer B-Gene -
- I-Gene -
binding I-Gene +
proteins I-Gene +
. O +

With O +
the O +
aim O +
of O +
gaining O +
insight O +
into O +
the O +
function O +
of O +
context B-Gene -
- I-Gene -
dependent I-Gene +
activation I-Gene +
domains I-Gene +
, O +
we O +
cloned O +
ALY B-Gene +
, O +
a O +
novel O +
LEF-1-interacting B-Gene +
protein I-Gene +
. O +

ALY B-Gene +
is O +
a O +
ubiquitously O +
expressed O +
, O +
nuclear O +
protein O +
that O +
specifically O +
associates O +
with O +
the O +
activation B-Gene +
domains I-Gene +
of O +
LEF-1 B-Gene +
and O +
AML-1 B-Gene +
( O +
CBF B-Gene +
alpha2 I-Gene +
, O +
PEBP2 B-Gene +
alpha I-Gene +
( O +
B O +
) O +
, O +
which O +
is O +
another O +
protein O +
component O +
of O +
the O +
TCR B-Gene +
alpha I-Gene +
enhancer I-Gene +
complex I-Gene +
. O +

In O +
addition O +
, O +
ALY B-Gene +
can O +
increase O +
DNA O +
binding O +
by O +
both O +
LEF-1 B-Gene +
and O +
AML B-Gene +
proteins I-Gene +
. O +

Overexpression O +
of O +
ALY B-Gene +
stimulates O +
the O +
activity O +
of O +
the O +
TCR B-Gene +
alpha I-Gene +
enhancer I-Gene +
complex I-Gene +
reconstituted O +
in O +
transfected O +
nonlymphoid O +
HeLa O +
cells O +
, O +
whereas O +
down O -
- O -
regulation O +
of O +
ALY B-Gene +
by O +
anti O -
- O -
sense O +
oligonucleotides O +
virtually O +
eliminates O +
TCR O +
alpha O +
enhancer O +
activity O +
in O +
T O +
cells O +
. O +

Similar O +
to O +
LEF-1 B-Gene +
, O +
ALY B-Gene +
can O +
stimulate O +
transcription O +
in O +
the O +
context O +
of O +
the O +
TCR O +
alpha O +
enhancer O +
but O +
apparently O +
not O +
when O +
tethered O +
to O +
DNA O +
through O +
an O +
heterologous B-Gene +
DNA I-Gene -
- I-Gene -
binding I-Gene +
domain I-Gene +
. O +

We O +
propose O +
that O +
ALY B-Gene +
mediates O +
context O -
- O -
dependent O +
transcriptional O +
activation O +
by O +
facilitating O +
the O +
functional O +
collaboration O +
of O +
multiple B-Gene +
proteins I-Gene +
in O +
the O +
TCR B-Gene +
alpha I-Gene +
enhancer I-Gene +
complex I-Gene +
. O +

Estrogen B-Gene +
and O +
progesterone B-Gene +
receptors I-Gene +
in O +
vernal O +
keratoconjunctivitis O +
. O +

PURPOSE O +
: O +
Sex O -
- O -
related O +
influences O +
have O +
been O +
implicated O +
in O +
the O +
pathogenesis O +
of O +
vernal O +
keratoconjunctivitis O +
( O +
VKC O +
) O +
, O +
an O +
allergic O +
eosinophilic O +
disease O +
. O +

METHODS O +
: O +
The O +
authors O +
evaluated O +
tarsal O +
and O +
bulbar O +
conjunctival O +
biopsies O +
from O +
seven O +
patients O +
with O +
severe O +
and O +
symptomatic O +
VKC O +
for O +
the O +
presence O +
of O +
estrogen B-Gene +
and O +
progesterone B-Gene +
receptors I-Gene +
by O +
using O +
monoclonal B-Gene +
antibodies I-Gene +
with O +
a O +
peroxidase O -
- O -
antiperoxidase O +
technique O +
. O +

RESULTS O +
: O +
Both O +
the O +
epithelium O +
and O +
subepithelium O +
of O +
the O +
tarsal O +
and O +
bulbar O +
conjunctiva O +
of O +
patients O +
with O +
VKC O +
, O +
but O +
not O +
those O +
of O +
four O +
nonatopic O +
control O +
subjects O +
, O +
showed O +
intense O +
positive O +
staining O +
for O +
estrogen O +
and O +
progesterone B-Gene +
receptors I-Gene +
. O +

Immunofluorescence O +
colocalization O +
of O +
both O +
estrogen B-Gene +
and O +
progesterone B-Gene +
receptors I-Gene +
with O +
eosinophil B-Gene +
cationic I-Gene +
protein I-Gene +
showed O +
that O +
approximately O +
70 O +
% O +
of O +
positive O +
cells O +
were O +
eosinophils O +
. O +

CONCLUSIONS O +
: O +
Sexual O +
hormones O +
, O +
through O +
their O +
receptors B-Gene +
, O +
may O +
influence O +
the O +
activity O +
of O +
eosinophils O +
in O +
patients O +
with O +
VKC O +
. O +

Induction O +
of O +
relA B-Gene +
( I-Gene +
p65 I-Gene +
) I-Gene +
and O +
I B-Gene +
kappa I-Gene +
B I-Gene +
alpha I-Gene +
subunit I-Gene +
expression O +
during O +
differentiation O +
of O +
human O +
peripheral O +
blood O +
monocytes O +
to O +
macrophages O +
. O +

We O +
evaluated O +
the O +
expression O +
and O +
DNA O +
binding O +
activity O +
of O +
nuclear B-Gene +
factor I-Gene +
( I-Gene +
NF I-Gene +
) I-Gene +
-kappa I-Gene +
B I-Gene +
subunits I-Gene +
in O +
human O +
peripheral O +
blood O +
monocytes O +
and O +
in O +
monocyte O -
- O -
derived O +
macrophages O +
( O +
MDMs O +
) O +
. O +

Constitutive O +
DNA O +
binding O +
activity O +
consisting O +
of O +
p50 B-Gene +
homodimers I-Gene +
was O +
detected O +
in O +
nuclear O +
extracts O +
from O +
both O +
cell O +
types O +
. O +

An O +
additional O +
complex O +
composed O +
of O +
p50 B-Gene -
/ I-Gene -
RelA I-Gene +
( I-Gene +
p65 I-Gene +
) I-Gene +
heterodimers I-Gene +
appeared O +
only O +
in O +
nuclear O +
extracts O +
from O +
7-day O +
MDMs O +
. O +

Immunoblot O +
analysis O +
showed O +
that O +
the O +
p50 O +
subunit O +
was O +
constitutively O +
expressed O +
in O +
monocytes O +
and O +
MDMs O +
. O +

In O +
contrast O +
, O +
the O +
RelA B-Gene +
( I-Gene +
p65 I-Gene +
) I-Gene +
subunit I-Gene +
was O +
barely O +
detectable O +
in O +
monocytes O +
, O +
but O +
its O +
level O +
increased O +
markedly O +
in O +
MDMs O +
. O +

Analysis O +
of O +
RelA O +
( O +
p65 O +
) O +
mRNA O +
revealed O +
that O +
the O +
stability O +
of O +
RelA O +
( O +
p65 O +
) O +
mRNA O +
was O +
significantly O +
higher O +
in O +
MDMs O +
, O +
compared O +
with O +
monocytes O +
. O +

In O +
MDMs O +
, O +
an O +
upregulation O +
of O +
I B-Gene +
kappa I-Gene +
B I-Gene +
alpha I-Gene +
synthesis O +
as O +
well O +
as O +
the O +
appearance O +
of O +
a O +
novel O +
M O +
( O +
r O +
) O +
40 O +
, O +
000 O +
form O +
of O +
I B-Gene +
kappa I-Gene +
B I-Gene +
alpha I-Gene +
were O +
also O +
observed O +
. O +

These O +
results O +
suggest O +
that O +
macrophage O +
differentiation O +
results O +
in O +
the O +
expression O +
of O +
active O +
p50 B-Gene -
/ I-Gene -
RelA I-Gene +
( I-Gene +
p65 I-Gene +
) I-Gene +
heterodimers I-Gene +
with O +
the O +
capacity O +
to O +
activate O +
target O +
gene O +
expression O +
. O +

The O +
parallel O +
induction O +
of O +
I B-Gene +
kappa I-Gene +
B I-Gene +
alpha I-Gene +
synthesis O +
may O +
allow O +
for O +
the O +
continuous O +
presence O +
of O +
a O +
cytoplasmic O +
reservoir O +
of O +
p50 B-Gene -
/ I-Gene -
RelA I-Gene +
( I-Gene +
p65 I-Gene +
) I-Gene +
complexes I-Gene +
that O +
are O +
readily O +
available O +
for O +
inducer O -
- O -
mediated O +
stimulation O +
. O +

Requirement O +
of O +
prestimulated O +
THP-1 O +
monocytic O +
cells O +
for O +
endothelial O +
cell O +
activation O +
. O +

Involvement O +
of O +
TNF O +
alpha O +
. O +

Blood O +
monocytes O +
spontaneously O +
activate O +
endothelial O +
cells O +
in O +
culture O +
, O +
leading O +
to O +
adhesion O +
of O +
monocytic O +
cells O +
onto O +
the O +
endothelial O +
surface O +
and O +
overproduction O +
of O +
endothelial O +
proteins O +
such O +
as O +
von B-Gene +
Willebrand I-Gene +
factor I-Gene +
( O +
vWf B-Gene +
) O +
and O +
plasminogen B-Gene +
activator I-Gene +
inhibitor I-Gene +
type I-Gene +
1 I-Gene +
( O +
PAI-1 B-Gene +
) O +
. O +

To O +
overcome O +
the O +
difficulty O +
in O +
obtaining O +
quiescent O +
monocytes O +
, O +
we O +
studied O +
the O +
ability O +
of O +
promonocytic O +
THP-1 O +
cells O +
to O +
activate O +
endothelial O +
cells O +
. O +

Lipopolysaccharide O +
( O +
LPS O +
) O +
-prestimulated O +
and O +
untreated O +
THP-1 O +
cells O +
were O +
cocultured O +
with O +
resting O +
human O +
umbilical O +
vein O +
endothelial O +
cells O +
( O +
HUVEC O +
) O +
for O +
3 O +
and O +
24 O +
h O +
in O +
the O +
presence O +
of O +
colimycin O +
to O +
neutralize O +
LPS O +
traces O +
. O +

Addition O +
of O +
untreated O +
THP-1 O +
cells O +
had O +
little O +
effect O +
on O +
HUVEC O +
adhesiveness O +
. O +

Addition O +
of O +
prestimulated O +
THP-1 O +
cells O +
was O +
followed O +
by O +
a O +
noticeable O +
adhesion O +
after O +
3 O +
h O +
which O +
reversed O +
to O +
basal O +
values O +
within O +
24 O +
h O +
. O +

Under O +
these O +
conditions O +
HUVEC B-Gene +
adhesion I-Gene +
molecules I-Gene +
, O +
E B-Gene -
- I-Gene -
selectin I-Gene +
, O +
VCAM-1 B-Gene +
and O +
ICAM-1 B-Gene +
, O +
were O +
increased O +
at O +
3 O +
h O +
with O +
only O +
ICAM-1 B-Gene +
remaining O +
overexpressed O +
at O +
24 O +
h O +
. O +

Diffusible B-Gene +
endothelial I-Gene +
proteins I-Gene +
such O +
as O +
soluble O +
E B-Gene -
- I-Gene -
selectin I-Gene +
, O +
PAI-1 B-Gene +
and O +
vWf B-Gene +
to O +
a O +
minimal O +
extent O +
, O +
increased O +
in O +
supernatants O +
from O +
HUVEC O +
cocultured O +
for O +
24 O +
h O +
with O +
prestimulated O +
THP-1 O +
cells O +
. O +

In O +
those O +
cocultures O +
, O +
TNF B-Gene +
alpha I-Gene +
concentrations O +
peaked O +
at O +
3 O +
h O +
whereas O +
IL-1 O +
beta O +
levels O +
progressively O +
rose O +
until O +
24 O +
h O +
. O +

Addition O +
of O +
an O +
anti B-Gene -
- I-Gene -
TNF I-Gene +
alpha I-Gene +
antibody I-Gene +
decreased O +
by O +
40 O +
% O +
E B-Gene -
- I-Gene -
selectin I-Gene +
and O +
ICAM-1 B-Gene +
induction O +
and O +
suppressed O +
PAI-1 B-Gene +
overproduction O +
with O +
a O +
weak O +
effect O +
on O +
vWf B-Gene +
. O +

An O +
anti B-Gene -
- I-Gene -
IL-1 I-Gene +
beta I-Gene +
antibody I-Gene +
had O +
negligible O +
effects O +
on O +
HUVEC B-Gene +
adhesion I-Gene +
molecules I-Gene +
, O +
PAI-1 B-Gene +
or O +
vWf B-Gene +
production O +
. O +

These O +
results O +
provide O +
evidence O +
that O +
promonocytic O +
THP-1 O +
cells O +
require O +
prestimulation O +
in O +
order O +
to O +
activate O +
HUVEC O +
and O +
that O +
TNF B-Gene +
alpha I-Gene +
contributes O +
to O +
this O +
phenomenon O +
. O +

Oncogenic O +
forms O +
of O +
NOTCH1 B-Gene +
lacking O +
either O +
the O +
primary O +
binding O +
site O +
for O +
RBP B-Gene -
- I-Gene -
Jkappa I-Gene +
or O +
nuclear B-Gene +
localization I-Gene +
sequences I-Gene +
retain O +
the O +
ability O +
to O +
associate O +
with O +
RBP B-Gene -
- I-Gene -
Jkappa I-Gene +
and O +
activate O +
transcription O +
. O +

Truncated O +
forms O +
of O +
the O +
NOTCH1 B-Gene +
transmembrane I-Gene +
receptor I-Gene +
engineered O +
to O +
resemble O +
mutant O +
forms O +
of O +
NOTCH1 B-Gene +
found O +
in O +
certain O +
cases O +
of O +
human O +
T O +
cell O +
leukemia O -
/ O -
lymphoma O +
( O +
T O -
- O -
ALL O +
) O +
efficiently O +
induce O +
T O -
- O -
ALL O +
when O +
expressed O +
in O +
the O +
bone O +
marrow O +
of O +
mice O +
. O +

Unlike O +
full O -
- O -
sized O +
NOTCH1 B-Gene +
, O +
two O +
such O +
truncated O +
forms O +
of O +
the O +
protein O +
either O +
lacking O +
a O +
major O +
portion O +
of O +
the O +
extracellular B-Gene +
domain I-Gene +
( O +
DeltaE B-Gene +
) O +
or O +
consisting O +
only O +
of O +
the O +
intracellular B-Gene +
domain I-Gene +
( O +
ICN B-Gene +
) O +
were O +
found O +
to O +
activate O +
transcription O +
in O +
cultured O +
cells O +
, O +
presumably O +
through O +
RBP B-Gene -
- I-Gene -
Jkappa I-Gene +
response O +
elements O +
within O +
DNA O +
. O +

Both O +
truncated O +
forms O +
also O +
bound O +
to O +
the O +
transcription B-Gene +
factor I-Gene +
RBP I-Gene -
- I-Gene -
Jkappa I-Gene +
in O +
extracts O +
prepared O +
from O +
human O +
and O +
murine O +
T O -
- O -
ALL O +
cell O +
lines O +
. O +

Transcriptional O +
activation O +
required O +
the O +
presence O +
of O +
a O +
weak O +
RBP B-Gene -
- I-Gene -
Jkappa I-Gene -
- I-Gene -
binding I-Gene +
site I-Gene +
within O +
the O +
NOTCH1 B-Gene +
ankyrin I-Gene +
repeat I-Gene +
region I-Gene +
of O +
the O +
intracellular B-Gene +
domain I-Gene +
. O +

Unexpectedly O +
, O +
a O +
second O +
, O +
stronger O +
RBP B-Gene -
- I-Gene -
Jkappa I-Gene -
- I-Gene -
binding I-Gene +
site I-Gene +
, O +
which O +
lies O +
within O +
the O +
intracellular B-Gene +
domain I-Gene +
close O +
to O +
the O +
transmembrane O +
region O +
and O +
significantly O +
augments O +
association O +
with O +
RBP B-Gene -
- I-Gene -
Jkappa I-Gene +
, O +
was O +
not O +
needed O +
for O +
oncogenesis O +
or O +
for O +
transcriptional O +
activation O +
. O +

While O +
ICN B-Gene +
appeared O +
primarily O +
in O +
the O +
nucleus O +
, O +
DeltaE B-Gene +
localized O +
to O +
cytoplasmic O +
and O +
nuclear O +
membranes O +
, O +
suggesting O +
that O +
intranuclear O +
localization O +
is O +
not O +
essential O +
for O +
oncogenesis O +
or O +
transcriptional O +
activation O +
. O +

In O +
support O +
of O +
this O +
interpretation O +
, O +
mutation O +
of O +
putative O +
nuclear B-Gene +
localization I-Gene +
sequences I-Gene +
decreased O +
nuclear O +
localization O +
and O +
increased O +
transcriptional O +
activation O +
by O +
membrane B-Gene -
- I-Gene -
bound I-Gene +
DeltaE I-Gene +
. O +

Transcriptional O +
activation O +
by O +
this O +
mutant O +
form O +
of O +
membrane B-Gene -
- I-Gene -
bound I-Gene +
DeltaE I-Gene +
was O +
approximately O +
equivalent O +
to O +
that O +
produced O +
by O +
intranuclear B-Gene +
ICN I-Gene +
. O +

These O +
data O +
are O +
most O +
consistent O +
with O +
NOTCH1 B-Gene +
oncogenesis O +
and O +
transcriptional O +
activation O +
being O +
independent O +
of O +
association O +
with O +
RBP B-Gene -
- I-Gene -
Jkappa I-Gene +
at O +
promoter O +
sites O +
. O +

Glucocorticoid O -
- O -
resistance O +
in O +
peripheral O -
- O -
blood O +
lymphocytes O +
does O +
not O +
correlate O +
with O +
number O +
of O +
affinity O +
of O +
glucocorticoid B-Gene -
- I-Gene -
receptors I-Gene +
in O +
chronic O +
renal O +
failure O +
patients O +
. O +

Glucocorticoid O +
( O +
GC O +
) O +
resistance O +
in O +
patients O +
with O +
chronic O +
renal O +
failure O +
( O +
CRF O +
) O +
seriously O +
impairs O +
successive O +
GC O +
therapy O +
after O +
renal O +
transplantation O +
. O +

We O +
examined O +
the O +
relationship O +
between O +
GC O -
- O -
receptor O +
( O +
GC O -
- O -
R O +
) O +
parameters O +
in O +
peripheral O -
- O -
blood O +
mononuclear O +
cells O +
( O +
PBMC O +
) O +
and O +
PBMC O +
resistance O +
to O +
GC O +
in O +
21 O +
CRF O +
patients O +
and O +
18 O +
healthy O +
subjects O +
. O +

Each O +
subject O +
group O +
was O +
divided O +
into O +
two O +
subgroups O +
according O +
to O +
PBMC O +
sensitivity O +
to O +
prednisolone O +
in O +
a O +
mitogen O +
assay O +
procedure O +
; O +
i.e. O +
, O +
sensitive O +
( O +
IC50 O +
< O +
381 O +
ng O -
/ O -
mL O +
) O +
and O +
resistant O +
( O +
IC50 O +
> O +
381 O +
ng O -
/ O -
mL O +
) O +
groups O +
. O +

In O +
healthy O +
subjects O +
, O +
the O +
mean O +
GC B-Gene -
- I-Gene -
R I-Gene +
Bmax O +
and O +
Kd O +
in O +
quiescent O +
PBMC O +
of O +
the O +
GC O -
- O -
sensitive O +
group O +
were O +
2.89 O +
+ O -
/- O +
1.23 O +
fmol O -
/ O -
10 O +
( O +
6 O +
) O +
cells O +
and O +
4.00 O +
+ O -
/- O +
2.24 O +
nM O +
, O +
respectively O +
. O +

The O +
Bmax O +
in O +
these O +
subjects O +
significantly O +
increased O +
to O +
6.61 O +
+ O -
/- O +
2.02 O +
( O +
257.7 O +
+ O -
/- O +
107.8 O +
% O +
) O +
after O +
24 O +
h O +
stimulation O +
with O +
concanavalin O +
A O +
( O +
p O +
< O +
0.01 O +
) O +
, O +
while O +
the O +
Kd O +
change O +
was O +
not O +
significant O +
. O +

The O +
GC B-Gene -
- I-Gene -
R I-Gene +
Bmax O +
and O +
Kd O +
in O +
quiescent O +
PBMC O +
of O +
the O +
GC O -
- O -
resistant O +
group O +
were O +
5.33 O +
+ O -
/- O +
1.37 O +
fmol O -
/ O -
10 O +
( O +
6 O +
) O +
cells O +
and O +
3.20 O +
+ O -
/- O +
1.39 O +
nM O +
, O +
respectively O +
. O +

Both O +
of O +
these O +
parameters O +
, O +
however O +
, O +
did O +
not O +
change O +
significantly O +
after O +
mitogen B-Gene +
stimulation O +
. O +

There O +
was O +
a O +
significant O +
negative O +
correlation O +
between O +
IC50S O +
of O +
prednisolone O +
and O +
increase O -
- O -
ratios O +
( O +
post O -
/ O -
pre O +
ratio O +
) O +
of O +
Bmax O +
after O +
mitogen B-Gene +
stimulation O +
( O +
p O +
< O +
0.05 O +
) O +
. O +

In O +
CRF O +
patients O +
, O +
Bmax O +
and O +
Kd O +
in O +
quiescent O +
PBMC O +
of O +
the O +
GC O -
- O -
sensitive O +
group O +
were O +
6.04 O +
+ O -
/- O +
2.35 O +
fmol O -
/ O -
10 O +
( O +
6 O +
) O +
cells O +
and O +
3.49 O +
+ O -
/- O +
1.72 O +
nM O +
, O +
respectively O +
, O +
while O +
those O +
in O +
PBMC O +
of O +
the O +
GC O -
- O -
resistant O +
group O +
were O +
5.13 O +
+ O -
/- O +
2.31 O +
fmol O -
/ O -
10 O +
( O +
6 O +
) O +
cells O +
and O +
4.04 O +
+ O -
/- O +
1.62 O +
nM O +
, O +
respectively O +
. O +

The O +
Bmax O +
and O +
Kd O +
were O +
not O +
significantly O +
changed O +
after O +
mitogen B-Gene +
stimulation O +
in O +
both O +
subgroups O +
of O +
CRF O +
. O +

Moreover O +
, O +
in O +
contrast O +
to O +
healthy O +
subjects O +
, O +
there O +
was O +
no O +
correlation O +
between O +
IC50 O +
and O +
GC B-Gene -
- I-Gene -
R I-Gene +
parameters O +
in O +
CRF O +
. O +

We O +
concluded O +
that O +
, O +
in O +
healthy O +
subjects O +
, O +
decreased O +
PBMC O +
capacity O +
to O +
amplify O +
GC B-Gene -
- I-Gene -
R I-Gene +
numbers O +
in O +
response O +
to O +
mitogen B-Gene +
is O +
correlated O +
with O +
GC O +
resistance O +
, O +
whereas O +
in O +
CRF O +
patients O +
the O +
resistant O +
mechanism O +
is O +
not O +
correlated O +
with O +
GC B-Gene -
- I-Gene -
R I-Gene +
parameters O +
. O +

An O +
unknown O +
event O +
might O +
be O +
involved O +
in O +
GC O -
- O -
resistance O +
of O +
CRF O +
. O +

Regulation O +
of O +
human O +
epsilon O +
germline O +
transcription O +
: O +
role O +
of O +
B B-Gene -
- I-Gene -
cell I-Gene -
- I-Gene -
specific I-Gene +
activator I-Gene +
protein I-Gene +
. O +

Germline B-Gene +
transcripts I-Gene +
initiate O +
from O +
promoters O +
upstream O +
of O +
the O +
immunoglobulin O +
switch O +
region O +
, O +
and O +
are O +
necessary O +
to O +
target O +
the O +
appropriate O +
switch O +
region O +
for O +
recombination O +
and O +
switching O +
. O +

Different O +
cytokines B-Gene +
activate O +
transcription O +
at O +
the O +
appropriate O +
germline O +
promoter O +
. O +

Because O +
binding O +
sites O +
for O +
B B-Gene -
- I-Gene -
cell I-Gene -
- I-Gene -
specific I-Gene +
activator I-Gene +
protein I-Gene +
( O +
BSAP B-Gene +
) O +
are O +
located O +
upstream O +
of O +
several O +
switch O +
regions O +
in O +
the O +
immunoglobulin O +
heavy O +
chain O +
gene O +
cluster O +
, O +
BSAP B-Gene +
might O +
play O +
a O +
role O +
in O +
the O +
regulation O +
of O +
germline O +
transcription O +
and O +
isotype O +
switching O +
. O +

We O +
investigated O +
whether O +
BSAP B-Gene +
plays O +
a O +
role O +
in O +
the O +
transcriptional O +
regulation O +
of O +
the O +
epsilon O +
germline O +
promoter O +
in O +
human O +
B O +
cells O +
. O +

Our O +
results O +
showed O +
that O +
BSAP B-Gene +
plays O +
a O +
role O +
in O +
both O +
IL-4 B-Gene +
-dependent O +
induction O +
and O +
CD40 B-Gene +
-mediated O +
upregulation O +
of O +
human O +
epsilon O +
germline O +
transcription O +
. O +

BSAP B-Gene +
is O +
unique O +
among O +
the O +
transcription B-Gene +
factors I-Gene +
that O +
regulate O +
epsilon O +
germline O +
expression O +
, O +
because O +
it O +
is O +
B O +
cell O +
specific O +
, O +
and O +
is O +
at O +
the O +
merging O +
point O +
of O +
two O +
signalling O +
pathways O +
that O +
are O +
critical O +
for O +
IgE B-Gene +
switching O +
. O +

Molecular O +
actions O +
of O +
prolactin O +
in O +
the O +
immune O +
system O +
. O +

The O +
immunoregulatory B-Gene +
properties O +
of O +
prolactin O +
, O +
a O +
pituitary O +
peptide O +
hormone O +
, O +
have O +
received O +
renewed O +
attention O +
. O +

The O +
prolactin B-Gene +
receptor I-Gene +
, O +
a O +
member O +
of O +
the O +
hematopoietin B-Gene -
/ I-Gene -
cytokine I-Gene +
receptor I-Gene +
superfamily I-Gene +
, O +
is O +
ubiquitously O +
expressed O +
by O +
cells O +
in O +
the O +
immune O +
system O +
. O +

Certain O +
subpopulations O +
of O +
lymphocytes O +
synthesize O +
and O +
secrete O +
biologically O +
active O +
prolactin O +
, O +
which O +
suggests O +
that O +
prolactin O +
can O +
act O +
as O +
an O +
autocrine O +
and/or O +
paracrine O +
factor O +
to O +
modulate O +
the O +
activities O +
of O +
cells O +
of O +
the O +
immune O +
system O +
. O +

This O +
review O +
focuses O +
on O +
the O +
molecular O +
actions O +
of O +
prolactin O +
in O +
the O +
immune O +
system O +
. O +

Emphasis O +
is O +
given O +
to O +
recent O +
information O +
about O +
the O +
molecular O +
mechanisms O +
of O +
prolactin O +
receptor O +
signal O +
transduction O +
, O +
and O +
the O +
signaling B-Gene +
molecules I-Gene +
and O +
prolactin O -
- O -
inducible O +
target O +
genes O +
that O +
participate O +
in O +
these O +
responses O +
. O +

In O +
particular O +
, O +
the O +
prolactin O -
- O -
inducible O +
interferon O +
regulatory O +
factor-1 O +
gene O +
and O +
its O +
roles O +
in O +
mediating O +
diverse O +
immune O +
responses O +
. O +

A O +
new O +
mouse O +
gene O +
, O +
SRG3 O +
, O +
related O +
to O +
the O +
SWI3 O +
of O +
Saccharomyces O +
cerevisiae O +
, O +
is O +
required O +
for O +
apoptosis O +
induced O +
by O +
glucocorticoids O +
in O +
a O +
thymoma O +
cell O +
line O +
. O +

We O +
isolated O +
a O +
new O +
mouse O +
gene O +
that O +
is O +
highly O +
expressed O +
in O +
thymocytes O +
, O +
testis O +
, O +
and O +
brain O +
. O +

This O +
gene O +
, O +
SRG3 O +
, O +
showed O +
a O +
significant O +
sequence O +
homology O +
to O +
SWI3 O +
, O +
a O +
yeast O +
transcriptional O +
activator O +
, O +
and O +
its O +
human O +
homolog O +
BAF155 O +
. O +

SRG3 O +
encodes O +
1 O +
, O +
100 O +
amino O +
acids O +
and O +
has O +
33 O -
- O -
47 O +
% O +
identity O +
with O +
SWI3 B-Gene +
protein I-Gene +
over O +
three O +
regions O +
. O +

The O +
SRG3 B-Gene +
protein I-Gene +
contains O +
an O +
acidic B-Gene +
NH2 I-Gene +
terminus I-Gene +
, O +
a O +
myb B-Gene -
- I-Gene -
like I-Gene +
DNA I-Gene +
binding I-Gene +
domain I-Gene +
, O +
a O +
leucine B-Gene -
- I-Gene -
zipper I-Gene +
motif I-Gene +
, O +
and O +
a O +
proline- B-Gene +
and I-Gene +
glutamine I-Gene -
- I-Gene -
rich I-Gene +
region I-Gene +
at O +
its O +
COOH B-Gene +
terminus I-Gene +
. O +

Rabbit O +
antiserum O +
raised O +
against O +
a O +
COOH O -
- O -
terminal O +
polypeptide O +
of O +
the O +
SRG3 O +
recognized O +
a O +
protein O +
with O +
an O +
apparent O +
molecular O +
mass O +
of O +
155 O +
kD O +
. O +

The O +
serum O +
also O +
detected O +
a O +
170-kD B-Gene +
protein I-Gene +
that O +
seems O +
to O +
be O +
a O +
mouse O +
homologue O +
of O +
human B-Gene +
BAF170 I-Gene +
. O +

Immunoprecipitation O +
of O +
cell O +
extract O +
with O +
the O +
antiserum O +
against O +
the O +
mouse B-Gene +
SRG3 I-Gene +
also O +
brought O +
down O +
a O +
195-kD B-Gene +
protein I-Gene +
that O +
could O +
be O +
recognized O +
by O +
an O +
antiserum O +
raised O +
against O +
human B-Gene +
SWI2 I-Gene +
protein I-Gene +
. O +

The O +
results O +
suggest O +
that O +
the O +
SRG3 B-Gene +
protein I-Gene +
associates O +
with O +
a O +
mouse B-Gene +
SWI2 I-Gene +
. O +

The O +
SRG3 B-Gene +
protein I-Gene +
is O +
expressed O +
about O +
three O +
times O +
higher O +
in O +
thymocytes O +
than O +
in O +
peripheral O +
lymphocytes O +
. O +

The O +
expression O +
of O +
anti B-Gene -
- I-Gene -
sense I-Gene +
RNA I-Gene +
to O +
SRG3 O +
mRNA O +
in O +
a O +
thymoma O +
cell O +
line O +
, O +
S49.1 O +
, O +
reduced O +
the O +
expression O +
level O +
of O +
the O +
SRG3 B-Gene +
protein I-Gene +
, O +
and O +
decreased O +
the O +
apoptotic O +
cell O +
death O +
induced O +
by O +
glucocorticoids O +
. O +

These O +
results O +
suggest O +
that O +
the O +
SRG3 B-Gene +
protein I-Gene +
is O +
involved O +
in O +
the O +
glucocorticoid O -
- O -
induced O +
apoptosis O +
in O +
the O +
thymoma O +
cell O +
line O +
. O +

This O +
implicates O +
that O +
the O +
SRG3 O +
may O +
play O +
an O +
important O +
regulatory O +
role O +
during O +
T O +
cell O +
development O +
in O +
thymus O +
. O +

The O +
IL-4 B-Gene +
receptor I-Gene +
alpha I-Gene -
- I-Gene -
chain I-Gene +
cytoplasmic I-Gene +
domain I-Gene +
is O +
sufficient O +
for O +
activation O +
of O +
JAK-1 B-Gene +
and O +
STAT6 B-Gene +
and O +
the O +
induction O +
of O +
IL-4 B-Gene +
-specific O +
gene O +
expression O +
. O +

The O +
common B-Gene +
gamma I-Gene -
- I-Gene -
chain I-Gene +
( O +
gamma B-Gene +
( I-Gene +
c I-Gene +
) I-Gene +
) O +
is O +
a O +
functional O +
component O +
of O +
the O +
IL-4R B-Gene +
, O +
yet O +
cells O +
lacking O +
gamma B-Gene +
( I-Gene +
c I-Gene +
) I-Gene +
are O +
able O +
to O +
respond O +
to O +
IL-4 B-Gene +
. O +

This O +
has O +
led O +
to O +
the O +
suggestion O +
that O +
a O +
surrogate B-Gene +
gamma'-chain I-Gene +
, O +
which O +
can O +
interact O +
with O +
the O +
IL-4R B-Gene +
alpha I-Gene +
chain I-Gene +
to O +
mediate O +
signaling O +
, O +
is O +
expressed O +
on O +
cells O +
lacking O +
gamma B-Gene +
( I-Gene +
c I-Gene +
) I-Gene +
. O +

An O +
alternative O +
possibility O +
is O +
that O +
in O +
the O +
absence O +
of O +
gamma B-Gene +
( I-Gene +
c I-Gene +
) I-Gene +
, O +
the O +
IL-4R B-Gene +
alpha I-Gene +
chain I-Gene +
is O +
able O +
to O +
transduce O +
signals O +
by O +
homodimerization O +
. O +

To O +
test O +
this O +
latter O +
possibility O +
, O +
a O +
chimeric B-Gene +
receptor I-Gene +
containing O +
the O +
extracellular B-Gene +
domain I-Gene +
of O +
c B-Gene -
- I-Gene -
kit I-Gene +
( O +
the O +
stem B-Gene +
cell I-Gene +
factor I-Gene +
( I-Gene +
SCF I-Gene +
) I-Gene +
receptor I-Gene +
) O +
and O +
the O +
cytoplasmic B-Gene +
and I-Gene +
transmembrane I-Gene +
domains I-Gene +
of O +
the O +
IL-4R B-Gene +
alpha I-Gene +
chain I-Gene +
was O +
generated O +
. O +

Treatment O +
of O +
cells O +
expressing O +
the O +
chimeric B-Gene +
receptor I-Gene +
kit B-Gene -
/ I-Gene -
IL-4R I-Gene +
alpha I-Gene +
with O +
SCF B-Gene +
induces O +
activation O +
of O +
the O +
IL-4R B-Gene +
alpha I-Gene -
- I-Gene -
associated I-Gene +
kinase I-Gene +
JAK-1 B-Gene +
and O +
the O +
transcription B-Gene +
factor I-Gene +
STAT6 B-Gene +
. O +

However O +
, O +
tyrosine O +
phosphorylation O +
of O +
JAK-3 B-Gene +
, O +
which O +
associates O +
with O +
gamma B-Gene +
( I-Gene +
c I-Gene +
) I-Gene +
, O +
is O +
not O +
induced O +
by O +
SCF B-Gene +
in O +
these O +
cells O +
. O +

SCF B-Gene +
-mediated O +
ligation O +
of O +
kit B-Gene -
/ I-Gene -
IL-4R I-Gene +
alpha I-Gene +
is O +
sufficient O +
to O +
elicit O +
IL-4 B-Gene +
-specific O +
gene O +
expression O +
, O +
including O +
up O -
- O -
regulation O +
of O +
CD23 B-Gene +
and O +
synthesis O +
of O +
germ O -
- O -
line O +
epsilon O +
transcripts O +
. O +

In O +
the O +
T O +
cell O +
line O +
CTLL2 O +
, O +
ligation O +
of O +
kit B-Gene -
/ I-Gene -
IL-4R I-Gene +
alpha I-Gene +
induces O +
cellular O +
proliferation O +
. O +

Finally O +
, O +
in O +
JAK-1-deficient O +
HeLa O +
cells O +
, O +
STAT6 B-Gene +
activation O +
by O +
IL-4 B-Gene +
is O +
completely O +
abolished O +
. O +

Together O +
, O +
these O +
data O +
demonstrate O +
that O +
the O +
IL-4R B-Gene +
alpha I-Gene +
cytoplasmic I-Gene +
domain I-Gene +
is O +
sufficient O +
to O +
activate O +
JAK-1 B-Gene +
and O +
STAT6 B-Gene +
and O +
to O +
induce O +
expression O +
of O +
IL-4 O +
target O +
genes O +
, O +
thus O +
identifying O +
a O +
mechanism O +
by O +
which O +
IL-4 B-Gene +
signaling O +
can O +
proceed O +
in O +
the O +
absence O +
of O +
JAK-3 B-Gene +
and O +
gamma B-Gene +
( I-Gene +
c I-Gene +
) I-Gene +
. O +

AP-1 B-Gene +
derived O +
from O +
mature O +
monocytes O +
and O +
astrocytes O +
preferentially O +
interacts O +
with O +
the O +
HTLV O -
- O -
I O +
promoter O +
central O +
21 O +
bp O +
repeat O +
. O +

Characterization O +
of O +
the O +
cellular O +
transcription B-Gene +
factors I-Gene +
interacting O +
with O +
the O +
human O +
T O +
cell O +
lymphotropic O +
virus O +
type O +
I O +
( O +
HTLV O -
- O -
I O +
) O +
long O +
terminal O +
repeat O +
( O +
LTR O +
) O +
is O +
essential O +
to O +
dissecting O +
the O +
mechanisms O +
involved O +
in O +
viral O +
transcription O +
that O +
may O +
be O +
pertinent O +
to O +
the O +
oncogenic O +
and O +
neuropathogenic O +
processes O +
associated O +
with O +
HTLV O -
- O -
I O +
infection O +
in O +
both O +
the O +
immune O +
and O +
nervous O +
systems O +
. O +

Electrophoretic O +
mobility O +
shift O +
( O +
EMS O +
) O +
analyses O +
utilizing O +
oligonucleotides O +
homologous O +
to O +
each O +
of O +
the O +
21 O +
bp O +
repeat O +
elements O +
reacted O +
with O +
nuclear O +
extracts O +
derived O +
from O +
cell O +
lines O +
of O +
lymphocytic O +
, O +
monocytic O +
, O +
neuronal O +
, O +
and O +
glial O +
cell O +
origin O +
have O +
demonstrated O +
differential O +
binding O +
of O +
cellular B-Gene +
factors I-Gene +
to O +
the O +
three O +
21 O +
bp O +
repeats O +
( O +
1 O -
- O -
4 O +
) O +
. O +

ATF B-Gene -
/ I-Gene -
CREB I-Gene +
and O +
Sp B-Gene +
family I-Gene +
members I-Gene +
interacted O +
with O +
the O +
21 O +
bp O +
repeats O +
to O +
form O +
DNA B-Gene -
- I-Gene -
protein I-Gene +
complexes I-Gene +
common O +
to O +
all O +
cell O +
types O +
examined O +
. O +

However O +
, O +
a O +
unique O +
DNA B-Gene -
- I-Gene -
protein I-Gene +
complex I-Gene +
was O +
detected O +
when O +
the O +
promoter O +
central O +
21 O +
bp O +
repeat O +
was O +
reacted O +
with O +
nuclear O +
extracts O +
derived O +
from O +
either O +
the O +
U-373 O +
MG O +
glioblastoma O +
cell O +
line O +
or O +
the O +
THP-1 O +
mature O +
monocytic O +
cell O +
line O +
. O +

Based O +
on O +
nucleotide O +
sequence O +
requirements O +
and O +
immunoreactivity O +
, O +
we O +
demonstrate O +
that O +
this O +
DNA B-Gene -
- I-Gene -
protein I-Gene +
complex I-Gene +
is O +
comprised O +
of O +
the O +
AP-1 B-Gene +
components O +
, O +
Fos B-Gene +
and O +
Jun B-Gene +
. O +

Expression O +
of O +
transcription B-Gene +
factors I-Gene +
during O +
sodium O +
phenylacetate O +
induced O +
erythroid O +
differentiation O +
in O +
K562 O +
cells O +
. O +

During O +
15 O +
days O +
of O +
treatment O +
of O +
K562 O +
cells O +
with O +
sodium O +
phenylacetate O +
, O +
we O +
observed O +
an O +
increase O +
in O +
the O +
cellular O +
hemoglobin B-Gene +
concentration O +
with O +
a O +
similar O +
increase O +
in O +
the O +
expression O +
of O +
gamma O -
- O -
globin O +
mRNA O +
. O +

Morphological O +
studies O +
demonstrated O +
characteristic O +
features O +
of O +
erythroid O +
differentiation O +
and O +
maturation O +
. O +

At O +
the O +
same O +
time O +
there O +
was O +
no O +
change O +
in O +
the O +
level O +
of O +
expression O +
of O +
the O +
cell B-Gene +
surface I-Gene +
antigenes I-Gene +
CD33 B-Gene +
, O +
CD34 B-Gene +
, O +
CD45 B-Gene +
, O +
CD71 B-Gene +
and O +
glycophorin B-Gene +
A I-Gene +
. O +

Likewise O +
, O +
the O +
level O +
of O +
expression O +
of O +
the O +
erythroid B-Gene +
transcription I-Gene +
factors I-Gene +
GATA-1 B-Gene +
, O +
GATA-2 B-Gene +
, O +
NF B-Gene -
- I-Gene -
E2 I-Gene +
, O +
SCL B-Gene +
and O +
RBTN2 B-Gene +
, O +
all O +
expressed O +
in O +
untreated O +
K562 O +
cells O +
, O +
did O +
not O +
increase O +
during O +
sodium O +
phenylacetate O +
induced O +
erythroid O +
differentiation O +
. O +

The O +
expression O +
of O +
the O +
nuclear B-Gene +
factors I-Gene +
Evi-1 B-Gene +
and O +
c B-Gene -
- I-Gene -
myb I-Gene +
, O +
known O +
to O +
inhibit O +
erythroid O +
differentiation O +
, O +
did O +
not O +
decrease O +
. O +

We O +
conclude O +
that O +
sodium O +
phenylacetate O +
treatment O +
of O +
K562 O +
cells O +
increases O +
gamma O -
- O -
globin O +
mRNA O +
and O +
induces O +
cell O +
maturation O +
as O +
judged O +
by O +
morphology O +
without O +
affecting O +
the O +
expression O +
of O +
the O +
erythroid B-Gene +
transcription I-Gene +
factors I-Gene +
, O +
some O +
of O +
which O +
are O +
known O +
to O +
be O +
involved O +
in O +
the O +
regulation O +
of O +
beta O -
- O -
like O +
globin O +
genes O +
. O +

c O -
- O -
Myb O +
and O +
Ets B-Gene +
proteins I-Gene +
synergize O +
to O +
overcome O +
transcriptional O +
repression O +
by O +
ZEB B-Gene +
. O +

The O +
Zfh B-Gene +
family I-Gene +
of O +
zinc B-Gene +
finger I-Gene -
/ I-Gene -
homeodomain I-Gene +
proteins I-Gene +
was O +
first O +
identified O +
in O +
Drosophila O +
where O +
it O +
is O +
required O +
for O +
differentiation O +
of O +
tissues O +
such O +
as O +
the O +
central O +
nervous O +
system O +
and O +
muscle O +
. O +

ZEB B-Gene +
, O +
a O +
vertebrate O +
homolog O +
of O +
Zfh-1 B-Gene +
, O +
binds O +
a O +
subset O +
of O +
E O +
boxes O +
and O +
blocks O +
myogenesis O +
through O +
transcriptional O +
repression O +
of O +
muscle O +
genes O +
. O +

We O +
present O +
evidence O +
here O +
that O +
ZEB B-Gene +
also O +
has O +
an O +
important O +
role O +
in O +
controlling O +
hematopoietic O +
gene O +
transcription O +
. O +

Two O +
families O +
of O +
transcription B-Gene +
factors I-Gene +
that O +
are O +
required O +
for O +
normal O +
hematopoiesis O +
are O +
c B-Gene -
- I-Gene -
Myb I-Gene +
and O +
Ets B-Gene +
. O +

These O +
factors O +
act O +
synergistically O +
to O +
activate O +
transcription O +
, O +
and O +
this O +
synergy O +
is O +
required O +
for O +
transcription O +
of O +
at O +
least O +
several O +
important O +
hematopoietic O +
genes O +
. O +

ZEB B-Gene +
blocks O +
the O +
activity O +
of O +
c B-Gene -
- I-Gene -
Myb I-Gene +
and O +
Ets B-Gene +
individually O +
, O +
but O +
together O +
the O +
factors O +
synergize O +
to O +
resist O +
this O +
repression O +
. O +

Such O +
repression O +
imposes O +
a O +
requirement O +
for O +
both O +
c B-Gene -
- I-Gene -
Myb I-Gene +
and O +
Ets B-Gene +
for O +
transcriptional O +
activity O +
, O +
providing O +
one O +
explanation O +
for O +
why O +
synergy O +
between O +
these O +
factors O +
is O +
important O +
. O +

The O +
balance O +
between O +
repression O +
by O +
ZEB B-Gene +
and O +
transcriptional O +
activation O +
by O +
c B-Gene -
- I-Gene -
Myb I-Gene +
/Ets B-Gene +
provides O +
a O +
flexible O +
regulatory O +
mechanism O +
for O +
controlling O +
gene O +
expression O +
in O +
hematopoietic O +
cells O +
. O +

We O +
demonstrate O +
that O +
one O +
target O +
of O +
this O +
positive O -
/ O -
negative O +
regulation O +
in O +
vivo O +
is O +
the O +
alpha4 B-Gene +
integrin I-Gene +
, O +
which O +
play O +
a O +
key O +
role O +
in O +
normal O +
hematopoiesis O +
and O +
function O +
of O +
mature O +
leukocytes O +
. O +

Opposite O +
effects O +
of O +
the O +
acute B-Gene +
promyelocytic I-Gene +
leukemia I-Gene +
PML I-Gene -
- I-Gene -
retinoic I-Gene +
acid I-Gene +
receptor I-Gene +
alpha I-Gene +
( O +
RAR B-Gene +
alpha I-Gene +
) O +
and O +
PLZF B-Gene -
- I-Gene -
RAR I-Gene +
alpha I-Gene +
fusion I-Gene +
proteins I-Gene +
on O +
retinoic O +
acid O +
signalling O +
. O +

Fusion O +
proteins O +
involving O +
the O +
retinoic O +
acid O +
receptor B-Gene +
alpha I-Gene +
( O +
RAR B-Gene +
alpha I-Gene +
) O +
and O +
the O +
PML B-Gene +
or O +
PLZF B-Gene +
nuclear I-Gene +
protein I-Gene +
are O +
the O +
genetic O +
markers O +
of O +
acute O +
promyelocytic O +
leukemias O +
( O +
APLs O +
) O +
. O +

APLs O +
with O +
the O +
PML B-Gene -
- I-Gene -
RAR I-Gene +
alpha I-Gene +
or O +
the O +
PLZF B-Gene -
- I-Gene -
RAR I-Gene +
alpha I-Gene +
fusion I-Gene +
protein I-Gene +
are O +
phenotypically O +
indistinguishable O +
except O +
that O +
they O +
differ O +
in O +
their O +
sensitivity O +
to O +
retinoic O +
acid O +
( O +
RA O +
) O +
-induced O +
differentiation O +
: O +
PML B-Gene -
- I-Gene -
RAR I-Gene +
alpha I-Gene +
blasts O +
are O +
sensitive O +
to O +
RA O +
and O +
patients O +
enter O +
disease O +
remission O +
after O +
RA O +
treatment O +
, O +
while O +
patients O +
with O +
PLZF B-Gene -
- I-Gene -
RAR I-Gene +
alpha I-Gene +
do O +
not O +
. O +

We O +
here O +
report O +
that O +
( O +
i O +
) O +
like O +
PML B-Gene -
- I-Gene -
RAR I-Gene +
alpha I-Gene +
expression O +
, O +
PLZF B-Gene -
- I-Gene -
RAR I-Gene +
alpha I-Gene +
expression O +
blocks O +
terminal O +
differentiation O +
of O +
hematopoietic O +
precursor O +
cell O +
lines O +
( O +
U937 O +
and O +
HL-60 O +
) O +
in O +
response O +
to O +
different O +
stimuli O +
( O +
vitamin O +
D3 O +
, O +
transforming O +
growth O +
factor O +
beta1 O +
, O +
and O +
dimethyl O +
sulfoxide O +
) O +
; O +
( O +
ii O +
) O +
PML B-Gene -
- I-Gene -
RAR I-Gene +
alpha I-Gene +
, O +
but O +
not O +
PLZF B-Gene -
- I-Gene -
RAR I-Gene +
alpha I-Gene +
, O +
increases O +
RA O +
sensitivity O +
of O +
hematopoietic O +
precursor O +
cells O +
and O +
restores O +
RA O +
sensitivity O +
of O +
RA O -
- O -
resistant O +
hematopoietic O +
cells O +
; O +
( O +
iii O +
) O +
PML B-Gene -
- I-Gene -
RAR I-Gene +
alpha I-Gene +
and O +
PLZF B-Gene -
- I-Gene -
RAR I-Gene +
alpha I-Gene +
have O +
similar O +
RA O +
binding O +
affinities O +
; O +
and O +
( O +
iv O +
) O +
PML B-Gene -
- I-Gene -
RAR I-Gene +
alpha I-Gene +
enhances O +
the O +
RA O +
response O +
of O +
RA O +
target O +
genes O +
( O +
those O +
for O +
RAR B-Gene +
beta I-Gene +
, O +
RAR B-Gene +
gamma I-Gene +
, O +
and O +
transglutaminase B-Gene +
type I-Gene +
II I-Gene +
[ O +
TGase B-Gene +
] O +
) O +
in O +
vivo O +
, O +
while O +
PLZF B-Gene -
- I-Gene -
RAR I-Gene +
alpha I-Gene +
expression O +
has O +
either O +
no O +
effect O +
( O +
RAR B-Gene +
beta I-Gene +
) O +
or O +
an O +
inhibitory O +
activity O +
( O +
RAR B-Gene +
gamma I-Gene +
and O +
type B-Gene +
II I-Gene +
TGase I-Gene +
) O +
. O +

These O +
data O +
demonstrate O +
that O +
PML B-Gene -
- I-Gene -
RAR I-Gene +
alpha I-Gene +
and O +
PLZF B-Gene -
- I-Gene -
RAR I-Gene +
alpha I-Gene +
have O +
similar O +
( O +
inhibitory O +
) O +
effects O +
on O +
RA O -
- O -
independent O +
differentiation O +
and O +
opposite O +
( O +
stimulatory O +
or O +
inhibitory O +
) O +
effects O +
on O +
RA O -
- O -
dependent O +
differentiation O +
and O +
that O +
they O +
behave O +
in O +
vivo O +
as O +
RA O -
- O -
dependent O +
enhancers O +
or O +
inhibitors O +
of O +
RA O -
- O -
responsive O +
genes O +
, O +
respectively O +
. O +

Their O +
different O +
activities O +
on O +
the O +
RA O +
signalling O +
pathway O +
might O +
underlie O +
the O +
different O +
responses O +
of O +
PML B-Gene -
- I-Gene -
RAR I-Gene +
alpha I-Gene +
and O +
PLZF B-Gene -
- I-Gene -
RAR I-Gene +
alpha I-Gene +
APLs O +
to O +
RA O +
treatment O +
. O +

The O +
PLZF B-Gene -
- I-Gene -
RAR I-Gene +
alpha I-Gene +
fusion I-Gene +
protein I-Gene +
contains O +
an O +
approximately O +
120-amino B-Gene -
- I-Gene -
acid I-Gene +
N I-Gene -
- I-Gene -
terminal I-Gene +
motif I-Gene +
( O +
called O +
the O +
POZ B-Gene +
domain I-Gene +
) O +
, O +
which O +
is O +
also O +
found O +
in O +
a O +
variety O +
of O +
zinc O +
finger O +
proteins O +
and O +
a O +
group O +
of O +
poxvirus B-Gene +
proteins I-Gene +
and O +
which O +
mediates O +
protein O -
- O -
protein O +
interactions O +
. O +

Deletion O +
of O +
the O +
PLZF B-Gene +
POZ I-Gene +
domain I-Gene +
partially O +
abrogated O +
the O +
inhibitory O +
effect O +
of O +
PLZF B-Gene -
- I-Gene -
RAR I-Gene +
alpha I-Gene +
on O +
RA O -
- O -
induced O +
differentiation O +
and O +
on O +
RA O -
- O -
mediated O +
type B-Gene +
II I-Gene +
TGase I-Gene +
up O -
- O -
regulation O +
, O +
suggesting O +
that O +
POZ O -
- O -
mediated O +
protein O +
interactions O +
might O +
be O +
responsible O +
for O +
the O +
inhibitory O +
transcriptional O +
activities O +
of O +
PLZF B-Gene -
- I-Gene -
RAR I-Gene +
alpha I-Gene +
. O +

Regulation O +
of O +
B O -
- O -
cell O +
commitment O +
to O +
plasma O +
cells O +
or O +
to O +
memory O +
B O +
cells O +
. O +

During O +
humoral O +
immune O +
responses O +
, O +
B O -
- O -
lymphocyte O +
activation O +
is O +
followed O +
by O +
differentiation O +
along O +
either O +
the O +
plasma O +
cell O +
pathway O +
or O +
the O +
memory O +
B O -
- O -
cell O +
pathway O +
. O +

Recent O +
studies O +
suggest O +
that O +
CD40-CD40 B-Gene +
ligand I-Gene +
, O +
OX B-Gene -
- I-Gene -
OX40 I-Gene +
ligand I-Gene +
, O +
a O +
group O +
of O +
cytokines B-Gene +
and O +
intracellular O +
transcriptional O +
factors O +
may O +
all O +
contribute O +
to O +
B O -
- O -
lymphocyte O +
differentiation O +
control O +
. O +

Transcription B-Gene +
factor I-Gene +
GATA-3 I-Gene +
is O +
differentially O +
expressed O +
in O +
murine O +
Th1 O +
and O +
Th2 O +
cells O +
and O +
controls O +
Th2-specific O +
expression O +
of O +
the O +
interleukin-5 O +
gene O +
. O +

Interleukin-5 B-Gene +
( O +
IL-5 B-Gene +
) O +
, O +
which O +
is O +
produced O +
by O +
CD4 O +
( O +
+ O +
) O +
T O +
helper O +
2 O +
( O +
Th2 O +
) O +
cells O +
, O +
but O +
not O +
by O +
Th1 O +
cells O +
, O +
plays O +
a O +
key O +
role O +
in O +
the O +
development O +
of O +
eosinophilia O +
in O +
asthma O +
. O +

Despite O +
increasing O +
evidence O +
that O +
the O +
outcome O +
of O +
many O +
diseases O +
is O +
determined O +
by O +
the O +
ratio O +
of O +
the O +
two O +
subsets O +
of O +
CD4 O +
( O +
+ O +
) O +
T O +
helper O +
cells O +
, O +
Th1 O +
and O +
Th2 O +
, O +
the O +
molecular O +
basis O +
for O +
Th1- O +
and O +
Th2- O +
specific O +
gene O +
expression O +
remains O +
to O +
be O +
elucidated O +
. O +

We O +
previously O +
established O +
a O +
critical O +
role O +
for O +
the O +
transcription B-Gene +
factor I-Gene +
GATA-3 B-Gene +
in O +
IL-5 O +
promoter O +
activation O +
in O +
EL-4 O +
cells O +
, O +
which O +
express O +
both O +
Th1- B-Gene +
and I-Gene +
Th2-type I-Gene +
cytokines I-Gene +
. O +

Our O +
studies O +
reported O +
here O +
demonstrate O +
that O +
GATA-3 B-Gene +
is O +
critical O +
for O +
expression O +
of O +
the O +
IL-5 B-Gene +
gene O +
in O +
bona O +
fide O +
Th2 O +
cells O +
. O +

Whereas O +
mutations O +
in O +
the O +
GATA-3 B-Gene +
site O +
abolished O +
antigen- O +
or O +
cAMP- O +
stimulated O +
IL-5 O +
promoter O +
activation O +
in O +
Th2 O +
cells O +
, O +
ectopic O +
expression O +
of O +
GATA-3 B-Gene +
in O +
Th1 O +
cells O +
or O +
in O +
a O +
non O -
- O -
lymphoid O +
, O +
non O -
- O -
IL-5-producing O +
cell O +
line O +
activated O +
the O +
IL-5 O +
promoter O +
. O +

During O +
the O +
differentiation O +
of O +
naive O +
CD4 O +
( O +
+ O +
) O +
T O +
cells O +
isolated O +
from O +
T O +
cell O +
receptor O +
transgenic O +
mice O +
, O +
GATA-3 B-Gene +
gene O +
expression O +
was O +
up O -
- O -
regulated O +
in O +
developing O +
Th2 O +
cells O +
, O +
but O +
was O +
down O -
- O -
regulated O +
in O +
Th1 O +
cells O +
, O +
and O +
antigen- O +
or O +
cAMP O -
- O -
activated O +
Th2 O +
cells O +
( O +
but O +
not O +
Th1 O +
cells O +
) O +
expressed O +
the O +
GATA-3 B-Gene +
protein I-Gene +
. O +

Thus O +
, O +
GATA-3 B-Gene +
may O +
play O +
an O +
important O +
role O +
in O +
the O +
balance O +
between O +
Th1 O +
and O +
Th2 O +
subsets O +
in O +
immune O +
responses O +
. O +

Inhibition O +
of O +
GATA-3 B-Gene +
activity O +
has O +
therapeutic O +
potential O +
in O +
the O +
treatment O +
of O +
asthma O +
and O +
other O +
hypereosinophilic O +
diseases O +
. O +

Rel B-Gene -
/ I-Gene -
NF I-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
transcription B-Gene +
factors I-Gene +
and O +
the O +
control O +
of O +
apoptosis O +
. O +

The O +
process O +
of O +
apoptosis O +
is O +
used O +
to O +
eliminate O +
unwanted O +
cells O +
from O +
a O +
wide O +
variety O +
of O +
organisms O +
. O +

Various O +
extracellular O +
signals O +
, O +
often O +
converging O +
in O +
common O +
intracellular O +
pathways O +
, O +
can O +
induce O +
apoptosis O +
in O +
a O +
cell O -
- O -
type O -
- O -
specific O +
fashion O +
. O +

Recent O +
work O +
from O +
several O +
laboratories O +
has O +
demonstrated O +
that O +
Rel B-Gene -
/ I-Gene -
NF I-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
transcription B-Gene +
factors I-Gene +
regulate O +
apoptosis O +
in O +
many O +
cell O +
types O +
. O +

In O +
most O +
cells O +
, O +
Rel B-Gene -
/ I-Gene -
NF I-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
transcription B-Gene +
factors I-Gene +
appear O +
to O +
mediate O +
survival O +
signals O +
that O +
protect O +
cells O +
from O +
apoptosis O +
; O +
however O +
, O +
under O +
some O +
circumstances O +
, O +
activation O +
of O +
these O +
factors O +
may O +
also O +
promote O +
apoptosis O +
. O +

The O +
ability O +
of O +
BHRF1 B-Gene +
to O +
inhibit O +
apoptosis O +
is O +
dependent O +
on O +
stimulus O +
and O +
cell O +
type O +
. O +

The O +
development O +
of O +
resistance O +
to O +
host O +
defense O +
mechanisms O +
such O +
as O +
tumor O +
necrosis O +
factor O +
( O +
TNF O +
) O +
- O +
and O +
Fas O -
- O -
mediated O +
apoptosis O +
of O +
transformed O +
or O +
virus O -
- O -
infected O +
cells O +
may O +
be O +
a O +
critical O +
component O +
in O +
the O +
development O +
of O +
disease O +
. O +

To O +
find O +
genes O +
that O +
protect O +
cells O +
from O +
apoptosis O +
, O +
we O +
used O +
an O +
expression O +
cloning O +
strategy O +
and O +
identified O +
BHRF1 B-Gene +
, O +
an O +
Epstein B-Gene -
- I-Gene -
Barr I-Gene +
virus I-Gene +
( I-Gene +
EBV I-Gene +
) I-Gene +
early I-Gene -
- I-Gene -
lytic I-Gene -
- I-Gene -
cycle I-Gene +
protein I-Gene +
with O +
distant O +
homology O +
to O +
Bcl-2 B-Gene +
, O +
as O +
an O +
anti B-Gene -
- I-Gene -
apoptosis I-Gene +
protein I-Gene +
. O +

Expression O +
of O +
BHRF1 B-Gene +
in O +
MCF O -
- O -
Fas O +
cells O +
conferred O +
nearly O +
complete O +
resistance O +
against O +
both O +
anti B-Gene -
- I-Gene -
Fas I-Gene +
antibody I-Gene +
and O +
TNF O -
- O -
mediated O +
apoptosis O +
. O +

In O +
addition O +
, O +
BHRF1 B-Gene +
protected O +
these O +
cells O +
from O +
monocyte O -
- O -
mediated O +
killing O +
but O +
failed O +
to O +
protect O +
them O +
from O +
killing O +
mediated O +
by O +
lymphokine O -
- O -
activated O +
killer O +
cells O +
. O +

The O +
ability O +
of O +
BHRF1 B-Gene +
to O +
protect O +
MCF O -
- O -
Fas O +
cells O +
from O +
apoptosis O +
induced O +
by O +
various O +
stimuli O +
was O +
identical O +
to O +
that O +
of O +
Bcl-2 B-Gene +
and O +
Bcl B-Gene -
- I-Gene -
xL I-Gene +
. O +

Moreover O +
, O +
the O +
mechanism O +
of O +
action O +
of O +
BHRF1 B-Gene +
resembled O +
that O +
of O +
Bcl-2 B-Gene +
and O +
Bcl B-Gene -
- I-Gene -
xL I-Gene +
as O +
it O +
inhibited O +
TNF- O +
and O +
anti O -
- O -
Fas O -
- O -
induced O +
activation O +
of O +
two O +
enzymes O +
participating O +
in O +
the O +
apoptosis O +
pathway O +
, O +
cytosolic B-Gene +
phospholipase I-Gene +
A2 I-Gene +
and O +
caspase-3 B-Gene -
/ I-Gene -
CPP32 I-Gene +
, O +
but O +
did O +
not O +
interfere O +
with O +
the O +
activation O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene -
- I-Gene -
like I-Gene +
transcription I-Gene +
factors I-Gene +
. O +

A O +
putative O +
function O +
of O +
BHRF1 B-Gene +
in O +
EBV O -
- O -
infected O +
epithelial O +
cells O +
may O +
be O +
to O +
protect O +
virus O -
- O -
infected O +
cells O +
from O +
TNF- O +
and/or O +
anti O -
- O -
Fas- O +
induced O +
cell O +
death O +
in O +
order O +
to O +
maximize O +
virus O +
production O +
. O +

Surprisingly O +
, O +
expression O +
of O +
neither O +
BHRF1 B-Gene +
nor O +
Bcl-2 B-Gene +
in O +
a O +
B O -
- O -
cell O +
line O +
, O +
BJAB O +
, O +
protected O +
the O +
cells O +
from O +
anti O -
- O -
Fas O -
- O -
mediated O +
apoptosis O +
even O +
though O +
they O +
increased O +
the O +
survival O +
of O +
serum O -
- O -
starved O +
cells O +
. O +

Thus O +
, O +
the O +
protective O +
role O +
of O +
BHRF1 B-Gene +
against O +
apoptosis O +
resembles O +
that O +
of O +
Bcl-2 B-Gene +
in O +
being O +
cell O +
type O +
specific O +
and O +
dependent O +
on O +
the O +
apoptotic O +
stimulus O +
. O +

Expression O +
of O +
bcl-6 B-Gene +
protein I-Gene +
in O +
normal O +
skin O +
and O +
epidermal O +
neoplasms O +
. O +

Bcl-6 B-Gene +
protein I-Gene +
is O +
a O +
recently O +
identified O +
novel O +
transcription B-Gene +
factor I-Gene +
whose O +
deregulated O +
expression O +
is O +
associated O +
with O +
diffuse O +
large O +
B O +
cell O +
lymphomas O +
. O +

It O +
was O +
recently O +
shown O +
by O +
us O +
that O +
the O +
protein O +
is O +
located O +
in O +
germinal O +
center O +
B O +
cells O +
and O +
their O +
neoplastic O +
counterparts O +
. O +

In O +
the O +
present O +
study O +
, O +
the O +
expression O +
of O +
bcl-6 B-Gene +
protein I-Gene +
on O +
normal O +
epidermis O +
, O +
benign O +
, O +
and O +
malignant O +
tumors O +
originating O +
from O +
epidermal O +
cells O +
, O +
and O +
squamous O +
cell O +
carcinoma O +
( O +
SCC O +
) O +
cell O +
lines O +
are O +
investigated O +
. O +

With O +
the O +
use O +
of O +
immunohistochemistry O +
, O +
bcl-6 B-Gene +
protein I-Gene +
was O +
shown O +
to O +
stain O +
intensely O +
on O +
normal O +
prickle O +
cells O +
, O +
but O +
none O +
to O +
only O +
slightly O +
on O +
epidermal O +
basal O +
cells O +
. O +

Papillomas O +
and O +
keratoacanthomas O +
copied O +
their O +
normal O +
counterparts O +
in O +
the O +
mode O +
of O +
expression O +
. O +

Various O +
levels O +
of O +
expression O +
were O +
found O +
on O +
seborrheic O +
keratoses O +
, O +
while O +
the O +
expression O +
level O +
on O +
basal O +
cell O +
epitheliomas O +
was O +
low O +
. O +

Peculiarly O +
, O +
eccrine O +
poromas O +
and O +
undifferentiated O +
spindle O -
- O -
shaped O +
basal O +
cell O +
epitheliomas O +
were O +
totally O +
unstained O +
. O +

Squamous O +
cell O +
carcinomas O +
showed O +
a O +
variety O +
of O +
expression O +
levels O +
, O +
while O +
two O +
undifferentiated O +
spindle O -
- O -
shaped O +
carcinomas O +
and O +
one O +
undifferentiated O +
SCC O +
cell O +
line O +
remained O +
unstained O +
. O +

These O +
results O +
suggest O +
that O +
the O +
expression O +
of O +
bcl-6 B-Gene +
protein I-Gene +
may O +
be O +
associated O +
with O +
morphological O +
differentiation O +
in O +
normal O +
and O +
neoplastic O +
epidermal O +
cells O +
. O +

HIV-1 B-Gene +
Vpr I-Gene +
suppresses O +
immune O +
activation O +
and O +
apoptosis O +
through O +
regulation O +
of O +
nuclear B-Gene +
factor I-Gene +
kappa I-Gene +
B I-Gene +
[ O +
see O +
comments O +
] O +

The O +
HIV-1 B-Gene +
accessory I-Gene +
gene I-Gene +
product I-Gene +
Vpr B-Gene +
can O +
influence O +
viral O +
pathogenesis O +
by O +
affecting O +
viral O +
replication O +
as O +
well O +
as O +
host O +
cell O +
transcription O +
and O +
proliferation O +
. O +

We O +
have O +
investigated O +
the O +
effects O +
of O +
Vpr B-Gene +
on O +
host O +
cell O +
activation O +
and O +
confirm O +
that O +
it O +
influences O +
cellular O +
proliferation O +
. O +

However O +
, O +
we O +
have O +
also O +
found O +
that O +
Vpr B-Gene +
modulates O +
T O -
- O -
cell O +
receptor O +
( O +
TCR B-Gene +
) O +
-triggered O +
apoptosis O +
in O +
a O +
manner O +
similar O +
to O +
that O +
of O +
glucocorticoids O +
. O +

In O +
the O +
absence O +
of O +
TCR B-Gene +
-mediated O +
activation O +
, O +
Vpr B-Gene +
induces O +
apoptosis O +
whereas O +
in O +
its O +
presence O +
, O +
Vpr B-Gene +
interrupts O +
the O +
expected O +
induction O +
of O +
apoptosis O +
. O +

This O +
regulation O +
of O +
apoptosis O +
is O +
linked O +
to O +
Vpr B-Gene +
suppression O +
of O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
activity O +
via O +
the O +
induction O +
of O +
I B-Gene +
kappa I-Gene +
B I-Gene +
, O +
an O +
inhibitor O +
of O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
. O +

Further O +
, O +
Vpr B-Gene +
suppresses O +
expression O +
of O +
IL-2 B-Gene +
, O +
IL-10 B-Gene +
, O +
IL-12 B-Gene +
, O +
TNF B-Gene +
alpha I-Gene +
and O +
IL-4 B-Gene +
, O +
all O +
of O +
which O +
are O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
-dependent O +
. O +

The O +
effects O +
of O +
Vpr B-Gene +
could O +
be O +
reversed O +
by O +
RU486 O +
. O +

Our O +
finding O +
that O +
Vpr B-Gene +
can O +
regulate O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
supports O +
the O +
hypothesis O +
that O +
some O +
aspects O +
of O +
viral O +
pathogenesis O +
are O +
the O +
consequence O +
of O +
cell O +
dysregulation O +
by O +
Vpr B-Gene +
. O +

Nuclear O +
localization O +
of O +
RelB B-Gene +
is O +
associated O +
with O +
effective O +
antigen O -
- O -
presenting O +
cell O +
function O +
. O +

Dendritic O +
cells O +
( O +
DC O +
) O +
are O +
potent O +
APCs O +
that O +
enter O +
resting O +
tissues O +
as O +
precursors O +
and O +
, O +
after O +
Ag O +
exposure O +
, O +
differentiate O +
and O +
migrate O +
to O +
draining O +
lymph O +
nodes O +
. O +

The O +
phenotype O +
of O +
RelB B-Gene +
knockout O +
mice O +
implicates O +
this O +
member O +
of O +
the O +
NF B-Gene +
kappa I-Gene +
B I-Gene -
/ I-Gene -
Rel I-Gene +
family I-Gene +
in O +
DC O +
differentiation O +
. O +

To O +
further O +
elucidate O +
the O +
role O +
of O +
RelB B-Gene +
in O +
DC O +
differentiation O +
, O +
mRNA O +
, O +
intracellular O +
protein O +
expression O +
, O +
and O +
DNA O +
binding O +
activity O +
of O +
RelB B-Gene +
were O +
examined O +
in O +
immature O +
and O +
differentiated O +
human O +
DC O +
, O +
as O +
well O +
as O +
other O +
PB O +
mononuclear O +
cell O +
populations O +
. O +

RelB B-Gene +
protein O +
and O +
mRNA O +
were O +
detected O +
constitutively O +
in O +
lymphocytes O +
and O +
in O +
activated O +
monocytes O +
, O +
differentiated O +
DC O +
, O +
and O +
monocyte O -
- O -
derived O +
DC O +
. O +

Immunohistochemical O +
staining O +
demonstrated O +
RelB B-Gene +
within O +
the O +
differentiated O +
lymph O +
node O +
interdigitating O +
DC O +
and O +
follicular O +
DC O +
, O +
but O +
not O +
undifferentiated O +
DC O +
in O +
normal O +
skin O +
. O +

Active O +
nuclear O +
RelB B-Gene +
was O +
detected O +
by O +
supershift O +
assay O +
only O +
in O +
differentiated O +
DC O +
derived O +
from O +
either O +
PB O +
precursors O +
or O +
monocytes O +
and O +
in O +
activated O +
B O +
cells O +
. O +

These O +
RelB+ O +
APC O +
were O +
potent O +
stimulators O +
of O +
the O +
MLR B-Gene +
. O +

The O +
data O +
indicate O +
that O +
RelB B-Gene +
expression O +
is O +
regulated O +
both O +
transcriptionally O +
and O +
post O -
- O -
translationally O +
in O +
myeloid O +
cells O +
. O +

Within O +
the O +
nucleus O +
, O +
RelB B-Gene +
may O +
specifically O +
transactivate O +
genes O +
that O +
are O +
critical O +
for O +
APC O +
function O +
. O +

Expression O +
of O +
c O -
- O -
fos O +
correlates O +
with O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
responsiveness O +
in O +
Philadelphia O +
chromosome O +
positive O +
chronic O +
myelogenous O +
leukemia O +
. O +

This O +
study O +
evaluates O +
( O +
i O +
) O +
constitutive O +
levels O +
of O +
oncogene O +
and O +
p53 O +
transcripts O +
in O +
chronic O +
phase O +
CML O +
patients O +
and O +
( O +
ii O +
) O +
their O +
modulations O +
subsequent O +
to O +
in O +
vivo O +
therapy O +
with O +
rIFN B-Gene -
- I-Gene -
alpha I-Gene +
2c I-Gene +
. O +

Peripheral O +
blood O +
mononuclear O +
cells O +
( O +
pbmc O +
) O +
and O +
bone O +
marrow O +
cells O +
of O +
26 O +
patients O +
were O +
examined O +
for O +
c O -
- O -
fos O +
, O +
c O -
- O -
myc O +
, O +
p53 O +
and O +
the O +
hybrid O +
bcr O -
/ O -
abl O +
mRNA O +
levels O +
. O +

Results O +
indicated O +
that O +
( O +
i O +
) O +
constitutive O +
c O -
- O -
fos O +
transcript O +
levels O +
are O +
significantly O +
higher O +
in O +
patients O +
subsequently O +
responding O +
to O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
therapy O +
( O +
p O +
< O +
0.01 O +
) O +
and O +
positively O +
correlated O +
with O +
the O +
proportion O +
of O +
lymphocytes O +
( O +
r O +
= O +
0.6895 O +
, O +
p O +
< O +
0.01 O +
) O +
and O +
negatively O +
with O +
the O +
proportion O +
of O +
immature O +
cells O +
( O +
r O +
= O +
-0.568 O +
, O +
p O +
< O +
0.01 O +
) O +
contained O +
in O +
the O +
pbmc O +
preparations O +
tested O +
, O +
( O +
ii O +
) O +
constitutive O +
mRNA O +
levels O +
of O +
the O +
hybrid O +
bcr O -
/ O -
abl O +
, O +
c O -
- O -
myc O +
and O +
p53 O +
are O +
positively O +
correlated O +
with O +
each O +
other O +
, O +
but O +
failed O +
to O +
relate O +
to O +
disease O +
parameters O +
, O +
and O +
( O +
iii O +
) O +
acute O +
and O +
chronic O +
in O +
vivo O +
exposure O +
to O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
is O +
accompanied O +
by O +
upregulation O +
of O +
c O -
- O -
fos O +
and O +
downregulation O +
of O +
c O -
- O -
myc O +
mRNA O +
levels O +
in O +
responder O +
patients O +
. O +

Aberrant O +
splicing O +
of O +
the O +
TSG101 O +
and O +
FHIT O +
genes O +
occurs O +
frequently O +
in O +
multiple O +
malignancies O +
and O +
in O +
normal O +
tissues O +
and O +
mimics O +
alterations O +
previously O +
described O +
in O +
tumours O +
. O +

Intragenic O +
deletions O +
of O +
TSG101 O +
, O +
the O +
human O +
homolog O +
of O +
a O +
mouse O +
gene O +
( O +
tsg101 O +
) O +
that O +
acts O +
to O +
suppress O +
malignant O +
cell O +
growth O +
, O +
were O +
reported O +
in O +
human O +
breast O +
tumours O +
. O +

We O +
screened O +
TSG101 O +
for O +
somatic O +
mutations O +
in O +
DNA O +
and O +
RNA O +
samples O +
isolated O +
from O +
a O +
variety O +
of O +
common O +
human O +
malignancies O +
, O +
EBV O -
- O -
immortalised O +
B O -
- O -
cells O +
, O +
and O +
normal O +
lung O +
parenchyma O +
. O +

Intragenic O +
TSG101 O +
deletions O +
in O +
RNA O +
transcripts O +
were O +
frequently O +
found O +
in O +
all O +
types O +
of O +
samples O +
. O +

Analysis O +
of O +
DNA O +
failed O +
to O +
show O +
genomic O +
rearrangements O +
corresponding O +
to O +
transcripts O +
containing O +
deletions O +
in O +
the O +
same O +
samples O +
. O +

The O +
breakpoints O +
of O +
most O +
transcript O +
deletions O +
coincide O +
with O +
genuine O +
or O +
cryptic O +
splice O +
site O +
sequences O +
, O +
suggesting O +
that O +
they O +
result O +
from O +
alternative O +
or O +
aberrant O +
splicing O +
. O +

A O +
similar O +
spectrum O +
of O +
transcript O +
deletions O +
has O +
previously O +
been O +
described O +
in O +
the O +
putative O +
tumour O +
suppressor O +
gene O +
FHIT O +
. O +

We O +
analysed O +
FHIT O +
in O +
the O +
same O +
series O +
of O +
RNA O +
samples O +
and O +
detected O +
truncated O +
FHIT O +
transcripts O +
frequently O +
in O +
both O +
tumour O +
and O +
normal O +
tissues O +
. O +

In O +
addition O +
, O +
transcripts O +
from O +
TSG101 O +
, O +
FHIT O +
and O +
seven O +
other O +
genes O +
were O +
analysed O +
in O +
RNA O +
isolated O +
from O +
normal O +
peripheral O +
blood O +
lymphocytes O +
. O +

Large O +
TSG101 O +
and O +
FHIT O +
intragenic O +
transcript O +
deletions O +
were O +
detected O +
and O +
these O +
appeared O +
to O +
be O +
the O +
predominant O +
transcript O +
in O +
' O -
aged O +
' O +
lymphocytes O +
. O +

Similar O +
alterations O +
were O +
not O +
detected O +
in O +
transcripts O +
of O +
the O +
other O +
genes O +
which O +
were O +
analysed O +
. O +

Our O +
findings O +
demonstrate O +
that O +
truncated O +
TSG101 O +
and O +
FHIT O +
transcripts O +
are O +
commonly O +
detected O +
in O +
both O +
normal O +
and O +
malignant O +
tissues O +
and O +
that O +
a O +
significant O +
fraction O +
of O +
these O +
are O +
likely O +
to O +
be O +
the O +
result O +
of O +
aberrant O +
splicing O +
. O +

While O +
we O +
can O +
not O +
exclude O +
that O +
alterations O +
in O +
TSG101 O +
and O +
FHIT O +
occur O +
during O +
cancer O +
development O +
, O +
our O +
data O +
indicate O +
that O +
in O +
this O +
context O +
the O +
commonly O +
observed O +
transcript O +
abnormalities O +
are O +
misleading O +
. O +

OCA B-Gene -
- I-Gene -
B I-Gene +
is O +
a O +
functional O +
analog O +
of O +
VP16 B-Gene +
but O +
targets O +
a O +
separate O +
surface O +
of O +
the O +
Oct-1 B-Gene +
POU I-Gene +
domain I-Gene +
[ O +
published O +
erratum O +
appears O +
in O +
Mol O +
Cell O +
Biol O +
1998 O +
Apr O +
; O +
18 O +
( O +
4 O +
) O +
: O +
2430 O +
] O +

OCA B-Gene -
- I-Gene -
B I-Gene +
is O +
a O +
B B-Gene -
- I-Gene -
cell I-Gene -
- I-Gene -
specific I-Gene +
coregulator I-Gene +
of O +
the O +
broadly O +
expressed O +
POU B-Gene +
domain I-Gene +
transcription I-Gene +
factor I-Gene +
Oct-1 B-Gene +
. O +

OCA B-Gene -
- I-Gene -
B I-Gene +
associates O +
with O +
the O +
Oct-1 B-Gene +
POU I-Gene +
domain I-Gene +
, O +
a O +
bipartite O +
DNA O -
- O -
binding O +
structure O +
containing O +
a O +
POU B-Gene -
- I-Gene -
specific I-Gene +
( I-Gene +
POU I-Gene +
[ I-Gene +
S I-Gene +
] I-Gene +
) I-Gene +
domain I-Gene +
joined O +
by O +
a O +
flexible O +
linker O +
to O +
a O +
POU B-Gene +
homeodomain I-Gene +
( O +
POU B-Gene +
[ I-Gene +
H I-Gene +
] I-Gene +
) O +
. O +

Here O +
, O +
we O +
show O +
that O +
OCA B-Gene -
- I-Gene -
B I-Gene +
alters O +
the O +
activity O +
of O +
Oct-1 B-Gene +
in O +
two O +
ways O +
. O +

It O +
provides O +
a O +
transcriptional O +
activation O +
domain O +
which O +
, O +
unlike O +
Oct-1 B-Gene +
, O +
activates O +
an O +
mRNA O -
- O -
type O +
promoter O +
effectively O +
, O +
and O +
it O +
stabilizes O +
Oct-1 B-Gene +
on O +
the O +
Oct-1-responsive O +
octamer O +
sequence O +
ATGCAAAT O +
. O +

These O +
properties O +
of O +
OCA B-Gene -
- I-Gene -
B I-Gene +
parallel O +
those O +
displayed O +
by O +
the O +
herpes B-Gene +
simplex I-Gene +
virus I-Gene +
Oct-1 I-Gene +
coregulator I-Gene +
VP16 B-Gene +
. O +

OCA B-Gene -
- I-Gene -
B I-Gene +
, O +
however O +
, O +
interacts O +
with O +
a O +
different O +
surface O +
of O +
the O +
DNA O -
- O -
bound O +
Oct-1 B-Gene +
POU I-Gene +
domain I-Gene +
, O +
interacting O +
with O +
both O +
the O +
POU B-Gene +
( I-Gene +
S I-Gene +
) I-Gene +
and I-Gene +
POU I-Gene +
( I-Gene +
H I-Gene +
) I-Gene +
domains I-Gene +
and O +
the O +
center O +
of O +
the O +
ATGCAAAT O +
octamer O +
sequence O +
. O +

The O +
OCA O -
- O -
B O +
and O +
VP16 B-Gene +
interactions O +
with O +
the O +
Oct-1 B-Gene +
POU I-Gene +
domain I-Gene +
are O +
sufficiently O +
different O +
to O +
permit O +
OCA B-Gene -
- I-Gene -
B I-Gene +
and O +
VP16 B-Gene +
to O +
bind O +
the O +
Oct-1 B-Gene +
POU I-Gene +
domain I-Gene +
simultaneously O +
. O +

These O +
results O +
emphasize O +
the O +
structural O +
versatility O +
of O +
the O +
Oct-1 B-Gene +
POU I-Gene +
domain I-Gene +
in O +
its O +
interaction O +
with O +
coregulators O +
. O +

Cyclosporin O +
A O +
inhibits O +
monocyte O +
tissue B-Gene +
factor I-Gene +
activation O +
in O +
cardiac O +
transplant O +
recipients O +
. O +

BACKGROUND O +
: O +
Fibrin O +
deposition O +
and O +
thrombosis O +
have O +
been O +
implicated O +
in O +
both O +
allograft O +
rejection O +
and O +
vasculopathy O +
after O +
cardiac O +
transplantation O +
. O +

Because O +
monocytes O +
play O +
a O +
pivotal O +
role O +
in O +
the O +
pathophysiology O +
of O +
intravascular O +
coagulation O +
activation O +
through O +
their O +
ability O +
to O +
synthesize O +
tissue B-Gene +
factor I-Gene +
( O +
TF B-Gene +
) O +
, O +
we O +
asked O +
( O +
1 O +
) O +
whether O +
monocyte O +
TF B-Gene +
activation O +
occurs O +
in O +
cardiac O +
transplant O +
recipients O +
and O +
( O +
2 O +
) O +
whether O +
monocyte O +
TF B-Gene +
expression O +
is O +
affected O +
by O +
treatment O +
with O +
cyclosporin O +
A O +
( O +
CsA O +
) O +
. O +

METHODS O +
AND O +
RESULTS O +
: O +
We O +
measured O +
levels O +
of O +
TF B-Gene +
activity O +
in O +
peripheral O +
blood O +
mononuclear O +
cells O +
and O +
highly O +
purified O +
monocytes O -
/ O -
macrophages O +
from O +
10 O +
consecutive O +
cardiac O +
transplant O +
recipients O +
and O +
10 O +
healthy O +
control O +
subjects O +
. O +

TF B-Gene +
activity O +
generated O +
by O +
both O +
unstimulated O +
and O +
endotoxin O -
- O -
stimulated O +
cells O +
was O +
significantly O +
higher O +
in O +
transplant O +
recipients O +
than O +
in O +
control O +
subjects O +
( O +
P O +
< O +
.05 O +
) O +
. O +

Increased O +
monocyte O +
TF B-Gene +
expression O +
in O +
transplant O +
recipients O +
was O +
shown O +
to O +
be O +
adversely O +
affected O +
by O +
treatment O +
with O +
CsA O +
: O +
TF B-Gene +
induction O +
was O +
markedly O +
reduced O +
by O +
CsA O +
serum O +
concentrations O +
reaching O +
peak O +
CsA O +
drug O +
levels O +
. O +

Inhibition O +
of O +
TF B-Gene +
induction O +
in O +
the O +
presence O +
of O +
high O +
CsA O +
blood O +
concentrations O +
was O +
also O +
observed O +
when O +
stimulation O +
of O +
cells O +
was O +
performed O +
with O +
interferon B-Gene -
- I-Gene -
gamma I-Gene +
or O +
interleukin-1beta B-Gene +
. O +

As O +
shown O +
by O +
reverse O +
transcription O -
- O -
polymerase O +
chain O +
reaction O +
and O +
electrophoretic O +
mobility O +
shift O +
assay O +
, O +
respectively O +
, O +
treatment O +
with O +
CsA O +
leads O +
to O +
decreased O +
TF O +
mRNA O +
expression O +
and O +
reduced O +
activation O +
of O +
the O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
transcription I-Gene +
factor I-Gene +
, O +
which O +
is O +
known O +
to O +
contribute O +
to O +
the O +
induction O +
of O +
the O +
TF O +
promotor O +
in O +
human O +
monocytes O +
. O +

CONCLUSIONS O +
: O +
This O +
study O +
demonstrates O +
that O +
TF B-Gene +
activation O +
, O +
occurring O +
in O +
mononuclear O +
cells O +
of O +
cardiac O +
transplant O +
recipients O +
, O +
is O +
inhibited O +
by O +
treatment O +
with O +
CsA O +
. O +

Inhibition O +
of O +
monocyte O +
TF B-Gene +
induction O +
by O +
CsA O +
may O +
contribute O +
to O +
its O +
successful O +
use O +
in O +
cardiac O +
transplant O +
medicine O +
and O +
might O +
be O +
useful O +
in O +
managing O +
further O +
settings O +
of O +
vascular O +
pathology O +
also O +
known O +
to O +
involve O +
TF B-Gene +
expression O +
and O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
activation O +
. O +

Competent O +
transcription O +
initiation O +
by O +
RNA B-Gene +
polymerase I-Gene +
II I-Gene +
in O +
cell O -
- O -
free O +
extracts O +
from O +
xeroderma O +
pigmentosum O +
groups O +
B O +
and O +
D O +
in O +
an O +
optimized O +
RNA O +
transcription O +
assay O +
. O +

The O +
human O +
autosomal O +
recessive O +
disease O +
, O +
xeroderma O +
pigmentosum O +
( O +
XP O +
) O +
, O +
can O +
result O +
from O +
mutations O +
in O +
any O +
one O +
of O +
seven O +
genes O +
, O +
designated O +
XPA O +
through O +
XPG O +
. O +

Of O +
these O +
, O +
the O +
XPB O +
and O +
XPD O +
genes O +
encode O +
proteins O +
that O +
are O +
subunits O +
of O +
a O +
general B-Gene +
transcription I-Gene +
factor I-Gene +
, O +
TFIIH B-Gene +
, O +
involved O +
in O +
both O +
nucleotide O +
excision O +
repair O +
( O +
NER O +
) O +
and O +
initiation O +
of O +
mRNA O +
transcription O +
by O +
RNA B-Gene +
polymerase I-Gene +
II I-Gene +
. O +

In O +
humans O +
, O +
mutation O +
of O +
the O +
XPB O +
or O +
XPD O +
gene O +
impairs O +
NER O +
, O +
resulting O +
in O +
hyper O -
- O -
sensitivity O +
to O +
sunlight O +
and O +
greatly O +
increased O +
skin O +
tumor O +
formation O +
. O +

However O +
, O +
no O +
transcription O +
deficiency O +
has O +
been O +
demonstrated O +
in O +
either O +
XP O -
- O -
B O +
or O +
XP O -
- O -
D O +
. O +

We O +
have O +
employed O +
an O +
optimized O +
cell O -
- O -
free O +
RNA O +
transcription O +
assay O +
to O +
analyze O +
transcription O +
activity O +
of O +
XP O -
- O -
B O +
and O +
XP O -
- O -
D O +
. O +

Although O +
the O +
growth O +
rate O +
was O +
normal O +
, O +
the O +
XP O -
- O -
B O +
and O +
XP O -
- O -
D O +
cells O +
contained O +
reduced O +
amounts O +
of O +
TFIIH B-Gene +
. O +

Extracts O +
prepared O +
from O +
XP O -
- O -
B O +
and O +
XP O -
- O -
D O +
lymphoblastoid O +
cells O +
exhibited O +
similar O +
transcription O +
activity O +
from O +
the O +
adenovirus O +
major O +
late O +
promoter O +
when O +
compared O +
to O +
that O +
in O +
extracts O +
from O +
normal O +
cells O +
. O +

Thus O +
, O +
we O +
conclude O +
that O +
the O +
XP O -
- O -
B O +
and O +
XP O -
- O -
D O +
lymphoblastoid O +
cells O +
do O +
not O +
have O +
impaired O +
RNA O +
transcription O +
activity O +
. O +

We O +
consider O +
the O +
possible O +
consequences O +
of O +
the O +
reduced O +
cellular O +
content O +
of O +
TFIIH B-Gene +
for O +
the O +
clinical O +
symptoms O +
in O +
XP O -
- O -
B O +
or O +
XP O -
- O -
D O +
patients O +
, O +
and O +
discuss O +
a O +
' O -
conditional O +
phenotype O +
' O +
that O +
may O +
involve O +
an O +
impairment O +
of O +
cellular O +
function O +
only O +
under O +
certain O +
growth O +
conditions O +
. O +

Temporal O +
control O +
of O +
IgH O +
gene O +
expression O +
in O +
developing O +
B O +
cells O +
by O +
the O +
3 O +
' O +
locus O +
control O +
region O +
. O +

The O +
suggested O +
roles O +
of O +
the O +
downstream O +
3 O +
' O +
regions O +
acting O +
as O +
a O +
Locus O +
Control O +
Region O +
( O +
LCR O +
) O +
, O +
have O +
allowed O +
comparisons O +
to O +
be O +
made O +
between O +
the O +
regulation O +
of O +
the O +
IgH O +
locus O +
with O +
other O +
model O +
systems O +
whose O +
gene O +
expression O +
is O +
governed O +
by O +
LCR O +
activity O +
. O +

Here O +
we O +
summarize O +
the O +
importance O +
of O +
the O +
IgH O +
3'LCR O +
and O +
its O +
putative O +
functional O +
role O +
in O +
IgH O +
gene O +
expression O +
and O +
compare O +
it O +
with O +
the O +
5'LCR O +
regulatory O +
region O +
of O +
the O +
human O +
beta O -
- O -
globin O +
locus O +
. O +

Expression O +
of O +
transcription O +
factor O +
genes O +
after O +
influenza O +
A O +
virus O +
infection O +
. O +

Infection O +
of O +
human O +
monocytes O +
with O +
influenza O +
A O +
virus O +
induces O +
a O +
broad O +
range O +
of O +
proinflammatory B-Gene +
cytokines I-Gene +
and O +
mononuclear O +
cell O +
attracting O +
chemokines B-Gene +
before O +
the O +
infected O +
cells O +
undergo O +
apoptosis O +
. O +

The O +
underlying O +
mechanisms O +
by O +
which O +
the O +
corresponding O +
genes O +
are O +
transcriptionally O +
initiated O +
after O +
virus O +
infection O +
are O +
still O +
poorly O +
understood O +
. O +

Activation O +
of O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
seems O +
to O +
play O +
an O +
important O +
role O +
in O +
the O +
regulation O +
of O +
many O +
proinflammatory O +
cytokine O +
genes O +
, O +
but O +
can O +
not O +
be O +
the O +
only O +
mechanism O +
, O +
since O +
several O +
cytokine O +
genes O +
lack O +
respective O +
binding O +
sites O +
in O +
their O +
promoter O +
regions O +
. O +

Therefore O +
, O +
we O +
additionally O +
investigated O +
other O +
transcription B-Gene +
factors I-Gene +
of O +
possible O +
importance O +
such O +
as O +
CREB B-Gene +
, O +
CTF B-Gene +
, O +
OTF-1 B-Gene +
, O +
and O +
OTF-2 B-Gene +
. O +

To O +
explore O +
long O -
- O -
term O +
regulatory O +
mechanisms O +
, O +
we O +
investigated O +
the O +
induction O +
of O +
transcription B-Gene +
factors I-Gene +
on O +
the O +
gene O +
expression O +
level O +
which O +
may O +
be O +
important O +
to O +
substitute O +
for O +
metabolized B-Gene +
transcription I-Gene +
factor I-Gene +
proteins I-Gene +
after O +
their O +
activation O +
. O +

We O +
identified O +
a O +
cell O -
- O -
type O -
- O -
specific O +
differential O +
response O +
: O +
CREB O +
, O +
CTF O +
, O +
OTF-1 O +
, O +
OFT-2 O +
, O +
and O +
NF O -
- O -
kappa O +
B O +
genes O +
were O +
strongly O +
induced O +
1 O +
to O +
4 O +
hours O +
after O +
influenza O +
A O +
virus O +
infection O +
in O +
the O +
monocytic O +
cell O +
line O +
Mono O +
Mac O +
6 O +
, O +
while O +
in O +
freshly O +
prepared O +
human O +
monocytes O +
no O +
significant O +
changes O +
were O +
detected O +
. O +

In O +
infected O +
monocytes O +
, O +
which O +
die O +
by O +
apoptosis O +
, O +
the O +
expression O +
of O +
CREB B-Gene +
, O +
CTF B-Gene +
, O +
and O +
OTF-2 B-Gene +
was O +
rather O +
suppressed O +
8 O +
hours O +
after O +
infection O +
. O +

In O +
conclusion O +
, O +
the O +
long O -
- O -
term O +
regulation O +
of O +
transcription B-Gene +
factor I-Gene +
gene O +
expression O +
in O +
non O -
- O -
proliferating O +
cells O +
seems O +
to O +
be O +
of O +
minor O +
importance O +
after O +
influenza O +
infection O +
since O +
in O +
apoptosisprone O +
cells O +
an O +
immediate O +
availability O +
of O +
transcription B-Gene +
factor I-Gene +
proteins I-Gene +
is O +
required O +
. O +

Genes O +
that O +
regulate O +
interleukin-4 B-Gene +
expression O +
in O +
T O +
cells O +
. O +

Interleukin-4 B-Gene +
is O +
an O +
immunomodulatory B-Gene +
cytokine I-Gene +
which O +
plays O +
a O +
central O +
role O +
in O +
the O +
regulation O +
of O +
allergic O +
and O +
atopic O +
immune O +
responses O +
. O +

Significant O +
progress O +
has O +
been O +
made O +
in O +
gaining O +
a O +
detailed O +
understanding O +
of O +
the O +
transcriptional O +
regulation O +
of O +
the O +
interleukin-4 O +
gene O +
. O +

The O +
recent O +
identification O +
and O +
characterization O +
of O +
several O +
key O +
transcription B-Gene +
factors I-Gene +
has O +
helped O +
to O +
elucidate O +
the O +
molecular O +
mechanisms O +
of O +
T O +
helper O +
cell O +
cytokine O +
gene O +
expression O +
. O +

Role O +
of O +
cyclic B-Gene +
AMP I-Gene +
response I-Gene +
element I-Gene -
- I-Gene -
binding I-Gene +
protein I-Gene +
in O +
cyclic O +
AMP O +
inhibition O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
-mediated O +
transcription O +
. O +

The O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
family O +
of O +
transcription O +
factors O +
regulates O +
the O +
inducible O +
expression O +
of O +
a O +
variety O +
of O +
genes O +
. O +

Recently O +
, O +
we O +
showed O +
that O +
elevation O +
of O +
intracellular O +
cyclic O +
AMP O +
inhibits O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
-mediated O +
transcription O +
in O +
human O +
monocytes O +
and O +
endothelial O +
cells O +
without O +
preventing O +
nuclear O +
translocation O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
complexes I-Gene +
. O +

The O +
present O +
study O +
examined O +
the O +
molecular O +
mechanism O +
of O +
this O +
inhibition O +
. O +

We O +
hypothesized O +
that O +
activation O +
of O +
the O +
protein B-Gene +
kinase I-Gene +
A I-Gene +
signaling O +
pathway O +
may O +
inhibit O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
-mediated O +
transcription O +
by O +
phosphorylating O +
proteins O +
, O +
such O +
as O +
cAMP B-Gene +
response I-Gene +
element I-Gene -
- I-Gene -
binding I-Gene +
protein I-Gene +
( O +
CREB B-Gene +
) O +
, O +
which O +
compete O +
for O +
limiting O +
amounts O +
of O +
the O +
coactivator O +
CBP B-Gene +
. O +

Here O +
, O +
we O +
show O +
that O +
the O +
amino B-Gene -
- I-Gene -
terminal I-Gene +
region I-Gene +
( O +
amino B-Gene +
acids I-Gene +
1 I-Gene -
- I-Gene -
450 I-Gene +
) O +
of O +
CBP B-Gene +
specifically O +
interacts O +
with O +
the O +
carboxyl B-Gene -
- I-Gene -
terminal I-Gene +
region I-Gene +
( O +
amino B-Gene +
acids I-Gene +
286 I-Gene -
- I-Gene -
551 I-Gene +
) O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
p65 B-Gene +
( O +
RelA B-Gene +
) O +
both O +
in O +
vitro O +
and O +
in O +
vivo O +
. O +

Functional O +
studies O +
using O +
human O +
endothelial O +
cells O +
demonstrated O +
that O +
overexpression O +
of O +
CBP B-Gene +
rescued O +
cAMP O +
inhibition O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
-mediated O +
transcription O +
and O +
transcription O +
mediated O +
by O +
a O +
chimeric B-Gene +
protein I-Gene +
, O +
GAL4-p65 B-Gene +
( I-Gene +
286 I-Gene -
- I-Gene -
551 I-Gene +
) I-Gene +
, O +
which O +
contained O +
the O +
GAL4 B-Gene +
DNA I-Gene +
binding I-Gene +
domain I-Gene +
fused O +
to O +
the O +
carboxyl B-Gene -
- I-Gene -
terminal I-Gene +
region I-Gene +
of O +
p65 B-Gene +
( O +
amino B-Gene +
acids I-Gene +
286 I-Gene -
- I-Gene -
551 I-Gene +
) O +
. O +

In O +
contrast O +
, O +
overexpression O +
of O +
CREB B-Gene +
inhibited O +
GAL4 B-Gene +
-p65 O +
( O +
286 O -
- O -
551 O +
) O +
-mediated O +
transcription O +
. O +

These O +
results O +
suggest O +
that O +
activation O +
of O +
the O +
protein B-Gene +
kinase I-Gene +
A I-Gene +
pathway O +
inhibits O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
transcription O +
by O +
phosphorylating O +
CREB B-Gene +
, O +
which O +
competes O +
with O +
p65 B-Gene +
for O +
limiting O +
amounts O +
of O +
CBP B-Gene +
. O +

Mycobacterium O +
tuberculosis O +
mannose O -
- O -
capped O +
lipoarabinomannan O +
can O +
induce O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
-dependent O +
activation O +
of O +
human O +
immunodeficiency O +
virus O +
type O +
1 O +
long O +
terminal O +
repeat O +
in O +
T O +
cells O +
. O +

Tuberculosis O +
has O +
emerged O +
as O +
an O +
epidemic O +
, O +
extended O +
by O +
the O +
large O +
number O +
of O +
individuals O +
infected O +
with O +
human O +
immunodeficiency O +
virus O +
type O +
1 O +
( O +
HIV-1 O +
) O +
. O +

The O +
major O +
goal O +
of O +
this O +
study O +
was O +
to O +
determine O +
whether O +
the O +
mycobacterial O +
cell O +
wall O +
component O +
mannose O -
- O -
capped O +
lipoarabinomannan O +
( O +
ManLAM O +
) O +
of O +
Mycobacterium O +
tuberculosis O +
( O +
M. O +
tuberculosis O +
) O +
could O +
activate O +
transcription O +
of O +
HIV-1 O +
in O +
T O +
cells O +
with O +
the O +
use O +
of O +
an O +
in O +
vitro O +
cell O +
culture O +
system O +
. O +

These O +
experiments O +
are O +
of O +
prime O +
importance O +
considering O +
that O +
CD4 B-Gene +
-expressing O +
T O +
lymphocytes O +
represent O +
the O +
major O +
virus O +
reservoir O +
in O +
the O +
peripheral O +
blood O +
of O +
infected O +
individuals O +
. O +

Using O +
the O +
1G5 O +
cell O +
line O +
harbouring O +
the O +
luciferase O +
reporter O +
gene O +
under O +
the O +
control O +
of O +
the O +
HIV-1 O +
LTR O +
, O +
it O +
was O +
first O +
found O +
that O +
culture O +
protein O +
filtrates O +
( O +
CFP O +
) O +
from O +
M. O +
tuberculosis O +
or O +
purified O +
ManLAM O +
could O +
activate O +
HIV-1 O +
LTR O -
- O -
dependent O +
gene O +
expression O +
unlike O +
similarly O +
prepared O +
CFP O +
extracts O +
devoid O +
of O +
ManLAM O +
. O +

The O +
implication O +
of O +
protein B-Gene +
tyrosine I-Gene +
kinase I-Gene +
( I-Gene +
s I-Gene +
) I-Gene +
, O +
protein B-Gene +
kinase I-Gene +
A I-Gene +
and/or O +
protein B-Gene +
kinase I-Gene +
C I-Gene +
was O +
highlighted O +
by O +
the O +
abrogation O +
of O +
the O +
ManLAM O -
- O -
mediated O +
activation O +
of O +
HIV-1 O +
LTR O -
- O -
driven O +
gene O +
expression O +
using O +
herbimycin O +
A O +
and O +
H7 O +
. O +

It O +
was O +
also O +
determined O +
, O +
using O +
electrophoresis O +
mobility O +
shift O +
assays O +
, O +
that O +
M. O +
tuberculosis O +
ManLAM O +
led O +
to O +
the O +
nuclear O +
translocation O +
of O +
the O +
transcription B-Gene +
factor I-Gene +
NF I-Gene -
- I-Gene -
kappaB I-Gene +
. O +

M. O +
tuberculosis O +
ManLAM O +
resulted O +
in O +
clear O +
induction O +
of O +
the O +
luciferase O +
gene O +
placed O +
under O +
the O +
control O +
of O +
the O +
wild O -
- O -
type O +
, O +
but O +
not O +
the O +
kappaB O -
- O -
mutated O +
, O +
HIV-1 O +
LTR O +
region O +
. O +

Finally O +
, O +
the O +
ManLAM O -
- O -
mediated O +
activation O +
of O +
HIV-1 O +
LTR O +
transcription O +
was O +
found O +
to O +
be O +
independent O +
of O +
the O +
autocrine O +
or O +
paracrine O +
action O +
of O +
endogenous B-Gene +
TNF I-Gene -
- I-Gene -
alpha I-Gene +
. O +

The O +
results O +
suggest O +
that O +
M. O +
tuberculosis O +
can O +
upregulate O +
HIV-1 O +
expression O +
in O +
T O +
cells O +
and O +
could O +
thus O +
have O +
the O +
potential O +
to O +
influence O +
the O +
pathogenesis O +
of O +
HIV-1 O +
infection O +
. O +

Coactivation O +
by O +
OCA B-Gene -
- I-Gene -
B I-Gene +
: O +
definition O +
of O +
critical O +
regions O +
and O +
synergism O +
with O +
general O +
cofactors O +
. O +

Molecular O +
dissection O +
of O +
the O +
B O -
- O -
cell O -
- O -
specific O +
transcription O +
coactivator O +
OCA B-Gene -
- I-Gene -
B I-Gene +
has O +
revealed O +
distinct O +
regions O +
important O +
, O +
respectively O +
, O +
for O +
recruitment O +
to O +
immunoglobulin O +
promoters O +
through O +
interaction O +
with O +
octamer B-Gene -
- I-Gene -
bound I-Gene +
Oct-1 I-Gene +
and O +
for O +
subsequent O +
coactivator O +
function O +
. O +

Further O +
analysis O +
of O +
general O +
coactivator O +
requirements O +
showed O +
that O +
selective O +
removal O +
of O +
PC4 B-Gene +
from O +
the O +
essential O +
USA O +
fraction O +
severely O +
impairs O +
Oct-1 O +
and O +
OCA O -
- O -
B O +
function O +
in O +
a O +
cell O -
- O -
free O +
system O +
reconstituted O +
with O +
partially O +
purified O +
factors O +
. O +

Full O +
activity O +
can O +
be O +
restored O +
by O +
the O +
combined O +
action O +
of O +
recombinant O +
PC4 B-Gene +
and O +
the O +
PC4 B-Gene +
-depleted O +
USA O +
fraction O +
, O +
thus O +
suggesting O +
a O +
joint O +
requirement O +
for O +
PC4 B-Gene +
and O +
another O +
, O +
USA O -
- O -
derived O +
component O +
( O +
s O +
) O +
for O +
optimal O +
function O +
of O +
Oct-1 B-Gene +
/OCA B-Gene -
- I-Gene -
B I-Gene +
in O +
the O +
reconstituted O +
system O +
. O +

Indeed O +
, O +
USA B-Gene -
- I-Gene -
derived I-Gene +
PC2 I-Gene +
was O +
found O +
to O +
act O +
synergistically O +
with O +
PC4 B-Gene +
in O +
reproducing O +
the O +
function O +
of O +
intact O +
USA O +
in O +
the O +
assay O +
system O +
. O +

Consistent O +
with O +
the O +
requirement O +
for O +
PC4 B-Gene +
in O +
the O +
reconstituted O +
system O +
, O +
OCA B-Gene -
- I-Gene -
B I-Gene +
was O +
found O +
to O +
interact O +
directly O +
with O +
PC4 B-Gene +
. O +

Surprisingly O +
, O +
however O +
, O +
removal O +
of O +
PC4 B-Gene +
from O +
the O +
unfractionated O +
nuclear O +
extract O +
has O +
no O +
detrimental O +
effect O +
on O +
OCA B-Gene -
- I-Gene -
B I-Gene +
/ O +
Oct-1 B-Gene +
-dependent O +
transcription O +
. O +

These O +
results O +
lead O +
to O +
a O +
general O +
model O +
for O +
the O +
synergistic O +
function O +
of O +
activation O +
domains O +
in O +
Oct-1 B-Gene +
and O +
OCA B-Gene -
- I-Gene -
B I-Gene +
( O +
mediated O +
by O +
the O +
combined O +
action O +
of O +
the O +
multiple O +
USA O +
components O +
) O +
and O +
, O +
further O +
, O +
suggest O +
a O +
functional O +
redundancy O +
in O +
general B-Gene +
coactivators I-Gene +
. O +

Differential O +
regulation O +
of O +
the O +
Janus B-Gene +
kinase I-Gene +
-STAT B-Gene +
pathway O +
and O +
biologic O +
function O +
of O +
IL-13 B-Gene +
in O +
primary O +
human O +
NK O +
and O +
T O +
cells O +
: O +
a O +
comparative O +
study O +
with O +
IL-4 B-Gene +
. O +

IL-13 B-Gene +
, O +
a O +
cytokine O +
similar O +
to O +
IL-4 B-Gene +
, O +
is O +
a O +
regulator O +
of O +
human O +
B O +
cell O +
and O +
monocyte O +
functions O +
. O +

Biologic O +
effects O +
of O +
IL-13 B-Gene +
on O +
primary O +
human O +
NK O +
and O +
T O +
cells O +
have O +
not O +
been O +
well O +
defined O +
. O +

We O +
demonstrate O +
that O +
, O +
in O +
primary O +
NK O +
cells O +
, O +
IL-13 B-Gene +
, O +
but O +
not O +
IL-4 B-Gene +
, O +
may O +
induce O +
low O +
levels O +
of O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
secretion O +
. O +

When O +
NK O +
cells O +
were O +
costimulated O +
with O +
IL-13 B-Gene +
and O +
IL-2 B-Gene +
, O +
IL-13 B-Gene +
generally O +
resulted O +
in O +
two O +
types O +
of O +
reactivity O +
: O +
IL-13 B-Gene +
synergized O +
with O +
IL-2 B-Gene +
to O +
stimulate O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
production O +
or O +
it O +
modestly O +
inhibited O +
IL-2 B-Gene +
-mediated O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
production O +
. O +

In O +
both O +
types O +
of O +
donors O +
, O +
the O +
effect O +
of O +
IL-13 B-Gene +
on O +
IL-2 B-Gene +
-induced O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
production O +
was O +
in O +
marked O +
contrast O +
to O +
the O +
strong O +
inhibition O +
seen O +
with O +
IL-4 B-Gene +
in O +
NK O +
cells O +
. O +

Additionally O +
, O +
IL-13 B-Gene +
suppresses O +
IL-2-induced O +
NK O +
cytolytic O +
and O +
proliferative O +
activities O +
although O +
less O +
efficiently O +
than O +
IL-4 B-Gene +
. O +

In O +
T O +
cells O +
, O +
IL-13 B-Gene +
inhibits O +
anti O -
- O -
CD3 O +
mAb O -
/ O -
IL-2- O +
or O +
PHA O -
- O -
mediated O +
IFN O -
- O -
gamma O +
production O +
and O +
enhances O +
cytolytic O +
potential O +
. O +

Furthermore O +
, O +
we O +
demonstrate O +
that O +
IL-13 B-Gene +
, O +
like O +
IL-4 B-Gene +
, O +
induces O +
distinct O +
STAT6-DNA B-Gene +
binding I-Gene +
complexes I-Gene +
and O +
tyrosine O +
phosphorylation O +
of O +
STAT6 B-Gene +
and O +
Janus B-Gene +
kinase I-Gene +
3 I-Gene +
( O +
JAK3 B-Gene +
) O +
in O +
NK O +
and O +
T O +
cells O +
. O +

We O +
observed O +
that O +
Abs O +
directed O +
against O +
unique O +
domains O +
of O +
STAT6 B-Gene +
have O +
differential O +
effects O +
on O +
complexes O +
in O +
T O +
cells O +
but O +
not O +
in O +
NK O +
cells O +
, O +
suggesting O +
different O +
STAT6 B-Gene +
isoforms I-Gene +
. O +

These O +
findings O +
show O +
that O +
IL-13 B-Gene +
and O +
IL-4 B-Gene +
have O +
the O +
ability O +
to O +
regulate O +
NK O +
and O +
T O +
cell O +
activation O +
and O +
that O +
IL-13 B-Gene +
is O +
a O +
potent O +
regulator O +
of O +
STAT6 B-Gene +
and O +
JAK3 B-Gene +
in O +
these O +
cell O +
types O +
. O +

Oxidative O +
stress O +
suppresses O +
transcription B-Gene +
factor I-Gene +
activities O +
in O +
stimulated O +
lymphocytes O +
. O +

Effects O +
of O +
oxidative O +
stress O +
on O +
stimulation O -
- O -
dependent O +
signal O +
transduction O +
, O +
leading O +
to O +
IL-2 B-Gene +
expression O +
, O +
were O +
studied O +
. O +

Purified O +
quiescent O +
human O +
blood O +
T O +
lymphocytes O +
were O +
subjected O +
to O +
: O +
( O +
i O +
) O +
acute O +
exposure O +
to O +
hydrogen O +
peroxide O +
; O +
( O +
ii O +
) O +
chronic O +
exposure O +
to O +
hydrogen O +
peroxide O +
; O +
and O +
( O +
iii O +
) O +
acute O +
exposure O +
to O +
ionizing O +
radiation O +
. O +

The O +
cells O +
were O +
then O +
stimulated O +
for O +
6 O +
h O +
. O +

DNA O -
- O -
binding O +
activities O +
( O +
determined O +
by O +
the O +
electrophoretic O +
mobility O +
shift O +
assay O +
) O +
of O +
three O +
transcription B-Gene +
factors I-Gene +
: O +
NFkappaB B-Gene +
, O +
AP-1 B-Gene +
and O +
NFAT B-Gene +
, O +
were O +
abolished O +
in O +
the O +
lymphocytes O +
by O +
all O +
three O +
modes O +
of O +
oxidative O +
stress O +
. O +

The O +
lymphocytes O +
exhibited O +
lipid O +
peroxidation O +
only O +
upon O +
exposure O +
to O +
the O +
lowest O +
level O +
of O +
hydrogen O +
peroxide O +
used O +
( O +
20 O +
microM O +
) O +
. O +

All O +
three O +
modes O +
of O +
oxidative O +
stress O +
induced O +
catalase B-Gene +
activity O +
in O +
the O +
lymphocytes O +
. O +

The O +
only O +
exception O +
was O +
hydrogen O +
peroxide O +
at O +
20 O +
microM O +
, O +
which O +
did O +
not O +
induce O +
catalase B-Gene +
activity O +
. O +

We O +
conclude O +
that O +
: O +
( O +
i O +
) O +
suppression O +
of O +
specific O +
transcription B-Gene +
factor I-Gene +
functions O +
can O +
potentially O +
serve O +
as O +
a O +
marker O +
of O +
exposure O +
to O +
oxidative O +
stress O +
and O +
its O +
effects O +
on O +
human O +
lymphocytes O +
; O +
( O +
ii O +
) O +
lipid O +
peroxidation O +
is O +
only O +
detectable O +
in O +
human O +
lymphocytes O +
upon O +
exposure O +
to O +
weak O +
oxidative O +
stress O +
which O +
does O +
not O +
induce O +
catalase B-Gene +
activity O +
; O +
( O +
iii O +
) O +
therefore O +
, O +
transcription B-Gene +
factor I-Gene +
DNA O -
- O -
binding O +
activities O +
are O +
more O +
sensitive O +
to O +
oxidative O +
stress O +
than O +
lipid O +
peroxidation O +
. O +

Macrophages O +
in O +
human O +
atheroma O +
contain O +
PPARgamma B-Gene +
: O +
differentiation B-Gene -
- I-Gene -
dependent I-Gene +
peroxisomal I-Gene +
proliferator I-Gene -
- I-Gene -
activated I-Gene +
receptor I-Gene +
gamma I-Gene +
( O +
PPARgamma B-Gene +
) O +
expression O +
and O +
reduction O +
of O +
MMP-9 B-Gene +
activity O +
through O +
PPARgamma B-Gene +
activation O +
in O +
mononuclear O +
phagocytes O +
in O +
vitro O +
. O +

Mononuclear O +
phagocytes O +
play O +
an O +
important O +
role O +
in O +
atherosclerosis O +
and O +
its O +
sequela O +
plaque O +
rupture O +
in O +
part O +
by O +
their O +
secretion O +
of O +
matrix B-Gene +
metalloproteinases I-Gene +
( O +
MMPs B-Gene +
) O +
, O +
including O +
MMP-9 B-Gene +
. O +

Peroxisomal B-Gene +
proliferator I-Gene -
- I-Gene -
activated I-Gene +
receptor I-Gene +
gamma I-Gene +
( O +
PPARgamma B-Gene +
) O +
, O +
a O +
transcription B-Gene +
factor I-Gene +
in O +
the O +
nuclear O +
receptor O +
superfamily O +
, O +
regulates O +
gene O +
expression O +
in O +
response O +
to O +
various O +
activators O +
, O +
including O +
15-deoxy O -
- O -
delta12 O +
, O +
14-prostaglandin O +
J2 O +
and O +
the O +
antidiabetic O +
agent O +
troglitazone O +
. O +

The O +
role O +
of O +
PPARgamma B-Gene +
in O +
human O +
atherosclerosis O +
is O +
unexplored O +
. O +

We O +
report O +
here O +
that O +
monocytes O -
/ O -
macrophages O +
in O +
human O +
atherosclerotic O +
lesions O +
( O +
n O +
= O +
12 O +
) O +
express O +
immunostainable B-Gene +
PPARgamma I-Gene +
. O +

Normal O +
artery O +
specimens O +
( O +
n O +
= O +
6 O +
) O +
reveal O +
minimal B-Gene +
immunoreactive I-Gene +
PPARgamma I-Gene +
. O +

Human O +
monocytes O +
and O +
monocyte O -
- O -
derived O +
macrophages O +
cultured O +
for O +
6 O +
days O +
in O +
5 O +
% O +
human O +
serum O +
expressed O +
PPARgamma O +
mRNA O +
and O +
protein O +
by O +
reverse O +
transcription O -
- O -
polymerase O +
chain O +
reaction O +
and O +
Western O +
blotting O +
, O +
respectively O +
. O +

In O +
addition O +
, O +
PPARgamma O +
mRNA O +
expression O +
in O +
U937 O +
cells O +
increased O +
during O +
phorbol O +
12-myristate O +
13 O +
acetate O -
- O -
induced O +
differentiation O +
. O +

Stimulation O +
of O +
PPARgamma B-Gene +
with O +
troglitazone O +
or O +
15-deoxy O -
- O -
delta12 O +
, O +
14-prostaglandin O +
J2 O +
in O +
human O +
monocyte O -
- O -
derived O +
macrophages O +
inhibited O +
MMP-9 B-Gene +
gelatinolytic O +
activity O +
in O +
a O +
concentration O -
- O -
dependent O +
fashion O +
as O +
revealed O +
by O +
zymography O +
. O +

This O +
inhibition O +
correlates O +
with O +
decreased O +
MMP-9 B-Gene +
secretion O +
as O +
determined O +
by O +
Western O +
blotting O +
. O +

Thus O +
, O +
PPARgamma B-Gene +
is O +
present O +
in O +
macrophages O +
in O +
human O +
atherosclerotic O +
lesions O +
and O +
may O +
regulate O +
expression O +
and O +
activity O +
of O +
MMP-9 B-Gene +
, O +
an O +
enzyme O +
implicated O +
in O +
plaque O +
rupture O +
. O +

PPARgamma B-Gene +
is O +
likely O +
to O +
be O +
an O +
important O +
regulator O +
of O +
monocyte O -
/ O -
macrophage O +
function O +
with O +
relevance O +
for O +
human O +
atherosclerotic O +
disease O +
. O +

Suppression O +
of O +
human O +
anti O -
- O -
porcine O +
T O -
- O -
cell O +
immune O +
responses O +
by O +
major O +
histocompatibility O +
complex O +
class O +
II O +
transactivator O +
constructs O +
lacking O +
the O +
amino O +
terminal O +
domain O +
. O +

BACKGROUND O +
: O +
The O +
class B-Gene +
II I-Gene +
transactivator I-Gene +
( O +
CIITA B-Gene +
) O +
is O +
a O +
bi- B-Gene +
or I-Gene +
multifunctional I-Gene +
domain I-Gene +
protein I-Gene +
that O +
acts O +
as O +
a O +
transcriptional B-Gene +
activator I-Gene +
and O +
plays O +
a O +
critical O +
role O +
in O +
the O +
expression O +
of O +
MHC O +
class O +
II O +
genes O +
. O +

We O +
have O +
previously O +
demonstrated O +
that O +
a O +
mutated O +
form O +
of O +
the O +
human O +
CIITA O +
gene O +
, O +
coding O +
for O +
a O +
protein O +
lacking O +
the O +
amino B-Gene +
terminal I-Gene +
151 I-Gene +
amino I-Gene +
acids I-Gene +
, O +
acts O +
as O +
a O +
potent O +
dominant O -
- O -
negative O +
suppressor O +
of O +
HLA B-Gene +
class I-Gene +
II I-Gene +
expression O +
. O +

Porcine B-Gene +
MHC I-Gene +
class I-Gene +
II I-Gene +
antigens I-Gene +
are O +
potent O +
stimulators O +
of O +
direct O +
T O -
- O -
cell O +
recognition O +
by O +
human O +
CD4 O -
+ O +
T O +
cells O +
and O +
are O +
, O +
therefore O +
, O +
likely O +
to O +
play O +
an O +
important O +
role O +
in O +
the O +
rejection O +
responses O +
to O +
transgenic O +
pig O +
donors O +
in O +
clinical O +
xenotransplantation O +
. O +

We O +
were O +
, O +
therefore O +
, O +
interested O +
in O +
examining O +
mutated O +
CIITA O +
constructs O +
for O +
their O +
effect O +
on O +
porcine O +
MHC B-Gene +
class I-Gene +
II I-Gene +
expression O +
. O +

METHODS O +
: O +
Stable O +
transfectants O +
of O +
the O +
porcine O +
vascular O +
endothelial O +
cell O +
line O +
PIEC O +
with O +
mutated O +
CIITA O +
constructs O +
were O +
tested O +
for O +
SLA B-Gene -
- I-Gene -
DR I-Gene +
and O +
SLA B-Gene -
- I-Gene -
DQ I-Gene +
induction O +
by O +
recombinant B-Gene +
porcine I-Gene +
interferon I-Gene -
- I-Gene -
gamma I-Gene +
. O +

Transient O +
transfectants O +
of O +
the O +
porcine O +
B O -
- O -
cell O +
line O +
L23 O +
with O +
the O +
mutated O +
CIITA O +
constructs O +
were O +
tested O +
for O +
the O +
suppression O +
of O +
constitutive O +
SLA O -
- O -
DR O +
and O +
SLA O -
- O -
DQ O +
expression O +
. O +

T O -
- O -
cell O +
proliferation O +
studies O +
were O +
performed O +
using O +
highly O +
purified O +
human O +
CD4 O -
+ O +
T O +
cells O +
. O +

RESULTS O +
: O +
In O +
preliminary O +
studies O +
, O +
we O +
demonstrated O +
that O +
transfection O +
of O +
the O +
PIEC O +
line O +
with O +
full O -
- O -
length O +
human O +
CIITA O +
constructs O +
resulted O +
in O +
strong O +
expression O +
of O +
SLA B-Gene -
- I-Gene -
DR I-Gene +
and O +
SLA B-Gene -
- I-Gene -
DQ I-Gene +
antigens O +
, O +
thus O +
establishing O +
the O +
cross O -
- O -
species O +
effectiveness O +
of O +
human B-Gene +
CIITA I-Gene +
in O +
the O +
pig O +
. O +

The O +
mutated O +
human O +
CIITA O +
constructs O +
were O +
, O +
therefore O +
, O +
tested O +
in O +
the O +
pig O +
. O +

PIEC O +
clones O +
stably O +
transfected O +
with O +
one O +
of O +
these O +
constructs O +
showed O +
up O +
to O +
99 O +
% O +
suppression O +
of O +
SLA B-Gene -
- I-Gene -
DR I-Gene +
and O +
SLA B-Gene -
- I-Gene -
DQ I-Gene +
antigen O +
induction O +
and O +
marked O +
suppression O +
of O +
SLA O -
- O -
DRA O +
mRNA O +
induction O +
. O +

Moreover O +
, O +
transient O +
transfection O +
of O +
the O +
porcine O +
B O -
- O -
cell O +
line O +
L23 O +
showed O +
up O +
to O +
90 O +
% O +
suppression O +
of O +
constitutive O +
SLA O -
- O -
DR O +
and O +
SLA O -
- O -
DQ O +
antigen O +
expression O +
in O +
5 O -
- O -
8 O +
days O +
. O +

In O +
functional O +
studies O +
, O +
interferon O -
- O -
gamma O -
- O -
stimulated O +
PIEC O +
clones O +
transfected O +
with O +
this O +
mutated B-Gene +
CIITA I-Gene +
construct O +
failed O +
to O +
stimulate O +
purified O +
human O +
CD4 O -
+ O +
T O +
lymphocytes O +
. O +

CONCLUSION O +
: O +
Mutated O +
human O +
CIITA O +
constructs O +
are O +
potent O +
suppressors O +
of O +
porcine O +
MHC B-Gene +
class I-Gene +
II I-Gene +
expression O +
. O +

Redox O +
signals O +
and O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
activation O +
in O +
T O +
cells O +
. O +

Accumulating O +
data O +
from O +
a O +
number O +
of O +
laboratories O +
have O +
recently O +
indicated O +
that O +
the O +
response O +
of O +
transcription B-Gene +
factor I-Gene +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
to O +
alterations O +
in O +
the O +
redox O +
homeostasis O +
of O +
cells O +
may O +
play O +
an O +
important O +
role O +
in O +
modulating O +
immune O +
function O +
. O +

The O +
activation O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
has O +
been O +
recognized O +
to O +
regulate O +
a O +
number O +
of O +
genes O +
necessary O +
for O +
normal O +
T O +
cell O +
responses O +
including O +
IL-2 B-Gene +
, O +
IL-6 B-Gene +
, O +
IL-8 B-Gene +
, O +
and O +
several O +
T B-Gene +
cell I-Gene +
surface I-Gene +
receptors I-Gene +
. O +

Diminished O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
activity O +
has O +
been O +
shown O +
to O +
occur O +
in O +
T O +
cells O +
with O +
aging O +
, O +
suggesting O +
that O +
impaired O +
activation O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
might O +
occur O +
during O +
cellular O +
senescence O +
. O +

In O +
addition O +
, O +
aberrancies O +
in O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
activity O +
have O +
been O +
implicated O +
in O +
the O +
immunopathogenesis O +
of O +
diseases O +
involving O +
immune O +
or O +
inflammatory O +
processes O +
such O +
as O +
atherosclerosis O +
and O +
HIV-1 O +
infection O +
. O +

The O +
role O +
of O +
H2O2 O +
and O +
other O +
reactive O +
oxygen O +
species O +
( O +
ROS O +
) O +
as O +
an O +
integratory O +
secondary O +
messenger O +
for O +
divergent O +
T O +
cell O +
signals O +
has O +
been O +
complicated O +
by O +
the O +
fact O +
that O +
various O +
T O +
cell O +
lines O +
and O +
peripheral O +
blood O +
T O +
cells O +
differ O +
markedly O +
in O +
the O +
levels O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
activation O +
induced O +
by O +
oxidant O +
stress O +
. O +

Additionally O +
, O +
proposed O +
pathways O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
activation O +
have O +
been O +
based O +
on O +
indirect O +
evidence O +
provided O +
by O +
experiments O +
which O +
used O +
antioxidants O +
to O +
inhibit O +
active O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
formation O +
. O +

Further O +
, O +
complete O +
activation O +
of O +
T O +
cells O +
requires O +
at O +
least O +
two O +
signals O +
, O +
one O +
that O +
stimulates O +
an O +
increase O +
in O +
intracellular O +
calcium O +
and O +
one O +
that O +
stimulates O +
enzymatic O +
processes O +
including O +
kinases O +
. O +

Similarly O +
, O +
substantial O +
evidence O +
indicates O +
that O +
full O +
activation O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
requires O +
dual O +
signals O +
. O +

The O +
ability O +
of O +
H2O2 O +
or O +
other O +
ROS O +
to O +
induce O +
T O +
cell O +
signals O +
and O +
functional O +
responses O +
by O +
these O +
two O +
mechanisms O +
is O +
reviewed O +
and O +
the O +
specific O +
response O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
to O +
redox O +
changes O +
in O +
T O +
cells O +
is O +
examined O +
. O +

Data O +
are O +
also O +
presented O +
to O +
suggest O +
that O +
the O +
redox O +
regulation O +
in O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
activation O +
may O +
be O +
relevant O +
to O +
immune O -
- O -
related O +
diseases O +
and O +
to O +
aging O +
. O +

Ex O +
vivo O +
activation O +
of O +
tumor O -
- O -
draining O +
lymph O +
node O +
T O +
cells O +
reverses O +
defects O +
in O +
signal B-Gene +
transduction I-Gene +
molecules I-Gene +
. O +

The O +
adoptive O +
transfer O +
of O +
tumor O -
- O -
draining O +
lymph O +
node O +
( O +
LN O +
) O +
T O +
cells O +
activated O +
ex O +
vivo O +
with O +
anti B-Gene -
- I-Gene -
CD3 I-Gene +
and O +
interleukin B-Gene +
2 I-Gene +
( O +
IL-2 B-Gene +
) O +
mediates O +
the O +
regression O +
of O +
the O +
poorly O +
immunogenic O +
murine O +
melanoma O +
D5 O +
. O +

The O +
efficacy O +
of O +
the O +
activated O +
LN O +
cells O +
is O +
augmented O +
when O +
the O +
sensitizing O +
tumor O +
is O +
a O +
genetically O +
modified O +
variant O +
( O +
designated O +
D5G6 O +
) O +
that O +
secretes O +
granulocyte B-Gene -
/ I-Gene -
macrophage I-Gene -
- I-Gene -
colony I-Gene -
- I-Gene -
stimulating I-Gene +
factor I-Gene +
. O +

In O +
contrast O +
to O +
anti O -
- O -
CD3 O -
/ O -
IL-2-activated O +
LN O +
cells O +
, O +
adoptive O +
transfer O +
of O +
freshly O +
isolated O +
tumor O -
- O -
draining O +
LN O +
T O +
cells O +
has O +
no O +
therapeutic O +
activity O +
. O +

To O +
determine O +
whether O +
the O +
acquisition O +
of O +
antitumor O +
function O +
during O +
ex O +
vivo O +
activation O +
is O +
associated O +
with O +
modifications O +
in O +
signal O +
transduction O +
capacity O +
, O +
the O +
protein O +
tyrosine B-Gene +
kinases I-Gene +
p56lck B-Gene +
and O +
p59fyn B-Gene +
and O +
proteins O +
of O +
the O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
family I-Gene +
were O +
analyzed O +
in O +
tumor O -
- O -
draining O +
LN O +
T O +
cells O +
. O +

The O +
levels O +
of O +
p56lck B-Gene +
and O +
p59fyn B-Gene +
were O +
lower O +
in O +
tumor O -
- O -
draining O +
than O +
in O +
normal O +
LN O +
T O +
cells O +
and O +
production O +
of O +
tyrosine B-Gene -
- I-Gene -
phosphorylated I-Gene +
substrates I-Gene +
was O +
markedly O +
depressed O +
following O +
anti B-Gene -
- I-Gene -
CD3 I-Gene +
stimulation O +
. O +

After O +
5-day O +
anti B-Gene -
- I-Gene -
CD3 I-Gene +
/IL-2 B-Gene +
activation O +
, O +
levels O +
of O +
p56lck B-Gene +
and O +
p59fyn B-Gene +
and O +
protein O +
tyrosine O +
kinase O +
activity O +
increased O +
. O +

Interestingly O +
, O +
the O +
levels O +
of O +
p56lck B-Gene +
, O +
p59fyn B-Gene +
, O +
and O +
tyrosine O +
kinase O +
activity O +
were O +
higher O +
in O +
activated O +
T O +
cells O +
derived O +
from O +
LN O +
that O +
drained O +
D5G6 O +
than O +
they O +
were O +
in O +
those O +
from O +
D5 O +
tumors O +
. O +

In O +
contrast O +
, O +
the O +
cytoplasmic O +
levels O +
of O +
c B-Gene -
- I-Gene -
Rel I-Gene +
and O +
Rel B-Gene +
A I-Gene +
were O +
normal O +
in O +
freshly O +
isolated O +
tumor O -
- O -
draining O +
LN O +
, O +
as O +
was O +
nuclear O +
kappaB B-Gene +
DNA O -
- O -
binding O +
activity O +
induced O +
by O +
anti B-Gene -
- I-Gene -
CD3 I-Gene +
mAb I-Gene +
or O +
phorbol O +
myristate O +
acetate O +
. O +

Stimulation O +
of O +
activated O +
LN O +
cells O +
with O +
D5 O +
tumor O +
cells O +
induced O +
the O +
nuclear O +
translocation O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
. O +

These O +
findings O +
indicate O +
that O +
the O +
recovery O +
of O +
proteins O +
mediating O +
signal O +
transduction O +
through O +
the O +
T B-Gene +
cell I-Gene +
receptor I-Gene -
/ I-Gene -
CD3 I-Gene +
complex I-Gene +
in O +
LN O +
T O +
cells O +
activated O +
ex O +
vivo O +
was O +
associated O +
with O +
the O +
acquisition O +
of O +
antitumor O +
function O +
. O +

Targeted O +
disruption O +
of O +
the O +
MyD88 O +
gene O +
results O +
in O +
loss O +
of O +
IL-1- O +
and O +
IL-18-mediated O +
function O +
. O +

MyD88 B-Gene +
, O +
originally O +
isolated O +
as O +
a O +
myeloid O +
differentiation O +
primary O +
response O +
gene O +
, O +
is O +
shown O +
to O +
act O +
as O +
an O +
adaptor O +
in O +
interleukin-1 B-Gene +
( O +
IL-1 B-Gene +
) O +
signaling O +
by O +
interacting O +
with O +
both O +
the O +
IL-1 B-Gene +
receptor I-Gene +
complex I-Gene +
and O +
IL-1 B-Gene +
receptor I-Gene -
- I-Gene -
associated I-Gene +
kinase I-Gene +
( O +
IRAK B-Gene +
) O +
. O +

Mice O +
generated O +
by O +
gene O +
targeting O +
to O +
lack O +
MyD88 B-Gene +
have O +
defects O +
in O +
T O +
cell O +
proliferation O +
as O +
well O +
as O +
induction O +
of O +
acute O +
phase O +
proteins O +
and O +
cytokines B-Gene +
in O +
response O +
to O +
IL-1 B-Gene +
. O +

Increases O +
in O +
interferon B-Gene -
- I-Gene -
gamma I-Gene +
production O +
and O +
natural O +
killer O +
cell O +
activity O +
in O +
response O +
to O +
IL-18 B-Gene +
are O +
abrogated O +
. O +

In O +
vivo O +
Th1 O +
response O +
is O +
also O +
impaired O +
. O +

Furthermore O +
, O +
IL-18 B-Gene +
-induced O +
activation O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
and O +
c B-Gene -
- I-Gene -
Jun I-Gene +
N I-Gene -
- I-Gene -
terminal I-Gene +
kinase I-Gene +
( O +
JNK B-Gene +
) O +
is O +
blocked O +
in O +
MyD88- O -
/ O -
- O +
Th1-developing O +
cells O +
. O +

Taken O +
together O +
, O +
these O +
results O +
demonstrate O +
that O +
MyD88 B-Gene +
is O +
a O +
critical O +
component O +
in O +
the O +
signaling O +
cascade O +
that O +
is O +
mediated O +
by O +
IL-1 B-Gene +
receptor I-Gene +
as O +
well O +
as O +
IL-18 B-Gene +
receptor I-Gene +
. O +

Characterization O +
of O +
cytokine B-Gene +
differential O +
induction O +
of O +
STAT B-Gene +
complexes I-Gene +
in O +
primary O +
human O +
T O +
and O +
NK O +
cells O +
. O +

Cytokines B-Gene +
, O +
IL-2 B-Gene +
, O +
IL-4 B-Gene +
, O +
IL-6 B-Gene +
, O +
IL-7 B-Gene +
, O +
IL-12 B-Gene +
, O +
and O +
IL-15 B-Gene +
are O +
key O +
regulators O +
of O +
human O +
peripheral O +
blood O +
T O +
and O +
NK O +
cell O +
activation O +
and O +
differentiation O +
but O +
the O +
precise O +
mechanisms O +
that O +
give O +
rise O +
to O +
their O +
differential O +
activities O +
within O +
these O +
cells O +
are O +
not O +
clear O +
. O +

Recent O +
studies O +
reveal O +
that O +
a O +
family O +
of O +
transcription B-Gene +
factors I-Gene +
, O +
signal B-Gene +
transducers I-Gene +
and I-Gene +
activators I-Gene +
of I-Gene +
transcription I-Gene +
( O +
STATs B-Gene +
) O +
directly O +
mediate O +
many O +
cytokine B-Gene +
signals O +
. O +

We O +
analyzed O +
the O +
activation O +
of O +
STATs B-Gene +
in O +
primary O +
human O +
T O +
and O +
NK O +
cells O +
by O +
a O +
variety O +
of O +
specific O +
cytokines B-Gene +
. O +

We O +
demonstrate O +
that O +
IL-12 B-Gene +
induces O +
STAT4 B-Gene +
only O +
in O +
freshly O +
isolated O +
primary O +
NK O +
cells O +
, O +
but O +
not O +
in O +
primary O +
T O +
cells O +
, O +
consistent O +
with O +
the O +
lack O +
of O +
the O +
IL-12 B-Gene +
receptor I-Gene +
in O +
resting O +
T O +
cells O +
. O +

In O +
contrast O +
, O +
IL-4 B-Gene +
induces O +
different O +
C B-Gene +
epsilon I-Gene +
GAS I-Gene +
DNA I-Gene -
- I-Gene -
protein I-Gene +
binding I-Gene +
complexes I-Gene +
in O +
both O +
T O +
and O +
NK O +
cells O +
. O +

Moreover O +
, O +
IL-4 B-Gene +
costimulation O +
with O +
IL-2 B-Gene +
or O +
IL-12 B-Gene +
does O +
not O +
alter O +
their O +
own O +
preferential O +
GAS O +
-like O +
DNA O +
binding O +
patterns O +
when O +
C O +
epsilon- O +
, O +
Fc O +
gamma O +
RI- O +
, O +
and O +
SIE O +
GAS O +
motif O +
containing O +
oligonucleotide O +
probes O +
are O +
compared O +
, O +
suggesting O +
that O +
induction O +
of O +
GAS B-Gene -
- I-Gene -
like I-Gene +
DNA I-Gene -
- I-Gene -
protein I-Gene +
binding I-Gene +
complexes I-Gene +
by O +
IL-2 B-Gene +
, O +
IL-4 B-Gene +
, O +
and O +
IL-12 B-Gene +
is O +
highly O +
selective O +
and O +
represents O +
one O +
important O +
factor O +
in O +
determining O +
specific O +
gene O +
activation O +
. O +

In O +
addition O +
, O +
IL-6 B-Gene +
and O +
IL-2 B-Gene +
synergistically O +
induce O +
homo- O +
and O +
heterodimerized O +
STAT1 B-Gene +
alpha I-Gene +
and O +
STAT3 B-Gene +
in O +
both O +
NK O +
and O +
T O +
cells O +
, O +
consistent O +
with O +
their O +
reported O +
synergism O +
in O +
modulating O +
perforin O +
gene O +
expression O +
. O +

We O +
further O +
demonstrated O +
that O +
IL-2 B-Gene +
, I-Gene +
-7 I-Gene +
, I-Gene +
and I-Gene +
-15 I-Gene +
induce O +
multiple B-Gene +
STAT I-Gene +
proteins I-Gene +
, O +
including O +
STAT5a B-Gene +
, O +
STAT5b B-Gene +
, O +
STAT1 B-Gene +
alpha I-Gene +
, O +
STAT3 B-Gene +
, O +
and O +
another O +
unidentified O +
Fc B-Gene +
gamma I-Gene +
RI I-Gene +
GAS I-Gene +
DNA I-Gene -
- I-Gene -
binding I-Gene +
protein I-Gene +
. O +

Finally O +
, O +
we O +
observed O +
that O +
activated O +
STAT5a B-Gene +
and O +
STAT5b B-Gene +
proteins O +
form O +
distinct O +
Fc O +
gamma O +
RI O +
GAS O +
binding O +
patterns O +
in O +
T O +
and O +
NK O +
cells O +
, O +
suggesting O +
that O +
they O +
might O +
have O +
different O +
roles O +
in O +
gene O +
regulation O +
. O +

Our O +
data O +
provide O +
evidence O +
that O +
the O +
differential O +
responses O +
in O +
gene O +
expression O +
and O +
cell O +
activation O +
seen O +
in O +
primary O +
NK O +
and O +
T O +
cells O +
on O +
direct O +
stimulation O +
with O +
different O +
cytokines B-Gene +
may O +
be O +
a O +
direct O +
result O +
of O +
distinct O +
activation O +
of O +
STAT B-Gene +
transcription I-Gene +
factors I-Gene +
. O +

Interleukin-6 B-Gene +
production O +
in O +
hemorrhagic O +
shock O +
is O +
accompanied O +
by O +
neutrophil O +
recruitment O +
and O +
lung O +
injury O +
. O +

Hemorrhagic O +
shock O +
( O +
HS O +
) O +
initiates O +
an O +
inflammatory O +
cascade O +
that O +
includes O +
the O +
production O +
of O +
cytokines B-Gene +
and O +
recruitment O +
of O +
neutrophils O +
( O +
PMN O +
) O +
and O +
may O +
progress O +
to O +
organ O +
failure O +
, O +
inducing O +
acute O +
respiratory O +
distress O +
syndrome O +
( O +
ARDS O +
) O +
. O +

To O +
examine O +
the O +
hypothesis O +
that O +
interleukin-6 B-Gene +
( O +
IL-6 B-Gene +
) O +
contributes O +
to O +
PMN O +
infiltration O +
and O +
lung O +
damage O +
in O +
HS O +
, O +
we O +
examined O +
the O +
lungs O +
of O +
rats O +
subjected O +
to O +
unresuscitated O +
and O +
resuscitated O +
HS O +
for O +
the O +
production O +
of O +
IL-6 B-Gene +
and O +
activation O +
of O +
Stat3 B-Gene +
. O +

Using O +
semiquantitative O +
RT O -
- O -
PCR O +
, O +
we O +
found O +
a O +
striking O +
increase O +
in O +
IL-6 O +
mRNA O +
levels O +
only O +
in O +
resuscitated O +
HS O +
, O +
with O +
peak O +
levels O +
observed O +
1 O +
h O +
after O +
initiation O +
of O +
resuscitation O +
. O +

Increased O +
IL-6 B-Gene +
protein O +
expression O +
was O +
localized O +
to O +
bronchial O +
and O +
alveolar O +
cells O +
. O +

Electrophoretic O +
mobility O +
shift O +
assay O +
of O +
protein O +
extracts O +
from O +
shock O +
lungs O +
exhibited O +
an O +
increase O +
in O +
Stat3 B-Gene +
activation O +
with O +
kinetics O +
similar O +
to O +
IL-6 O +
mRNA O +
. O +

In O +
situ O +
DNA O +
binding O +
assay O +
determined O +
Stat3 B-Gene +
activation O +
predominantly O +
within O +
alveoli O +
. O +

Intratracheal O +
instillation O +
of O +
IL-6 B-Gene +
alone O +
into O +
normal O +
rats O +
resulted O +
in O +
PMN O +
infiltration O +
into O +
lung O +
interstitium O +
and O +
alveoli O +
, O +
marked O +
elevation O +
of O +
bronchoalveolar O +
lavage O +
cellularity O +
, O +
and O +
increased O +
wet O -
- O -
to O -
- O -
dry O +
ratio O +
. O +

These O +
findings O +
indicate O +
that O +
IL-6 B-Gene +
production O +
and O +
Stat3 B-Gene +
activation O +
occur O +
early O +
in O +
HS O +
and O +
may O +
contribute O +
to O +
PMN O -
- O -
mediated O +
lung O +
injury O +
, O +
including O +
ARDS O +
after O +
HS O +
. O +

Activation O +
of O +
distinct O +
transcription B-Gene +
factors I-Gene +
in O +
neutrophils O +
by O +
bacterial O +
LPS O +
, O +
interferon B-Gene -
- I-Gene -
gamma I-Gene +
, O +
and O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
and O +
the O +
necessity O +
to O +
overcome O +
the O +
action O +
of O +
endogenous B-Gene +
proteases I-Gene +
. O +

Human O +
neutrophils O +
can O +
be O +
induced O +
to O +
actively O +
transcribe O +
a O +
number O +
of O +
early O -
- O -
response O +
genes O +
, O +
in O +
particular O +
those O +
encoding O +
cytokines B-Gene +
, O +
chemokines B-Gene +
, O +
and O +
the O +
high O -
- O -
affinity O +
surface O +
receptor O +
for O +
IgG B-Gene +
, O +
FcgammaRI B-Gene +
. O +

Although O +
little O +
is O +
known O +
to O +
date O +
about O +
the O +
regulation O +
of O +
gene O +
transcription O +
in O +
neutrophils O +
, O +
several O +
indications O +
point O +
to O +
a O +
role O +
for O +
distinct O +
transcription B-Gene +
factors I-Gene +
, O +
such O +
as O +
members O +
of O +
the O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
and O +
STAT B-Gene +
families I-Gene +
. O +

In O +
this O +
study O +
, O +
we O +
investigated O +
whether O +
these O +
transcription B-Gene +
factors I-Gene +
become O +
activated O +
under O +
stimulatory O +
conditions O +
which O +
are O +
known O +
to O +
induce O +
gene O +
transcription O +
in O +
neutrophils O +
. O +

Unexpectedly O +
, O +
we O +
found O +
that O +
conventional O +
procedures O +
employed O +
to O +
prepare O +
cellular O +
extracts O +
cause O +
the O +
release O +
of O +
proteolytic O +
activities O +
that O +
are O +
normally O +
stored O +
in O +
intracellular O +
granules O +
, O +
resulting O +
in O +
the O +
degradation O +
of O +
various O +
NF B-Gene -
- I-Gene -
kappaB I-Gene -
/ I-Gene -
Rel I-Gene +
and O +
STAT B-Gene +
proteins I-Gene +
. O +

To O +
circumvent O +
this O +
problem O +
, O +
we O +
developed O +
an O +
alternative O +
procedure O +
which O +
allowed O +
us O +
to O +
show O +
that O +
in O +
neutrophils O +
, O +
LPS O +
and O +
TNFalpha B-Gene +
induce O +
a O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
DNA O -
- O -
binding O +
activity O +
which O +
essentially O +
consists O +
of O +
p50 B-Gene -
/ I-Gene -
RelA I-Gene +
dimers I-Gene +
, O +
and O +
that O +
IFNgamma B-Gene +
promotes O +
the O +
binding O +
of O +
STAT1 B-Gene +
homodimers I-Gene +
to O +
the O +
IFNgamma O +
response O +
region O +
of O +
the O +
FcgammaRI O +
promoter O +
. O +

Moreover O +
, O +
we O +
report O +
that O +
neutrophil O +
stimulation O +
with O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
results O +
in O +
the O +
formation O +
of O +
a O +
STAT5 B-Gene +
-containing O +
DNA O -
- O -
binding O +
activity O +
. O +

Collectively O +
, O +
the O +
current O +
findings O +
open O +
new O +
perspectives O +
about O +
mechanisms O +
that O +
are O +
likely O +
to O +
regulate O +
gene O +
transcription O +
in O +
neutrophils O +
. O +

In O +
addition O +
, O +
the O +
procedure O +
described O +
herein O +
could O +
prove O +
useful O +
in O +
other O +
cell O +
types O +
that O +
express O +
high O +
levels O +
of O +
endogenous B-Gene +
proteases I-Gene +
. O +

Prostaglandin O +
E2 O +
Up O -
- O -
regulates O +
HIV-1 O +
long O +
terminal O +
repeat O +
-driven O +
gene O +
activity O +
in O +
T O +
cells O +
via O +
NF O -
- O -
kappaB O -
- O -
dependent O +
and O +
-independent O +
signaling O +
pathways O +
. O +

Replication O +
of O +
human O +
immunodeficiency O +
virus O +
type-1 O +
( O +
HIV-1 O +
) O +
is O +
highly O +
dependent O +
on O +
the O +
state O +
of O +
activation O +
of O +
the O +
infected O +
cells O +
and O +
is O +
modulated O +
by O +
interactions O +
between O +
viral B-Gene +
and I-Gene +
host I-Gene +
cellular I-Gene +
factors I-Gene +
. O +

Prostaglandin O +
E2 O +
( O +
PGE2 O +
) O +
, O +
a O +
pleiotropic B-Gene +
immunomodulatory I-Gene +
molecule I-Gene +
, O +
is O +
observed O +
at O +
elevated O +
levels O +
during O +
HIV-1 O +
infection O +
as O +
well O +
as O +
during O +
the O +
course O +
of O +
other O +
pathogenic O +
infections O +
. O +

In O +
1G5 O +
, O +
a O +
Jurkat O -
- O -
derived O +
T O +
cell O +
line O +
stably O +
transfected O +
with O +
a O +
luciferase O +
gene O +
driven O +
by O +
HIV-1 O +
long O +
terminal O +
repeat O +
( O +
LTR O +
) O +
, O +
we O +
found O +
that O +
PGE2 O +
markedly O +
enhanced O +
HIV-1 O +
LTR O +
-mediated O +
reporter O +
gene O +
activity O +
. O +

Experiments O +
have O +
been O +
conducted O +
to O +
identify O +
second B-Gene +
messengers I-Gene +
involved O +
in O +
this O +
PGE2-dependent O +
up O -
- O -
regulating O +
effect O +
on O +
the O +
regulatory O +
element O +
of O +
HIV-1 O +
. O +

In O +
this O +
study O +
, O +
we O +
present O +
evidence O +
indicating O +
that O +
signal O +
transduction O +
pathways O +
induced O +
by O +
PGE2 O +
necessitate O +
the O +
participation O +
of O +
cyclic O +
AMP O +
, O +
protein B-Gene +
kinase I-Gene +
A I-Gene +
, O +
and O +
Ca2 O -
+ O +
. O +

Experiments O +
conducted O +
with O +
different O +
HIV-1 O +
LTR O -
- O -
based O +
vectors O +
suggested O +
that O +
PGE2-mediated O +
activation O +
effect O +
on O +
HIV-1 O +
transcription O +
was O +
transduced O +
via O +
both O +
NF O -
- O -
kappaB O -
- O -
dependent O +
and O +
-independent O +
signaling O +
pathways O +
. O +

The O +
involvement O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
in O +
the O +
PGE2-dependent O +
activating O +
effect O +
on O +
HIV-1 O +
transcription O +
was O +
further O +
confirmed O +
using O +
a O +
kappaB O -
- O -
regulated O +
luciferase O +
encoding O +
vector O +
and O +
by O +
electrophoretic O +
mobility O +
shift O +
assays O +
. O +

Results O +
from O +
Northern O +
blot O +
and O +
flow O +
cytometric O +
analyses O +
, O +
as O +
well O +
as O +
the O +
use O +
of O +
a O +
selective O +
antagonist O +
indicated O +
that O +
PGE2 O +
modulation O +
of O +
HIV-1 O +
LTR O +
-driven O +
reporter O +
gene O +
activity O +
in O +
studied O +
T O +
lymphoid O +
cells O +
is O +
transduced O +
via O +
the O +
EP4 B-Gene +
receptor I-Gene +
subtype I-Gene +
. O +

These O +
results O +
suggest O +
that O +
secretion O +
of O +
PGE2 O +
by O +
macrophages O +
in O +
response O +
to O +
infection O +
or O +
inflammatory O +
activators O +
could O +
induce O +
signaling O +
events O +
resulting O +
in O +
activation O +
of O +
proviral O +
DNA O +
present O +
into O +
T O +
cells O +
latently O +
infected O +
with O +
HIV-1 O +
. O +

Differential O +
regulation O +
of O +
coproporphyrinogen O +
oxidase O +
gene O +
between O +
erythroid O +
and O +
nonerythroid O +
cells O +
. O +

Coproporphyrinogen B-Gene +
oxidase I-Gene +
( O +
CPO B-Gene +
) O +
catalyzes O +
the O +
sixth O +
step O +
of O +
the O +
heme B-Gene +
biosynthetic O +
pathway O +
. O +

To O +
assess O +
the O +
tissue O -
- O -
specific O +
regulation O +
of O +
the O +
CPO O +
gene O +
promoter O +
, O +
mouse O +
genomic O +
DNA O +
clones O +
for O +
CPO B-Gene +
were O +
isolated O +
. O +

Structural O +
analysis O +
demonstrated O +
that O +
the O +
mouse O +
CPO O +
gene O +
spans O +
approximately O +
11 O +
kb O +
and O +
consists O +
of O +
seven O +
exons O +
, O +
just O +
like O +
its O +
human O +
counterpart O +
. O +

Functional O +
analysis O +
of O +
the O +
promoter O +
by O +
transient O +
transfection O +
assays O +
indicated O +
that O +
synergistic O +
action O +
between O +
an O +
SP-1-like O +
element O +
at O +
-21 O -
/ O -
-12 O +
, O +
a O +
GATA O +
site O +
at O +
-59 O -
/ O -
-54 O +
, O +
and O +
a O +
novel O +
regulatory O +
element O +
, O +
CPRE O +
( O +
- O +
GGACTACAG O +
- O +
) O +
at O +
-49 O -
/ O -
-41 O +
, O +
is O +
essential O +
for O +
the O +
promoter O +
activity O +
in O +
murine O +
erythroleukemia O +
( O +
MEL O +
) O +
cells O +
. O +

In O +
nonerythroid O +
NIH3T3 O +
cells O +
, O +
however O +
, O +
the O +
GATA O +
site O +
is O +
not O +
required O +
. O +

Gel O +
mobility O +
shift O +
assays O +
demonstrated O +
that O +
specific O +
DNA B-Gene -
- I-Gene -
protein I-Gene +
complexes I-Gene +
can O +
be O +
formed O +
with O +
each O +
element O +
, O +
and O +
that O +
there O +
are O +
cell O -
- O -
specific O +
differences O +
in O +
factors O +
, O +
which O +
bind O +
to O +
the O +
SP-1-like O +
element O +
between O +
MEL O +
and O +
NIH3T3 O +
cells O +
. O +

These O +
results O +
provide O +
evidence O +
for O +
differential O +
regulation O +
of O +
the O +
promoter O +
function O +
of O +
CPO B-Gene +
gene O +
between O +
erythroid O +
and O +
nonerythroid O +
cells O +
. O +

Copyright O +
1998 O +
by O +
The O +
American O +
Society O +
of O +
Hematology O +

Interleukin B-Gene +
1beta I-Gene +
mediates O +
the O +
modulatory O +
effects O +
of O +
monocytes O +
on O +
LNCaP O +
human O +
prostate O +
cancer O +
cells O +
. O +

Proliferative O +
and O +
secretory O +
responses O +
in O +
androgen O -
- O -
sensitive O +
prostate O +
cancer O +
LNCaP O +
cells O +
are O +
regulated O +
by O +
steroid O +
and O +
peptide O +
hormones O +
and O +
by O +
differentiation O -
- O -
promoting O +
substances O +
. O +

In O +
the O +
present O +
study O +
, O +
we O +
evaluated O +
whether O +
peripheral O +
blood O +
monocytes O +
that O +
exhibit O +
anti O -
- O -
tumour O +
activity O +
in O +
haematopoietic O +
and O +
solid O +
tumours O +
influence O +
growth O +
and O +
secretion O +
in O +
the O +
LNCaP O +
cell O +
line O +
. O +

For O +
this O +
purpose O +
, O +
LNCaP O +
cells O +
were O +
incubated O +
with O +
monocyte O -
- O -
conditioned O +
medium O +
( O +
MCM O +
) O +
, O +
and O +
proliferation O +
as O +
well O +
as O +
expression O +
of O +
androgen B-Gene +
receptor I-Gene +
( O +
AR B-Gene +
) O +
and O +
secretion O +
of O +
prostate B-Gene -
- I-Gene -
specific I-Gene +
antigen I-Gene +
( O +
PSA B-Gene +
) O +
were O +
assessed O +
. O +

Conditioned O +
medium O +
from O +
monocytes O +
reduced O +
proliferation O +
in O +
a O +
dose O -
- O -
dependent O +
manner O +
. O +

Incubation O +
with O +
40 O +
% O +
MCM O +
caused O +
a O +
50 O +
% O +
reduction O +
in O +
cell O +
proliferation O +
. O +

AR B-Gene +
protein I-Gene +
decreased O +
by O +
70 O +
% O +
and O +
PSA B-Gene +
levels O +
in O +
supernatants O +
from O +
LNCaP O +
cells O +
were O +
reduced O +
by O +
approximately O +
80 O +
% O +
following O +
treatment O +
with O +
MCM O +
. O +

We O +
focused O +
on O +
the O +
contribution O +
of O +
two O +
major O +
products O +
of O +
activated O +
monocytes O +
, O +
prostaglandin O +
E2 O +
and O +
interleukin B-Gene +
1beta I-Gene +
( O +
IL-1beta B-Gene +
) O +
, O +
to O +
the O +
MCM O +
modulatory O +
action O +
. O +

LNCaP O +
cells O +
treated O +
with O +
prostaglandin O +
E2 O +
showed O +
neither O +
a O +
reduction O +
in O +
proliferation O +
nor O +
a O +
down O -
- O -
regulation O +
of O +
AR B-Gene +
and O +
PSA B-Gene +
levels O +
. O +

The O +
effects O +
of O +
MCM O +
on O +
cellular O +
proliferation O +
, O +
AR B-Gene +
protein I-Gene +
and O +
PSA B-Gene +
secretion O +
were O +
abolished O +
by O +
pretreatment O +
of O +
MCM O +
with O +
a O +
neutralizing O +
anti B-Gene -
- I-Gene -
IL-1beta I-Gene +
antibody I-Gene +
. O +

In O +
addition O +
, O +
recombinant O +
IL-1beta B-Gene +
was O +
able O +
to O +
replace O +
MCM O +
for O +
the O +
inhibition O +
of O +
proliferation O +
and O +
down O -
- O -
regulation O +
of O +
AR B-Gene +
and O +
PSA B-Gene +
proteins O +
. O +

LNCaP O +
cells O +
were O +
shown O +
to O +
express O +
the O +
IL-1beta B-Gene +
receptor O +
type O +
1 O +
, O +
which O +
transduces O +
IL-1beta B-Gene +
signal O +
. O +

Our O +
findings O +
reveal O +
that O +
monocyte B-Gene -
- I-Gene -
derived I-Gene +
IL-1beta I-Gene +
inhibits O +
the O +
proliferation O +
of O +
androgen O -
- O -
responsive O +
prostate O +
tumour O +
cells O +
and O +
reduces O +
AR B-Gene +
and O +
PSA B-Gene +
levels O +
. O +

p21ras B-Gene +
initiates O +
Rac-1 B-Gene +
but O +
not O +
phosphatidyl B-Gene +
inositol I-Gene +
3 I-Gene +
kinase I-Gene -
/ I-Gene -
PKB I-Gene +
, O +
mediated O +
signaling O +
pathways O +
in O +
T O +
lymphocytes O +
. O +

p21ras B-Gene +
is O +
activated O +
by O +
the O +
T B-Gene +
cell I-Gene +
antigen I-Gene +
receptor I-Gene +
( O +
TCR B-Gene +
) O +
and O +
then O +
co O -
- O -
ordinates O +
important O +
signaling O +
pathways O +
for O +
T B-Gene +
lymphocyte I-Gene +
activation O +
. O +

Effector O +
pathways O +
for O +
this O +
guanine B-Gene +
nucleotide I-Gene +
binding I-Gene +
protein I-Gene +
in O +
T O +
cells O +
are O +
mediated O +
by O +
the O +
serine B-Gene -
/ I-Gene -
threonine I-Gene +
kinase I-Gene +
Raf-1 B-Gene +
and O +
the O +
Ras B-Gene -
- I-Gene -
related I-Gene +
GTPase I-Gene +
Rac-1 B-Gene +
. O +

In O +
fibroblasts O +
, O +
an O +
important O +
effector O +
for O +
the O +
Ras O +
oncogene O +
is O +
Phosphatidylinositol B-Gene +
3-kinase I-Gene +
( O +
PtdIns B-Gene +
3-kinase I-Gene +
) O +
. O +

Activation O +
of O +
this O +
lipid B-Gene +
kinase I-Gene +
is O +
able O +
to O +
induce O +
critical O +
Rac-1 B-Gene +
signaling O +
pathways O +
and O +
can O +
couple O +
p21ras B-Gene +
to O +
cell O +
survival O +
mechanisms O +
via O +
the O +
serine B-Gene -
/ I-Gene -
threonine I-Gene +
kinase I-Gene +
Akt I-Gene -
/ I-Gene -
PKB I-Gene +
. O +

The O +
role O +
of O +
PtdIns B-Gene +
3-kinase I-Gene +
in O +
Ras B-Gene +
signaling O +
in O +
T O +
cells O +
has O +
not O +
been O +
explored O +
. O +

In O +
the O +
present O +
study O +
, O +
we O +
examined O +
the O +
ability O +
of O +
PtdIns B-Gene +
3-kinase I-Gene +
to O +
initiate O +
the O +
Rac-1 B-Gene +
signaling O +
pathways O +
important O +
for O +
T O +
cell O +
activation O +
. O +

We O +
also O +
examined O +
the O +
possibility O +
that O +
Akt B-Gene -
/ I-Gene -
PKB I-Gene +
is O +
regulated O +
by O +
Ras O +
signaling O +
pathways O +
in O +
T O +
lymphocytes O +
. O +

The O +
results O +
show O +
that O +
Ras B-Gene +
can O +
initiate O +
a O +
Rac-1 B-Gene +
mediated O +
pathway O +
that O +
regulates O +
the O +
transcriptional O +
function O +
of O +
AP-1 B-Gene +
complexes I-Gene +
. O +

PtdIns B-Gene +
3-kinase I-Gene +
signals O +
can O +
not O +
mimic O +
p21ras B-Gene +
and O +
induce O +
the O +
Rac B-Gene +
mediated O +
responses O +
of O +
AP-1 B-Gene +
transcriptional O +
activation O +
. O +

Moreover O +
, O +
neither O +
TCR B-Gene +
or O +
Ras B-Gene +
activation O +
of O +
AP-1 B-Gene +
is O +
dependent O +
on O +
PtdIns B-Gene +
3-kinase I-Gene +
. O +

PKB B-Gene +
is O +
activated O +
in O +
response O +
to O +
triggering O +
of O +
the O +
T B-Gene +
cell I-Gene +
antigen I-Gene +
receptor I-Gene +
; O +
PtdIns B-Gene +
3-kinase I-Gene +
activity O +
is O +
both O +
required O +
and O +
sufficient O +
for O +
this O +
TCR B-Gene +
response O +
. O +

In O +
contrast O +
, O +
p21ras B-Gene +
signals O +
are O +
unable O +
to O +
induce O +
Akt B-Gene -
/ I-Gene -
PKB I-Gene +
activity O +
in O +
T O +
cell O +
nor O +
is O +
Ras B-Gene +
function O +
required O +
for O +
Akt B-Gene -
/ I-Gene -
PKB I-Gene +
activation O +
in O +
response O +
to O +
the O +
TCR B-Gene +
. O +

The O +
present O +
data O +
thus O +
highlight O +
that O +
PtdIns B-Gene +
3-kinase I-Gene +
and O +
Akt B-Gene -
/ I-Gene -
PKB I-Gene +
are O +
not O +
universal O +
Ras B-Gene +
effector I-Gene +
molecules I-Gene +
. O +

Ras B-Gene +
can O +
initiate O +
Rac-1 B-Gene +
regulated O +
signaling O +
pathways O +
in O +
the O +
context O +
of O +
T B-Gene +
cell I-Gene +
antigen I-Gene +
receptor I-Gene +
function O +
independently O +
of O +
PtdIns B-Gene +
3-kinase I-Gene +
activity O +
. O +

Differential O +
effects O +
of O +
protein B-Gene +
kinase I-Gene +
C I-Gene +
inhibitors O +
on O +
fibronectin B-Gene +
-induced O +
interleukin O -
- O -
beta O +
gene O +
transcription O +
, O +
protein O +
synthesis O +
and O +
secretion O +
in O +
human O +
monocytic O +
cells O +
. O +

Human O +
monocytic O +
cells O +
express O +
interleukin-1beta B-Gene +
( O +
IL-1beta B-Gene +
) O +
when O +
stimulated O +
with O +
the O +
extracellular B-Gene +
matrix I-Gene +
glycoprotein I-Gene +
, O +
fibronectin B-Gene +
( O +
FN B-Gene +
) O +
. O +

Protein B-Gene +
kinase I-Gene +
C I-Gene +
( O +
PKC B-Gene +
) O +
activation O +
is O +
considered O +
important O +
for O +
this O +
process O +
; O +
however O +
, O +
the O +
metabolic O +
steps O +
at O +
which O +
PKC B-Gene +
acts O +
upon O +
to O +
mediate O +
the O +
FN B-Gene +
-induced O +
IL-1beta B-Gene +
response O +
remain O +
unclear O +
. O +

We O +
performed O +
an O +
analysis O +
of O +
the O +
mechanisms O +
by O +
which O +
two O +
PKC B-Gene +
inhibitors O +
, O +
Calphostin O +
C O +
and O +
Staurosporine O +
, O +
prevent O +
the O +
FN B-Gene +
-induced O +
IL-1beta B-Gene +
response O +
. O +

Both O +
inhibitors O +
blocked O +
the O +
secretion O +
of O +
IL-1beta B-Gene +
protein I-Gene +
into O +
the O +
media O +
of O +
peripheral O +
blood O +
mononuclear O +
cells O +
exposed O +
to O +
FN B-Gene +
. O +

Immunoprecipitation O +
analysis O +
revealed O +
that O +
unde3r O +
these O +
circumstances O +
, O +
Calphostin O +
C O +
inhibited O +
the O +
production O +
of O +
IL-1beta B-Gene +
protein I-Gene +
, O +
whereas O +
Staurosporine O +
allowed O +
protein O +
production O +
, O +
but O +
inhibited O +
its O +
secretion O +
. O +

To O +
determine O +
the O +
mechanisms O +
responsible O +
for O +
these O +
differences O +
, O +
we O +
turned O +
to O +
human O +
U937 O +
promonocytic O +
cells O +
. O +

U937 O +
cells O +
transfected O +
with O +
the O +
human O +
full O -
- O -
length O +
IL-1beta O +
promoter O +
connected O +
to O +
a O +
luciferase O +
reporter O +
gene O +
were O +
submitted O +
to O +
transcription O +
assays O +
, O +
Northern O +
blotting O +
, O +
and O +
DNA O +
electrophoresis O +
mobility O +
gel O +
shift O +
assays O +
. O +

These O +
studies O +
revealed O +
that O +
Calphostin O +
C O +
inhibited O +
the O +
nuclear O +
translocation O +
of O +
the O +
transcription B-Gene +
factor I-Gene +
activator I-Gene +
protein-1 I-Gene +
( O +
AP-1 B-Gene +
) O +
which O +
is O +
considered O +
necessary O +
for O +
FN B-Gene +
induction O +
of O +
IL-1beta B-Gene +
gene O +
transcription O +
, O +
and O +
prevented O +
the O +
transcription O +
of O +
the O +
IL-1beta O +
gene O +
. O +

In O +
contrast O +
, O +
Staurosporine O +
alone O +
induced O +
AP-1 B-Gene +
translocation O +
and O +
stimulation O +
of O +
the O +
gene O +
. O +

Overall O +
, O +
our O +
data O +
indicate O +
that O +
Calphostin O +
C O +
prevents O +
the O +
transcription O +
of O +
the O +
IL-1beta O +
gene O +
thereby O +
inhibiting O +
protein O +
synthesis O +
. O +

Based O +
on O +
the O +
high O +
specificity O +
of O +
this O +
compound O +
for O +
PKC B-Gene +
, O +
we O +
conclude O +
that O +
PKC B-Gene +
is O +
necessary O +
for O +
FN B-Gene +
-induced O +
IL-1beta B-Gene +
protein O +
production O +
. O +

In O +
contrast O +
, O +
Staurosporine O +
prevented O +
secretion O +
of O +
IL-1beta B-Gene +
by O +
unknown O +
mechanisms O +

In O +
situ O +
RT O -
- O -
PCR O +
detection O +
of O +
Epstein O -
- O -
Barr O +
virus O +
immediate O -
- O -
early O +
transcripts O +
in O +
CD4 O -
+ O +
and O +
CD8 O -
+ O +
T O +
lymphocytes O +
. O +

AIDS O -
- O -
related O +
Epstein O -
- O -
Barr O +
virus O +
( O +
EBV O +
) O +
-associated O +
T O +
cell O +
lymphomas O +
are O +
emerging O +
as O +
a O +
new O +
, O +
distinct O +
histopathological O +
entity O +
. O +

The O +
pathway O +
whereby O +
EBV O +
infects O +
T O +
cells O +
as O +
well O +
as O +
the O +
initial O +
EBV O +
transcriptional O +
program O +
in O +
T O +
cells O +
has O +
not O +
been O +
established O +
. O +

In O +
order O +
to O +
shed O +
light O +
on O +
the O +
early O +
events O +
of O +
the O +
EBV O +
infection O +
of O +
T O +
cells O +
, O +
we O +
have O +
used O +
in O +
situ O +
reverse O +
transcription O +
based O +
polymerase O +
chain O +
reaction O +
( O +
RT O -
- O -
PCR O +
) O +
to O +
study O +
the O +
initial O +
EBV O +
transcriptional O +
program O +
in O +
homogeneous O +
CD4 O -
+ O +
and O +
CD8 O -
+ O +
lymphocytes O +
. O +

Following O +
EBV O +
infection O +
, O +
Epstein O -
- O -
Barr O +
nuclear O +
antigen O +
( O +
EBNA B-Gene +
) O +
expression O +
could O +
be O +
detected O +
in O +
T O +
rosetting O +
CD4 O -
+ O +
and O +
CD8 O -
+ O +
T O +
lymphocytes O +
. O +

Only O +
a O +
few O +
cells O +
showed O +
viral B-Gene +
capsid I-Gene +
antigen I-Gene +
( O +
VCA B-Gene +
) O +
. O +

EBV O +
immediate O -
- O -
early O +
gene O +
transcripts O +
( O +
BZLF1 O +
, O +
BRLF1 O +
, O +
and O +
BMLF1 O +
) O +
encoded O +
in O +
the O +
BamHI O +
Z O +
, O +
R O +
, O +
and O +
M O +
fragments O +
could O +
be O +
detected O +
by O +
in O +
situ O +
RT O -
- O -
PCR O +
in O +
the O +
EBV O +
producer O +
cell O +
line O +
B95.8 O +
. O +

Both O +
BZLF1 O +
and O +
BRLF1 O +
immediate O -
- O -
early O +
transcripts O +
, O +
but O +
not O +
BMLF1 O +
transcript O +
, O +
could O +
be O +
detected O +
in O +
individual O +
CD4 O -
+ O +
and O +
CD8 O -
+ O +
T O +
cells O +
infected O +
with O +
EBV O +
. O +

Demonstration O +
of O +
EBV O +
mRNA O +
transcripts O +
encoding O +
immediate B-Gene -
- I-Gene -
early I-Gene +
transcriptional I-Gene +
transactivators I-Gene +
in O +
EBV O -
- O -
infected O +
T O +
cells O +
provides O +
the O +
first O +
evidence O +
for O +
a O +
possible O +
mechanism O +
whereby O +
EBV O +
could O +
contribute O +
to O +
T O +
cell O +
proliferation O +
and O +
EBV O -
- O -
associated O +
T O +
cell O +
malignancies O +
. O +

Comparison O +
of O +
primary O +
sensitization O +
of O +
naive O +
human O +
T O +
cells O +
to O +
varicella O -
- O -
zoster O +
virus O +
peptides O +
by O +
dendritic O +
cells O +
in O +
vitro O +
with O +
responses O +
elicited O +
in O +
vivo O +
by O +
varicella O +
vaccination O +
. O +

Dendritic O +
cells O +
( O +
DC O +
) O +
are O +
potent O +
APC O +
during O +
primary O +
and O +
secondary O +
immune O +
responses O +
. O +

The O +
first O +
objective O +
of O +
this O +
study O +
was O +
to O +
determine O +
whether O +
human O +
DC O +
mediate O +
in O +
vitro O +
sensitization O +
of O +
naive O +
CD4 O -
+ O +
T O +
cells O +
to O +
epitopes B-Gene +
of O +
the O +
immediate B-Gene +
early I-Gene +
62 I-Gene +
( I-Gene +
IE62 I-Gene +
) I-Gene +
protein I-Gene +
of O +
varicella O +
zoster O +
virus O +
( O +
VZV O +
) O +
. O +

The O +
induction O +
of O +
CD4 B-Gene -
+ I-Gene +
T O +
cell O +
proliferative O +
responses O +
to O +
eight O +
synthetic O +
peptides O +
representing O +
amino O +
acid O +
sequences O +
of O +
the O +
VZV B-Gene +
IE62 I-Gene +
protein I-Gene +
was O +
assessed O +
using O +
T O +
cells O +
and O +
DC O +
from O +
VZV O -
- O -
susceptible O +
donors O +
. O +

The O +
second O +
objective O +
was O +
to O +
compare O +
in O +
vitro O +
responses O +
of O +
naive O +
T O +
cells O +
with O +
responses O +
to O +
VZV O +
peptides O +
induced O +
in O +
vivo O +
after O +
immunization O +
with O +
varicella O +
vaccine O +
. O +

T O +
cell O +
proliferation O +
was O +
induced O +
by O +
three O +
peptides O +
, O +
P1 O +
, O +
P4 O +
, O +
and O +
P7 O +
, O +
in O +
71 O -
- O -
100 O +
% O +
of O +
the O +
donors O +
tested O +
before O +
and O +
after O +
vaccination O +
using O +
DC O +
as O +
APC O +
. O +

Monocytes O +
were O +
effective O +
APC O +
for O +
VZV O +
peptides O +
only O +
after O +
immunization O +
. O +

Two O +
peptides O +
, O +
P2 O +
and O +
P8 O +
, O +
induced O +
naive O +
T O +
cell O +
proliferation O +
less O +
effectively O +
and O +
were O +
also O +
less O +
immunogenic O +
for O +
T O +
cells O +
from O +
vaccinated O +
or O +
naturally O +
immune O +
donors O +
. O +

T O +
cell O +
recognition O +
of O +
specific O +
peptides O +
was O +
concordant O +
between O +
naive O +
, O +
DC O +
-mediated O +
responses O +
, O +
and O +
postvaccine O +
responses O +
using O +
monocytes O +
as O +
APC O +
in O +
69 O +
% O +
of O +
comparisons O +
( O +
p O +
= O +
0.05 O +
; O +
chi2 O +
) O +
; O +
the O +
predictive O +
value O +
of O +
a O +
positive O +
response O +
to O +
an O +
IE62 O +
peptide O +
before O +
immunization O +
for O +
T O +
cell O +
sensitization O +
in O +
vivo O +
was O +
82 O +
% O +
. O +

These O +
observations O +
indicate O +
that O +
primary O +
T O +
cell O +
responses O +
detected O +
in O +
vitro O +
using O +
DC O +
as O +
APC O +
may O +
be O +
useful O +
to O +
characterize O +
the O +
potential O +
immunogenicity O +
of O +
viral O +
protein O +
epitopes O +
in O +
vivo O +
. O +

A O +
novel O +
growth O -
- O -
factor O -
- O -
dependent O +
myeloid O +
cell O +
line O +
derived O +
from O +
mouse O +
bone O +
marrow O +
cells O +
contains O +
progenitors O +
endowed O +
with O +
high O +
proliferative O +
potential O +
. O +

Constitutive O +
expression O +
of O +
human B-Gene +
colony I-Gene -
- I-Gene -
stimulating I-Gene +
factor-1 I-Gene +
receptor I-Gene +
( O +
CSF-1R B-Gene +
) O +
confers O +
long O -
- O -
lasting O +
CSF-1 B-Gene +
-dependent O +
proliferation O +
to O +
mouse O +
myeloid O +
cell O +
lines O +
. O +

We O +
developed O +
mice O +
transgenic O +
for O +
human O +
CSF-1R B-Gene +
because O +
mouse O +
CSF-1 B-Gene +
can O +
not O +
activate O +
human O +
CSF-1R B-Gene +
. O +

Then O +
bone O +
marrow O +
cells O +
from O +
transgenic O +
mice O +
were O +
plated O +
onto O +
MS-5 O +
stromal O +
cells O +
expressing O +
the O +
membrane B-Gene +
form I-Gene +
of O +
human B-Gene +
CSF-1 I-Gene +
( O +
2M-1 O +
cells O +
) O +
in O +
order O +
to O +
combine O +
the O +
hematopoietic O +
supporting O +
properties O +
of O +
stromal O +
cells O +
and O +
the O +
proliferative O +
effects O +
of O +
CSF-1 B-Gene +
. O +

Thus O +
, O +
we O +
were O +
able O +
to O +
derive O +
a O +
hematopoietic O +
cell O +
line O +
, O +
called O +
47.10 O +
, O +
that O +
grew O +
indefinitely O +
under O +
these O +
conditions O +
, O +
whereas O +
no O +
cell O +
line O +
could O +
be O +
developed O +
from O +
nontransgenic O +
mice O +
. O +

Proliferation O +
of O +
47.10 O +
cells O +
is O +
severely O +
affected O +
by O +
neutralizing O +
anti B-Gene -
- I-Gene -
CSF-1R I-Gene +
monoclonal I-Gene +
antibodies I-Gene +
. O +

Morphologic O +
and O +
cytofluorometry O +
analysis O +
established O +
that O +
most O +
47.10 O +
cells O +
are O +
immature O +
myelomonocytic O +
cells O +
. O +

Consistent O +
with O +
this O +
phenotype O +
, O +
the O +
myeloid B-Gene +
transcription I-Gene +
factor I-Gene +
PU.1 I-Gene +
, O +
but O +
not O +
the O +
erythroid B-Gene +
transcription I-Gene +
factor I-Gene +
GATA-1 I-Gene +
, O +
is O +
expressed O +
in O +
47.10 O +
cells O +
. O +

A O +
few O +
47.10 O +
cells O +
( O +
3 O -
- O -
5 O +
% O +
) O +
do O +
not O +
express O +
lineage O +
specific O +
markers O +
; O +
they O +
differentiate O +
spontaneously O +
to O +
lineage O -
- O -
positive O +
cells O +
after O +
replating O +
on O +
2M-1 O +
cells O +
. O +

In O +
agar O +
cultures O +
, O +
47.10 O +
cells O +
form O +
7- O +
and O +
14-day O +
colonies O +
in O +
response O +
to O +
a O +
cocktail O +
of O +
granulocyte B-Gene -
/ I-Gene -
macrophage I-Gene +
colony I-Gene -
- I-Gene -
stimulating I-Gene +
factor I-Gene +
( O +
2.5 O +
ng O -
/ O -
mL O +
) O +
, O +
interleukin-3 B-Gene +
( O +
1 O +
ng O -
/ O -
mL O +
) O +
, O +
and O +
mouse O +
CSF-1 B-Gene +
( O +
10 O +
ng O -
/ O -
mL O +
) O +
. O +

Under O +
these O +
conditions O +
, O +
about O +
0.5 O +
% O +
of O +
47.10 O +
cells O +
formed O +
large O +
14-day O +
colonies O +
( O +
> O +
1 O +
mm O +
) O +
composed O +
of O +
mature O +
monocytes O +
and O +
granulocytes O +
, O +
reflecting O +
the O +
presence O +
of O +
progenitors O +
endowed O +
with O +
high O +
proliferative O +
potential O +
( O +
HPP-47.10 O +
cells O +
) O +
. O +

In O +
conclusion O +
, O +
we O +
have O +
characterized O +
a O +
novel O +
continuous O +
myeloid O +
cell O +
line O +
presenting O +
a O +
hierarchical O +
structure O +
similar O +
to O +
that O +
of O +
the O +
bone O +
marrow O +
progenitor O +
cell O +
compartment O +
. O +

Phenotypic O +
and O +
functional O +
studies O +
of O +
leukocytes O +
in O +
human O +
endometrium O +
and O +
endometriosis O +
. O +

The O +
aetiology O +
of O +
endometriosis O +
, O +
a O +
common O +
and O +
disabling O +
disorder O +
, O +
is O +
presently O +
unknown O +
, O +
although O +
immune O +
dysfunction O +
could O +
allow O +
ectopic O +
endometrial O +
fragments O +
to O +
survive O +
outside O +
the O +
uterine O +
cavity O +
. O +

These O +
studies O +
investigate O +
the O +
relationship O +
between O +
leukocyte O +
populations O +
, O +
steroid B-Gene +
hormone I-Gene +
receptor I-Gene +
expression O +
, O +
proliferative O +
activity O +
, O +
bcl-2 B-Gene +
expression O +
and O +
apoptosis O +
in O +
eutopic O +
and O +
ectopic O +
endometrium O +
from O +
women O +
with O +
endometriosis O +
or O +
adenomyosis O +
at O +
different O +
phases O +
of O +
the O +
menstrual O +
cycle O +
. O +

Significantly O +
increased O +
oestrogen B-Gene +
receptor I-Gene +
expression O +
, O +
bcl-2 B-Gene +
expression O +
and O +
numbers O +
of O +
CD8 O -
+ O +
leukocytes O +
were O +
found O +
in O +
ectopic O +
compared O +
with O +
eutopic O +
endometrium O +
in O +
endometriosis O +
, O +
and O +
CD56 O -
+ O +
endometrial O +
granulated O +
lymphocytes O +
( O +
eGLs O +
) O +
were O +
significantly O +
reduced O +
in O +
ectopic O +
endometrium O +
. O +

Apoptotic O +
cells O +
were O +
rarely O +
found O +
in O +
control O +
and O +
subject O +
endometria O +
. O +

In O +
contrast O +
with O +
endometriosis O +
, O +
adenomyotic O +
lesions O +
showed O +
identical O +
steroid B-Gene +
hormone I-Gene +
receptor I-Gene +
expression O +
, O +
proliferative O +
activity O +
, O +
bcl-2 B-Gene +
expression O +
and O +
leukocyte O +
subpopulations O +
to O +
eutopic O +
endometrium O +
, O +
indicating O +
different O +
aetiologies O +
for O +
these O +
disorders O +
. O +

The O +
unusual O +
CD56 O -
+ O +
CD16- O +
eGLs O +
present O +
in O +
large O +
numbers O +
in O +
late O +
secretory O +
phase O +
eutopic O +
endometrium O +
were O +
highly O +
purified O +
( O +
> O +
98 O +
% O +
) O +
by O +
immunomagnetic O +
separation O +
. O +

Except O +
for O +
a O +
negligible O +
cytotoxic O +
activity O +
of O +
eGLs O +
from O +
early O +
proliferative O +
samples O +
, O +
cytotoxic O +
activity O +
of O +
eGLs O +
from O +
non O -
- O -
pregnant O +
endometrium O +
during O +
the O +
menstrual O +
cycle O +
was O +
comparable O +
with O +
those O +
in O +
peripheral O +
blood O +
, O +
predominantly O +
CD56 O -
+ O +
CD16 O -
+ O +
natural O +
killer O +
cells O +
. O +

eGLs O +
from O +
non O -
- O -
pregnant O +
endometrium O +
and O +
early O +
pregnancy O +
showed O +
a O +
variable O +
proliferative O +
response O +
to O +
5 O +
and O +
100 O +
U O -
/ O -
ml O +
interleukin-2 B-Gene +
over O +
48-h O +
and O +
120-h O +
time O +
courses O +
. O +

eGLs O +
are O +
evidently O +
functionally O +
important O +
in O +
the O +
eutopic O +
endometrium O +
. O +

Their O +
absence O +
in O +
endometriotic O +
lesions O +
together O +
with O +
increased O +
CD+8 O +
T O -
- O -
cell O +
numbers O +
and O +
increased O +
oestrogen B-Gene +
receptor I-Gene +
and O +
bcl-2 B-Gene +
expression O +
may O +
have O +
significant O +
effects O +
on O +
the O +
development O +
and O +
progression O +
of O +
endometriosis O +
. O +

Activation O +
of O +
human O +
immunodeficiency O +
virus O +
type O +
1 O +
expression O +
by O +
Gardnerella O +
vaginalis O +
. O +

Bacterial O +
vaginosis O +
( O +
BV O +
) O +
is O +
associated O +
with O +
an O +
increased O +
rate O +
of O +
sexual O +
transmission O +
of O +
human O +
immunodeficiency O +
virus O +
( O +
HIV O +
) O +
type O +
1 O +
, O +
and O +
Gardnerella O +
vaginalis O +
is O +
frequently O +
isolated O +
from O +
the O +
genital O +
tracts O +
of O +
women O +
with O +
BV O +
. O +

G. O +
vaginalis O +
lysates O +
were O +
found O +
to O +
significantly O +
stimulate O +
HIV O +
expression O +
in O +
monocytoid O +
cells O +
. O +

Stimulation O +
was O +
significantly O +
higher O +
when O +
lysates O +
were O +
heated O +
at O +
100 O +
degrees O +
C O +
for O +
5 O +
min O +
but O +
was O +
reduced O +
by O +
treatment O +
with O +
lysozyme B-Gene +
or O +
protease B-Gene +
. O +

G. O +
vaginalis O +
lysates O +
also O +
activated O +
HIV O +
expression O +
in O +
certain O +
T O +
cell O +
lines O +
. O +

G. O +
vaginalis O +
lysates O +
activated O +
HIV O +
long O -
- O -
terminal O +
repeat O +
transcription O +
in O +
HIV O -
- O -
infected O +
cells O +
and O +
increased O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
binding O +
activity O +
, O +
indicating O +
an O +
effect O +
by O +
G. O +
vaginalis O +
on O +
HIV O +
transcription O +
. O +

The O +
activation O +
of O +
HIV O +
production O +
by O +
G. O +
vaginalis O +
suggests O +
that O +
genital O +
tract O +
infection O +
with O +
G. O +
vaginalis O +
increases O +
the O +
risk O +
of O +
HIV O +
transmission O +
by O +
increasing O +
HIV O +
expression O +
in O +
the O +
genital O +
tract O +
. O +

This O +
may O +
explain O +
, O +
at O +
least O +
in O +
part O +
, O +
the O +
increased O +
rate O +
of O +
HIV O +
transmission O +
in O +
women O +
with O +
BV O +
. O +

Alternative O +
polyadenylation O +
events O +
contribute O +
to O +
the O +
induction O +
of O +
NF B-Gene -
- I-Gene -
ATc I-Gene +
in O +
effector O +
T O +
cells O +
. O +

The O +
transcription B-Gene +
factor I-Gene +
NF B-Gene -
- I-Gene -
ATc I-Gene +
is O +
synthesized O +
in O +
three O +
prominent O +
isoforms B-Gene +
. O +

These O +
differ O +
in O +
the O +
length O +
of O +
their O +
C O +
terminal O +
peptides O +
and O +
mode O +
of O +
synthesis O +
. O +

Due O +
to O +
a O +
switch O +
from O +
the O +
use O +
of O +
a O +
3 O +
' O +
polyA O +
site O +
to O +
a O +
more O +
proximal O +
polyA O +
site O +
, O +
NF B-Gene -
- I-Gene -
ATc I-Gene +
expression O +
switches O +
from O +
the O +
synthesis O +
of O +
the O +
two O +
longer O +
isoforms O +
in O +
naive O +
T O +
cells O +
to O +
that O +
of O +
short O +
isoform B-Gene +
A I-Gene +
in O +
T O +
effector O +
cells O +
. O +

The O +
relative O +
low O +
binding O +
affinity O +
of O +
cleavage B-Gene +
stimulation I-Gene +
factor I-Gene +
CstF-64 B-Gene +
to O +
the O +
proximal O +
polyA O +
site O +
seems O +
to O +
contribute O +
to O +
its O +
neglect O +
in O +
naive O +
T O +
cells O +
. O +

These O +
alternative O +
polyadenylation O +
events O +
ensure O +
the O +
rapid O +
accumulation O +
of O +
high O +
concentrations O +
of O +
NF B-Gene -
- I-Gene -
ATc I-Gene +
necessary O +
to O +
exceed O +
critical O +
threshold O +
levels O +
of O +
NF B-Gene -
- I-Gene -
ATc I-Gene +
for O +
gene O +
induction O +
in O +
effector O +
T O +
cells O +
. O +

1 O +
, O +
25-Dihydroxyvitamin O +
D3 O +
induces O +
differentiation O +
of O +
a O +
retinoic O +
acid O -
- O -
resistant O +
acute O +
promyelocytic O +
leukemia O +
cell O +
line O +
( O +
UF-1 O +
) O +
associated O +
with O +
expression O +
of O +
p21 B-Gene +
( I-Gene +
WAF1 I-Gene -
/ I-Gene -
CIP1 I-Gene +
) I-Gene +
and O +
p27 B-Gene +
( I-Gene +
KIP1 I-Gene +
) I-Gene +
. O +

Retinoic O +
acid O +
( O +
RA O +
) O +
resistance O +
is O +
a O +
serious O +
problem O +
for O +
patients O +
with O +
acute O +
promyelocytic O +
leukemia O +
( O +
APL O +
) O +
who O +
are O +
receiving O +
all O -
- O -
trans O +
RA O +
. O +

However O +
, O +
the O +
mechanisms O +
and O +
strategies O +
to O +
overcome O +
RA O +
resistance O +
by O +
APL O +
cells O +
are O +
still O +
unclear O +
. O +

The O +
biologic O +
effects O +
of O +
RA O +
are O +
mediated O +
by O +
two O +
distinct O +
families O +
of O +
transcriptional B-Gene +
factors I-Gene +
: O +
RA B-Gene +
receptors I-Gene +
( O +
RARs B-Gene +
) O +
and O +
retinoid B-Gene +
X I-Gene +
receptors I-Gene +
( O +
RXRs B-Gene +
) O +
. O +

RXRs B-Gene +
heterodimerize O +
with O +
1 B-Gene +
, I-Gene +
25-dihydroxyvitamin I-Gene +
D3 I-Gene +
[ I-Gene +
1 I-Gene +
, I-Gene +
25 I-Gene +
( I-Gene +
OH I-Gene +
) I-Gene +
2D3 I-Gene +
] I-Gene +
receptor I-Gene +
( O +
VDR B-Gene +
) O +
, O +
enabling O +
their O +
efficient O +
transcriptional O +
activation O +
. O +

The O +
cyclin B-Gene -
- I-Gene -
dependent I-Gene +
kinase I-Gene +
( I-Gene +
cdk I-Gene +
) I-Gene +
inhibitor I-Gene +
p21 B-Gene +
( I-Gene +
WAF1 I-Gene -
/ I-Gene -
CIP1 I-Gene +
) I-Gene +
has O +
a O +
vitamin O +
D3-responsive O +
element O +
( O +
VDRE O +
) O +
in O +
its O +
promoter O +
, O +
and O +
1 O +
, O +
25 O +
( O +
OH O +
) O +
2D3 O +
enhances O +
the O +
expression O +
of O +
p21 B-Gene +
( I-Gene +
WAF1 I-Gene -
/ I-Gene -
CIP1 I-Gene +
) I-Gene +
and O +
induces O +
differentiation O +
of O +
selected O +
myeloid O +
leukemic O +
cell O +
lines O +
. O +

We O +
have O +
recently O +
established O +
a O +
novel O +
APL O +
cell O +
line O +
( O +
UF-1 O +
) O +
with O +
features O +
of O +
RA O +
resistance O +
. O +

1 O +
, O +
25 O +
( O +
OH O +
) O +
2D3 O +
can O +
induce O +
growth O +
inhibition O +
and O +
G1 O +
arrest O +
of O +
UF-1 O +
cells O +
, O +
resulting O +
in O +
differentiation O +
of O +
these O +
cells O +
toward O +
granulocytes O +
. O +

This O +
1 O +
, O +
25 O +
( O +
OH O +
) O +
2D3-induced O +
G1 O +
arrest O +
is O +
enhanced O +
by O +
all O -
- O -
trans O +
RA O +
. O +

Also O +
, O +
1 O +
, O +
25 O +
( O +
OH O +
) O +
2D3 O +
( O +
10 O +
( O +
-10 O +
) O +
to O +
10 O +
( O +
-7 O +
) O +
mol O -
/ O -
L O +
) O +
in O +
combination O +
with O +
RA O +
markedly O +
inhibits O +
cellular O +
proliferation O +
in O +
a O +
dose- O +
and O +
time O -
- O -
dependent O +
manner O +
. O +

Associated O +
with O +
these O +
findings O +
, O +
the O +
levels O +
of O +
p21 B-Gene +
( I-Gene +
WAF1 I-Gene -
/ I-Gene -
CIP1 I-Gene +
) I-Gene +
and O +
p27 O +
( O +
KIP1 O +
) O +
mRNA O +
and O +
protein O +
increased O +
in O +
these O +
cells O +
. O +

Northern O +
blot O +
analysis O +
showed O +
that O +
p21 O +
( O +
WAF1 O -
/ O -
CIP1 O +
) O +
and O +
p27 O +
( O +
KIP1 O +
) O +
mRNA O +
and O +
protein O +
increased O +
in O +
these O +
cells O +
. O +

Northern O +
blot O +
analysis O +
showed O +
that O +
p21 B-Gene +
( I-Gene +
WAF1 I-Gene -
/ I-Gene -
CIP1 I-Gene +
) I-Gene +
and O +
p27 B-Gene +
( I-Gene +
KIP1 I-Gene +
) I-Gene +
transcripts O +
were O +
induced O +
after O +
6 O +
hours O +
' O +
exposure O +
to O +
1 O +
, O +
25 O +
( O +
OH O +
) O +
2D3 O +
and O +
then O +
decreased O +
to O +
basal O +
levels O +
over O +
48 O +
hours O +
. O +

Western O +
blot O +
experiments O +
showed O +
that O +
p21 B-Gene +
( I-Gene +
WAF1 I-Gene -
/ I-Gene -
CIP1 I-Gene +
) I-Gene +
protein O +
levels O +
increased O +
and O +
became O +
detectable O +
after O +
12 O +
hours O +
of O +
1 O +
, O +
25 O +
( O +
OH O +
) O +
2D3 O +
treatment O +
and O +
induction O +
of O +
p27 B-Gene +
( I-Gene +
KIP1 I-Gene +
) I-Gene +
protein O +
was O +
much O +
more O +
gradual O +
and O +
sustained O +
in O +
UF-1 O +
cells O +
. O +

Interestingly O +
, O +
the O +
combination O +
of O +
1 O +
, O +
25 O +
( O +
OH O +
) O +
2D3 O +
and O +
RA O +
markedly O +
enhanced O +
the O +
levels O +
of O +
p27 B-Gene +
( I-Gene +
KIP1 I-Gene +
) I-Gene +
transcript O +
and O +
protein O +
as O +
compared O +
with O +
levels O +
induced O +
by O +
1 O +
, O +
25 O +
( O +
OH O +
) O +
2D3 O +
alone O +
. O +

In O +
addition O +
, O +
exogenous O +
p27 B-Gene +
( I-Gene +
KIP1 I-Gene +
) I-Gene +
expression O +
can O +
enhance O +
the O +
level O +
of O +
CD11b B-Gene +
antigen I-Gene +
in O +
myeloid O +
leukemic O +
cells O +
. O +

In O +
contrast O +
, O +
RA O +
alone O +
can O +
induce O +
G1 O +
arrest O +
of O +
UF-1 O +
cells O +
; O +
however O +
, O +
it O +
did O +
not O +
result O +
in O +
an O +
increase O +
of O +
p21 B-Gene +
( I-Gene +
WAF1 I-Gene -
/ I-Gene -
CIP1 I-Gene +
) I-Gene +
and O +
p27 B-Gene +
( I-Gene +
KIP1 I-Gene +
) I-Gene +
transcript O +
and O +
protein O +
expression O +
in O +
RA O -
- O -
resistant O +
cells O +
. O +

Taken O +
together O +
, O +
we O +
conclude O +
that O +
1 O +
, O +
25 O +
( O +
OH O +
) O +
2D3 O +
induces O +
increased O +
expression O +
of O +
cdk B-Gene +
inhibitors I-Gene +
, O +
which O +
mediates O +
a O +
G1 O +
arrest O +
, O +
and O +
this O +
may O +
be O +
associated O +
with O +
differentiation O +
of O +
RA O -
- O -
resistant O +
UF-1 O +
cells O +
toward O +
mature O +
granulocytes O +
. O +

IL-2 B-Gene +
-mediated O +
cell O +
cycle O +
progression O +
and O +
inhibition O +
of O +
apoptosis O +
does O +
not O +
require O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
or O +
activating O +
protein-1 O +
activation O +
in O +
primary O +
human O +
T O +
cells O +
. O +

The O +
IL-2 B-Gene +
growth O +
hormone O +
is O +
the O +
major O +
growth O +
factor O +
of O +
activated O +
T O +
lymphocytes O +
during O +
a O +
developing O +
immune O +
response O +
. O +

IL-2 B-Gene +
is O +
required O +
not O +
only O +
for O +
cell O +
cycle O +
progression O +
but O +
also O +
to O +
protect O +
Ag O -
- O -
activated O +
T O +
cells O +
from O +
programmed O +
cell O +
death O +
. O +

In O +
several O +
cell O +
types O +
, O +
activation O +
of O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
and/or O +
activating B-Gene +
protein-1 I-Gene +
( O +
AP-1 B-Gene +
) O +
has O +
been O +
demonstrated O +
to O +
be O +
extremely O +
important O +
in O +
blocking O +
apoptosis O +
. O +

To O +
determine O +
whether O +
either O +
or O +
both O +
of O +
these O +
transcription B-Gene +
factors I-Gene +
are O +
involved O +
in O +
cell O +
survival O +
or O +
cell O +
cycle O +
progression O +
in O +
response O +
to O +
IL-2 B-Gene +
, O +
primary O +
human O +
T O +
cells O +
responsive O +
to O +
the O +
growth O +
factor O +
were O +
analyzed O +
for O +
NF O -
- O -
kappa O +
B O +
and O +
AP-1 O +
activation O +
. O +

The O +
current O +
study O +
clearly O +
demonstrates O +
that O +
IL-2 B-Gene +
does O +
not O +
induce O +
I B-Gene +
kappa I-Gene +
B I-Gene +
alpha O +
degradation O +
or O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
activation O +
in O +
primary O +
human O +
T O +
cells O +
that O +
respond O +
to O +
IL-2 B-Gene +
by O +
entering O +
the O +
cell O +
cycle O +
and O +
avoiding O +
apoptosis O +
. O +

Similarly O +
, O +
IL-2 B-Gene +
neither O +
activates O +
JNK B-Gene +
nor O +
increases O +
AP-1 B-Gene +
binding O +
activity O +
to O +
a O +
consensus O +
o O -
- O -
tetradecanoylphorbol O +
13-acetate O +
( O +
TPA O +
) O +
response O +
element O +
. O +

On O +
the O +
other O +
hand O +
, O +
the O +
growth B-Gene +
factor I-Gene +
does O +
induce O +
the O +
activation O +
of O +
STAT3 B-Gene +
and O +
STAT5 B-Gene +
in O +
these O +
cells O +
, O +
as O +
has O +
been O +
previously O +
demonstrated O +
. O +

These O +
data O +
show O +
that O +
neither O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
nor O +
AP-1 B-Gene +
activation O +
is O +
required O +
for O +
IL-2 B-Gene +
-mediated O +
survival O +
or O +
cell O +
cycle O +
progression O +
in O +
activated O +
primary O +
human O +
T O +
cells O +
. O +

Impaired O +
fetal O +
thymocyte O +
development O +
after O +
efficient O +
adenovirus O -
- O -
mediated O +
inhibition O +
of O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
activation O +
. O +

We O +
introduce O +
a O +
new O +
experimental O +
system O +
combining O +
adenovirus O -
- O -
mediated O +
gene O +
transfer O +
and O +
fetal O +
thymic O +
organ O +
culture O +
( O +
FTOC O +
) O +
. O +

This O +
system O +
allowed O +
us O +
to O +
efficiently O +
express O +
in O +
developing O +
thymocytes O +
a O +
mutant O +
form O +
of O +
the O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
inhibitor O +
I B-Gene +
kappa I-Gene +
B I-Gene +
alpha I-Gene +
( O +
mut B-Gene -
- I-Gene -
I I-Gene +
kappa I-Gene +
B I-Gene +
) O +
and O +
to O +
study O +
the O +
maturation O +
defects O +
occurring O +
when O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
activation O +
is O +
inhibited O +
during O +
fetal O +
development O +
. O +

Fetal O +
thymocytes O +
infected O +
with O +
adenovirus O +
containing O +
mut B-Gene -
- I-Gene -
I I-Gene +
kappa I-Gene +
B I-Gene +
were O +
found O +
to O +
develop O +
normally O +
until O +
the O +
CD44 B-Gene +
-CD25 O -
+ O +
, O +
CD4 B-Gene +
- O +
CD8 B-Gene +
- O +
double O -
- O -
negative O +
stage O +
, O +
while O +
production O +
of O +
more O +
mature O +
double O -
- O -
positive O +
and O +
single O -
- O -
positive O +
populations O +
was O +
strongly O +
decreased O +
. O +

Proliferation O +
, O +
as O +
measured O +
by O +
the O +
percentage O +
of O +
cells O +
in O +
cycle O +
appeared O +
normal O +
, O +
as O +
did O +
rearrangement O +
and O +
expression O +
of O +
the O +
TCR B-Gene +
beta I-Gene -
- I-Gene -
chain I-Gene +
. O +

However O +
, O +
apoptosis O +
was O +
much O +
higher O +
in O +
FTOC O +
infected O +
with O +
adenovirus O +
containing O +
mut B-Gene -
- I-Gene -
I I-Gene +
kappa I-Gene +
B I-Gene +
than O +
in O +
FTOC O +
infected O +
with O +
a O +
control O +
virus O +
. O +

Taken O +
together O +
, O +
these O +
results O +
suggest O +
that O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
plays O +
a O +
crucial O +
role O +
in O +
ensuring O +
the O +
differentiation O +
and O +
survival O +
of O +
thymocytes O +
in O +
the O +
early O +
stages O +
of O +
their O +
development O +
. O +

Transient O +
pseudo O -
- O -
hypoaldosteronism O +
following O +
resection O +
of O +
the O +
ileum O +
: O +
normal O +
level O +
of O +
lymphocytic B-Gene +
aldosterone I-Gene +
receptors I-Gene +
outside O +
the O +
acute O +
phase O +
. O +

Pseudo O -
- O -
hypoaldosteronism O +
( O +
PHA O +
) O +
is O +
due O +
to O +
mineralocorticoid O +
resistance O +
and O +
manifests O +
as O +
hyponatremia O +
and O +
hyperkalemia O +
with O +
increased O +
plasma O +
aldosterone O +
levels O +
. O +

It O +
may O +
be O +
familial O +
or O +
secondary O +
to O +
abnormal O +
renal O +
sodium O +
handling O +
. O +

We O +
report O +
the O +
case O +
of O +
a O +
54-year O -
- O -
old O +
woman O +
with O +
multifocal O +
cancer O +
of O +
the O +
colon O +
, O +
who O +
developed O +
PHA O +
after O +
subtotal O +
colectomy O +
, O +
ileal O +
resection O +
and O +
jejunostomy O +
. O +

She O +
was O +
treated O +
with O +
6 O +
g O +
of O +
salt O +
daily O +
to O +
prevent O +
dehydration O +
, O +
which O +
she O +
stopped O +
herself O +
because O +
of O +
reduced O +
fecal O +
losses O +
. O +

One O +
month O +
later O +
she O +
was O +
admitted O +
with O +
signs O +
of O +
acute O +
adrenal O +
failure O +
, O +
i.e. O +
fatigue O +
, O +
severe O +
nausea O +
, O +
blood O +
pressure O +
of O +
80 O -
/ O -
60 O +
mmHg O +
, O +
extracellular O +
dehydration O +
, O +
hyponatremia O +
( O +
118 O +
mmol O -
/ O -
l O +
) O +
; O +
hyperkalemia O +
( O +
7.6 O +
mmol O -
/ O -
l O +
) O +
, O +
increased O +
blood O +
urea O +
nitrogen O +
( O +
BUN O +
) O +
( O +
200 O +
mg O -
/ O -
dl O +
) O +
and O +
creatininemia O +
( O +
2.5 O +
mg O -
/ O -
dl O +
) O +
, O +
and O +
decreased O +
plasma O +
bicarbonates O +
level O +
( O +
HCO3- O +
: O +
16 O +
mmol O -
/ O -
l O +
; O +
N O +
: O +
27 O -
- O -
30 O +
) O +
. O +

However O +
, O +
the O +
plasma O +
cortisol O +
was O +
high O +
( O +
66 O +
microg O -
/ O -
100 O +
ml O +
at O +
10 O +
: O +
00 O +
h O +
; O +
N O +
: O +
8 O -
- O -
15 O +
) O +
and O +
the O +
ACTH O +
was O +
normal O +
( O +
13 O +
pg O -
/ O -
ml O +
, O +
N O +
: O +
10 O -
- O -
60 O +
) O +
; O +
there O +
was O +
a O +
marked O +
increase O +
in O +
plasma O +
renin O +
activity O +
( O +
> O +
37 O +
ng O -
/ O -
ml O -
/ O -
h O +
; O +
N O +
supine O +
< O +
3 O +
) O +
, O +
active O +
renin O +
( O +
869 O +
pg O -
/ O -
ml O +
; O +
N O +
supine O +
: O +
1.120 O +
) O +
, O +
aldosterone O +
( O +
> O +
2000 O +
pg O -
/ O -
ml O +
; O +
N O +
supine O +
< O +
150 O +
) O +
and O +
plasma O +
AVP O +
( O +
20 O +
pmol O -
/ O -
l O +
; O +
N O +
: O +
0.5 O -
- O -
2.5 O +
) O +
. O +

The O +
plasma O +
ANH O +
level O +
was O +
38 O +
pmol O -
/ O -
l O +
( O +
N O +
supine O +
: O +
5 O -
- O -
25 O +
) O +
. O +

A O +
urinary O +
steroidogram O +
resulted O +
in O +
highly O +
elevated O +
tetrahydrocortisol O +
( O +
THF O +
: O +
13.3 O +
mg O -
/ O -
24h O +
; O +
N O +
: O +
1.4+ O -
/ O -
-0.8 O +
) O +
with O +
no O +
increase O +
in O +
tetrahydrocortisone O +
( O +
THE O +
: O +
3.16 O +
mg O -
/ O -
24h O +
; O +
N O +
: O +
2.7+ O -
/ O -
-2.0 O +
) O +
excretion O +
, O +
and O +
with O +
low O +
THE O -
/ O -
THF O +
( O +
0.24 O +
; O +
N O +
: O +
1.87+ O -
/ O -
-0.36 O +
) O +
and O +
alpha O +
THF O -
/ O -
THF O +
( O +
0.35 O +
; O +
N O +
: O +
0.92+ O -
/ O -
-0.42 O +
) O +
ratios O +
. O +

The O +
number O +
of O +
mineralocorticoid B-Gene +
receptors I-Gene +
in O +
mononuclear O +
leukocytes O +
was O +
in O +
the O +
lower O +
normal O +
range O +
for O +
age O +
, O +
while O +
the O +
number O +
of O +
glucocorticoid B-Gene +
receptors I-Gene +
was O +
reduced O +
. O +

Small O -
- O -
bowel O +
resection O +
in O +
ileostomized O +
patients O +
causes O +
excessive O +
fecal O +
sodium O +
losses O +
and O +
results O +
in O +
chronic O +
sodium O +
depletion O +
with O +
contraction O +
of O +
the O +
plasma O +
volume O +
and O +
severe O +
secondary O +
hyperaldosteronism O +
. O +

Nevertheless O +
, O +
this O +
hyperaldosteronism O +
may O +
be O +
associated O +
with O +
hyponatremia O +
and O +
hyperkalemia O +
suggesting O +
PHA O +
related O +
to O +
the O +
major O +
importance O +
of O +
the O +
colon O +
for O +
the O +
absorption O +
of O +
sodium O +
. O +

In O +
conclusion O +
, O +
this O +
case O +
report O +
emphasizes O +
1 O +
) O +
the O +
possibility O +
of O +
a O +
syndrome O +
of O +
acquired O +
PHA O +
with O +
severe O +
hyperkalemia O +
after O +
resection O +
of O +
the O +
ileum O +
and O +
colon O +
responding O +
to O +
oral O +
salt O +
supplementation O +
; O +
2 O +
) O +
the O +
major O +
increase O +
in O +
AVP O +
and O +
the O +
small O +
increase O +
in O +
ANH O +
; O +
3 O +
) O +
the O +
strong O +
increase O +
in O +
urinary O +
THF O +
with O +
low O +
THE O -
/ O -
THF O +
and O +
alpha O +
THF O -
/ O -
THF O +
ratios O +
; O +
4 O +
) O +
the O +
normal O +
number O +
of O +
lymphocytic B-Gene +
mineralocorticoid I-Gene +
receptors I-Gene +
outside O +
the O +
acute O +
episode O +
. O +

SHP2-interacting B-Gene +
transmembrane I-Gene +
adaptor I-Gene +
protein I-Gene +
( O +
SIT B-Gene +
) O +
, O +
a O +
novel O +
disulfide B-Gene -
- I-Gene -
linked I-Gene +
dimer I-Gene +
regulating O +
human O +
T O +
cell O +
activation O +
. O +

T O +
lymphocytes O +
express O +
several O +
low B-Gene +
molecular I-Gene +
weight I-Gene +
transmembrane I-Gene +
adaptor I-Gene +
proteins I-Gene +
that O +
recruit O +
src B-Gene +
homology I-Gene +
( I-Gene +
SH I-Gene +
) I-Gene +
2 I-Gene +
domain I-Gene -
- I-Gene -
containing I-Gene +
intracellular I-Gene +
molecules I-Gene +
to O +
the O +
cell O +
membrane O +
via O +
tyrosine O -
- O -
based O +
signaling O +
motifs O +
. O +

We O +
describe O +
here O +
a O +
novel O +
molecule O +
of O +
this O +
group O +
termed O +
SIT B-Gene +
( O +
SHP2 B-Gene +
interacting I-Gene +
transmembrane I-Gene +
adaptor I-Gene +
protein I-Gene +
) O +
. O +

SIT B-Gene +
is O +
a O +
disulfide B-Gene -
- I-Gene -
linked I-Gene +
homodimeric I-Gene +
glycoprotein I-Gene +
that O +
is O +
expressed O +
in O +
lymphocytes O +
. O +

After O +
tyrosine O +
phosphorylation O +
by O +
src B-Gene +
and O +
possibly O +
syk B-Gene +
protein B-Gene +
tyrosine I-Gene +
kinases I-Gene +
SIT B-Gene +
recruits O +
the O +
SH2 B-Gene +
domain I-Gene -
- I-Gene -
containing I-Gene +
tyrosine I-Gene +
phosphatase I-Gene +
SHP2 B-Gene +
via O +
an O +
immunoreceptor O +
tyrosine O -
- O -
based O +
inhibition O +
motif O +
. O +

Overexpression O +
of O +
SIT B-Gene +
in O +
Jurkat O +
cells O +
downmodulates O +
T O +
cell O +
receptor- O +
and O +
phytohemagglutinin O -
- O -
mediated O +
activation O +
of O +
the O +
nuclear B-Gene +
factor I-Gene +
of I-Gene +
activated I-Gene +
T I-Gene +
cells I-Gene +
( O +
NF B-Gene -
- I-Gene -
AT I-Gene +
) O +
by O +
interfering O +
with O +
signaling O +
processes O +
that O +
are O +
probably O +
located O +
upstream O +
of O +
activation O +
of O +
phospholipase B-Gene +
C I-Gene +
. O +

However O +
, O +
binding O +
of O +
SHP2 B-Gene +
to O +
SIT B-Gene +
is O +
not O +
required O +
for O +
inhibition O +
of O +
NF B-Gene -
- I-Gene -
AT I-Gene +
induction O +
, O +
suggesting O +
that O +
SIT B-Gene +
not O +
only O +
regulates O +
NF B-Gene -
- I-Gene -
AT I-Gene +
activity O +
but O +
also O +
controls O +
NF B-Gene -
- I-Gene -
AT I-Gene +
unrelated O +
pathways O +
of O +
T O +
cell O +
activation O +
involving O +
SHP2 B-Gene +
. O +

GrpL B-Gene +
, O +
a O +
Grb2 B-Gene +
-related O +
adaptor B-Gene +
protein I-Gene +
, O +
interacts O +
with O +
SLP-76 B-Gene +
to O +
regulate O +
nuclear B-Gene +
factor I-Gene +
of I-Gene +
activated I-Gene +
T I-Gene +
cell I-Gene +
activation O +
. O +

Propagation O +
of O +
signals O +
from O +
the O +
T B-Gene +
cell I-Gene +
antigen I-Gene +
receptor I-Gene +
( O +
TCR B-Gene +
) O +
involves O +
a O +
number O +
of O +
adaptor O +
molecules O +
. O +

SH2 B-Gene +
domain I-Gene -
- I-Gene -
containing I-Gene +
protein I-Gene +
76 I-Gene +
( O +
SLP-76 B-Gene +
) O +
interacts O +
with O +
the O +
guanine B-Gene +
nucleotide I-Gene +
exchange I-Gene +
factor I-Gene +
Vav B-Gene +
to O +
activate O +
the O +
nuclear B-Gene +
factor I-Gene +
of I-Gene +
activated I-Gene +
cells I-Gene +
( O +
NF B-Gene -
- I-Gene -
AT I-Gene +
) O +
, O +
and O +
its O +
expression O +
is O +
required O +
for O +
normal O +
T O +
cell O +
development O +
. O +

We O +
report O +
the O +
cloning O +
and O +
characterization O +
of O +
a O +
novel O +
Grb2-like B-Gene +
adaptor I-Gene +
molecule I-Gene +
designated O +
as O +
Grb2-related B-Gene +
protein I-Gene +
of I-Gene +
the I-Gene +
lymphoid I-Gene +
system I-Gene +
( O +
GrpL B-Gene +
) O +
. O +

Expression O +
of O +
GrpL B-Gene +
is O +
restricted O +
to O +
hematopoietic O +
tissues O +
, O +
and O +
it O +
is O +
distinguished O +
from O +
Grb2 B-Gene +
by O +
having O +
a O +
proline B-Gene -
- I-Gene -
rich I-Gene +
region I-Gene +
. O +

GrpL B-Gene +
can O +
be O +
coimmunoprecipitated O +
with O +
SLP-76 B-Gene +
but O +
not O +
with O +
Sos1 B-Gene +
or O +
Sos2 B-Gene +
from O +
Jurkat O +
cell O +
lysates O +
. O +

In O +
contrast O +
, O +
Grb2 B-Gene +
can O +
be O +
coimmunoprecipitated O +
with O +
Sos1 B-Gene +
and O +
Sos2 B-Gene +
but O +
not O +
with O +
SLP-76 B-Gene +
. O +

Moreover O +
, O +
tyrosine B-Gene -
- I-Gene -
phosphorylated I-Gene +
LAT I-Gene -
/ I-Gene -
pp36 I-Gene -
/ I-Gene -
38 I-Gene +
in O +
detergent O +
lysates O +
prepared O +
from O +
anti O -
- O -
CD3 O +
stimulated O +
T O +
cells O +
associated O +
with O +
Grb2 B-Gene +
but O +
not O +
GrpL B-Gene +
. O +

These O +
data O +
reveal O +
the O +
presence O +
of O +
distinct O +
complexes O +
involving O +
GrpL B-Gene +
and O +
Grb2 B-Gene +
in O +
T O +
cells O +
. O +

A O +
functional O +
role O +
of O +
the O +
GrpL B-Gene -
- I-Gene -
SLP-76 I-Gene +
complex I-Gene +
is O +
suggested O +
by O +
the O +
ability O +
of O +
GrpL B-Gene +
to O +
act O +
alone O +
or O +
in O +
concert O +
with O +
SLP-76 B-Gene +
to O +
augment O +
NF B-Gene -
- I-Gene -
AT I-Gene +
activation O +
in O +
Jurkat O +
T O +
cells O +
. O +

Transcription B-Gene +
factors I-Gene +
Sp1 B-Gene +
and O +
AP-2 B-Gene +
mediate O +
induction O +
of O +
acid B-Gene +
sphingomyelinase I-Gene +
during O +
monocytic O +
differentiation O +
. O +

Cells O +
from O +
the O +
human O +
monocytic O +
leukemia O +
cell O +
line O +
THP-1 O +
differentiate O +
towards O +
a O +
macrophage O -
- O -
like O +
phenotype O +
when O +
stimulated O +
with O +
phorbol O +
12-myristate O +
-13- O +
acetate O +
( O +
PMA O +
) O +
, O +
1 O +
, O +
25-dihydroxy O -
- O -
vitamin O +
D3 O +
, O +
and O +
various O +
other O +
agents O +
. O +

We O +
demonstrate O +
here O +
that O +
the O +
expression O +
of O +
the O +
lysosomal B-Gene +
enzyme I-Gene +
acid B-Gene +
sphingomyelinase I-Gene +
( O +
ASM O +
; O +
E.C.3.1.4.12 O +
) O +
is O +
induced O +
during O +
this O +
process O +
and O +
is O +
strongly O +
elevated O +
in O +
differentiated O +
THP-1 O +
cells O +
, O +
as O +
well O +
as O +
in O +
differentiated O +
human O +
mononuclear O +
phagocytes O +
. O +

Using O +
Northern O +
blotting O +
, O +
RNase B-Gene +
protection O +
assay O +
, O +
and O +
nuclear O +
run O -
- O -
on O +
analyses O +
, O +
we O +
show O +
that O +
the O +
up O -
- O -
regulation O +
of O +
ASM O +
expression O +
is O +
regulated O +
mainly O +
at O +
the O +
level O +
of O +
transcription O +
and O +
that O +
new O +
protein O +
synthesis O +
is O +
required O +
for O +
enhanced O +
ASM O +
activity O +
. O +

This O +
cell O -
- O -
type O +
specific O +
induction O +
by O +
PMA O +
treatment O +
was O +
further O +
investigated O +
with O +
respect O +
to O +
transcriptional O +
control O +
. O +

A O +
series O +
of O +
5 O +
' O +
deletion O +
derivatives O +
of O +
the O +
upstream O +
regulatory O +
region O +
were O +
used O +
in O +
transient O +
transfection O +
assays O +
to O +
identify O +
promoter O +
elements O +
required O +
for O +
basal O +
and O +
inducible O +
gene O +
expression O +
. O +

A O +
PMA O +
responsive O +
element O +
was O +
localized O +
to O +
a O +
region O +
between O +
-319 O +
and O +
-219 O +
bp O +
upstream O +
of O +
the O +
initiation O +
codon O +
and O +
co O -
- O -
transfections O +
with O +
transcription O +
factor O +
expression O +
plasmids O +
for O +
AP-2 B-Gene +
and O +
Sp1 B-Gene +
resulted O +
in O +
augmented O +
ASM O +
promoter O +
activity O +
, O +
which O +
was O +
abolished O +
when O +
the O +
binding O +
sites O +
for O +
these O +
two O +
factors O +
were O +
deleted O +
. O +

Using O +
electrophoretic O +
mobility O +
shift O +
assays O +
and O +
supershift O +
assays O +
we O +
demonstrate O +
that O +
this O +
region O +
is O +
specifically O +
bound O +
by O +
Sp1 B-Gene +
and O +
AP-2 B-Gene +
. O +

These O +
factors O +
are O +
present O +
in O +
nuclear O +
extracts O +
prepared O +
from O +
both O +
induced O +
and O +
uninduced O +
THP-1 O +
cells O +
. O +

However O +
, O +
the O +
intensity O +
of O +
the O +
complex O +
formed O +
appeared O +
to O +
increase O +
when O +
nuclear O +
extracts O +
from O +
PMA O -
- O -
treated O +
cells O +
were O +
used O +
. O +

From O +
these O +
studies O +
, O +
we O +
conclude O +
that O +
a O +
concerted O +
action O +
of O +
the O +
transcription B-Gene +
factors I-Gene +
AP-2 B-Gene +
and O +
Sp1 B-Gene +
is O +
essential O +
for O +
the O +
up O +
-regulation O +
of O +
ASM O +
expression O +
during O +
the O +
process O +
of O +
macrophage O +
differentiation O +
. O +

Grf40 B-Gene +
, O +
A O +
novel O +
Grb2 B-Gene +
family I-Gene +
member I-Gene +
, O +
is O +
involved O +
in O +
T O +
cell O +
signaling O +
through O +
interaction O +
with O +
SLP-76 B-Gene +
and O +
LAT B-Gene +
. O +

We O +
molecularly O +
cloned O +
a O +
new O +
Grb2 B-Gene +
family I-Gene +
member I-Gene +
, O +
named O +
Grf40 B-Gene +
, O +
containing O +
the O +
common O +
SH3-SH2-SH3 B-Gene +
motif I-Gene +
. O +

Expression O +
of O +
Grf40 B-Gene +
is O +
predominant O +
in O +
hematopoietic O +
cells O +
, O +
particularly O +
T O +
cells O +
. O +

Grf40 B-Gene +
binds O +
to O +
the O +
SH2 B-Gene +
domain I-Gene -
- I-Gene -
containing I-Gene +
leukocyte I-Gene +
protein I-Gene +
of O +
76 O +
kD O +
( O +
SLP-76 B-Gene +
) O +
via O +
its O +
SH3 O +
domain O +
more O +
tightly O +
than O +
Grb2 B-Gene +
. O +

Incidentally O +
, O +
Grf40 B-Gene +
binds O +
to O +
linker B-Gene +
for I-Gene +
activation I-Gene +
of I-Gene +
T I-Gene +
cells I-Gene +
( O +
LAT B-Gene +
) O +
possibly O +
via O +
its O +
SH2 B-Gene +
domain I-Gene +
. O +

Overexpression O +
of O +
wild B-Gene -
- I-Gene -
type I-Gene +
Grf40 I-Gene +
in O +
Jurkat O +
cells O +
induced O +
a O +
significant O +
increase O +
of O +
SLP-76-dependent O +
interleukin O +
( O +
IL O +
) O +
-2 O +
promoter O +
and O +
nuclear B-Gene +
factor I-Gene +
of I-Gene +
activated I-Gene +
T I-Gene +
cell I-Gene +
( O +
NF B-Gene -
- I-Gene -
AT I-Gene +
) O +
activation O +
upon O +
T B-Gene +
cell I-Gene +
receptor I-Gene +
( O +
TCR B-Gene +
) O +
stimulation O +
, O +
whereas O +
the O +
COOH B-Gene -
- I-Gene -
terminal I-Gene +
SH3-deleted I-Gene +
Grf40 I-Gene +
mutant I-Gene +
lacked O +
any O +
recognizable O +
increase O +
in O +
IL-2 O +
promoter O +
activity O +
. O +

Furthermore O +
, O +
the O +
SH2-deleted B-Gene +
Grf40 I-Gene +
mutant I-Gene +
led O +
to O +
a O +
marked O +
inhibition O +
of O +
these O +
regulatory O +
activities O +
, O +
the O +
effect O +
of O +
which O +
is O +
apparently O +
stronger O +
than O +
that O +
of O +
the O +
SH2-deleted B-Gene +
Grb2 I-Gene +
mutant I-Gene +
. O +

Our O +
data O +
suggest O +
that O +
Grf40 B-Gene +
is O +
an O +
adaptor B-Gene +
molecule I-Gene +
involved O +
in O +
TCR B-Gene +
-mediated O +
signaling O +
through O +
a O +
more O +
efficient O +
interaction O +
than O +
Grb2 B-Gene +
with O +
SLP-76 B-Gene +
and O +
LAT B-Gene +
. O +

High O +
molecular O +
weight O +
dextran O +
sulfate O +
increases O +
the O +
activity O +
of O +
NF O -
- O -
kappaB O -
- O -
regulated O +
promoter O +
in O +
monocyte O -
- O -
derived O +
macrophages O +
. O +

It O +
is O +
known O +
that O +
sulfated O +
polysaccharides O +
can O +
mimic O +
the O +
action O +
of O +
common B-Gene +
T I-Gene -
- I-Gene -
cell I-Gene +
mitogens I-Gene +
. O +

To O +
investigate O +
the O +
molecular O +
basis O +
of O +
the O +
mitogenic O +
effect O +
of O +
high O +
molecular O +
weight O +
dextran O +
sulfate O +
( O +
HMDS O +
) O +
, O +
monocyte O -
- O -
derived O +
macrophages O +
were O +
transfected O +
with O +
recombinant O +
plasmid O +
containing O +
chloramphenicol O +
acetyl O +
transferase O +
( O +
CAT O +
) O +
reporter O +
gene O +
under O +
the O +
control O +
of O +
the O +
HIV-1 O +
long O +
terminal O +
repeat O +
( O +
LTR O +
) O +
promoter O +
, O +
which O +
is O +
regulated O +
by O +
transcription B-Gene +
factor I-Gene +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
. O +

We O +
observed O +
that O +
HMDS O +
, O +
similar O +
to O +
bacterial O +
lipopolysaccharide O +
( O +
LPS O +
) O +
, O +
increases O +
the O +
expression O +
of O +
CAT O +
reporter O +
gene O +
suggesting O +
increased O +
activity O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
. O +

The O +
activation O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
correlated O +
with O +
the O +
increased O +
expression O +
of O +
B7.1 B-Gene +
molecules I-Gene +
. O +

It O +
was O +
postulated O +
that O +
this O +
NF O -
- O -
kappaB O -
- O -
regulated O +
promoter O +
might O +
play O +
a O +
role O +
in O +
the O +
activation O +
of O +
the O +
accessory O +
cells O +
as O +
well O +
as O +
the O +
rate O +
of O +
replication O +
of O +
HIV-1 O +
in O +
monocyte O -
- O -
derived O +
macrophages O +
. O +

HLA B-Gene +
class I-Gene +
I I-Gene +
-mediated O +
induction O +
of O +
cell O +
proliferation O +
involves O +
cyclin O +
E O +
-mediated O +
inactivation O +
of O +
Rb O +
function O +
and O +
induction O +
of O +
E2F B-Gene +
activity O +
. O +

Chronic O +
rejection O +
of O +
transplanted O +
organs O +
is O +
manifested O +
as O +
atherosclerosis O +
of O +
the O +
blood O +
vessels O +
of O +
the O +
allograft O +
. O +

HLA B-Gene +
class I-Gene +
I I-Gene +
Ags I-Gene +
have O +
been O +
implicated O +
to O +
play O +
a O +
major O +
role O +
in O +
this O +
process O +
, O +
since O +
signaling O +
via O +
HLA B-Gene +
class I-Gene +
I I-Gene +
molecules I-Gene +
can O +
induce O +
the O +
proliferation O +
of O +
aortic O +
endothelial O +
as O +
well O +
as O +
smooth O +
muscle O +
cells O +
. O +

In O +
this O +
study O +
, O +
we O +
show O +
that O +
HLA B-Gene +
class I-Gene +
I I-Gene +
-mediated O +
induction O +
of O +
cell O +
proliferation O +
correlates O +
with O +
inactivation O +
of O +
the O +
Rb B-Gene +
protein I-Gene +
in O +
the O +
T O +
cell O +
line O +
Jurkat O +
as O +
well O +
as O +
human O +
aortic O +
endothelial O +
cells O +
. O +

HLA B-Gene +
class I-Gene +
I I-Gene +
-mediated O +
inactivation O +
of O +
Rb B-Gene +
can O +
be O +
inhibited O +
specifically O +
by O +
neutralizing B-Gene +
Abs I-Gene +
to O +
basic B-Gene +
fibroblast I-Gene +
growth I-Gene +
factor I-Gene +
( O +
bFGF B-Gene +
) O +
, O +
suggesting O +
a O +
role O +
for O +
FGF B-Gene +
receptors I-Gene +
in O +
the O +
signaling O +
process O +
. O +

Signaling O +
through O +
HLA B-Gene +
class I-Gene +
I I-Gene +
molecules I-Gene +
induced O +
cyclin O +
E O +
-associated O +
kinase O +
activity O +
within O +
4 O +
h O +
in O +
quiescent O +
endothelial O +
cells O +
, O +
and O +
appeared O +
to O +
mediate O +
the O +
inactivation O +
of O +
Rb B-Gene +
. O +

A O +
cdk2 O +
inhibitor O +
, O +
Olomoucine O +
, O +
as O +
well O +
as O +
a O +
dominant O -
- O -
negative O +
cdk2 O +
construct O +
prevented O +
HLA B-Gene +
class I-Gene +
I I-Gene +
-mediated O +
inactivation O +
of O +
Rb B-Gene +
; O +
in O +
contrast O +
, O +
dominant O -
- O -
negative O +
cdk4 O +
and O +
cdk6 O +
constructs O +
had O +
no O +
effect O +
. O +

Furthermore O +
, O +
there O +
was O +
no O +
increase O +
in O +
cyclin B-Gene +
D I-Gene -
- I-Gene -
associated I-Gene +
kinase I-Gene +
activity O +
upon O +
HLA B-Gene +
class I-Gene +
I I-Gene +
ligation O +
, O +
suggesting O +
that O +
cyclin B-Gene +
E I-Gene -
- I-Gene -
dependent I-Gene +
kinase I-Gene +
activity O +
mediates O +
Rb B-Gene +
inactivation O +
, O +
leading O +
to O +
E2F B-Gene +
activation O +
and O +
cell O +
proliferation O +
. O +

Protein B-Gene +
kinase I-Gene +
B I-Gene +
( O +
c B-Gene -
- I-Gene -
Akt I-Gene +
) O +
, O +
phosphatidylinositol B-Gene +
3-kinase I-Gene +
, O +
and O +
STAT5 B-Gene +
are O +
activated O +
by O +
erythropoietin B-Gene +
( O +
EPO B-Gene +
) O +
in O +
HCD57 O +
erythroid O +
cells O +
but O +
are O +
constitutively O +
active O +
in O +
an O +
EPO O -
- O -
independent O +
, O +
apoptosis O -
- O -
resistant O +
subclone O +
( O +
HCD57-SREI O +
cells O +
) O +
. O +

We O +
found O +
that O +
erythropoietin B-Gene +
( O +
EPO B-Gene +
) O +
and O +
stem B-Gene +
cell I-Gene +
factor I-Gene +
( O +
SCF B-Gene +
) O +
activated B-Gene +
protein I-Gene +
kinase I-Gene +
B I-Gene +
( O +
PKB B-Gene -
/ I-Gene -
Akt I-Gene +
) O +
in O +
EPO O -
- O -
dependent O +
HCD57 O +
erythroid O +
cells O +
. O +

To O +
better O +
understand O +
signals O +
controlling O +
proliferation O +
and O +
viability O +
, O +
erythroid O +
cells O +
that O +
resist O +
apoptosis O +
in O +
the O +
absence O +
of O +
EPO B-Gene +
were O +
subcloned O +
and O +
characterized O +
( O +
HCD57-SREI O +
cells O +
) O +
. O +

Constitutive O +
activations O +
of O +
PKB B-Gene -
/ I-Gene -
Akt I-Gene +
, O +
STAT5a B-Gene +
, O +
and O +
STAT5b B-Gene +
were O +
noted O +
in O +
these O +
EPO O -
- O -
independent O +
cells O +
. O +

PI3-kinase B-Gene +
activity O +
was O +
an O +
upstream O +
activator O +
of O +
PKB B-Gene -
/ I-Gene -
Akt I-Gene +
because O +
the O +
PI3-kinase B-Gene +
inhibitor O +
LY294002 O +
blocked O +
both O +
constitutive O +
PKB B-Gene -
/ I-Gene -
Akt I-Gene +
and O +
factor O -
- O -
dependent O +
PKB B-Gene -
/ I-Gene -
Akt I-Gene +
activity O +
. O +

The O +
LY294002 O +
study O +
showed O +
that O +
proliferation O +
and O +
viability O +
of O +
both O +
HCD57-SREI O +
and O +
HCD57 O +
cells O +
correlated O +
with O +
the O +
activity O +
of O +
PKB B-Gene -
/ I-Gene -
Akt I-Gene +
; O +
however O +
, O +
PKB B-Gene -
/ I-Gene -
Akt I-Gene +
activity O +
alone O +
did O +
not O +
protect O +
these O +
cells O +
from O +
apoptosis O +
. O +

Treatment O +
of O +
HCD57 O +
cells O +
with O +
SCF B-Gene +
also O +
activated O +
PKB B-Gene -
/ I-Gene -
Akt I-Gene +
, O +
but O +
did O +
not O +
protect O +
from O +
apoptosis O +
. O +

This O +
result O +
suggested O +
that O +
PKB B-Gene -
/ I-Gene -
PI3-kinase I-Gene +
activity O +
is O +
necessary O +
but O +
not O +
sufficient O +
to O +
promote O +
viability O +
and/or O +
proliferation O +
. O +

Constitutive O +
STAT5 B-Gene +
activity O +
, O +
activated O +
through O +
an O +
unknown O +
pathway O +
not O +
including O +
JAK2 B-Gene +
or O +
EPOR B-Gene +
, O +
may O +
act O +
in O +
concert O +
with O +
the O +
constitutive O +
PI3-kinase B-Gene +
/PKB B-Gene -
/ I-Gene -
Akt I-Gene +
pathway O +
to O +
protect O +
the O +
EPO O -
- O -
independent O +
HCD57-SREI O +
cells O +
from O +
apoptosis O +
and O +
promote O +
limited O +
proliferation O +
. O +

Targeted O +
remodeling O +
of O +
human O +
beta O -
- O -
globin O +
promoter O +
chromatin O +
structure O +
produces O +
increased O +
expression O +
and O +
decreased O +
silencing O +
. O +

The O +
chromatin O +
structure O +
of O +
the O +
human O +
beta O -
- O -
globin O +
gene O +
locus O +
assumes O +
a O +
transcriptionally O -
- O -
active O +
conformation O +
in O +
erythroid O +
cells O +
. O +

One O +
feature O +
of O +
this O +
chromatin O +
reorganization O +
is O +
the O +
formation O +
of O +
DNase O +
1 O +
hypersensitive O +
sites O +
in O +
the O +
regions O +
of O +
active O +
globin O +
gene O +
promoters O +
. O +

This O +
reorganization O +
requires O +
the O +
globin O +
locus O +
control O +
region O +
and O +
is O +
associated O +
with O +
normal O +
expression O +
of O +
the O +
beta O -
- O -
like O +
globin O +
genes O +
. O +

To O +
determine O +
whether O +
it O +
is O +
possible O +
to O +
artificially O +
enhance O +
the O +
opening O +
of O +
the O +
chromatin O +
structure O +
of O +
a O +
minimal O +
beta O -
- O -
globin O +
promoter O +
, O +
we O +
placed O +
a O +
101bp O +
, O +
erythroid O -
- O -
specific O +
DNase O +
1 O +
hypersensitive O +
site O -
- O -
forming O +
element O +
( O +
HSFE O +
) O +
immediately O +
upstream O +
of O +
the O +
beta O -
- O -
globin O +
promoter O +
and O +
gene O +
. O +

This O +
element O +
includes O +
binding O +
sites O +
for O +
NF B-Gene -
- I-Gene -
E2 I-Gene +
, O +
AP-1 B-Gene +
, O +
GATA-1 B-Gene +
and O +
Sp-1 B-Gene +
. O +

Constructs O +
were O +
stably O +
transfected O +
into O +
murine O +
erythroleukemia O +
cells O +
and O +
promoter O +
chromatin O +
structure O +
and O +
gene O +
expression O +
were O +
analyzed O +
. O +

The O +
HSFE O +
induced O +
an O +
area O +
of O +
enhanced O +
DNase B-Gene +
1 I-Gene +
hypersensitivity O +
extending O +
from O +
the O +
transcriptional O +
start O +
site O +
to O +
-300bp O +
of O +
the O +
artificial O +
promoter O +
and O +
significantly O +
increased O +
the O +
proportion O +
of O +
beta O -
- O -
globin O +
promoters O +
in O +
an O +
open O +
chromatin O +
configuration O +
. O +

This O +
remodeling O +
of O +
promoter O +
chromatin O +
structure O +
resulted O +
in O +
3-fold O +
increases O +
in O +
beta O -
- O -
globin O +
gene O +
transcription O +
and O +
induction O +
, O +
and O +
inhibited O +
long O -
- O -
term O +
beta O -
- O -
globin O +
gene O +
silencing O +
. O +

These O +
results O +
indicate O +
that O +
a O +
relatively O +
small O +
cis O -
- O -
acting O +
element O +
is O +
able O +
to O +
enhance O +
remodeling O +
of O +
promoter O +
chromatin O +
structure O +
resulting O +
in O +
increased O +
beta O -
- O -
globin O +
gene O +
expression O +
. O +

Modulation O +
of O +
CD28 B-Gene +
expression O +
: O +
distinct O +
regulatory O +
pathways O +
during O +
activation O +
and O +
replicative O +
senescence O +
. O +

The O +
costimulatory B-Gene +
molecule I-Gene +
CD28 B-Gene +
has O +
a O +
restricted O +
tissue O +
distribution O +
and O +
is O +
expressed O +
on O +
T O +
cells O +
and O +
some O +
plasmacytoma O +
cells O +
. O +

Although O +
CD28 B-Gene +
is O +
constitutively O +
expressed O +
, O +
its O +
expression O +
is O +
transiently O +
down O -
- O -
regulated O +
following O +
T O +
cell O +
activation O +
and O +
declines O +
progressively O +
with O +
in O +
vitro O +
senescence O +
. O +

In O +
vivo O +
, O +
CD8 O -
+ O +
T O +
cells O +
and O +
, O +
less O +
frequently O +
, O +
CD4 O -
+ O +
T O +
cells O +
may O +
completely O +
lose O +
CD28 B-Gene +
surface O +
expression O +
during O +
chronic O +
infections O +
and O +
with O +
aging O +
. O +

This O +
correlates O +
with O +
changes O +
of O +
nuclear O +
protein O -
- O -
binding O +
activities O +
to O +
two O +
motifs O +
, O +
site B-Gene +
alpha I-Gene +
and I-Gene +
beta I-Gene +
, O +
within O +
the O +
CD28 O +
minimal O +
promoter O +
. O +

Both O +
alpha- O +
and O +
beta O -
- O -
bound O +
complexes O +
are O +
found O +
only O +
in O +
lymphoid O +
tissues O +
, O +
in O +
CD28 O -
+ O +
T O +
cells O +
, O +
and O +
in O +
some O +
transformed O +
B O +
cells O +
. O +

These O +
complexes O +
are O +
coordinately O +
expressed O +
except O +
during O +
replicative O +
senescence O +
, O +
which O +
is O +
characterized O +
by O +
the O +
down O -
- O -
modulation O +
of O +
site B-Gene +
beta I-Gene +
-but O +
not O +
site B-Gene +
alpha I-Gene +
-binding O +
activities O +
. O +

In O +
contrast O +
, O +
T O +
cell O +
activation O +
induces O +
a O +
parallel O +
decline O +
in O +
both O +
site O +
alpha- O +
and O +
beta O -
- O -
binding O +
activities O +
. O +

CD4 O -
+ O +
and O +
CD8 O -
+ O +
T O +
cells O +
differ O +
in O +
their O +
beta O -
- O -
binding O +
profiles O +
, O +
which O +
may O +
explain O +
the O +
more O +
pronounced O +
down O -
- O -
regulation O +
of O +
CD28 B-Gene +
in O +
senescent O +
CD8 O -
+ O +
T O +
cells O +
. O +

In O +
vivo O +
expanded O +
CD4+CD28null O +
and O +
CD8+CD28null O +
T O +
cells O +
uniformly O +
lack O +
alpha- B-Gene +
and I-Gene +
beta- I-Gene +
bound I-Gene +
complexes I-Gene +
, O +
resembling O +
the O +
pattern O +
seen O +
in O +
chronically O +
activated O +
cells O +
and O +
not O +
of O +
senescent O +
cells O +
. O +

UV O -
- O -
induced O +
CYP1A1 B-Gene +
gene O +
expression O +
in O +
human O +
cells O +
is O +
mediated O +
by O +
tryptophan O +
. O +

Induction O +
of O +
cytochrome B-Gene +
P-4501A1 I-Gene +
( O +
CYP1A1 B-Gene +
) O +
activity O +
by O +
UV O +
has O +
been O +
observed O +
earlier O +
in O +
animal O +
studies O +
via O +
a O +
mechanism O +
that O +
has O +
not O +
yet O +
been O +
resolved O +
. O +

Our O +
previous O +
data O +
have O +
indicated O +
that O +
formylated O +
indolocarbazoles O +
which O +
are O +
formed O +
by O +
UV O +
irradiation O +
of O +
tryptophan O +
solutions O +
are O +
very O +
potent O +
Ah O -
- O -
receptor O +
agonists O +
. O +

To O +
evaluate O +
the O +
effect O +
of O +
UV O +
light O +
on O +
cytochrome B-Gene +
P4501A1 I-Gene +
gene O +
expression O +
, O +
we O +
studied O +
the O +
induction O +
of O +
CYP1A1 O +
mRNA O +
by O +
UV O +
irradiation O +
of O +
cultured O +
human O +
keratinocytes O +
( O +
HaCaT O +
cell O +
line O +
) O +
, O +
primary O +
human O +
blood O +
lymphocytes O +
and O +
mouse O +
Hepa-1 O +
cells O +
. O +

The O +
cells O +
were O +
exposed O +
to O +
UV O +
light O +
delivered O +
by O +
a O +
bank O +
of O +
6 O +
Philips O +
TL20 O -
/ O -
12RS O +
sun O +
lamps O +
emitting O +
primarily O +
in O +
the O +
UVB O +
range O +
in O +
the O +
absence O +
and O +
presence O +
of O +
tryptophan O +
. O +

A O +
semiquantitative O +
reverse B-Gene +
transcriptase I-Gene +
-linked O +
polymerase O +
chain O +
reaction O +
( O +
RT O -
- O -
PCR O +
) O +
was O +
used O +
for O +
analysis O +
of O +
gene O +
expression O +
in O +
the O +
treated O +
cells O +
. O +

The O +
results O +
show O +
that O +
the O +
CYP1A1 O +
mRNA O +
level O +
induced O +
by O +
UV O +
in O +
the O +
presence O +
of O +
tryptophan O +
was O +
higher O +
than O +
that O +
induced O +
by O +
UV O +
alone O +
in O +
both O +
HaCaT O +
cells O +
and O +
lymphocytes O +
after O +
3 O +
h O +
of O +
incubation O +
post O -
- O -
UV O +
irradiation O +
. O +

To O +
find O +
out O +
if O +
the O +
induction O +
by O +
UV O +
light O +
is O +
caused O +
by O +
the O +
formation O +
of O +
an O +
Ah O +
receptor O +
ligand O +
, O +
Hepa-1 O +
wild O -
- O -
type O +
and O +
Ah O +
receptor O +
deficient O +
c12 O +
cell O +
lines O +
were O +
applied O +
. O +

Wild O -
- O -
type O +
( O +
wt O +
) O +
cells O +
were O +
inducible O +
either O +
by O +
the O +
tryptophan O +
photoproduct O +
6-formylindolo O +
[ O +
3 O +
, O +
2-b O +
] O +
carbazole O +
( O +
FICZ O +
) O +
or O +
by O +
UV O -
- O -
irradiation O +
but O +
very O +
low O +
or O +
undetectable O +
levels O +
were O +
observed O +
in O +
the O +
c12 O +
cells O +
. O +

This O +
shows O +
that O +
the O +
induction O +
of O +
gene O +
expression O +
by O +
FICZ O +
and O +
UV O +
is O +
Ah B-Gene +
receptor I-Gene +
dependent O +
. O +

Together O +
, O +
these O +
results O +
indicate O +
that O +
UV O -
- O -
induced O +
CYP1A1 B-Gene +
gene O +
expression O +
in O +
mammalian O +
cells O +
is O +
mediated O +
by O +
an O +
Ah B-Gene +
receptor I-Gene +
ligand O +
formed O +
from O +
tryptophan O +
. O +

Thus O +
, O +
the O +
photoproducts O +
of O +
tryptophan O +
are O +
suggested O +
to O +
be O +
mediators O +
of O +
light O +
via O +
binding O +
to O +
the O +
Ah B-Gene +
receptor I-Gene +
and O +
as O +
such O +
also O +
could O +
have O +
a O +
role O +
in O +
light O -
- O -
regulated O +
biological O +
rhythms O +
. O +

Transcriptional O +
regulation O +
of O +
T O +
lymphocyte O +
development O +
and O +
function O +
. O +

The O +
development O +
and O +
function O +
of O +
T O +
lymphocytes O +
are O +
regulated O +
tightly O +
by O +
signal O +
transduction O +
pathways O +
that O +
include O +
specific O +
cell B-Gene -
- I-Gene -
surface I-Gene +
receptors I-Gene +
, O +
intracellular B-Gene +
signaling I-Gene +
molecules I-Gene +
, O +
and O +
nuclear B-Gene +
transcription I-Gene +
factors I-Gene +
. O +

Since O +
1988 O +
, O +
several O +
families O +
of O +
functionally O +
important O +
T B-Gene +
cell I-Gene +
transcription I-Gene +
factors I-Gene +
have O +
been O +
identified O +
. O +

These O +
include O +
the O +
Ikaros B-Gene +
, O +
LKLF B-Gene +
, O +
and O +
GATA3 B-Gene +
zinc I-Gene -
- I-Gene -
finger I-Gene +
proteins I-Gene +
; O +
the O +
Ets B-Gene +
, O +
CREB B-Gene -
/ I-Gene -
ATF I-Gene +
, O +
and O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene -
/ I-Gene -
Rel I-Gene -
/ I-Gene -
NFAT I-Gene +
transcription I-Gene +
factors I-Gene +
; O +
the O +
Stat B-Gene +
proteins I-Gene +
; O +
and O +
HMG B-Gene +
box I-Gene +
transcription I-Gene +
factors I-Gene +
such O +
as O +
LEF1 B-Gene +
, O +
TCF1 B-Gene +
, O +
and O +
Sox4 B-Gene +
. O +

In O +
this O +
review O +
, O +
we O +
summarize O +
our O +
current O +
understanding O +
of O +
the O +
transcriptional O +
regulation O +
of O +
T O +
cell O +
development O +
and O +
function O +
with O +
particular O +
emphasis O +
on O +
the O +
results O +
of O +
recent O +
gene O +
targeting O +
and O +
transgenic O +
experiments O +
. O +

In O +
addition O +
to O +
increasing O +
our O +
understanding O +
of O +
the O +
molecular O +
pathways O +
that O +
regulate O +
T O +
cell O +
development O +
and O +
function O +
, O +
these O +
results O +
have O +
suggested O +
novel O +
targets O +
for O +
genetic O +
and O +
pharmacological O +
manipulation O +
of O +
T O +
cell O +
immunity O +
. O +

20-Epi O +
analogues O +
of O +
1 O +
, O +
25-dihydroxyvitamin O +
D3 O +
are O +
highly O +
potent O +
inducers O +
of O +
DRIP B-Gene +
coactivator I-Gene +
complex I-Gene +
binding O +
to O +
the O +
vitamin B-Gene +
D3 I-Gene +
receptor I-Gene +
. O +

1 O +
, O +
25-Dihydroxyvitamin O +
D3 O +
( O +
1 O +
, O +
25 O +
( O +
OH O +
) O +
2D3 O +
) O +
plays O +
a O +
major O +
role O +
in O +
the O +
stimulation O +
of O +
bone O +
growth O +
, O +
mineralization O +
, O +
and O +
intestinal O +
calcium O +
and O +
phosphate O +
absorption O +
; O +
it O +
also O +
acts O +
as O +
a O +
general O +
inhibitor O +
of O +
cellular O +
proliferation O +
. O +

Several O +
new O +
, O +
clinically O +
relevant O +
compounds O +
dissociate O +
antiproliferative O +
and O +
calcemic O +
activities O +
of O +
1 O +
, O +
25 O +
( O +
OH O +
) O +
2D3 O +
, O +
but O +
the O +
molecular O +
basis O +
for O +
this O +
has O +
not O +
been O +
clearly O +
elucidated O +
. O +

Here O +
, O +
we O +
tested O +
whether O +
the O +
potency O +
of O +
one O +
class O +
of O +
compounds O +
, O +
20-epi O +
analogues O +
, O +
to O +
induce O +
myeloid O +
cell O +
differentiation O +
, O +
is O +
because O +
of O +
direct O +
molecular O +
effects O +
on O +
vitamin B-Gene +
D I-Gene +
receptor I-Gene +
( O +
VDR B-Gene +
) O +
. O +

We O +
report O +
that O +
two O +
20-epi O +
analogues O +
, O +
MC1627 O +
and O +
MC1288 O +
, O +
induced O +
differentiation O +
and O +
transcription O +
of O +
p21 O +
( O +
Waf1 O +
, O +
Cip1 O +
) O +
, O +
a O +
key O +
VDR O +
target O +
gene O +
involved O +
in O +
growth O +
inhibition O +
, O +
at O +
a O +
concentration O +
100-fold O +
lower O +
than O +
that O +
of O +
1 O +
, O +
25 O +
( O +
OH O +
) O +
2D3 O +
. O +

We O +
compared O +
this O +
sensitivity O +
to O +
analogue O +
effects O +
on O +
VDR B-Gene +
interacting O +
proteins O +
: O +
RXR B-Gene +
, O +
GRIP-1 B-Gene +
, O +
and O +
DRIP205 B-Gene +
, O +
a O +
subunit O +
of O +
the O +
DRIP B-Gene +
coactivator I-Gene +
complex I-Gene +
. O +

Compared O +
with O +
the O +
interaction O +
of O +
VDR B-Gene +
with O +
RXR B-Gene +
or O +
GRIP-1 B-Gene +
, O +
the O +
differentiation O +
dose O -
- O -
response O +
most O +
closely O +
correlated O +
to O +
the O +
ligand O -
- O -
dependent O +
recruitment O +
of O +
the O +
DRIP B-Gene +
coactivator I-Gene +
complex I-Gene +
to O +
VDR B-Gene +
and O +
to O +
the O +
ability O +
of O +
the O +
receptor O +
to O +
activate O +
transcription O +
in O +
a O +
cell O -
- O -
free O +
system O +
. O +

These O +
results O +
provide O +
compelling O +
links O +
between O +
the O +
efficiency O +
of O +
the O +
20-epi O +
analogue O +
in O +
inducing O +
VDR B-Gene +
/DRIP O +
interactions O +
, O +
transactivation O +
in O +
vitro O +
, O +
and O +
its O +
enhanced O +
ability O +
to O +
induce O +
cellular O +
differentiation O +
. O +

A O +
polymorphism O +
that O +
affects O +
OCT-1 B-Gene +
binding O +
to O +
the O +
TNF O +
promoter O +
region O +
is O +
associated O +
with O +
severe O +
malaria O +
[ O +
see O +
comments O +
] O +

Genetic O +
variation O +
in O +
cytokine O +
promoter O +
regions O +
is O +
postulated O +
to O +
influence O +
susceptibility O +
to O +
infection O +
, O +
but O +
the O +
molecular O +
mechanisms O +
by O +
which O +
such O +
polymorphisms O +
might O +
affect O +
gene O +
regulation O +
are O +
unknown O +
. O +

Through O +
systematic O +
DNA O +
footprinting O +
of O +
the O +
TNF O +
( O +
encoding O +
tumour O +
necrosis O +
factor O +
, O +
TNF O +
) O +
promoter O +
region O +
, O +
we O +
have O +
identified O +
a O +
single O +
nucleotide O +
polymorphism O +
( O +
SNP O +
) O +
that O +
causes O +
the O +
helix O -
- O -
turn O -
- O -
helix O +
transcription B-Gene +
factor I-Gene +
OCT-1 O +
to O +
bind O +
to O +
a O +
novel O +
region O +
of O +
complex O +
protein O -
- O -
DNA O +
interactions O +
and O +
alters O +
gene O +
expression O +
in O +
human O +
monocytes O +
. O +

The O +
OCT-1-binding O +
genotype O +
, O +
found O +
in O +
approximately O +
5 O +
% O +
of O +
Africans O +
, O +
is O +
associated O +
with O +
fourfold O +
increased O +
susceptibility O +
to O +
cerebral O +
malaria O +
in O +
large O +
case O -
- O -
control O +
studies O +
of O +
West O +
African O +
and O +
East O +
African O +
populations O +
, O +
after O +
correction O +
for O +
other O +
known O +
TNF O +
polymorphisms O +
and O +
linked O +
HLA O +
alleles O +
. O +

Novel O +
therapies O +
for O +
inflammatory O +
bowel O +
disease O +
. O +

Looking O +
back O +
at O +
successes O +
and O +
failures O +
in O +
newer O +
approaches O +
to O +
treating O +
IBD O +
, O +
it O +
is O +
tempting O +
-- O +
although O +
still O +
difficult O +
-- O +
to O +
draw O +
conclusions O +
about O +
pathogenesis O +
. O +

When O +
a O +
therapy O +
proves O +
effective O +
, O +
do O +
clinicians O +
truly O +
know O +
how O +
it O +
works O +
? O +
Even O +
with O +
a O +
therapy O +
as O +
specific O +
as O +
anti B-Gene -
- I-Gene -
TNF I-Gene +
antibody I-Gene +
, O +
it O +
is O +
not O +
clear O +
if O +
the O +
benefit O +
is O +
attributable O +
to O +
simple O +
binding O +
and O +
clearance O +
of O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
or O +
to O +
binding O +
on O +
the O +
cell O +
surface O +
and O +
subsequent O +
deletion O +
of O +
the O +
activated O +
macrophage O +
. O +

When O +
a O +
drug O +
appears O +
to O +
be O +
less O +
effective O +
than O +
preclinical O +
models O +
suggest O +
, O +
can O +
failures O +
in O +
effectiveness O +
from O +
delivery O +
or O +
dosing O +
be O +
differentiated O +
? O +
The O +
disappointing O +
results O +
of O +
clinical O +
trials O +
with O +
IL-10 B-Gene +
-- O +
so O +
at O +
odds O +
with O +
the O +
prediction O +
of O +
benefit O +
from O +
animal O +
models O +
-- O +
bring O +
into O +
question O +
the O +
validity O +
of O +
those O +
models O +
as O +
well O +
as O +
the O +
soundness O +
of O +
design O +
of O +
the O +
clinical O +
trials O +
on O +
which O +
efficacy O +
of O +
IL-10 B-Gene +
is O +
judged O +
. O +

The O +
variability O +
of O +
response O +
even O +
to O +
the O +
most O +
narrowly O +
targeted O +
agents O +
suggests O +
that O +
these O +
diseases O +
are O +
far O +
more O +
heterogeneous O +
in O +
humans O +
than O +
in O +
their O +
murine O +
counterparts O +
. O +

Clinicians O +
are O +
only O +
just O +
beginning O +
to O +
recognize O +
subclinical O +
markers O +
of O +
response O +
, O +
and O +
it O +
may O +
soon O +
be O +
possible O +
to O +
predict O +
response O +
on O +
the O +
basis O +
of O +
genetic O +
composition O +
. O +

For O +
the O +
moment O +
, O +
however O +
, O +
the O +
field O +
of O +
pharmacogenetics O +
is O +
embryonic O +
. O +

Challenges O +
in O +
developing O +
new O +
therapeutic O +
strategies O +
include O +
not O +
only O +
identifying O +
novel O +
agents O +
, O +
but O +
also O +
improving O +
the O +
definitions O +
of O +
clinical O +
endpoints O +
and O +
defining O +
efficacy O +
at O +
the O +
biologic O +
level O +
. O +

Only O +
through O +
considered O +
evaluation O +
of O +
clinical O +
evidence O +
may O +
clinicians O +
determine O +
which O +
therapies O +
should O +
remain O +
novelties O +
and O +
which O +
should O +
become O +
an O +
accepted O +
part O +
of O +
the O +
armamentarium O +
. O +

The O +
intracellular O +
parasite O +
Theileria O +
parva O +
protects O +
infected O +
T O +
cells O +
from O +
apoptosis O +
. O +

Parasites O +
have O +
evolved O +
a O +
plethora O +
of O +
strategies O +
to O +
ensure O +
their O +
survival O +
. O +

The O +
intracellular O +
parasite O +
Theileria O +
parva O +
secures O +
its O +
propagation O +
and O +
spreads O +
through O +
the O +
infected O +
animal O +
by O +
infecting O +
and O +
transforming O +
T O +
cells O +
, O +
inducing O +
their O +
continuous O +
proliferation O +
and O +
rendering O +
them O +
metastatic O +
. O +

In O +
previous O +
work O +
, O +
we O +
have O +
shown O +
that O +
the O +
parasite O +
induces O +
constitutive O +
activation O +
of O +
the O +
transcription B-Gene +
factor I-Gene +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
, O +
by O +
inducing O +
the O +
constitutive O +
degradation O +
of O +
its O +
cytoplasmic B-Gene +
inhibitors I-Gene +
. O +

The O +
biological O +
significance O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
activation O +
in O +
T. O +
parva O -
- O -
infected O +
cells O +
, O +
however O +
, O +
has O +
not O +
yet O +
been O +
defined O +
. O +

Cells O +
that O +
have O +
been O +
transformed O +
by O +
viruses O +
or O +
oncogenes O +
can O +
persist O +
only O +
if O +
they O +
manage O +
to O +
avoid O +
destruction O +
by O +
the O +
apoptotic O +
mechanisms O +
that O +
are O +
activated O +
on O +
transformation O +
and O +
that O +
contribute O +
to O +
maintain O +
cellular O +
homeostasis O +
. O +

We O +
now O +
demonstrate O +
that O +
parasite O -
- O -
induced O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
activation O +
plays O +
a O +
crucial O +
role O +
in O +
the O +
survival O +
of O +
T. O +
parva O -
- O -
transformed O +
T O +
cells O +
by O +
conveying O +
protection O +
against O +
an O +
apoptotic O +
signal O +
that O +
accompanies O +
parasite O -
- O -
mediated O +
transformation O +
. O +

Consequently O +
, O +
inhibition O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
nuclear O +
translocation O +
and O +
the O +
expression O +
of O +
dominant B-Gene +
negative I-Gene +
mutant I-Gene +
forms O +
of O +
components O +
of O +
the O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
activation O +
pathway O +
, O +
such O +
as O +
IkappaBalpha B-Gene +
or O +
p65 B-Gene +
, O +
prompt O +
rapid O +
apoptosis O +
of O +
T. O +
parva O -
- O -
transformed O +
T O +
cells O +
. O +

Our O +
findings O +
offer O +
important O +
insights O +
into O +
parasite O +
survival O +
strategies O +
and O +
demonstrate O +
that O +
parasite O -
- O -
induced O +
constitutive O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
activation O +
is O +
an O +
essential O +
step O +
in O +
maintaining O +
the O +
transformed O +
phenotype O +
of O +
the O +
infected O +
cells O +
. O +

Signaling O +
events O +
induced O +
by O +
lipopolysaccharide B-Gene -
- I-Gene -
activated I-Gene +
toll I-Gene -
- I-Gene -
like I-Gene +
receptor I-Gene +
2 I-Gene +
. O +

Human B-Gene +
Toll I-Gene -
- I-Gene -
like I-Gene +
receptor I-Gene +
2 I-Gene +
( I-Gene +
TLR2 I-Gene +
) I-Gene +
is O +
a O +
signaling B-Gene +
receptor I-Gene +
that O +
responds O +
to O +
LPS O +
and O +
activates O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
. O +

Here O +
, O +
we O +
investigate O +
further O +
the O +
events O +
triggered O +
by O +
TLR2 B-Gene +
in O +
response O +
to O +
LPS O +
. O +

We O +
show O +
that O +
TLR2 B-Gene +
associates O +
with O +
the O +
high B-Gene -
- I-Gene -
affinity I-Gene +
LPS I-Gene +
binding I-Gene +
protein I-Gene +
membrane O +
CD14 B-Gene +
to O +
serve O +
as O +
an O +
LPS B-Gene +
receptor I-Gene +
complex I-Gene +
, O +
and O +
that O +
LPS O +
treatment O +
enhances O +
the O +
oligomerization O +
of O +
TLR2 B-Gene +
. O +

Concomitant O +
with O +
receptor O +
oligomerization O +
, O +
the O +
IL-1R B-Gene -
- I-Gene -
associated I-Gene +
kinase I-Gene +
( I-Gene +
IRAK I-Gene +
) I-Gene +
is O +
recruited O +
to O +
the O +
TLR2 B-Gene +
complex O +
. O +

Intracellular O +
deletion O +
variants O +
of O +
TLR2 B-Gene +
lacking O +
C O -
- O -
terminal O +
13 O +
or O +
141 O +
aa O +
fail O +
to O +
recruit O +
IRAK B-Gene +
, O +
which O +
is O +
consistent O +
with O +
the O +
inability O +
of O +
these O +
mutants O +
to O +
transmit O +
LPS O +
cellular O +
signaling O +
. O +

Moreover O +
, O +
both O +
deletion O +
mutants O +
could O +
still O +
form O +
complexes O +
with O +
wild B-Gene -
- I-Gene -
type I-Gene +
TLR2 I-Gene +
and O +
act O +
in O +
a O +
dominant O -
- O -
negative O +
( O +
DN O +
) O +
fashion O +
to O +
block O +
TLR2 B-Gene +
-mediated O +
signal O +
transduction O +
. O +

DN O +
constructs O +
of O +
myeloid B-Gene +
differentiation I-Gene +
protein I-Gene +
, O +
IRAK B-Gene +
, O +
TNF B-Gene +
receptor I-Gene -
- I-Gene -
associated I-Gene +
factor I-Gene +
6 I-Gene +
, O +
and O +
NF B-Gene -
- I-Gene -
kappaB I-Gene -
- I-Gene -
inducing I-Gene +
kinase I-Gene +
, O +
when O +
coexpressed O +
with O +
TLR2 B-Gene +
, O +
abrogate O +
TLR2 B-Gene +
-mediated O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
activation O +
. O +

These O +
results O +
reveal O +
a O +
conserved O +
signaling O +
pathway O +
for O +
TLR2 B-Gene +
and O +
IL-1Rs B-Gene +
and O +
suggest O +
a O +
molecular O +
mechanism O +
for O +
the O +
inhibition O +
of O +
TLR2 B-Gene +
by O +
DN O +
variants O +
. O +

Escape O +
of O +
human O +
cytomegalovirus O +
from O +
HLA B-Gene -
- I-Gene -
DR I-Gene +
-restricted O +
CD4 O +
( O +
+ O +
) O +
T O -
- O -
cell O +
response O +
is O +
mediated O +
by O +
repression O +
of O +
gamma B-Gene +
interferon I-Gene +
-induced O +
class B-Gene +
II I-Gene +
transactivator I-Gene +
expression O +
. O +

Human O +
cytomegalovirus O +
( O +
HCMV O +
) O +
, O +
a O +
betaherpesvirus O +
, O +
is O +
a O +
pathogen O +
which O +
escapes O +
immune O +
recognition O +
through O +
various O +
mechanisms O +
. O +

In O +
this O +
paper O +
, O +
we O +
show O +
that O +
HCMV O +
down O +
regulates O +
gamma O +
interferon O +
( O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
) O +
-induced O +
HLA B-Gene -
- I-Gene -
DR I-Gene +
expression O +
in O +
U373 O +
MG O +
astrocytoma O +
cells O +
due O +
to O +
a O +
defect O +
downstream O +
of O +
STAT1 B-Gene +
phosphorylation O +
and O +
nuclear O +
translocation O +
. O +

Repression O +
of O +
class O +
II O +
transactivator O +
( O +
CIITA O +
) O +
mRNA O +
expression O +
is O +
detected O +
within O +
the O +
first O +
hours O +
of O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
-HCMV O +
coincubation O +
and O +
results O +
in O +
the O +
absence O +
of O +
HLA B-Gene -
- I-Gene -
DR I-Gene +
synthesis O +
. O +

This O +
defect O +
leads O +
to O +
the O +
absence O +
of O +
presentation O +
of O +
the O +
major B-Gene +
immediate I-Gene -
- I-Gene -
early I-Gene +
protein I-Gene +
IE1 B-Gene +
to O +
specific O +
CD4 O +
( O +
+ O +
) O +
T O -
- O -
cell O +
clones O +
when O +
U373 O +
MG O +
cells O +
, O +
used O +
as O +
antigen O -
- O -
presenting O +
cells O +
, O +
are O +
treated O +
with O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
plus O +
HCMV O +
. O +

However O +
, O +
presentation O +
of O +
endogenously O +
synthesized O +
IE1 B-Gene +
can O +
be O +
restored O +
when O +
U373 O +
MG O +
cells O +
are O +
transfected O +
with O +
CIITA O +
prior O +
to O +
infection O +
with O +
HCMV O +
. O +

Altogether O +
, O +
the O +
data O +
indicate O +
that O +
the O +
defect O +
induced O +
by O +
HCMV O +
resides O +
in O +
the O +
activation O +
of O +
the O +
IFN O -
- O -
gamma O -
- O -
responsive O +
promoter O +
of O +
CIITA O +
. O +

This O +
is O +
the O +
first O +
demonstration O +
of O +
a O +
viral O +
inhibition O +
of O +
CIITA O +
expression O +
. O +

Bcl-2 B-Gene +
-mediated O +
drug O +
resistance O +
: O +
inhibition O +
of O +
apoptosis O +
by O +
blocking O +
nuclear B-Gene +
factor I-Gene +
of I-Gene +
activated I-Gene +
T I-Gene +
lymphocytes I-Gene +
( O +
NFAT B-Gene +
) O +
-induced O +
Fas B-Gene +
ligand O +
transcription O +
. O +

Bcl-2 B-Gene +
inhibits O +
apoptosis O +
induced O +
by O +
a O +
variety O +
of O +
stimuli O +
, O +
including O +
chemotherapy O +
drugs O +
and O +
glucocorticoids O +
. O +

It O +
is O +
generally O +
accepted O +
that O +
Bcl-2 B-Gene +
exerts O +
its O +
antiapoptotic O +
effects O +
mainly O +
by O +
dimerizing O +
with O +
proapoptotic O +
members O +
of O +
the O +
Bcl-2 B-Gene +
family I-Gene +
such O +
as O +
Bax B-Gene +
and O +
Bad B-Gene +
. O +

However O +
, O +
the O +
mechanism O +
of O +
the O +
antiapoptotic O +
effects O +
is O +
unclear O +
. O +

Paclitaxel O +
and O +
other O +
drugs O +
that O +
disturb O +
microtubule B-Gene +
dynamics O +
kill O +
cells O +
in O +
a O +
Fas B-Gene +
/Fas B-Gene +
ligand I-Gene +
( O +
FasL B-Gene +
) O +
-dependent O +
manner O +
; O +
antibody O +
to O +
FasL B-Gene +
inhibits O +
paclitaxel O -
- O -
induced O +
apoptosis O +
. O +

We O +
have O +
found O +
that O +
Bcl-2 B-Gene +
overexpression O +
leads O +
to O +
the O +
prevention O +
of O +
chemotherapy O +
( O +
paclitaxel O +
) O +
-induced O +
expression O +
of O +
FasL B-Gene +
and O +
blocks O +
paclitaxel O -
- O -
induced O +
apoptosis O +
. O +

The O +
mechanism O +
of O +
this O +
effect O +
is O +
that O +
Bcl-2 B-Gene +
prevents O +
the O +
nuclear O +
translocation O +
of O +
NFAT B-Gene +
( O +
nuclear B-Gene +
factor I-Gene +
of I-Gene +
activated I-Gene +
T I-Gene +
lymphocytes I-Gene +
, O +
a O +
transcription B-Gene +
factor I-Gene +
activated O +
by O +
microtubule B-Gene +
damage O +
) O +
by O +
binding O +
and O +
sequestering O +
calcineurin O +
, O +
a O +
calcium O -
- O -
dependent O +
phosphatase O +
that O +
must O +
dephosphorylate O +
NFAT B-Gene +
to O +
move O +
to O +
the O +
nucleus O +
. O +

Without O +
NFAT B-Gene +
nuclear O +
translocation O +
, O +
the O +
FasL B-Gene +
gene O +
is O +
not O +
transcribed O +
. O +

Thus O +
, O +
it O +
appears O +
that O +
paclitaxel O +
and O +
other O +
drugs O +
that O +
disturb O +
microtubule B-Gene +
function O +
kill O +
cells O +
at O +
least O +
in O +
part O +
through O +
the O +
induction O +
of O +
FasL B-Gene +
. O +

Furthermore O +
, O +
Bcl-2 B-Gene +
antagonizes O +
drug O -
- O -
induced O +
apoptosis O +
by O +
inhibiting O +
calcineurin B-Gene +
activation O +
, O +
blocking O +
NFAT B-Gene +
nuclear O +
translocation O +
, O +
and O +
preventing O +
FasL B-Gene +
expression O +
. O +

The O +
effects O +
of O +
Bcl-2 B-Gene +
can O +
be O +
overcome O +
, O +
at O +
least O +
partially O +
, O +
through O +
phosphorylation O +
of O +
Bcl-2 B-Gene +
. O +

Phosphorylated O +
Bcl-2 B-Gene +
can O +
not O +
bind O +
calcineurin B-Gene +
, O +
and O +
NFAT B-Gene +
activation O +
, O +
FasL B-Gene +
expression O +
, O +
and O +
apoptosis O +
can O +
occur O +
after O +
Bcl-2 B-Gene +
phosphorylation O +
. O +

TCL1 O +
oncogene O +
expression O +
in O +
AIDS O -
- O -
related O +
lymphomas O +
and O +
lymphoid O +
tissues O +
. O +

AIDS O -
- O -
related O +
non O -
- O -
Hodgkin O +
's O +
lymphoma O +
( O +
AIDS O +
NHL O +
) O +
comprises O +
a O +
diverse O +
and O +
heterogeneous O +
group O +
of O +
high O -
- O -
grade O +
B O +
cell O +
tumors O +
. O +

Certain O +
classes O +
of O +
AIDS O +
NHL O +
are O +
associated O +
with O +
alterations O +
in O +
oncogenes O +
or O +
tumor O -
- O -
suppressor O +
genes O +
or O +
infections O +
by O +
oncogenic O +
herpesviruses O +
. O +

However O +
, O +
the O +
clinically O +
significant O +
class O +
of O +
AIDS O +
NHL O +
designated O +
immunoblastic O +
lymphoma O +
plasmacytoid O +
( O +
AIDS O +
IBLP O +
) O +
lacks O +
any O +
consistent O +
genetic O +
alterations O +
. O +

We O +
identified O +
the O +
TCL1 O +
oncogene O +
from O +
a O +
set O +
of O +
AIDS O +
IBLP O -
- O -
associated O +
cDNA O +
fragments O +
generated O +
by O +
subtractive O +
hybridization O +
with O +
non O -
- O -
AIDS O +
IBLP O +
. O +

Aberrant O +
TCL1 B-Gene +
expression O +
has O +
been O +
implicated O +
in O +
T O +
cell O +
leukemia O -
/ O -
lymphoma O +
development O +
, O +
and O +
its O +
expression O +
also O +
has O +
been O +
seen O +
in O +
many O +
established O +
B O +
cell O +
tumor O +
lines O +
. O +

However O +
, O +
TCL1 B-Gene +
expression O +
has O +
not O +
been O +
reported O +
in O +
AIDS O +
NHL O +
. O +

We O +
find O +
that O +
TCL1 B-Gene +
is O +
expressed O +
in O +
the O +
majority O +
of O +
AIDS O +
IBLP O +
tumors O +
examined O +
. O +

TCL1 B-Gene +
protein O +
expression O +
is O +
restricted O +
to O +
tumor O +
cells O +
in O +
AIDS O +
IBLP O +
tissue O +
samples O +
analyzed O +
with O +
immunohistochemical O +
staining O +
. O +

Hyperplastic O +
lymph O +
node O +
and O +
tonsil O +
also O +
exhibit O +
strong O +
TCL1 B-Gene +
protein O +
expression O +
in O +
mantle O +
zone O +
B O +
cells O +
and O +
in O +
rare O +
interfollicular O +
zone O +
cells O +
, O +
whereas O +
follicle O -
- O -
center O +
B O +
cells O +
( O +
centroblasts O +
and O +
centrocytes O +
) O +
show O +
weaker O +
expression O +
. O +

These O +
results O +
establish O +
TCL1 B-Gene +
as O +
the O +
most O +
prevalent O +
of O +
all O +
of O +
the O +
surveyed O +
oncogenes O +
associated O +
with O +
AIDS O +
IBLP O +
. O +

They O +
also O +
indicate O +
that O +
abundant O +
TCL1 B-Gene +
expression O +
in O +
quiescent O +
mantle O +
zone O +
B O +
cells O +
is O +
down O -
- O -
regulated O +
in O +
activated O +
germinal O +
center O +
follicular O +
B O +
cells O +
in O +
parallel O +
to O +
the O +
known O +
expression O +
pattern O +
of O +
BCL-2 B-Gene +
. O +

High O -
- O -
level O +
expression O +
in O +
nonproliferating O +
B O +
cells O +
suggests O +
that O +
TCL1 B-Gene +
may O +
function O +
in O +
protecting O +
naive O +
preactivated O +
B O +
cells O +
from O +
apoptosis O +
. O +

Induction O +
of O +
Bcl B-Gene -
- I-Gene -
x I-Gene +
( I-Gene +
L I-Gene +
) I-Gene +
expression O +
by O +
human B-Gene +
T I-Gene -
- I-Gene -
cell I-Gene +
leukemia I-Gene +
virus I-Gene +
type I-Gene +
1 I-Gene +
Tax I-Gene +
through O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
in O +
apoptosis O -
- O -
resistant O +
T O -
- O -
cell O +
transfectants O +
with O +
Tax B-Gene +
. O +

Human O +
T O -
- O -
cell O +
leukemia O +
virus O +
type O +
1 O +
( O +
HTLV-1 O +
) O +
Tax B-Gene +
is O +
thought O +
to O +
play O +
a O +
pivotal O +
role O +
in O +
immortalization O +
of O +
T O +
cells O +
. O +

We O +
have O +
recently O +
shown O +
that O +
the O +
expression O +
of O +
Tax B-Gene +
protected O +
the O +
mouse O +
T O -
- O -
cell O +
line O +
CTLL-2 O +
against O +
apoptosis O +
induced O +
by O +
interleukin-2 B-Gene +
( O +
IL-2 B-Gene +
) O +
deprivation O +
and O +
converted O +
its O +
growth O +
from O +
being O +
IL-2 B-Gene +
dependent O +
to O +
being O +
IL-2 B-Gene +
independent O +
. O +

In O +
this O +
study O +
, O +
we O +
demonstrate O +
that O +
constitutive O +
expression O +
of O +
bcl B-Gene -
- I-Gene -
xl I-Gene +
but O +
not O +
bcl-2 B-Gene +
, O +
bcl B-Gene -
- I-Gene -
xs I-Gene +
, O +
bak B-Gene +
, O +
bad B-Gene +
, O +
or O +
bax B-Gene +
was O +
associated O +
with O +
apoptosis O +
resistance O +
after O +
IL-2 B-Gene +
deprivation O +
in O +
CTLL-2 O +
cells O +
that O +
expressed O +
Tax B-Gene +
. O +

Transient O -
- O -
transfection O +
assays O +
showed O +
that O +
bcl O -
- O -
x O +
promoter O +
was O +
transactivated O +
by O +
wild B-Gene -
- I-Gene -
type I-Gene +
Tax I-Gene +
. O +

Similar O +
effects O +
were O +
observed O +
in O +
mutant O +
Tax B-Gene +
retaining O +
transactivating O +
ability O +
through O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
. O +

Deletion O +
or O +
substitution O +
of O +
a O +
putative B-Gene +
NF I-Gene -
- I-Gene -
kappaB I-Gene +
binding I-Gene +
site I-Gene +
identified O +
in O +
the O +
bcl O -
- O -
x O +
promoter O +
significantly O +
decreased O +
Tax B-Gene +
-induced O +
transactivation O +
. O +

This O +
NF O -
- O -
kappaB O -
- O -
like O +
element O +
was O +
able O +
to O +
form O +
a O +
complex O +
with O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
family I-Gene +
proteins I-Gene +
in O +
vitro O +
. O +

Furthermore O +
, O +
Tax B-Gene +
-induced O +
transactivation O +
of O +
the O +
bcl O -
- O -
x O +
promoter O +
was O +
also O +
diminished O +
by O +
the O +
mutant B-Gene +
IkappaBalpha I-Gene +
, O +
which O +
specifically O +
inhibits O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
activity O +
. O +

Our O +
findings O +
suggest O +
that O +
constitutive O +
expression O +
of O +
Bcl B-Gene -
- I-Gene -
x I-Gene +
( I-Gene +
L I-Gene +
) I-Gene +
induced O +
by O +
Tax B-Gene +
through O +
the O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
pathway O +
contributes O +
to O +
the O +
inhibition O +
of O +
apoptosis O +
in O +
CTLL-2 O +
cells O +
after O +
IL-2 B-Gene +
deprivation O +
. O +

Renal O +
cell O +
carcinoma O -
- O -
derived O +
gangliosides O +
suppress O +
nuclear B-Gene +
factor I-Gene -
- I-Gene -
kappaB I-Gene +
activation O +
in O +
T O +
cells O +
. O +

Activation O +
of O +
the O +
transcription B-Gene +
factor I-Gene +
nuclear I-Gene +
factor I-Gene -
- I-Gene -
kappaB I-Gene +
( O +
NFkappaB B-Gene +
) O +
is O +
impaired O +
in O +
T O +
cells O +
from O +
patients O +
with O +
renal O +
cell O +
carcinomas O +
( O +
RCCs O +
) O +
. O +

In O +
circulating O +
T O +
cells O +
from O +
a O +
subset O +
of O +
patients O +
with O +
RCCs O +
, O +
the O +
suppression O +
of O +
NFkappaB B-Gene +
binding O +
activity O +
is O +
downstream O +
from O +
the O +
stimulus O -
- O -
induced O +
degradation O +
of O +
the O +
cytoplasmic B-Gene +
factor I-Gene +
IkappaBalpha B-Gene +
. O +

Tumor B-Gene -
- I-Gene -
derived I-Gene +
soluble I-Gene +
products I-Gene +
from O +
cultured O +
RCC O +
explants O +
inhibit O +
NFkappaB B-Gene +
activity O +
in O +
T O +
cells O +
from O +
healthy O +
volunteers O +
, O +
despite O +
a O +
normal O +
level O +
of O +
stimulus O -
- O -
induced O +
IkappaBalpha B-Gene +
degradation O +
in O +
these O +
cells O +
. O +

The O +
inhibitory O +
agent O +
has O +
several O +
features O +
characteristic O +
of O +
a O +
ganglioside O +
, O +
including O +
sensitivity O +
to O +
neuraminidase B-Gene +
but O +
not O +
protease B-Gene +
treatment O +
; O +
hydrophobicity O +
; O +
and O +
molecular O +
weight O +
less O +
than O +
3 O +
kDa O +
. O +

Indeed O +
, O +
we O +
detected O +
gangliosides O +
in O +
supernatants O +
from O +
RCC O +
explants O +
and O +
not O +
from O +
adjacent O +
normal O +
kidney O +
tissue O +
. O +

Gangliosides O +
prepared O +
from O +
RCC O +
supernatants O +
, O +
as O +
well O +
as O +
the O +
purified O +
bovine O +
gangliosides O +
G O +
( O +
m1 O +
) O +
and O +
G O +
( O +
d1a O +
) O +
, O +
suppressed O +
NFkappaB B-Gene +
binding O +
activity O +
in O +
T O +
cells O +
and O +
reduced O +
expression O +
of O +
the O +
cytokines B-Gene +
IL-2 B-Gene +
and O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
. O +

Taken O +
together O +
, O +
our O +
findings O +
suggest O +
that O +
tumor O -
- O -
derived O +
gangliosides O +
may O +
blunt O +
antitumor O +
immune O +
responses O +
in O +
patients O +
with O +
RCCs O +
. O +

